FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU dos Anjos, RS
   Walfrido, GND
   Valente, ROD
   Gueiros, LA
   Carvalho, AAT
   Patel, P
   Porter, S
   Leao, JC
   Silva, IHM
AF dos Anjos, Raissa Soares
   de Padua Walfrido, Giovana Nobrega
   de Hollanda Valente, Romulo Oliveira
   Gueiros, Luiz Alcino
   Carvalho, Alessandra Albuquerque Tavares
   Patel, Preeyan
   Porter, Stephen
   Leao, Jair Carneiro
   Silva, Igor Henrique Morais
TI Pentoxifylline, tocopherol, and sequestrectomy are effective for the
   management of advanced osteoradionecrosis of the jaws-a case series
SO SUPPORTIVE CARE IN CANCER
LA English
DT Article; Early Access
DE Osteoradionecrosis; Radiotherapy; Pentoxifylline; Tocopherol
AB Background The aim of the present study was to evaluate the efficacy of pentoxifylline and tocopherol for the management of osteoradionecrosis of the jaws. Methods Twenty-five patients diagnosed with osteoradionecrosis of the jaws treated with pentoxifylline 400 mg + tocopherol 400 mg three times daily (tid) were evaluated. Clinical records and image tests were reviewed. All patients were previously submitted to head and neck radiation therapy and presented with a clinical and radiographic diagnosis of osteoradionecrosis of the jaws. Results Following therapy with pentoxifylline and tocopherol, 76% (19/25) of the patients showed complete mucosal healing, in which 47.3% (9/19) did not undergo sequestrectomy. From this particular group, 77.7% (7/9) were in stage I and 33.3% (3/9) used the protocol for up to 3 months. Among those who underwent to sequestrectomy, complete mucosal healing was observed in 52.7% (10/19). Among these, 60% (6/10) were in stage I and 100% of the patients were using the protocol for more than 3 months. In all other patients, partial healing of the mucosa was observed since they presented advanced disease. These represented 24% of the sample (6/25), 66.6% (4/6) were in stage III, and 60% (4/6) used the protocol for over 6 months. Conclusion Pentoxifylline and tocopherol may provide effective management of osteoradionecrosis of the jaws, and the association with sequestrectomy may avoid major surgical procedures.
C1 [dos Anjos, Raissa Soares; de Padua Walfrido, Giovana Nobrega; de Hollanda Valente, Romulo Oliveira; Silva, Igor Henrique Morais] Hosp Canc Pernambuco HCP PE, Dept Oral Oncol, Recife, PE, Brazil.
   [Gueiros, Luiz Alcino; Carvalho, Alessandra Albuquerque Tavares; Leao, Jair Carneiro] Fed Univ Pernambuco UFPE, Dept Clin & Prevent Dent, Recife, PE, Brazil.
   [Patel, Preeyan] UCL Eastman Dent Inst, Prosthodont, London, England.
   [Porter, Stephen] UCL Eastman Dent Inst, Oral Med, London, England.
   [Silva, Igor Henrique Morais] Hosp Canc Pernambuco, Dept Odontol Clin, Ave Cruz Cabuga 1597, BR-50040000 Recife, PE, Brazil.
RP Silva, IHM (corresponding author), Hosp Canc Pernambuco HCP PE, Dept Oral Oncol, Recife, PE, Brazil.; Silva, IHM (corresponding author), Hosp Canc Pernambuco, Dept Odontol Clin, Ave Cruz Cabuga 1597, BR-50040000 Recife, PE, Brazil.
EM igorrecife@hotmail.com
OI Porter, Stephen/0000-0002-3328-2759
CR Aldunate B, 2010, REV BRAS CIR PLAST, V25, P381
   Chronopoulos A, 2015, THESIS
   Chronopoulos A, 2018, INT DENT J, V68, P22, DOI 10.1111/idj.12318
   Delanian S, 2005, HEAD NECK-J SCI SPEC, V27, P114, DOI 10.1002/hed.20121
   Delanian S, 2000, RADIOTHER ONCOL, V56, P129, DOI [10.1016/S0167-8140(00)00197-3, DOI 10.1016/S0167-8140(00)00197-3]
   Gude RP, 2001, J CANCER RES CLIN, V127, P625, DOI 10.1007/s004320100262
   Hamama S, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S13
   Instituto Nacional De Cancer Jose Alencar Gomes Da Silva (INCA)-CoordenacAo de PrevencAo e Vigilancia, 2018, EST 2018 INC CANC BR
   Instituto Nacional De Cancer Jose Alencar Gomes Da Silva (INCA)-CoordenacAo de PrevencAo e Vigilancia, COORD PREV VIG EST 2
   Kolokythas A, 2019, INT J ORAL MAX SURG, V48, P173, DOI 10.1016/j.ijom.2018.08.007
   Koyfman SA, 2019, GEN PRINCIPLES RAD T
   Lang T, 2009, ANESTH ANALG, V108, P751, DOI 10.1213/ane.0b013e3181966675
   Li YX, 1998, RADIAT RES, V149, P338, DOI 10.2307/3579695
   Lyons AJ, 2017, BRIT J ORAL MAX SURG, V55, P230, DOI 10.1016/j.bjoms.2016.12.006
   Lyons A, 2008, BRIT J ORAL MAX SURG, V46, P653, DOI 10.1016/j.bjoms.2008.04.006
   MARX RE, 1987, ORAL SURG ORAL MED O, V64, P379, DOI 10.1016/0030-4220(87)90136-8
   Moura JFB, 2015, TUMORES CABECA PESCO, P505
   Nabil S, 2011, INT J ORAL MAX SURG, V40, P229, DOI 10.1016/j.ijom.2010.10.005
   Notani K, 2003, HEAD NECK-J SCI SPEC, V25, P181, DOI 10.1002/hed.10171
   Patel V, 2017, BRIT J ORAL MAX SURG, V55, P235, DOI 10.1016/j.bjoms.2016.11.323
   Patel V, 2016, BRIT J ORAL MAX SURG, V54, P342, DOI 10.1016/j.bjoms.2015.11.027
   Pitak-Arnnop P, 2008, EJSO-EUR J SURG ONC, V34, P1123, DOI 10.1016/j.ejso.2008.03.014
   Ramli Roszalina, 2006, Singapore Dent J, V28, P11
   Raoul G, 2005, EMC STOMATOLOGIE, V1, P255
   Ribeiro Isabella Lima Arrais, 2015, Rev. bras. epidemiol., V18, P618, DOI 10.1590/1980-5497201500030008
   Rice N, 2015, SURG-J R COLL SURG E, V13, P101, DOI 10.1016/j.surge.2014.07.003
   Santos RCS, 2011, REV ESC ENFERM USP, V45, P1336
   Shin DM, 2013, HEAD NECK-J SCI SPEC, V35, P443, DOI 10.1002/hed.21910
   Sultan A, 2017, ONCOLOGIST, V22, P343, DOI 10.1634/theoncologist.2016-0298
   Teng Marita S, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P217, DOI 10.1097/01.moo.0000170527.59017.ff
NR 30
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0941-4355
EI 1433-7339
J9 SUPPORT CARE CANCER
JI Support. Care Cancer
DI 10.1007/s00520-020-05847-6
EA OCT 2020
PG 7
WC Oncology; Health Care Sciences & Services; Rehabilitation
SC Oncology; Health Care Sciences & Services; Rehabilitation
GA OJ5BA
UT WOS:000583975500001
PM 33106977
DA 2020-11-30
ER

PT J
AU da Silva, GSG
   de Melo, MLM
   Leao, JC
   Carvalho, AT
   Porter, S
   Duarte, ALBP
   Dantas, AT
   Gueiros, LA
AF Gomes da Silva, Guilherme Soares
   Maymone de Melo, Marina Lins
   Leao, Jair Carneiro
   Carvalho, Alessandra Tavares
   Porter, Stephen
   Duarte, Angela Luzia Branco Pinto
   Dantas, Andrea Tavares
   Gueiros, Luiz Alcino
TI Sjogren's syndrome in systemic sclerosis: Impact on oral features
SO ORAL DISEASES
LA English
DT Letter
ID DISEASE
C1 [Gomes da Silva, Guilherme Soares; Maymone de Melo, Marina Lins; Leao, Jair Carneiro; Carvalho, Alessandra Tavares; Gueiros, Luiz Alcino] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Oral Med Unit, Recife, PE, Brazil.
   [Porter, Stephen] UCL Eastman Dent Inst, London, England.
   [Duarte, Angela Luzia Branco Pinto; Dantas, Andrea Tavares] Univ Fed Pernambuco, Hosp Cin, Rheumatol Unit, Recife, PE, Brazil.
RP Gueiros, LA (corresponding author), Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Oral Med Unit, Recife, PE, Brazil.
EM luiz.mgueiros@ufpe.br
RI Gueiros, Luiz Alcino/B-6429-2015
OI Gueiros, Luiz Alcino/0000-0003-4979-4318; Porter,
   Stephen/0000-0002-3328-2759
CR Baron M, 2015, ARTHRIT CARE RES, V67, P681, DOI 10.1002/acr.22490
   Berman N, 2019, OR SURG OR MED OR PA, V128, P117, DOI 10.1016/j.oooo.2019.04.011
   da Silva GSG, 2019, ORAL DIS, V25, P1995, DOI 10.1111/odi.13174
   Knas M, 2014, J ORAL PATHOL MED, V43, P521, DOI 10.1111/jop.12166
   Maarse F, 2019, CLIN EXP RHEUMATOL, V37, pS225
   Parat K., 2020, SJOGRENS SYNDROME IM, V26, P1592
   Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554
NR 7
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1354-523X
EI 1601-0825
J9 ORAL DIS
JI Oral Dis.
PD OCT
PY 2020
VL 26
IS 7
BP 1594
EP 1595
DI 10.1111/odi.13497
PG 2
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA NP1FC
UT WOS:000569926200028
PM 32559012
DA 2020-11-30
ER

PT J
AU Goldemberg, DC
   de Melo, AC
   Pino, LCD
   Antunes, HS
   Leao, JC
   Porter, S
AF Cohen Goldemberg, Daniel
   de Melo, Andreia Cristina
   de Melo Pino, Livia Cristina
   Antunes, Heliton Spindola
   Leao, Jair Carneiro
   Porter, Stephen
TI Lessening COVID-19 healthcare burden in dental practice via rapid
   serological tests
SO ORAL DISEASES
LA English
DT Letter; Early Access
DE cancer; COVID-19; dentistry; oral medicine; serology
C1 [Cohen Goldemberg, Daniel; de Melo, Andreia Cristina; Antunes, Heliton Spindola] Natl Canc Inst Brazil INCA, Rio De Janeiro, Brazil.
   [de Melo Pino, Livia Cristina] Med Sch Valenca UNIFAA, Rio De Janeiro, Brazil.
   [Leao, Jair Carneiro] Fed Univ Pernambuco UFPE, Recife, PE, Brazil.
   [Porter, Stephen] UCL, NIHR Univ Coll London Hosp, Biomed Res Ctr, Eastman Dent Inst, London, England.
RP Goldemberg, DC (corresponding author), COPQ INCA, Natl Canc Inst, Rua Andre Cavalcanti,37-5 Andar Anexo, BR-20231050 Rio De Janeiro, RJ, Brazil.
EM daniel.cohen@inca.gov.br
RI Goldemberg, Daniel Cohen/N-5484-2018
OI Goldemberg, Daniel Cohen/0000-0002-0089-1910; Antunes,
   Heliton/0000-0002-1076-8019; Porter, Stephen/0000-0002-3328-2759
CR Abadeh A, 2019, J AM DENT ASSOC, V150, P531, DOI 10.1016/j.adaj.2019.01.026
   Cohen Goldemberg D., 2020, SCI REPORTS, V10, P1
   Goldemberg DC, 2018, HEAD NECK-J SCI SPEC, V40, P1834, DOI 10.1002/hed.25166
   Gosain R, 2020, CURR ONCOL REP, V22, DOI 10.1007/s11912-020-00934-7
   Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015
   Hoffman Tove, 2020, Infection Ecology & Epidemiology, V10, P1754538, DOI 10.1080/20008686.2020.1754538
   Lau H, 2020, J MICROBIOL IMMUNOL, V53, P454, DOI 10.1016/j.jmii.2020.03.013
   Li RY, 2020, SCIENCE, V368, P489, DOI 10.1126/science.abb3221
   Meng L, 2020, J DENT RES, V99, P481, DOI 10.1177/0022034520914246
   Odeh ND, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093151
NR 10
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1354-523X
EI 1601-0825
J9 ORAL DIS
JI Oral Dis.
DI 10.1111/odi.13543
EA AUG 2020
PG 2
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA NG4RO
UT WOS:000563971300001
PM 32654279
OA Bronze, Green Published
DA 2020-11-30
ER

PT J
AU da Silva, TMV
   Melo, TS
   de Alencar, RC
   Pereira, JRD
   Leao, JC
   Silva, IHM
   Gueiros, LA
AF da Silva, Thyago Morais Vicente
   Melo, Thayanara Silva
   de Alencar, Romulo Cesar
   Pereira, Jose Ricardo Dias
   Leao, Jair Carneiro
   Silva, Igor Henrique Morais
   Gueiros, Luiz Alcino
TI Photobiomodulation for mucosal repair in patients submitted to dental
   extraction after head and neck radiation therapy: a double-blind
   randomized pilot study
SO SUPPORTIVE CARE IN CANCER
LA English
DT Article; Early Access
DE Dental extraction; Photobiomodulation therapy; Radiotherapy;
   Osteoradionecrosis
ID LEVEL LASER THERAPY; LOW-POWER LASER; CLINICAL-TRIAL;
   OSTEORADIONECROSIS; OSTEONECROSIS; MANAGEMENT; RADIOTHERAPY; PREVENTION;
   EFFICACY; JAWS
AB Objective The aim of this study was to evaluate the efficacy of photobiomodulation therapy (PBMT) on the mucosal healing of patients submitted to simple dental extractions after head and neck radiation therapy (HNRT). Methods Forty surgical procedures were randomly assigned into two groups: G1: dental extraction + PBMT (n = 19) and G2: dental extraction + sham-PBMT (n = 21). All patients received antibiotic therapy and the surgical alveolotomy to promote primary closure of the surgical site. Group 1 was submitted to PMBT according to the following parameters: 808 nm, 40 mW, 100 J/cm(2), 70 s, 2.8 J/point, 14 J/session, and area of 0.028cm(2). The primary outcome was complete mucosal lining at 14 days, and the secondary outcomes were the presence of infection, postoperative pain, and analgesics intake at 7 days. The patients were evaluated every 7 days until 28 days. Results Alveolar mucosal lining was faster in G1, and at 14 postoperative days, 94.7% patients evolved with complete alveolar mucosal lining compared to no patient from G2 (p < 0.001). Patients from G1 reported postoperative pain less frequently (G1 = 4, 21.1% x G2 = 14, 66.7%,p = 0.005), and also reported lower intake of analgesic pills at D7 (21.1% x 66.7%,p = 0.005%). PBMT had a significant positive impact on both postoperative pain (NNT = 2.192, CI95% = 1.372-5.445) and mucosal healing (NNT = 1.056, CI95% = 0.954-1.181). Conclusions This preliminary study strongly supports the use of PMBT to promote surgical alveolar mucosal lining in a shorter time and with less postoperative pain.
C1 [da Silva, Thyago Morais Vicente; de Alencar, Romulo Cesar; Pereira, Jose Ricardo Dias; Leao, Jair Carneiro; Gueiros, Luiz Alcino] Univ Fed Pernambuco, Oral Med Unit, Hosp Clin, CDU, Ave Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
   [da Silva, Thyago Morais Vicente; Melo, Thayanara Silva; Leao, Jair Carneiro; Gueiros, Luiz Alcino] Univ Fed Pernambuco, Grad Program Dent, Recife, PE, Brazil.
   [Silva, Igor Henrique Morais] Hosp Canc Pernambuco, Dent Oncol Unit, Recife, PE, Brazil.
RP Gueiros, LA (corresponding author), Univ Fed Pernambuco, Oral Med Unit, Hosp Clin, CDU, Ave Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.; Gueiros, LA (corresponding author), Univ Fed Pernambuco, Grad Program Dent, Recife, PE, Brazil.
EM luiz.mgueiros@ufpe.br
RI Gueiros, Luiz Alcino/B-6429-2015
OI Gueiros, Luiz Alcino/0000-0003-4979-4318; Melo,
   Thayanara/0000-0002-4184-4635
CR Agbaje JO, 2009, CLIN ORAL INVEST, V13, P257, DOI 10.1007/s00784-008-0231-7
   Lins RDAU, 2010, AN BRAS DERMATOL, V85, P849, DOI 10.1590/S0365-05962010000600011
   Ballonoff A, 2006, OTOLARYNG CLIN N AM, V39, P365, DOI 10.1016/j.otc.2005.11.004
   Batista JD, 2014, LASER MED SCI, V29, P1913, DOI 10.1007/s10103-014-1602-8
   Bonan Paulo Rogério Ferreti, 2006, Braz. Dent. J., V17, P336, DOI 10.1590/S0103-64402006000400013
   Curi MM, 1997, J ORAL MAXIL SURG, V55, P540, DOI 10.1016/S0278-2391(97)90478-X
   Epstein J, 1997, ORAL SURG ORAL MED O, V83, P657, DOI 10.1016/S1079-2104(97)90314-0
   EPSTEIN JB, 1987, HEAD NECK-J SCI SPEC, V10, P48, DOI 10.1002/hed.2890100108
   FRANDSEN ASGER M., 1962, ACTA ODONTOL SCAND, V20, P307
   Garavello-Freltas I, 2003, J PHOTOCH PHOTOBIO B, V70, P81, DOI 10.1016/S1011-1344(03)00058-7
   Gurler G, 2018, J STOMATOL ORAL MAXI, V119, P469, DOI 10.1016/j.jormas.2018.05.006
   HORIOT JC, 1981, INT J RADIAT ONCOL, V7, P1025, DOI 10.1016/0360-3016(81)90154-1
   Kanatas AN, 2002, BRIT DENT J, V192, P157, DOI 10.1038/sj.bdj.4801322a
   Kulkarni S, 2019, LASER MED SCI, V34, P685, DOI 10.1007/s10103-018-2641-3
   MARX RE, 1985, J AM DENT ASSOC, V111, P49, DOI 10.14219/jada.archive.1985.0074
   MAXYMIW WG, 1991, ORAL SURG ORAL MED O, V72, P270, DOI 10.1016/0030-4220(91)90212-U
   Naal FD, 2008, ARCH ORTHOP TRAUM SU, V128, P317, DOI 10.1007/s00402-007-0561-y
   Nabil S, 2011, INT J ORAL MAX SURG, V40, P229, DOI 10.1016/j.ijom.2010.10.005
   Nemeth Zsolt, 2000, Pathology Oncology and Research, V6, P53
   Oh HK, 2004, J ORAL MAXIL SURG, V62, P139, DOI 10.1016/j.joms.2003.08.009
   Paglioni MD, 2019, ORAL ONCOL, V93, P21, DOI 10.1016/j.oraloncology.2019.04.004
   Santinoni CD, 2017, J PHOTOCH PHOTOBIO B, V169, P83, DOI 10.1016/j.jphotobiol.2017.03.004
   Sarmadi S, 2019, J LASERS MED SCI, V10, P330, DOI 10.15171/jlms.2019.53
   Schubert MM, 2007, SUPPORT CARE CANCER, V15, P1145, DOI 10.1007/s00520-007-0238-7
   Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232
   Tong ACK, 1999, AUST DENT J, V44, P187, DOI 10.1111/j.1834-7819.1999.tb00220.x
   VAN PT, 1982, CELL TISSUE RES, V225, P283
   Vescovi P, 2012, PHOTOMED LASER SURG, V30, P5, DOI 10.1089/pho.2010.2955
   Wanifuchi S, 2016, ORAL MAXILLOFAC SURG, V20, P337, DOI 10.1007/s10006-016-0570-5
   Woodruff LD, 2004, PHOTOMED LASER SURG, V22, P241, DOI 10.1089/1549541041438623
NR 30
TC 0
Z9 0
U1 4
U2 4
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0941-4355
EI 1433-7339
J9 SUPPORT CARE CANCER
JI Support. Care Cancer
DI 10.1007/s00520-020-05608-5
EA JUL 2020
PG 8
WC Oncology; Health Care Sciences & Services; Rehabilitation
SC Oncology; Health Care Sciences & Services; Rehabilitation
GA MH1XG
UT WOS:000546525900001
PM 32642953
DA 2020-11-30
ER

PT J
AU Sales, PHD
   Gomes, MVSW
   de Oliveira-Neto, OB
   de Lima, FJC
   Leao, JC
AF da Hora Sales, Pedro Henrique
   Silva Weigel Gomes, Marcus Vinicius
   de Oliveira-Neto, Olavo Barbosa
   Camello de Lima, Fernando Jose
   Leao, Jair Carneiro
TI Quality assessment of systematic reviews regarding the effectiveness of
   zygomatic implants: an overview of systematic reviews
SO MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL
LA English
DT Review
DE Zygomatic Implants; dental Implants; complications; oral rehabilitation
ID POSTERIOR MAXILLA; ATROPHIC MAXILLA; DENTAL IMPLANTS; REHABILITATION;
   SURVIVAL; COMPLICATIONS; AUGMENTATION; BONE
AB Background: Oral rehabilitation of atrophic maxillae features high complexity, for which there are several therapeutic modalities reported on scientific literature. Zygomatic implant placement is a viable option that features low morbidity and allows immediate prosthetic loading. The purpose of the present study was to determine the methodological quality of systematic reviews that assessed the effectiveness of zygomatic implants placed in atrophic maxillae.
   Material and Methods: Searches were conducted on Medline via Pubmed, LILACS, Dare Cochrane. Scopus, and Sigle via Open Grey up to June 2019.
   Results: Seven systematic reviews were eligible for Overview and comprised a total of 2313 patients. 4812 zygomatic implants, and a 96,72% success rate. Common surgical complications, in decreasing order, were: maxillary sinusitis, peri-implant mucositis, prosthetic fracture, and infections. Methodological quality was assessed using the AMSTAR 2 tool, which revealed that six systematic reviews showed critically low methodological quality and one review was assessed as of low methodological quality.
   Conclusions: Zygomatic implants seem to be an adequate option for atrophic maxilla rehabilitation, however, new studies with a higher methodological rigor are needed to provide more reliable results to professionals and patients undergoing this modality of oral rehabilitation.
C1 [da Hora Sales, Pedro Henrique] Univ Fed Pernambuco, Dent Sch, Dept Prosthesis & Oral & Maxillofacial Surg, Recife, PE, Brazil.
   [Silva Weigel Gomes, Marcus Vinicius] Univ Fed Alagoas, Dent Sch, Maceio, Alagoas, Brazil.
   [de Oliveira-Neto, Olavo Barbosa] Univ Fed Alagoas, Inst Hlth & Biol Sci, Maceio, Alagoas, Brazil.
   [Camello de Lima, Fernando Jose] Univ Fed Alagoas, Inst Hlth & Biol Sci, Human Anat Area, Maceio, Alagoas, Brazil.
   [Leao, Jair Carneiro] Univ Fed Pernambuco, Dent Sch, Dept Clin & Prevent Dent, Recife, PE, Brazil.
RP Sales, PHD (corresponding author), Ave Prof Moraes Rego,1235 Cidade Univ, Recife, PE, Brazil.
EM salespedro@gmail.com
CR Centenero SAH, 2018, IMPLANT DENT, V27, P246, DOI 10.1097/ID.0000000000000726
   Agliardi EL, 2017, INT J ORAL MAX SURG, V46, P1592, DOI 10.1016/j.ijom.2017.05.023
   Aleksandrowicz P, 2019, J ORAL IMPLANTOL, V45, P73, DOI 10.1563/aaid-joi-D-18-00034
   Ali Seyed Asharaf, 2014, J Indian Prosthodont Soc, V14, P196, DOI 10.1007/s13191-014-0360-4
   Aparicio C, 2014, PERIODONTOL 2000, V66, P41, DOI 10.1111/prd.12038
   Araujo RZ, 2019, J CRANIO MAXILL SURG, V47, P651, DOI 10.1016/j.jcms.2019.01.030
   Bedrossian E, 2001, J PROSTHET DENT, V86, P10, DOI 10.1067/mpr.2001.115890
   Branemark PI, 2004, SCAND J PLAST RECONS, V38, P70, DOI 10.1080/02844310310023918
   de Lima FJC, 2016, LASER MED SCI, V31, P779, DOI 10.1007/s10103-016-1893-z
   Candel-Marti E, 2012, J ORAL IMPLANTOL, V38, P653, DOI 10.1563/AAID-JOI-D-10-00126
   Cannizzaro G, 2013, EUR J ORAL IMPLANTOL, V6, P13
   Castro AA, 2017, REV ASSOC MED BRAS, V63, P278, DOI 10.1590/1806-9282.63.03.278
   Chrcanovic BR, 2016, J ORAL MAXIL SURG, V74, P1949, DOI 10.1016/j.joms.2016.06.166
   Chrcanovic BR, 2013, ORAL MAXILLOFAC SURG, V17, P81, DOI 10.1007/s10006-012-0331-z
   Chrcanovic BR, 2013, ORAL MAXILLOFAC SURG, V17, P1, DOI 10.1007/s10006-012-0316-y
   Cisternas FAC, 2016, INT J MED SURG SCI, V3, P771
   Corbella S, 2015, CLIN IMPLANT DENT R, V17, P120, DOI 10.1111/cid.12077
   Cunha G, 2018, J CRANIOFAC SURG, V29, P2218, DOI 10.1097/SCS.0000000000005023
   Davo R, 2019, ORAL MAXIL SURG CLIN, V31, P285, DOI 10.1016/j.coms.2018.12.006
   de Oliveira-Neto OB, 2018, J PROSTHET DENT, V120, P198, DOI 10.1016/j.prosdent.2017.12.026
   DeAntonio JH, 2019, WORLD J EMERG SURG, V14, DOI 10.1186/s13017-019-0225-6
   Esfahrood ZR, 2017, J KOR ASSOC ORAL MAX, V43, P70, DOI 10.5125/jkaoms.2017.43.2.70
   Esposito M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004151.pub2
   Esposito M, 2003, COCHRANE DB SYST REV
   Esposito M, 2015, EUR J ORAL IMPLANTOL, V8, P257
   Galan Gil Sonica, 2007, Med Oral Patol Oral Cir Bucal, V12, pE216
   Goiato MC, 2014, INT J ORAL MAX SURG, V43, P748, DOI 10.1016/j.ijom.2014.01.004
   Hung KF, 2017, CLIN IMPLANT DENT R, V19, P841, DOI 10.1111/cid.12524
   Jokstad A, 2016, INT J ORAL MAX IMPL, V31, pS43, DOI 10.11607/jomi.16suppl.g2
   Malevez C, 2012, REV STOMATOL CHIR, V113, P299, DOI 10.1016/j.stomax.2012.06.001
   Malo P, 2012, EUR J ORAL IMPLANTOL, V5, P37
   Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
   Molinero-Mourelle P, 2016, MED ORAL PATOL ORAL, V21, pE751, DOI 10.4317/medoral.21357
   OliveiraNeto OB, 2017, J PROSTHET DENT, V117, P601
   Petrungaro Paul S, 2018, Compend Contin Educ Dent, V39, P636
   Urgell JP, 2008, MED ORAL PATOL ORAL, V13, pE363
   Pieri F, 2016, INT J ORAL MAX IMPL, V31, P1179, DOI 10.11607/jomi.4370
   Ravida A, 2019, INT J ORAL MAX IMPL, V34, P68, DOI 10.11607/jomi.6893
   Rinaldi Marco, 2019, Compend Contin Educ Dent, V40, pe1
   Sakkas A, 2017, INT J IMPLANT DENT, V3, DOI 10.1186/s40729-017-0084-4
   Sales PHH, 2019, INT J ORAL MAXILLOF, V19, P30040
   Sharma A, 2013, J ORAL IMPLANTOL, V39, P215, DOI 10.1563/AAID-JOI-D-11-00055
   Shea BJ, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4008
   Tuminelli FJ, 2017, EUR J ORAL IMPLANTOL, V10, P79
   Wang F, 2015, INT J ORAL MAX IMPL, V30, P293, DOI 10.11607/jomi.3691
NR 45
TC 0
Z9 0
U1 0
U2 0
PU MEDICINA ORAL S L
PI VALENCIA
PA CALLE DANIEL BALACIART N 4 PTA 17, VALENCIA, 46020, SPAIN
SN 1698-6946
J9 MED ORAL PATOL ORAL
JI Med. Oral Patol. Oral Cir. Bucal
PD JUL
PY 2020
VL 25
IS 4
BP E541
EP E548
AR 23569
DI 10.4317/medoral.23569
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA MI4JX
UT WOS:000547377500015
PM 32520920
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Leao, JC
   Gusmao, TPD
   Zarzar, AM
   Leao, JC
   de Faria, ABS
   Silva, IHM
   Gueiros, LAM
   Robinson, NA
   Porter, S
   Carvalho, ADT
AF Leao, Jair Carneiro
   Gusmao, Teresa Paula de Lima
   Zarzar, Adriana Machado
   Leao Filho, Jair Carneiro
   Barkokebas Santos de Faria, Andreza
   Morais Silva, Igor Henrique
   Gueiros, Luiz Alcino Monteiro
   Robinson, Narendran Andrew
   Porter, Stephen
   Carvalho, Alessandra de Albuquerque Tavares
TI Coronaviridae-Old friends, new enemy!
SO ORAL DISEASES
LA English
DT Review; Early Access
DE coronaviridae; coronavirus; covid-19
ID ACUTE RESPIRATORY SYNDROME; SYNDROME SARS; AVIAN CORONAVIRUSES; BAT
   CORONAVIRUSES; SAUDI-ARABIA; EPIDEMIOLOGY; PNEUMONIA; RECOMBINATION;
   INFECTION; VIRUS
AB Coronaviridae is a family of single-stranded positive enveloped RNA viruses. This article aimed to review the history of these viruses in the last 60 years since their discovery to understand what lessons can be learned from the past. A review of the PubMed database was carried out, describing taxonomy, classification, virology, genetic recombination, host adaptation, and main symptoms related to each type of virus. SARS-CoV-2 is responsible for the ongoing global pandemic, and SARS-CoV and MERS-CoV were responsible for causing severe respiratory illness and regional epidemics in the past while the four other strains of CoVs (229-E OC43, NL63, and HKU1) circulate worldwide and normally only cause mild upper respiratory tract infections. Given the enormous diversity of coronavirus viruses in wildlife and their continuous evolution and adaptation to humans, future outbreaks would undoubtedly occur. Restricting or banning all trade in wild animals in wet markets would be a necessary measure to reduce future zoonotic infections.
C1 [Leao, Jair Carneiro; Zarzar, Adriana Machado; Gueiros, Luiz Alcino Monteiro; Carvalho, Alessandra de Albuquerque Tavares] Univ Fed Pernambuco, Dept Clin Odontol & Prevent, Recife, PE, Brazil.
   [Gusmao, Teresa Paula de Lima] Hosp AC Camargo Fund Antonio Prudente, Dept Estomatol, Sao Paulo, Brazil.
   [Leao Filho, Jair Carneiro] Univ Sao Paulo, Dept Odontol Restauradora, Sao Paulo, Brazil.
   [Barkokebas Santos de Faria, Andreza] Prefeitura Cidade Recife, Secretaria Saude, Recife, PE, Brazil.
   [Morais Silva, Igor Henrique] Hosp Canc Pernambuco, Dept Odontol, Recife, PE, Brazil.
   [Robinson, Narendran Andrew] Natl Univ Singapore, Discipline Oral & Maxillofacial Surg, Fac Dent, Singapore, Singapore.
   [Porter, Stephen] UCL, Eastman Dent Inst, Maxillofacial Med & Surg Dept, London, England.
RP Leao, JC (corresponding author), Univ Fed Pernambuco, Programa Posgrad Odontol, Ave Prof Moraes Rego 1235, Recife, PE, Brazil.
EM jleao@ufpe.br
RI Gueiros, Luiz Alcino/B-6429-2015
OI Gueiros, Luiz Alcino/0000-0003-4979-4318; Porter,
   Stephen/0000-0002-3328-2759
CR Al-Tawfiq JA, 2014, CLIN INFECT DIS, V59, P160, DOI 10.1093/cid/ciu226
   Alanazi KH, 2019, INFECT CONT HOSP EP, V40, P79, DOI 10.1017/ice.2018.290
   Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560
   Angeletti S, 2020, J MED VIROL, V92, P584, DOI 10.1002/jmv.25719
   Centre for Infectious Disease Epidemiology and Research-NUS, 80WHO CTR INF DIS EP
   Chafekar A, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020093
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Chowell G, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0450-0
   Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9
   de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
   Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1
   Drexler JF, 2014, ANTIVIR RES, V101, P45, DOI 10.1016/j.antiviral.2013.10.013
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Esper F, 2006, EMERG INFECT DIS, V12, P775, DOI 10.3201/eid1205.051316
   Esper F, 2010, J CLIN VIROL, V48, P131, DOI 10.1016/j.jcv.2010.03.007
   Forni D, 2017, TRENDS MICROBIOL, V25, P35, DOI 10.1016/j.tim.2016.09.001
   Forster P, 2020, P NATL ACAD SCI USA, V117, P9241, DOI 10.1073/pnas.2004999117
   Frieman M, 2008, MICROBIOL MOL BIOL R, V72, P672, DOI 10.1128/MMBR.00015-08
   Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10
   Goh JSK, 2003, J THORAC IMAG, V18, P195, DOI 10.1097/00005382-200307000-00010
   Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z
   Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032
   Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
   Gudi SK, 2020, INT J OCCUP ENV MED, V11, P108, DOI 10.34172/ijoem.2020.1977
   Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
   HAMRE D, 1966, P SOC EXP BIOL MED, V121, P190, DOI 10.3181/00379727-121-30734
   Herrewegh AAPM, 1998, J VIROL, V72, P4508, DOI 10.1128/JVI.72.5.4508-4514.1998
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Lam TTY, 2020, NATURE, V583, P282, DOI 10.1038/s41586-020-2169-0
   Lau SKP, 2010, J VIROL, V84, P2808, DOI 10.1128/JVI.02219-09
   Leung GM, 2004, ANN INTERN MED, V141, P662, DOI 10.7326/0003-4819-141-9-200411020-00006
   Lin SY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102030
   Liu W, 2004, EMERG INFECT DIS, V10, P1841, DOI 10.3201/eid1010.040297
   Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953
   Memish ZA, 2014, EMERG INFECT DIS, V20, P1012, DOI 10.3201/eid2006.140402
   Mole B, 2013, NATURE, V499, P388, DOI 10.1038/499388a
   Muller NL, 2003, AM J ROENTGENOL, V181, P3, DOI 10.2214/ajr.181.1.1810003
   Ogimi C, 2020, J PEDIAT INF DIS SOC, V9, P210, DOI 10.1093/jpids/piaa037
   Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2
   Pene F, 2003, CLIN INFECT DIS, V37, P929, DOI 10.1086/377612
   Priestnall SL, 2006, VET MICROBIOL, V115, P43, DOI 10.1016/j.vetmic.2006.02.008
   Rabi FA, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030231
   Seto WH, 2003, LANCET, V361, P1519, DOI 10.1016/S0140-6736(03)13168-6
   SIDDELL SG, 1983, INTERVIROLOGY, V20, P181, DOI 10.1159/000149390
   Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003
   Szczepanski A, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040328
   TYRRELL DAJ, 1965, BMJ-BRIT MED J, V1, P1467, DOI 10.1136/bmj.1.5448.1467
   Vijayanand P, 2004, CLIN MED, V4, P152, DOI 10.7861/clinmedicine.4-2-152
   Vijgen L, 2005, VIROLOGY, V337, P85, DOI 10.1016/j.virol.2005.04.010
   Wang LS, 2020, SCI TOTAL ENVIRON, V727, DOI 10.1016/j.scitotenv.2020.138394
   Weiss SR, 2011, ADV VIRUS RES, V81, P85, DOI 10.1016/B978-0-12-385885-6.00009-2
   WHO, SIT REP COR DIS 100
   Wong RSM, 2003, BRIT MED J, V326, P1358, DOI 10.1136/bmj.326.7403.1358
   Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11
   Woo PCY, 2009, J VIROL, V83, P908, DOI 10.1128/JVI.01977-08
   World Health Organization, 2019, MIDDL E RESP SYNDR C
   Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156
   Xie MX, 2020, INT J INFECT DIS, V94, P119, DOI 10.1016/j.ijid.2020.03.071
   Yang Y, 2020, EPIDEMIOLOGICAL CLIN, DOI [10.1101/2020.02.10.20021675, DOI 10.1101/2020.02.10.20021675]
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   ZHANG LY, 2020, IND CROP PROD, V153
   Zhong NS, 2003, LANCET, V362, P1353, DOI 10.1016/S0140-6736(03)14630-2
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zou J, 2020, EUR REV MED PHARMACO, V24, P5778, DOI 10.26355/eurrev_202005_21371
   刘茜, 2020, [法医学杂志, Journal of Forensic Medicine], V36, P21
NR 67
TC 2
Z9 2
U1 4
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1354-523X
EI 1601-0825
J9 ORAL DIS
JI Oral Dis.
DI 10.1111/odi.13447
EA JUN 2020
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA MC4BF
UT WOS:000543233800001
PM 32475006
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Sorgato, CC
   Lins-e-Silva, M
   Leao, JC
   Vasconcelos, LR
   Romao, TP
   Duarte, AL
   Gueiros, LA
AF Sorgato, Camila Carvalho
   Lins-e-Silva, Marilia
   Leao, Jair Carneiro
   Vasconcelos, Luydson Richardson
   Romao, Tatiany Patricia
   Duarte, Angela Luzia
   Gueiros, Luiz Alcino
TI EBV and CMV viral load in rheumatoid arthritis and their role in
   associated Sjogren's syndrome
SO JOURNAL OF ORAL PATHOLOGY & MEDICINE
LA English
DT Article
DE cytomegalovirus; Epstein-Barr Virus Infections; rheumatoid arthritis;
   Sjogren's syndrome
ID EPSTEIN-BARR-VIRUS; LYMPHOID STRUCTURES; DISEASE-ACTIVITY; SICCA
   SYMPTOMS; HERPES VIRUSES; CYTOMEGALOVIRUS; MANIFESTATIONS;
   CLASSIFICATION; INFECTION; CRITERIA
AB Introduction The role of viral infections in the pathogenesis of autoimmune diseases has long been suggested, but little evidence is available.
   Objective This study aimed to evaluate an association between EBV and CMV and the presence of rheumatoid arthritis and its association with Sjogren's Syndrome.
   Patients and Method A case-control study was performed with 227 patients divided in RA (n = 99), RA/SS (n = 20), and C (n = 128). Resting salivary flow rate and Schirmer's test were performed; minor salivary gland biopsy was indicated in the case of suspected Sjogren's syndrome. CMV and EBV viral loads were quantified in peripheral blood, and their presence in glandular tissue samples was evaluated by in situ hybridization (EBV) and immunohistochemistry (CMV).
   Results EBV was more frequent in RA and RA/SS than in C (P < .000007). No correlation with clinical markers (P > .05) or between RA and RA/SS was found (P > .05). A higher number of EBV/DNA copies were found in RA (158.52 copies/mu L) and RA/SS (99.24 copies/mu L) (P = .739). EBV/DNA was associated with the Schirmer test (P = .0231). CMV was detected in one patient of the RA group. None of the viruses were detected in biopsies of minor salivary glands.
   Conclusions Detection of EBV/DNA in peripheral blood was associated with RA regardless of the presence of SS.
C1 [Sorgato, Camila Carvalho; Lins-e-Silva, Marilia] Univ Fed Pernambuco, Programa Posgrad Odontol, Recife, PE, Brazil.
   [Leao, Jair Carneiro; Gueiros, Luiz Alcino] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Oral Med Unit, Recife, PE, Brazil.
   [Vasconcelos, Luydson Richardson; Romao, Tatiany Patricia] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Duarte, Angela Luzia] Univ Fed Pernambuco, Hosp Clin, Rheumatol Unit, Recife, PE, Brazil.
RP Gueiros, LA (corresponding author), Av Prof Moraes Rego,1235,Cidade Univ, BR-50670901 Recife, PE, Brazil.
EM luiz.mgueiros@ufpe.br
RI Gueiros, Luiz Alcino/B-6429-2015
OI Gueiros, Luiz Alcino/0000-0003-4979-4318
FU Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco
   [APQ-1092-4.02/15]
FX Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco,
   Grant/Award Number: APQ-1092-4.02/15
CR Alani H, 2018, SCAND J RHEUMATOL, V47, P141, DOI 10.1080/03009742.2017.1324909
   ALSPAUGH MA, 1978, J EXP MED, V147, P1018, DOI 10.1084/jem.147.4.1018
   Alvarez-Lafuente R, 2005, ANN RHEUM DIS, V64, P1357, DOI 10.1136/ard.2004.033514
   ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302
   Balandraud N, 2003, ARTHRITIS RHEUM, V48, P1223, DOI 10.1002/art.10933
   Carvalho CN, 2016, CLIN ORAL INVEST, V20, P495, DOI 10.1007/s00784-015-1540-2
   Crawford DH, 2001, PHILOS T R SOC B, V356, P461, DOI 10.1098/rstb.2000.0783
   Croia C, 2014, ARTHRITIS RHEUMATOL, V66, P2545, DOI 10.1002/art.38726
   Daniels TE, 2011, ARTHRITIS RHEUM-US, V63, P2021, DOI 10.1002/art.30381
   Delaleu N, 2008, RHEUM DIS CLIN N AM, V34, P833, DOI 10.1016/j.rdc.2008.08.004
   Dostal C, 1997, ANN NY ACAD SCI, V815, P334, DOI 10.1111/j.1749-6632.1997.tb52078.x
   Fairweather D, 2005, REV MED VIROL, V15, P17, DOI 10.1002/rmv.445
   Fleck M, 1998, ARTHRITIS RHEUM-US, V41, P2175, DOI 10.1002/1529-0131(199812)41:12<2175::AID-ART12>3.3.CO;2-9
   Fransen J, 2004, RHEUMATOLOGY, V43, P1252, DOI 10.1093/rheumatology/keh297
   Galossi A, 2007, J GASTROINTEST LIVER, V16, P65
   GLASER R, 1995, NEUROENDOCRINOLOGY, V62, P356, DOI 10.1159/000127025
   Griffiths DJ, 2000, HOSP MED, V61, P378, DOI 10.12968/hosp.2000.61.6.1349
   Haga HJ, 2012, INT J RHEUM DIS, V15, P284, DOI 10.1111/j.1756-185X.2012.01717.x
   INMAN RD, 1991, RHEUM DIS CLIN N AM, V17, P859
   Inoue-Toyoda M, 2015, BIOCHEM BIOPH RES CO, V458, P180, DOI 10.1016/j.bbrc.2015.01.091
   Silva MLE, 2016, J RHEUMATOL, V43, P1795, DOI 10.3899/jrheum.151211
   Lucchesi D, 2014, EXPERT REV CLIN IMMU, V10, P445, DOI 10.1586/1744666X.2014.892417
   MAITLAND N, 1995, J ORAL PATHOL MED, V24, P293, DOI 10.1111/j.1600-0714.1995.tb01187.x
   Marchese-Ragona R, 2002, ACTA OPHTHALMOL SCAN, V80, P345, DOI 10.1034/j.1600-0420.2002.800323.x
   Mourgues C, 2016, JOINT BONE SPINE, V83, P412, DOI 10.1016/j.jbspin.2015.07.009
   Rozman Blaz, 2004, Reumatizam, V51, P9
   Saal JG, 1999, ARTHRITIS RHEUM-US, V42, P1485, DOI 10.1002/1529-0131(199907)42:7<1485::AID-ANR24>3.0.CO;2-7
   SAITO I, 1989, J EXP MED, V169, P2191, DOI 10.1084/jem.169.6.2191
   Stefanski AL, 2017, DTSCH ARZTEBL INT, V114, P354, DOI 10.3238/arztebl.2017.0354
   TANNER OR, 1954, AMA ARCH OPHTHALMOL, V51, P229
   Uhlig T, 1999, ANN RHEUM DIS, V58, P415, DOI 10.1136/ard.58.7.415
   Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554
   Young A, 2007, BEST PRACT RES CL RH, V21, P907, DOI 10.1016/j.berh.2007.05.007
NR 33
TC 1
Z9 1
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0904-2512
EI 1600-0714
J9 J ORAL PATHOL MED
JI J. Oral Pathol. Med.
PD AUG
PY 2020
VL 49
IS 7
BP 693
EP 700
DI 10.1111/jop.13036
EA JUN 2020
PG 8
WC Dentistry, Oral Surgery & Medicine; Pathology
SC Dentistry, Oral Surgery & Medicine; Pathology
GA NG3EL
UT WOS:000539106500001
PM 32428250
DA 2020-11-30
ER

PT J
AU Leao, JC
AF Leao, Jair Carneiro
TI Political polarization at the time of the coronavirus: A Brazilian's
   view
SO ORAL DISEASES
LA English
DT Article; Early Access
DE COVID-19; pandemic; SARS-Cov-2
C1 [Leao, Jair Carneiro] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
RP Leao, JC (corresponding author), Univ Fed Pernambuco, Programa Posgrad Odontol, Ave Prof Mores Rego 1235, BR-51020041 Recife, PE, Brazil.
EM jleao@ufpe.br
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1354-523X
EI 1601-0825
J9 ORAL DIS
JI Oral Dis.
DI 10.1111/odi.13406
EA MAY 2020
PG 3
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA LQ5TZ
UT WOS:000535065200001
PM 32392364
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Batista, MIHD
   Paulino, MR
   Castro, KS
   Gueiros, LAM
   Leao, JC
   Carvalho, AAT
AF Holanda de Medeiros Batista, Mara Ilka
   Paulino, Marcilia Ribeiro
   Castro, Kaline Silva
   Monteiro Gueiros, Luiz Alcino
   Leao, Jair Carneiro
   Tavares Carvalho, Alessandra Albuquerque
TI High prevalence of syphilis in a female prison unit in Northeastern
   Brazil
SO EINSTEIN-SAO PAULO
LA English
DT Article
DE Sexually transmitted diseases; Infections; Syphilis/epidemiology;
   Women's health; Prisons; Women; Prisoners; Brazil
AB Objective: To determine the prevalence of syphilis and the associated risk factors in a female prison unit. Methods: This was a cross-sectional study including 113 women whom data were collected in two stages: first, blood test to check for syphilis seropositivity; and then collection of information through a form to assess risk situations for sexually transmitted infections. Results: Overall, syphilis prevalence was found to be 22.1% among the female prison population (n=25) and 28.6% among pregnant women. A statistically significant relationship was found between syphilis infection and previous history of sexually transmitted infections (p=0.04). However, most participants diagnosed with the disease were unaware of a history of sexually transmitted infection in the last 12 months (n=20/80.0%). The use of condom with fixed partners was considered to be a protective factor (odds ratio of 0.76; 95% of confidence interval 0.68-0.85). Conclusion: The prevalence of syphilis among the female prison population was high, particularly among pregnant women. Preventive and therapeutic measures as well as appropriate prenatal care can minimize the impact of syphilis in prison systems and, consequently, improve such health outcomes nationwide.
C1 [Holanda de Medeiros Batista, Mara Ilka; Paulino, Marcilia Ribeiro; Castro, Kaline Silva; Monteiro Gueiros, Luiz Alcino; Leao, Jair Carneiro; Tavares Carvalho, Alessandra Albuquerque] Univ Fed Pernambuco, Recife, PE, Brazil.
RP Batista, MIHD (corresponding author), Univ Fed Pernambuco, Ctr Hlth Sci, Grad Program Dent, Ave Prof Moraes Rego 1,235 Cidade Univ, BR-50670901 Recife, PE, Brazil.
EM marailka@hotmail.com
RI Gueiros, Luiz Alcino/B-6429-2015
OI Gueiros, Luiz Alcino/0000-0003-4979-4318
CR Adjei AA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-33
   [Anonymous], 2018, REP GLOB SEX TRANSM
   Belaunzaran-Zamudio PF, 2017, AIDS RES HUM RETROV, V33, P524, DOI [10.1089/aid.2016.0271, 10.1089/AID.2016.0271]
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de DST Aids e Hepatites Virais, 2015, B EP SIF 2017
   de Albuquerque ACC, 2014, CIENC SAUDE COLETIVA, V19, P2125, DOI 10.1590/1413-81232014197.08602013
   Coelho HC, 2011, BRAZ J INFECT DIS, V15, P94, DOI 10.1590/S1413-86702011000100020
   Marques NMD, 2011, BRAZ J INFECT DIS, V15, P272, DOI 10.1590/S1413-86702011000300016
   de la Calle M, 2013, MED CLIN-BARCELONA, V141, P141, DOI 10.1016/j.medcli.2012.11.033
   Sgarbi RVE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139487
   Garriga C., 2011, Rev. esp. sanid. penit., V13, P52, DOI [10.4321/s1575-06202011000200004, 10.1590/S1575-06202011000200004]
   Javanbakht M, 2014, AM J PUBLIC HEALTH, V104, pE103, DOI 10.2105/AJPH.2014.302186
   Lafetá Kátia Regina Gandra, 2016, Rev. bras. epidemiol., V19, P63, DOI 10.1590/1980-5497201600010006
   Lazarini FM, 2012, REV SAUDE PUBL, V46, P960, DOI [10.1590/S0034-89102013005000003, 10.1590/s0034-89102013005000003]
   Lopes F, 2001, Cad Saude Publica, V17, P1473, DOI 10.1590/S0102-311X2001000600031
   Posada A, 2008, Rev Esp Sanid Penit, V10, P73, DOI 10.4321/S1575-06202008000300003
   Sato Neuza Satomi, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P319, DOI 10.1590/S0036-46652003000600004
   Seibt CE, 2016, BRAZ J INFECT DIS, V20, P393, DOI 10.1016/j.bjid.2016.03.008
   Domingues RMSM, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00183616, 10.1590/0102-311x00183616]
NR 18
TC 0
Z9 0
U1 0
U2 0
PU INST ISRAELITA ENSINO & PESQUISA ALBERT EINSTEIN
PI SAO PAULO SP
PA AVENIDA ALBERT EINSTEIN, 627 701, SAO PAULO SP, 05651-901, BRAZIL
SN 1679-4508
EI 2317-6385
J9 EINSTEIN-SAO PAULO
JI Einstein
PY 2020
VL 18
AR eAO4978
DI 10.31744/einstein_journal/2020AO4978
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA MW9PZ
UT WOS:000557364400001
PM 32428062
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Gusmao, TPD
   de Faria, ABS
   Leao, JC
   Carvalho, ADT
   Gueiros, LAM
   Leao, JC
AF Gusmao, Teresa Paula de Lima
   de Faria, Andreza Barkokebas Santos
   Leao Filho, Jair Carneiro
   Carvalho, Alessandra de Albuquerque Tavares
   Gueiros, Luiz Alcino Monteiro
   Leao, Jair Carneiro
TI Dental changes in children with congenital Zika syndrome
SO ORAL DISEASES
LA English
DT Article
DE epidemiology; oral manifestations; Zika virus
ID VIRUS-INFECTION; TRANSMISSION; CHALLENGES; SPECTRUM; BRAZIL; CARE
AB Objective To describe oral alterations in children with congenital Zika syndrome (CZS). Methods This was a case series, whose research instrument was a structured questionnaire, associated with the use of medical record data and extra and intraoral clinical examination. Results Thirty-two children were evaluated, the majority male (18/32%-56.3%), mean age 22 months (SD = 2.71). It was also observed that the majority of the patients (19/32%-59.4%) presented a low family income. All the children had a mean head circumference of 29.43 cm (SD = 1.42). Regarding the alterations, an ogival-shaped palate was observed in 14 children (43.7%), and delayed chronology of eruption was observed in 15 children (46.9%), of whom 7 children (21.9%) did not present eruption of the upper left lateral incisor (p = .0002) and upper right lateral incisor (p = .002) until the moment of analysis. Additionally, 03 children with yellowish dental pigmentation were identified in erupted teeth after the onset of phenobarbital use. Enamel hypoplasia was identified in 9 children (28.1%) and only one child with ankyloglossia. Conclusion CZS may present delayed chronology of eruption, ankyloglossia, ogival-shaped palate, and enamel hypoplasia, requiring dental follow-up aimed at prevention, promotion, and rehabilitation of the health of these children.
C1 [Gusmao, Teresa Paula de Lima; de Faria, Andreza Barkokebas Santos; Leao Filho, Jair Carneiro; Carvalho, Alessandra de Albuquerque Tavares; Gueiros, Luiz Alcino Monteiro; Leao, Jair Carneiro] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Oral Med Unit, Recife, PE, Brazil.
RP Leao, JC (corresponding author), Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
EM jleao@ufpe.br
RI Gueiros, Luiz Alcino/B-6429-2015; Leao, Jair Carneiro/AAL-6154-2020
OI Gueiros, Luiz Alcino/0000-0003-4979-4318; Leao, Jair
   Carneiro/0000-0001-8303-2291
CR Alves Lucas Victor, 2016, Rev. Bras. Saude Mater. Infant., V16, pS27, DOI 10.1590/1806-9304201600s100003
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cavalcanti AL, 2017, CONTEMP CLIN DENT, V8, P345, DOI 10.4103/0976-237X.214553
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Eickmann SH, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00047716
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Goldstein J, 2008, J CHILD NEUROL, V23, P407, DOI 10.1177/0883073807309230
   Harris SR, 2015, CAN FAM PHYSICIAN, V61, P680
   Heckathorn DE, 2016, DYSPHAGIA, V31, P1, DOI 10.1007/s00455-015-9667-5
   Jaskoll T, 2008, ARCH ORAL BIOL, V53, P405, DOI 10.1016/j.archoralbio.2007.11.014
   Krause KK, 2017, IMMUNE NETW, V17, P287, DOI 10.4110/in.2017.17.5.287
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Leao JC, 2017, ORAL DIS, V23, P12, DOI 10.1111/odi.12512
   Lysell L., 1962, ODONTOL REVY, V13, P217
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/s1679-49742016000400004, 10.5123/S1679-49742016000400004]
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Matsuo K, 2008, PHYS MED REH CLIN N, V19, P691, DOI 10.1016/j.pmr.2008.06.001
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   PNUD, 2017, AV IMP SOC VIR ZIK A
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Saad T, 2018, CHILD NERV SYST, V34, P73, DOI 10.1007/s00381-017-3634-4
   Secretaria de Saude de Pernambuco, 2017, INF EP INF TECN 21 S
   Seow WK, 2014, AUST DENT J, V59, P143, DOI 10.1111/adj.12104
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Walter L. R. F., 1999, ODONTOLOGIA BEBE ODO
   World Health Organization, 2016, WHOZIKVMOC163
NR 33
TC 0
Z9 0
U1 1
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1354-523X
EI 1601-0825
J9 ORAL DIS
JI Oral Dis.
PD MAR
PY 2020
VL 26
IS 2
BP 457
EP 464
DI 10.1111/odi.13238
EA DEC 2019
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA KM7HG
UT WOS:000502876000001
PM 31742839
DA 2020-11-30
ER

PT J
AU Do Nascimento, ML
   De Farias, ABS
   Carvalho, AT
   De Albuquerque, RF
   Ribeiro, LN
   Leao, JC
   Silva, IHM
AF Do Nascimento, Michele-Lopes
   De Farias, Andreza-Barkokebas-Santos
   Carvalho, Alessandra-Tavares
   De Albuquerque, Raylane-Farias
   Ribeiro, Lucas-Nascimento
   Leao, Jair-Carneiro
   Silva, Igor-Henrique-Morais
TI Impact of xerostomia on the quality of life of patients submitted to
   head and neck radiotherapy
SO MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL
LA English
DT Article
DE Head and neck neoplasms; radiotherapy; xerostomia; quality of life
ID VALIDATION; VERSION; CANCER; CARE
AB Background: The aim of the present work was to evaluate the impact of xerostomia on the quality of life of patients who underwent radiotherapy in the head and neck region.
   Material and Methods: This was a cross-sectional, quantitative study. The sample comprised 40 patients whose xerostomia was classified through the xerostomia inventory and the quality of life evaluated through the oral health impact profile questionnaire (OHIP).
   Results: The majority of participants were male (75%), mean age 58.7 years. According to the degree of severity of the xerostomia, the average score among the participants was 36 points, this being considered moderate xerostomia. A significant impact was observed, with the median score 11 points, with the highest scores in the domains related to functional limitation, physical pain and physical disability. The majority of the participants (97.5%) had reduced salivary flow after the end of radiotherapy. There was a significant positive correlation between the degree of xerostomia and reduced quality of life, Pearson correlation 0.5421, (p<0.05).
   Conclusion: Based upon the results it is concluded that xerostomia has a negative impact on the quality of life of patients who undergo radiotherapy in the head and neck region.
C1 [Do Nascimento, Michele-Lopes; De Albuquerque, Raylane-Farias; Ribeiro, Lucas-Nascimento; Silva, Igor-Henrique-Morais] Hosp Canc Pernambuco, Dent Oncol, Recife, PE, Brazil.
   [De Farias, Andreza-Barkokebas-Santos] State Hlth Secretariat Pernambuco, Hlth Regulat, Recife, PE, Brazil.
   [Carvalho, Alessandra-Tavares; Leao, Jair-Carneiro] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Oral Med Unit, Oral Med, Recife, PE, Brazil.
RP Silva, IHM (corresponding author), Hosp Canc Pernambuco, Ave Cruz Cabuga 1597 Santo Amaro, BR-50040000 Recife, PE, Brazil.
EM Igorecife@hotmail.com
RI Leao, Jair Carneiro/AAL-6154-2020
OI Leao, Jair Carneiro/0000-0001-8303-2291
CR Gonzalez-Arriagada WA, 2018, J COSMET LASER THER, V20, P117, DOI 10.1080/14764172.2017.1376097
   Barkokebas A, 2015, J ORAL PATHOL MED, V44, P746, DOI 10.1111/jop.12282
   Carvalho CG, 2018, SUPPORT CARE CANCER, V26, P2651, DOI 10.1007/s00520-018-4111-7
   da Mata ADSP, 2012, ORAL DIS, V18, P293, DOI 10.1111/j.1601-0825.2011.01879.x
   de Oliveira BH, 2005, COMMUNITY DENT ORAL, V33, P307
   Dost F, 2013, AUST DENT J, V58, P11, DOI 10.1111/adj.12023
   Eisbruch A, 2003, SEMIN RADIAT ONCOL, V13, P226, DOI 10.1016/S1053-4296(03)00033-X
   Gonnelli Fernanda Aurora Stabile, 2016, Radiol Bras, V49, P86, DOI 10.1590/0100-3984.2014.0144
   Hsu PY, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/8359251
   Jabbari S, 2005, INT J RADIAT ONCOL, V63, P725, DOI 10.1016/j.ijrobp.2005.02.045
   Kho HS, 2014, CHIN J DENT RES, V17, P75, DOI 10.3290/j.cjdr.a33269
   Lanzos Isabel, 2015, J Clin Exp Dent, V7, pe613, DOI 10.4317/jced.52557
   Lastrucci L, 2018, RADIOL MED, V123, P44, DOI 10.1007/s11547-017-0798-7
   Lopez-Lopez J, 2014, MED CLIN-BARCELONA, V142, P119, DOI 10.1016/j.medcli.2013.02.036
   Mercadante V, 2017, ORAL ONCOL, V66, P64, DOI 10.1016/j.oraloncology.2016.12.031
   Navazesh M, 2008, J AM DENT ASSOC, V139, p35S, DOI 10.14219/jada.archive.2008.0353
   Niklander S, 2017, BRAZ ORAL RES, V31, DOI [10.1590/1807-3107BOR-2017.vol31.0014, 10.1590/1807-3107bor-2017.vol31.0014]
   Pellegrino F, 2015, SUPPORT CARE CANCER, V23, P925, DOI 10.1007/s00520-014-2438-2
   Sanguineti G, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0331-x
   Sasportas LS, 2013, OR SURG OR MED OR PA, V116, pE37, DOI 10.1016/j.oooo.2013.02.017
   Simoes A, 2010, PHOTOMED LASER SURG, V28, P357, DOI 10.1089/pho.2009.2486
   Slade G D, 1994, Community Dent Health, V11, P3
   Slade GD, 1997, COMMUNITY DENT ORAL, V25, P284, DOI 10.1111/j.1600-0528.1997.tb00941.x
   Thomson WM, 1999, COMMUNITY DENT HLTH, V16, P12
   Tiwana MS, 2011, INDIAN J CANCER, V48, P289, DOI 10.4103/0019-509X.84918
   Vissink A, 2012, Ned Tijdschr Tandheelkd, V119, P493
   Willumsen T, 2010, GERODONTOLOGY, V27, P251, DOI 10.1111/j.1741-2358.2009.00344.x
NR 27
TC 0
Z9 0
U1 0
U2 0
PU MEDICINA ORAL S L
PI VALENCIA
PA CALLE DANIEL BALACIART N 4 PTA 17, VALENCIA, 46020, SPAIN
SN 1698-6946
J9 MED ORAL PATOL ORAL
JI Med. Oral Patol. Oral Cir. Bucal
PD NOV 1
PY 2019
VL 24
IS 6
BP E770
EP E775
AR 23131
DI 10.4317/medoral.23131
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA JJ2JM
UT WOS:000493988000011
PM 31655838
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU da Silva, GSG
   de Melo, MLM
   Leao, JC
   Carvalho, AT
   Porter, S
   Duarte, ALBP
   Dantas, AT
   Gueiros, LA
AF Gomes da Silva, Guilherme Soares
   Maymone de Melo, Marina Lins
   Leao, Jair Carneiro
   Carvalho, Alessandra Tavares
   Porter, Stephen
   Branco Pinto Duarte, Angela Luzia
   Dantas, Andrea Tavares
   Gueiros, Luiz Alcino
TI Oral features of systemic sclerosis: A case-control study
SO ORAL DISEASES
LA English
DT Article
DE orofacial features; periodontal disease; Systemic sclerosis
ID GASTROESOPHAGEAL-REFLUX DISEASE; SJOGRENS-SYNDROME; OROFACIAL
   MANIFESTATIONS; CLASSIFICATION CRITERIA; RHEUMATOID-ARTHRITIS; SYMPTOMS;
   ADULTS; HEALTH
AB Objective The aim of this study was to evaluate the orofacial parameters of systemic sclerosis (SSc) and its related systemic features. Subjects and Methods A descriptive case-control study was performed from November 2015 to October 2016. Ninety-three individuals were included and divided into SSc group (n = 50) and healthy controls (C, n = 43). Results Systemic sclerosis individuals were mostly women (43/50, 86%), with a mean age of 46 years (+/- 11.6 years). Telangiectasia (42/50, 84%) and reduced mouth opening (35/50, 70%) were the most frequent orofacial findings. The periodontitis frequency was much higher in SSc individuals than in healthy controls (90.7% x 48.83%; p < .001). In addition, SSc individuals presented a distinctive pattern of periodontitis, with low probing pocket depth (2 +/- 0.65 mm x 2 +/- 0.24; p < .001), higher gingival recession (4 +/- 2.13 x 0.14 +/- 0,22; p < .001), higher periodontal attachment loss (6 +/- 1.34 mm x 2 +/- 0.43, p < .001), and lower gingival bleeding index values (7.05 +/- 7.25 x 21.57 +/- 15.66; p < .001). Conclusions Orofacial manifestations were common in SSc and included a unique pattern of periodontal manifestation, characterized by lower gingival bleeding index, higher periodontal attachment loss, and low probing depth.
C1 [Gomes da Silva, Guilherme Soares; Maymone de Melo, Marina Lins; Leao, Jair Carneiro; Carvalho, Alessandra Tavares; Gueiros, Luiz Alcino] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Oral Med Unit, Ave Prof Moraes Rego,1235 CDU, BR-50670901 Recife, PE, Brazil.
   [Porter, Stephen] UCL Eastman Dent Inst, London, England.
   [Branco Pinto Duarte, Angela Luzia; Dantas, Andrea Tavares] Univ Fed Pernambuco, Hosp Cin, Rheumatol Unit, Recife, PE, Brazil.
RP Gueiros, LA (corresponding author), Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Oral Med Unit, Ave Prof Moraes Rego,1235 CDU, BR-50670901 Recife, PE, Brazil.
EM luiz.mgueiros@ufpe.br
RI Leao, Jair Carneiro/AAL-6154-2020; Gueiros, Luiz Alcino/B-6429-2015
OI Leao, Jair Carneiro/0000-0001-8303-2291; Gueiros, Luiz
   Alcino/0000-0003-4979-4318; Porter, Stephen/0000-0002-3328-2759
CR AINAMO J, 1975, INT DENT J, V25, P229
   [Anonymous], 2015, J PERIODONTOL, V86, P835, DOI 10.1902/jop.2015.157001
   Baldrighi S. E. Z. D. M., 2016, DISTURBIOS COMUNICAC, V28
   Baron M, 2015, ARTHRIT CARE RES, V67, P681, DOI 10.1002/acr.22490
   CARTER HG, 1974, J PERIODONTOL, V45, P801, DOI 10.1902/jop.1974.45.11.801
   CLEMENTS P, 1995, J RHEUMATOL, V22, P1281
   Crincoli V, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071189
   Daniels TE, 2011, ARTHRITIS RHEUM-US, V63, P2021, DOI 10.1002/art.30381
   EVERSOLE LR, 1984, J PERIODONTOL, V55, P175, DOI 10.1902/jop.1984.55.3.175
   Ganss C, 2006, MG ORAL SCI, V20, P32, DOI 10.1159/000093349
   Ghom A, 2014, TXB ORAL MED
   Jagadish Rekha, 2012, J Indian Soc Periodontol, V16, P271, DOI 10.4103/0972-124X.99275
   Jung S, 2017, ORAL DIS, V23, P424, DOI 10.1111/odi.12507
   Kaur S, 2013, J DENT RES, V92, P399, DOI 10.1177/0022034513483142
   Kobak S, 2013, INT J RHEUM DIS, V16, P88, DOI 10.1111/j.1756-185X.2012.01810.x
   Kucuk U, 2018, INDIAN J PATHOL MICR, V61, P319, DOI 10.4103/IJPM.IJPM_416_17
   LeRoy EC, 2001, J RHEUMATOL, V28, P1573
   Leung WK, 2011, J PERIODONTOL, V82, P1140, DOI 10.1902/jop.2010.100593
   Linnett V, 2002, AUST DENT J, V47, P156, DOI 10.1111/j.1834-7819.2002.tb00321.x
   Lussi A, 2014, MONOGR ORAL SCI, V25, P1, DOI 10.1159/000360380
   Oliveira HF, 2015, OR SURG OR MED OR PA, V119, P628, DOI 10.1016/j.oooo.2015.02.479
   Pischon N, 2008, J PERIODONTOL, V79, P979, DOI [10.1902/jop.2008.070501, 10.1902/jop.2008.070501 ]
   Pischon N, 2016, J PERIODONTOL, V87, P763, DOI 10.1902/jop.2016.150475
   Pizzo G, 2003, Clin Oral Investig, V7, P175, DOI 10.1007/s00784-003-0216-5
   Poole J L, 2005, Int J Dent Hyg, V3, P13, DOI 10.1111/j.1601-5037.2004.00108.x
   Rannou F, 2017, ARTHRIT CARE RES, V69, P1050, DOI 10.1002/acr.23098
   Silvestre-Rangil J., 2015, J ORAL RES, V4, p[340, 350], DOI [10.17126/joralres.2015.065, DOI 10.17126/J0RALRES.2015.065]
   van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098
   Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554
   Vonk MC, 2009, ANN RHEUM DIS, V68, P961, DOI 10.1136/ard.2008.091710
   Wada T, 2013, CASE REP DENT, V2013, DOI 10.1155/2013/937487
   WHO, 2013, ORAL HLTH SURVEYS BA
   WOOD RE, 1988, ORAL SURG ORAL MED O, V65, P172, DOI 10.1016/0030-4220(88)90161-2
   Yenisey M, 2005, J ORAL REHABIL, V32, P696, DOI 10.1111/j.1365-2842.2005.01474.x
   Yoshikawa H, 2012, J GASTROENTEROL, V47, P412, DOI 10.1007/s00535-011-0515-6
   Yuen HK, 2014, INT J DENT HYG, V12, P55, DOI 10.1111/idh.12024
NR 36
TC 3
Z9 3
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1354-523X
EI 1601-0825
J9 ORAL DIS
JI Oral Dis.
PD NOV
PY 2019
VL 25
IS 8
BP 1995
EP 2002
DI 10.1111/odi.13174
EA SEP 2019
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA JZ7FQ
UT WOS:000486293800001
PM 31407451
DA 2020-11-30
ER

PT J
AU Barros, KMA
   Paulino, MR
   Batista, MIHD
   Gueiros, LAM
   de Souza, PRE
   Leao, JC
   Carvalho, ADT
AF Albuquerque Barros, Keylla Marinho
   Paulino, Marcilia Ribeiro
   Holanda de Medeiros Batista, Mara Ilka
   Monteiro Gueiros, Luiz Alcino
   Eleuterio de Souza, Paulo Roberto
   Leao, Jair Carneiro
   Tavares Carvalho, Alessandra de Albuquerque
TI Absence of influence of polymorphisms of the MBL2 gene in oral
   infections by HSV-1 in individuals with HIV
SO BRAZILIAN JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE HIV infection; HSV-1; Mannose-biding lectin; Gene polymorphisms; Oral
   manifestation
ID MANNOSE-BINDING LECTIN; SIMPLEX-VIRUS TYPE-2; PROTEIN; ASSOCIATION;
   SALIVA; SUSCEPTIBILITY; PREVALENCE; VARIANT; INNATE; ERA
AB Polymorphisms in the structural gene MBL-2 (mannose-binding lectin-2) may result in low MBL serum concentration, associated with greater susceptibility to infection. The study evaluated the effects of MBL-2 polymorphisms with the oral manifestations of the HSV in human immunodeficiency virus (HIV)-infected patients. An observational case-control study was carried out, with the sample comprising 64 HIV+ and 65 healthy individuals. The signs and symptoms of HSV oral infection were evaluated, and oral mucosa buccal smears were collected. Polymorphisms of the MBL-2 gene and HSV-1 DNA were amplified through real-time PCR. The data revealed that of 64 HIV+, 29.6% presented signs and symptoms of HSV oral infection. Of these, the HSV-1 DNA was detected through real-time PCR in 21% of cases, and in 13.3% of asymptomatic individuals. There was no statistically significant difference between the symptomatic (p = 1) and the asymptomatic (p = 0.52) individuals, HIV+ and HIV-. Different genotypes (AA, A0, or 00) did not contribute to the oral manifestation of HSV in the HIV+ patients (p = 0.81) or HIV- (p = 0.45). There was no statistically significant difference in either group (p = 0.52). No significant association was identified between the MBL-2 gene polymorphisms in the oral manifestation of HSV infection. However, further studies are recommended with larger population groups before discarding this interrelationship.
C1 [Albuquerque Barros, Keylla Marinho] Univ Pernambuco UPE, Ave Gen Newton Cavalcanti 1652, BR-54756220 Camaragibe, PE, Brazil.
   [Paulino, Marcilia Ribeiro; Holanda de Medeiros Batista, Mara Ilka; Monteiro Gueiros, Luiz Alcino; Leao, Jair Carneiro; Tavares Carvalho, Alessandra de Albuquerque] Univ Fed Pernambuco UFPE, Ave Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
   [Eleuterio de Souza, Paulo Roberto] Fed Rural Univ Pernambuco UFRPE, Recife, PE, Brazil.
RP Paulino, MR (corresponding author), Univ Fed Pernambuco UFPE, Ave Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
EM marcilia.paulino@yahoo.com.br
RI Gueiros, Luiz Alcino/B-6429-2015; Leao, Jair Carneiro/AAL-6154-2020
OI Gueiros, Luiz Alcino/0000-0003-4979-4318; Leao, Jair
   Carneiro/0000-0001-8303-2291
CR Bathum L, 2006, MOL IMMUNOL, V43, P473, DOI 10.1016/j.molimm.2005.02.017
   Carr DJJ, 2001, EXP BIOL MED, V226, P353
   Chakraborty N, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-147
   Christensen T, 2007, J NEUROIMMUNOL, V183, P175, DOI 10.1016/j.jneuroim.2006.09.014
   da Silva LM, 2005, ORAL DIS, V11, P13, DOI 10.1111/j.1601-0825.2004.01058.x
   Eisen DP, 2003, CLIN INFECT DIS, V37, P1496, DOI 10.1086/379324
   Garcia-Laorden MI, 2006, MOL IMMUNOL, V43, P2143, DOI 10.1016/j.molimm.2006.01.008
   Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1
   GARRED P, 1992, CLIN EXP IMMUNOL, V90, P517
   Harandi AM, 2001, J GEN VIROL, V82, P845, DOI 10.1099/0022-1317-82-4-845
   Kakkanaiah VN, 1998, CLIN DIAGN LAB IMMUN, V5, P319, DOI 10.1128/CDLI.5.3.319-321.1998
   Kaufman HE, 2005, INVEST OPHTH VIS SCI, V46, P241, DOI 10.1167/iovs.04-0614
   Kilpatrick DC, 2002, BBA-GEN SUBJECTS, V1572, P401, DOI 10.1016/S0304-4165(02)00321-5
   Knaup B, 2000, ORAL MICROBIOL IMMUN, V15, P281, DOI 10.1034/j.1399-302x.2000.150502.x
   Koch A, 2001, JAMA-J AM MED ASSOC, V285, P1316, DOI 10.1001/jama.285.10.1316
   Mbopi-Keou FX, 2003, CLIN MICROBIOL INFEC, V9, P161, DOI 10.1046/j.1469-0691.2003.00550.x
   Miller CS, 2006, J CLIN MICROBIOL, V44, P2409, DOI 10.1128/JCM.00256-06
   Minchinton RM, 2002, SCAND J IMMUNOL, V56, P630, DOI 10.1046/j.1365-3083.2002.01167.x
   Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000
   Pinheiro RD, 2013, REV SOC BRAS MED TRO, V46, P15, DOI 10.1590/0037-868217172013
   Reading PC, 1995, BIOCHEM BIOPH RES CO, V217, P1128, DOI 10.1006/bbrc.1995.2886
   SUPER M, 1989, LANCET, V2, P1236
   Tan DHS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004210
   Tran CT, 2007, CLIN EXP IMMUNOL, V148, P101, DOI 10.1111/j.1365-2249.2007.03324.x
   Turner MW, 2003, MOL IMMUNOL, V40, P423, DOI 10.1016/S0161-5890(03)00155-X
   Valdimarsson H, 1998, SCAND J IMMUNOL, V48, P116
   VanCott KE, 1997, TRANSGENIC RES, V6, P203, DOI 10.1023/A:1018442124584
   WALD A, 1995, NEW ENGL J MED, V333, P770, DOI 10.1056/NEJM199509213331205
   Wang CC, 2010, ORAL SURG ORAL MED O, V109, P232, DOI 10.1016/j.tripleo.2009.08.037
   Worthley DL, 2005, INTERN MED J, V35, P548, DOI 10.1111/j.1445-5994.2005.00908.x
NR 30
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1517-8382
EI 1678-4405
J9 BRAZ J MICROBIOL
JI Braz. J. Microbiol.
PD JUL
PY 2019
VL 50
IS 3
BP 663
EP 668
DI 10.1007/s42770-019-00074-6
PG 6
WC Microbiology
SC Microbiology
GA IO0JS
UT WOS:000479065800010
PM 31001794
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Silva, LB
   Neto, APD
   Maia, SMAS
   Guimaraes, CD
   Quidute, IL
   Carvalho, ADT
   Junior, SA
   Leao, JC
AF Silva, Luciano B.
   dos Santos Neto, Alexandrino P.
   Maia, Sandra M. A. S.
   Guimaraes, Carolina dos Santos
   Quidute, Iliana L.
   Carvalho, Alessandra de A. T.
   Junior, Severino A.
   Leao, Jair C.
TI The Role of TNF-alpha as a Proinflammatory Cytokine in Pathological
   Processes
SO OPEN DENTISTRY JOURNAL
LA English
DT Review
DE Tumor necrosis factor; Inflammation; Cytokine(s); Leucocytes; Antigen
   Presenting Cells (APCs); Interferon (IFN)
ID TUMOR-NECROSIS-FACTOR; TRANSMEMBRANE TNF; CROHNS-DISEASE;
   MYOCARDIAL-INFARCTION; APICAL PERIODONTITIS; RADICULAR CYSTS; RECEPTOR;
   MECHANISMS; INFLIXIMAB; EXPRESSION
AB TNF-alpha is a member of the vast cytokine family being considered a proinflammatory substance produced many by macrophages and other cells belonging to the innate immunity, many of them classified as indeed Antigen Presenting Cells (APCs) involved in the complex chemotactic process of activation of the adaptive immunity. The aim of this work was to accomplish a literature review concerning the main pathologies that have TNF-alpha as a modulating agent in other to bring light to the main interactions present in the inflammation installed.
C1 [Silva, Luciano B.; Maia, Sandra M. A. S.; Guimaraes, Carolina dos Santos; Quidute, Iliana L.] Univ Pernambuco UPE, Dept Endodont, 1650 Gal Ne Wton Cavalcanti Ave, BR-54753020 Camaragibe, PE, Brazil.
   [dos Santos Neto, Alexandrino P.; Carvalho, Alessandra de A. T.; Leao, Jair C.] Fed Univ Pernambuco UFPE, Dept Clin & Prevent Dent, Hlth Sci Ctr, 1235 Prof Moraes Rego St, BR-50670901 Recife, PE, Brazil.
   [Junior, Severino A.] Fed Univ Pernambuco UFPE, Exact & Nat Sci Ctr, Dept Fundamental Chem, Prof Luis Freire St, BR-50740540 Recife, PE, Brazil.
RP Neto, APD (corresponding author), Fed Univ Pernambuco UFPE, Dept Clin & Prevent Dent, Hlth Sci Ctr, 1235 Prof Moraes Rego St, BR-50670901 Recife, PE, Brazil.
EM alexandrinoneto@live.com
RI Leao, Jair Carneiro/AAL-6154-2020
OI Leao, Jair Carneiro/0000-0001-8303-2291
CR Aggarwal BB, 2000, ANN RHEUM DIS, V59, P6
   Alam R, 2003, ALLERGY CLIN IMMUNOL, V111, P5687
   Antonicelli R, 2005, CORONARY ARTERY DIS, V16, P489, DOI 10.1097/00019501-200512000-00006
   Arcaroli J, 2005, SHOCK, V24, P300, DOI 10.1097/01.shk.0000180621.52058.e1
   Armuzzi A, 2008, DIGEST LIVER DIS, V40, pS271, DOI 10.1016/S1590-8658(08)60537-X
   Asgharpour A, 2013, CLIN EXP GASTROENTER, V6, P153, DOI 10.2147/CEG.S35163
   Badorff C, 1997, J AM COLL CARDIOL, V29, P429, DOI 10.1016/S0735-1097(96)00475-5
   BAKER E, 1991, CYTOGENET CELL GENET, V57, P117, DOI 10.1159/000133127
   Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3
   Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607
   BLICK M, 1987, CANCER RES, V47, P2986
   Bolli R, 1999, PHYSIOL REV, V79, P609
   Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086
   Boyce Brendan F., 2005, Keio Journal of Medicine, V54, P127, DOI 10.2302/kjm.54.127
   Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X
   Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543
   CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666
   Chang WT, 2012, INT J MOL SCI, V13, P1846, DOI 10.3390/ijms13021846
   Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980
   Chen H, 2011, J LEUKOCYTE BIOL, V89, P917, DOI 10.1189/jlb.1209812
   Cheng X, 2014, DRUG DISCOV TODAY, V19, P1822, DOI 10.1016/j.drudis.2014.06.029
   Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492
   Colombel JF, 2009, INFLAMM BOWEL DIS, V15, P1308, DOI 10.1002/ibd.20956
   Delima AJ, 2001, J CLIN PERIODONTOL, V28, P233, DOI 10.1034/j.1600-051x.2001.028003233.x
   DELREY A, 1987, ANN NY ACAD SCI, V496, P85
   DEMBIC Z, 1990, Cytokine, V2, P231, DOI 10.1016/1043-4666(90)90022-L
   Dhalla NS, 1999, CAN J CARDIOL, V15, P587
   Dinarello C. A., 1997, REV E, V8, P253, DOI DOI 10.1016/S1359-6101(97)00023-3
   ENGELMANN H, 1990, J BIOL CHEM, V265, P1531
   FINKEL MS, 1992, SCIENCE, V257, P387, DOI 10.1126/science.1631560
   Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607
   Galbraith GMP, 1998, J PERIODONTOL, V69, P428, DOI 10.1902/jop.1998.69.4.428
   Georgopoulos S, 1996, J INFLAMM, V46, P86
   Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa
   Habib FM, 1996, LANCET, V347, P1151, DOI 10.1016/S0140-6736(96)90610-8
   Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4
   HIEBER U, 1994, ONCOLOGY-BASEL, V51, P142, DOI 10.1159/000227329
   Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8
   Hu X, 2014, J IMMUNOL, V192, P1320, DOI 10.4049/jimmunol.1203195
   JAATTELA M, 1991, LAB INVEST, V64, P724
   Kabashima H, 2002, J ORAL PATHOL MED, V31, P175, DOI 10.1034/j.1600-0714.2002.310309.x
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x
   Kim EY, 2004, J IMMUNOL, V173, P4500, DOI 10.4049/jimmunol.173.7.4500
   Kotze PG, 2010, GUIA PRATICO TERAPIA, P24
   LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405
   Li QF, 2006, CANCER IMMUNOL IMMUN, V55, P1470, DOI 10.1007/s00262-006-0150-x
   Li Yao-Chen, 2006, Ai Zheng, V25, P560
   Liapatas S, 2003, INT ENDOD J, V36, P464, DOI 10.1046/j.1365-2591.2003.00627.x
   LIGHT R. J., 2005, COCHRANE HDB SYSTEMA
   Lin LM, 2007, J ENDODONT, V33, P908, DOI 10.1016/j.joen.2007.02.006
   Marr RA, 1997, GENE THER, V4, P1181, DOI 10.1038/sj.gt.3300528
   MATSUMORI A, 1994, BRIT HEART J, V72, P561
   MCINTOSH JK, 1988, CANCER RES, V48, P4011
   Mehrad B, 1999, IMMUNOL RES, V20, P15, DOI 10.1007/BF02786504
   Meyer O., 2003, B ACAD NATL MED
   Morsani JM, 2011, J ENDODONT, V37, P455, DOI 10.1016/j.joen.2011.01.009
   MORSE DR, 1973, ORAL SURG ORAL MED O, V35, P249, DOI 10.1016/0030-4220(73)90292-2
   Nair PNR, 2004, CRIT REV ORAL BIOL M, V15, P348, DOI 10.1177/154411130401500604
   Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10
   PENNICA D, 1984, NATURE, V312, P724, DOI 10.1038/312724a0
   Prso IB, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/38210
   Qidwai T, 2011, SCAND J IMMUNOL, V74, P522, DOI 10.1111/j.1365-3083.2011.02602.x
   Reid CL, 2002, CRIT CARE MED, V30, P2216, DOI 10.1097/00003246-200210000-00007
   Ricucci D, 2009, J ENDODONT, V35, P493, DOI 10.1016/j.joen.2008.12.014
   Rubenstein JH, 2002, J CLIN GASTROENTEROL, V35, P151, DOI 10.1097/00004836-200208000-00007
   Sanchez-Munoz F, 2008, WORLD J GASTROENTERO, V14, P4280, DOI 10.3748/wjg.14.4280
   Santee SM, 1996, J BIOL CHEM, V271, P21151, DOI 10.1074/jbc.271.35.21151
   SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W
   Schroder JM, 2000, CLIN DERMATOL, V18, P245, DOI 10.1016/S0738-081X(99)00117-0
   SECKINGER P, 1988, J EXP MED, V167, P1511, DOI 10.1084/jem.167.4.1511
   SHROUT MK, 1993, ORAL SURG ORAL MED O, V76, P356, DOI 10.1016/0030-4220(93)90268-9
   Silva L., 2015, GLOB J INFECT DIS CL, V1, P21
   Spector TD, 1990, EPIDEMIOLOGY RHEUMAT
   Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200
   TorreAmione G, 1996, CIRCULATION, V93, P704
   TRACEY KJ, 1993, ANNU REV CELL BIOL, V9, P317, DOI 10.1146/annurev.cb.09.110193.001533
   Trowbridge H. O., 1997, INFLAMMATION REV PRO
   Turner SJ, 2004, P NATL ACAD SCI USA, V101, P3545, DOI 10.1073/pnas.0307347101
   VanDeventer SJH, 1997, GUT, V40, P443, DOI 10.1136/gut.40.4.443
   VILCEK J, 1991, J BIOL CHEM, V266, P7313
   Zehnder M, 2003, CYTOKINE, V22, P84, DOI 10.1016/S1043-4666(03)00116-9
   Zhang P, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006569
   Zhang P, 2017, INT HEART J, V58, P245, DOI 10.1536/ihj.16-236
   ZIMMERMAN RJ, 1989, CANCER RES, V49, P1644
NR 85
TC 0
Z9 0
U1 0
U2 0
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1874-2106
J9 OPEN DENT J
JI Open Dent. J.
PY 2019
VL 13
BP 332
EP 338
DI 10.2174/1874210601913010332
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA JI0TT
UT WOS:000493180700048
OA Other Gold
DA 2020-11-30
ER

PT J
AU Porter, S
   Gueiros, LA
   Leao, JC
   Fedele, S
AF Porter, Stephen
   Gueiros, Luiz Alcino
   Leao, Jair Carneiro
   Fedele, Stefano
TI Risk factors and etiopathogenesis of potentially premalignant oral
   epithelial lesions
SO ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY
LA English
DT Article
ID HUMAN PAPILLOMA-VIRUS; SQUAMOUS-CELL CARCINOMAS; SMOKELESS TOBACCO USE;
   LICHEN-PLANUS; MALIGNANT-TRANSFORMATION; SYSTEMIC-SCLEROSIS;
   DYSKERATOSIS-CONGENITA; SUBMUCOUS FIBROSIS; FANCONI-ANEMIA; CANCER
   INCIDENCE
AB Potentially malignant oral mucosal disease has some ability to give rise to malignancy of the oral epithelium, that is, oral squamous cell carcinoma (OSCC). The present article provides a succinct review of the possible or probable causes of potentially premalignant oral epithelial lesions. There is a focus upon studies that examined the causes or etiologic associations with clinically likely or histopathologically detectable oral epithelial dysplasia.
C1 [Porter, Stephen; Fedele, Stefano] UCL Eastman Dent Inst, 256 Grays Inn Rd, London WC1X 8LD, England.
   [Gueiros, Luiz Alcino; Leao, Jair Carneiro] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Oral Med Unit, Recife, PE, Brazil.
   [Fedele, Stefano] UCL UCLH NIHR Biomed Res Ctr, Oral Theme, London, England.
RP Porter, S (corresponding author), UCL Eastman Dent Inst, 256 Grays Inn Rd, London WC1X 8LD, England.
EM s.porter@ucl.ac.uk
RI Leao, Jair Carneiro/AAL-6154-2020; Gueiros, Luiz Alcino/B-6429-2015
OI Leao, Jair Carneiro/0000-0001-8303-2291; Gueiros, Luiz
   Alcino/0000-0003-4979-4318; Porter, Stephen/0000-0002-3328-2759
CR Agbor MA, 2013, AFR HEALTH SCI, V13, P785, DOI 10.4314/ahs.v13i3.38
   Aghbari SMH, 2017, ORAL ONCOL, V68, P92, DOI 10.1016/j.oraloncology.2017.03.012
   Al-Attas SA, 2014, ASIAN PAC J CANCER P, V15, P757, DOI 10.7314/APJCP.2014.15.2.757
   Amor-Gueret M, 2006, CANCER LETT, V236, P1, DOI 10.1016/j.canlet.2005.04.023
   Arduino PG, 2013, ORAL DIS, V19, P642, DOI 10.1111/odi.12065
   Arora H, 2014, INT J DERMATOL, V53, P798, DOI 10.1111/ijd.12408
   Awan KH, 2016, JCPSP-J COLL PHYSICI, V26, P775, DOI 2434
   Baig S, 2012, JCPSP-J COLL PHYSICI, V22, P135, DOI 02.2012/JCPSP.135138
   BARIC JM, 1982, ORAL SURG ORAL MED O, V54, P424, DOI 10.1016/0030-4220(82)90389-9
   Bodner L, 2014, ORAL ONCOL, V50, P84, DOI 10.1016/j.oraloncology.2013.11.001
   Boffetta P, 2008, LANCET ONCOL, V9, P667, DOI 10.1016/S1470-2045(08)70173-6
   Bosetti C, 2008, AM J EPIDEMIOL, V167, P468, DOI 10.1093/aje/kwm318
   Camara PR, 2016, ORAL DIS, V22, P523, DOI 10.1111/odi.12484
   Campisi G, 2004, ORAL SURG ORAL MED O, V98, P705, DOI 10.1016/j.tripleo.2004.04.012
   Cavalcanti LG, 2015, PEDIATR BLOOD CANCER, V62, P1024, DOI 10.1002/pbc.25417
   Chandra P, 2012, ORAL HLTH PREV DENT, V10, P149
   Chang CM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1617-5
   Chen X, 2017, ARCH ORAL BIOL, V83, P334, DOI 10.1016/j.archoralbio.2017.08.011
   Cheng YSL, 2016, OR SURG OR MED OR PA, V122, P332, DOI 10.1016/j.oooo.2016.05.004
   Chuang SL, 2017, CANCER-AM CANCER SOC, V123, P1597, DOI 10.1002/cncr.30517
   Coulombe J, 2016, J EUR ACAD DERMATOL, V30, pE157, DOI 10.1111/jdv.13464
   D'Souza G, 2017, ANN ONCOL, V28, P3065, DOI 10.1093/annonc/mdx535
   Delsing CE, 2012, MED MYCOL CASE REP, V1, P5, DOI 10.1016/j.mmcr.2012.02.003
   Derk CT, 2006, J RHEUMATOL, V33, P1113
   Derk CT, 2005, J RHEUMATOL, V32, P637
   Dietrich T, 2004, ORAL ONCOL, V40, P158, DOI 10.1016/S1368-8375(03)00145-3
   Dilhari A, 2016, ACTA ODONTOL SCAND, V74, P565, DOI 10.1080/00016357.2016.1220018
   Dombi C, 2001, COMMUNITY DENT ORAL, V29, P9
   Ekanayaka RP, 2016, OR SURG OR MED OR PA, V122, P192, DOI 10.1016/j.oooo.2015.12.018
   Fisher MA, 2005, COMMUNITY DENT ORAL, V33, P45, DOI 10.1111/j.1600-0528.2004.00195.x
   Fitzpatrick SG, 2014, J AM DENT ASSOC, V145, P45, DOI 10.14219/jada.2013.10
   Gandini S, 2008, INT J CANCER, V122, P155, DOI 10.1002/ijc.23033
   Georgakopoulou EA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/759626
   Ghittoni R, 2015, ECANCERMEDICALSCIENC, V9, DOI 10.3332/ecancer.2015.526
   Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025
   Gupta B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113385
   Gupta P C, 1995, Oral Dis, V1, P54
   Hashibe M, 2000, INT J CANCER, V88, P129, DOI 10.1002/1097-0215(20001001)88:1&lt;129::AID-IJC20&gt;3.0.CO;2-U
   Hubbers CU, 2015, VIRULENCE, V6, P244, DOI 10.1080/21505594.2014.999570
   IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC MONOG EVAL CARC, V96, P1
   Jacobsen S, 1998, BRIT J RHEUMATOL, V37, P750
   Kamat MS, 2011, J INVESTIG CLIN DENT, V2, P275, DOI 10.1111/j.2041-1626.2011.00078.x
   Khan Z, 2018, NICOTINE TOB RES, V20, P12, DOI 10.1093/ntr/ntw310
   Khan Z, 2014, J CANCER EPIDEMIOL, V2014, DOI 10.1155/2014/394696
   Kragelund C, 2013, CLIN ORAL INVEST, V17, P957, DOI 10.1007/s00784-012-0757-6
   KROGH P, 1987, CARCINOGENESIS, V8, P1543, DOI 10.1093/carcin/8.10.1543
   Kruger M, 2014, J CRANIO MAXILL SURG, V42, P1506, DOI 10.1016/j.jcms.2014.04.022
   Kruse ALD, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-29
   Kuo CF, 2012, SCAND J RHEUMATOL, V41, P44, DOI 10.3109/03009742.2011.618145
   Kutler DI, 2016, LARYNGOSCOPE, V126, P870, DOI 10.1002/lary.25726
   Leão Jair Carneiro, 2006, Clinics, V61, P161, DOI 10.1590/S1807-59322006000200012
   Lerman MA, 2017, MODERN PATHOL, V30, P1646, DOI 10.1038/modpathol.2017.71
   Lingen MW, 2013, ORAL ONCOL, V49, P1, DOI 10.1016/j.oraloncology.2012.07.002
   Liu W, 2011, HISTOPATHOLOGY, V59, P292, DOI 10.1111/j.1365-2559.2011.03934.x
   Lodi G, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001829.pub4
   Lubin JH, 2009, AM J EPIDEMIOL, V170, P937, DOI 10.1093/aje/kwp222
   Ma LH, 2013, ANN DIAGN PATHOL, V17, P327, DOI 10.1016/j.anndiagpath.2013.03.002
   Madiyal A, 2016, W INDIAN MED J, V65, P383, DOI 10.7727/wimj.2015.175
   Mallery SR, 2014, CANCER PREV RES, V7, P23, DOI 10.1158/1940-6207.CAPR-13-0262
   Marini A, 2007, DERMATOL SURG, V33, P756, DOI 10.1111/j.1524-4725.2007.33157.x
   Martin GC, 1999, J AM DENT ASSOC, V130, P945, DOI 10.14219/jada.archive.1999.0335
   Martinez P, 2017, J CELL BIOL, V216, P875, DOI 10.1083/jcb.201610111
   Maserejian NN, 2006, CANCER EPIDEM BIOMAR, V15, P774, DOI 10.1158/1055-9965.EPI-05-0842
   McCullough M, 2002, ORAL ONCOL, V38, P391, DOI 10.1016/S1368-8375(01)00079-3
   Mignogna MD, 2007, EJSO-EUR J SURG ONC, V33, P383, DOI 10.1016/j.ejso.2006.09.028
   Miller CS, 2001, ORAL SURG ORAL MED O, V91, P622, DOI 10.1067/moe.2001.115392
   Morse DE, 1996, CANCER EPIDEM BIOMAR, V5, P769
   Morse DE, 2007, CANCER CAUSE CONTROL, V18, P919, DOI 10.1007/s10552-007-9026-4
   Munshi T, 2015, J AM DENT ASSOC, V146, P760, DOI 10.1016/j.adaj.2015.04.014
   Narayan T V, 2016, J Oral Maxillofac Pathol, V20, P354
   Nilsson R, 2011, REGUL TOXICOL PHARM, V60, P268, DOI 10.1016/j.yrtph.2011.02.014
   Olesen AB, 2010, BRIT J DERMATOL, V163, P800, DOI 10.1111/j.1365-2133.2010.09861.x
   Onishi A, 2013, ARTHRITIS RHEUM-US, V65, P1913, DOI 10.1002/art.37969
   Ostwald C, 2003, MED MICROBIOL IMMUN, V192, P145, DOI 10.1007/s00430-002-0161-y
   Perez-Ortuno R, 2016, ENVIRON RES, V151, P635, DOI 10.1016/j.envres.2016.08.036
   Petti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078999
   Pindborg J J, 1972, J Oral Pathol, V1, P22
   Pivovar A, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26622
   Prakash P, 2013, J CLIN DIAGN RES, V7, P2793, DOI 10.7860/JCDR/2013/7720.3882
   Reddy Sujatha S, 2015, Indian J Dent Res, V26, P537, DOI 10.4103/0970-9290.172083
   Reichart PA, 2002, J ORAL PATHOL MED, V31, P468, DOI 10.1034/j.1600-0714.2002.00009.x
   ROEDPETERSEN B, 1982, ACTA DERM-VENEREOL, V62, P164
   Rosenberg PS, 2008, HAEMATOLOGICA, V93, P511, DOI 10.3324/haematol.12234
   Sadri GH, 2007, J RES HEALTH SCI, V7, P18
   Samatha Yalamanchili, 2014, J Contemp Dent Pract, V15, P466
   Sathish N, 2014, J DENT RES, V93, P29, DOI 10.1177/0022034514527969
   Savage SA, 2017, SEMIN HEMATOL, V54, P105, DOI 10.1053/j.seminhematol.2017.04.004
   Seif AE, 2011, CANCER GENET-NY, V204, P227, DOI 10.1016/j.cancergen.2011.04.005
   Shephard MK, 2012, OR SURG OR MED OR PA, V114, pE36, DOI 10.1016/j.oooo.2012.04.013
   Sikka S, 2014, INT J PREVENTIVE MED, V5, P430
   SILVERMAN S, 1984, CANCER, V53, P563
   Sinha DN, 2016, INT J CANCER, V138, P1368, DOI 10.1002/ijc.29884
   Sinusas K, 2006, MED SCI SPORT EXER, V38, P1204, DOI 10.1249/01.mss.0000227303.80783.46
   Garcia MSF, 2014, J BLOOD MED, V5, P157, DOI 10.2147/JBM.S47437
   Syrjanen S, 2011, ORAL DIS, V17, P58, DOI 10.1111/j.1601-0825.2011.01792.x
   TALAMINI R, 1990, INT J CANCER, V46, P391, DOI 10.1002/ijc.2910460310
   THEAKER JM, 1989, ORAL SURG ORAL MED O, V67, P81, DOI 10.1016/0030-4220(89)90307-1
   Touzot F, 2012, M S-MED SCI, V28, P618, DOI 10.1051/medsci/2012286015
   Tsai KY, 2009, COMMUNITY DENT ORAL, V37, P555, DOI 10.1111/j.1600-0528.2009.00504.x
   van der Meij EH, 2007, ORAL ONCOL, V43, P742, DOI 10.1016/j.oraloncology.2006.09.006
   van der Meij EH, 2003, ORAL SURG ORAL MED O, V96, P164, DOI 10.1016/S1079-2104(03)00305-6
   Velleuer E, 2017, CURR DRUG TARGETS, DOI [10.2174/1389450118666170525115651, DOI 10.2174/1389450118666170525115651]
   Vulliamy TJ, 2006, BLOOD, V107, P2680, DOI 10.1182/blood-2005-07-2622
   Warnakulasuriya KAAS, 2007, J ORAL PATHOL MED, V36, P63, DOI 10.1111/j.1600-0714.2007.00496.x
   Warnakulasuriya S, 2008, J ORAL PATHOL MED, V37, P157, DOI 10.1111/j.1600-0714.2007.00605.x
   Warnakulasuriya S, 2010, INT DENT J, V60, P7, DOI 10.1922/IDJ_2532Warnakulasuriya24
   Weitkunat R, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-334
   Wu L, 2013, ANN DIAGN PATHOL, V17, P37, DOI 10.1016/j.anndiagpath.2012.05.002
   Xu ZY, 2013, ANN DIAGN PATHOL, V17, P408, DOI 10.1016/j.anndiagpath.2013.04.008
   Yang PY, 2017, J ORAL PATHOL MED, V46, P1040, DOI 10.1111/jop.12570
   Yang SW, 2009, CANCER EPIDEMIOL, V33, P118, DOI 10.1016/j.canep.2009.05.003
NR 111
TC 11
Z9 11
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 2212-4403
EI 1528-395X
J9 OR SURG OR MED OR PA
JI Oral Surg. Oral Med. Oral Pathol. Oral Radiol.
PD JUN
PY 2018
VL 125
IS 6
BP 603
EP 611
DI 10.1016/j.oooo.2018.03.008
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA GK8XB
UT WOS:000436513900017
PM 29891084
OA Bronze
DA 2020-11-30
ER

PT J
AU Gueiros, LA
   Arao, T
   Souza, T
   Vieira, CL
   Gomez, RS
   Almeida, OP
   Lodi, G
   Leao, JC
AF Gueiros, L. A.
   Arao, T.
   Souza, T.
   Vieira, C. L.
   Gomez, R. S.
   Almeida, O. P.
   Lodi, G.
   Leao, J. C.
TI IL17A polymorphism and elevated IL17A serum levels are associated with
   oral lichen planus
SO ORAL DISEASES
LA English
DT Article
DE disease susceptibility; genetic polymorphism; interleukin 17; oral
   lichen planus
ID TH17-ASSOCIATED CYTOKINES; CHRONIC PERIODONTITIS; RHEUMATOID-ARTHRITIS;
   IL-17F POLYMORPHISMS; GENE POLYMORPHISMS; INTERLEUKIN 17A; EXPRESSION;
   PATHOGENESIS; LESIONS; CELLS
AB ObjectiveThe aim of this study was to evaluate the association of IL17A G197A polymorphism and serum levels with oral lichen planus (OLP) susceptibility and clinical presentation.
   Subjects and MethodsEighty-three individuals diagnosed with OLP and 99 healthy controls (C) were consecutively recruited. All participants had desquamating oral mucosal cells collected and DNA isolated for IL17A (G197A) genotyping. Blood samples of 42 OLP individuals and 23 healthy controls were collected for evaluation of IL17A serum levels.
   ResultsIL17A G197A genotypes were associated with an increased chance of having OLP (GA/AAxGG, OR=3.44, 95% CI=1.87-6.33, p<.001). Overall A carriers (GA or AA) were more common in OLP (38.1%) than in C (20.2%; OR=2.43, 95% CI=1.53-3.87, p<.001). Serum levels of IL17A were higher among patients with OLP than in healthy controls (reticular, p=.0003; erosive, p<.001), but no difference was found among the disease types.
   ConclusionsIL17A G197A is associated with a higher susceptibility of developing OLP and these patients seem to present a considerable increase in IL17A serum levels. These findings suggest that Th17 cells, and IL17A in particular, may play a pivotal role in OLP pathogenesis.
C1 [Gueiros, L. A.; Souza, T.; Vieira, C. L.; Leao, J. C.] Univ Fed Pernambuco, CEPLO, Programa Posgrad Odontol, Recife, PE, Brazil.
   [Arao, T.; Gomez, R. S.] Univ Fed Minas Gerais, Dept Cirurgia Oral & Patol, Fac Odontol, Belo Horizonte, MG, Brazil.
   [Almeida, O. P.] Univ Estadual Campinas, Area Patol, Fac Odontol Piracicaba, Piracicaba, Brazil.
   [Lodi, G.] Univ Milan, Oral Med Unit, Dipartimento Sci Biomed Chirurg & Odontoiatr, Milan, Italy.
RP Gueiros, LA (corresponding author), Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Ave Prof Moraes Rego 1235, BR-1235 Recife, PE, Brazil.
EM luiz.mgueiros@ufpe.br
RI Gueiros, Luiz Alcino/B-6429-2015; Gomez, Ricardo Santiago/G-1976-2012;
   Leao, Jair Carneiro/AAL-6154-2020; Lodi, Giovanni/C-1049-2013
OI Gueiros, Luiz Alcino/0000-0003-4979-4318; Gomez, Ricardo
   Santiago/0000-0001-8770-8009; Leao, Jair Carneiro/0000-0001-8303-2291;
   Lodi, Giovanni/0000-0002-0218-8292; Paes de Almeida,
   Oslei/0000-0003-2002-8003
FU Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco
   [1092-4.02/15]
FX Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco,
   Grant/Award Number: 1092-4.02/15
CR Albert PR, 2011, J PSYCHIATR NEUROSCI, V36, P363, DOI 10.1503/jpn.110137
   Carvalho CN, 2016, CLIN ORAL INVEST, V20, P495, DOI 10.1007/s00784-015-1540-2
   Espinoza JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026229
   Gueiros LA, 2012, OR SURG OR MED OR PA, V113, P661, DOI 10.1016/j.oooo.2011.12.008
   Hammad A, 2016, AUTOIMMUNITY, V49, P31, DOI 10.3109/08916934.2015.1101071
   Huang CH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004501
   Khan A, 2003, J ORAL PATHOL MED, V32, P77, DOI 10.1034/j.1600-0714.2003.00077.x
   Linhartova PB, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/2979846
   Liu JW, 2015, HUM IMMUNOL, V76, P6, DOI 10.1016/j.humimm.2014.12.011
   Lu R, 2015, J ORAL PATHOL MED, V44, P1, DOI 10.1111/jop.12142
   Lu R, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/701094
   Nemati K, 2015, GENE, V561, P88, DOI 10.1016/j.gene.2015.02.014
   Nordang GBN, 2009, RHEUMATOLOGY, V48, P367, DOI 10.1093/rheumatology/ken512
   Piccinni MP, 2014, ORAL DIS, V20, P212, DOI 10.1111/odi.12094
   Pouralibaba Firoz, 2013, J Dent Res Dent Clin Dent Prospects, V7, P91, DOI 10.5681/joddd.2013.016
   Vidal-Castineira JR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158905
   Rhodus NL, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/19854
   Roopashree MR, 2010, J ORAL PATHOL MED, V39, P729, DOI 10.1111/j.1600-0714.2010.00946.x
   Shaker O, 2012, BRIT J DERMATOL, V166, P1367, DOI 10.1111/j.1365-2133.2011.10793.x
   Shen ZY, 2014, ARCH DERMATOL RES, V306, P441, DOI 10.1007/s00403-013-1429-3
   Shi GC, 2015, GENET MOL RES, V14, P8526, DOI 10.4238/2015.July.28.22
   Siew LQC, 2017, CLIN EXP ALLERGY, V47, P740, DOI 10.1111/cea.12907
   Sugerman PB, 2002, CRIT REV ORAL BIOL M, V13, P350, DOI 10.1177/154411130201300405
   Thongprasom K, 2006, J ORAL PATHOL MED, V35, P161, DOI 10.1111/j.1600-0714.2006.00392.x
   van der Meij EH, 2003, ORAL SURG ORAL MED O, V96, P164, DOI 10.1016/S1079-2104(03)00305-6
   Vered M, 2013, CLIN ORAL INVEST, V17, P1365, DOI 10.1007/s00784-012-0814-1
   Wang H, 2014, CLIN ORAL INVEST, V18, P1647, DOI 10.1007/s00784-013-1131-z
   Wang H, 2013, INFLAMMATION, V36, P696, DOI 10.1007/s10753-013-9594-2
   Xie SX, 2012, J HUAZHONG U SCI-MED, V32, P451, DOI 10.1007/s11596-012-0078-7
   Yang LJ, 2016, EUR REV MED PHARMACO, V20, P1271
   Yu JJ, 2008, FRONT BIOSCI-LANDMRK, V13, P170, DOI 10.2741/2667
   Yu PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044380
   Zhang XF, 2013, INFLAMM RES, V62, P743, DOI 10.1007/s00011-013-0629-9
NR 33
TC 5
Z9 6
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1354-523X
EI 1601-0825
J9 ORAL DIS
JI Oral Dis.
PD APR
PY 2018
VL 24
IS 3
BP 377
EP 383
DI 10.1111/odi.12718
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA GA0TT
UT WOS:000428027900012
PM 28741807
DA 2020-11-30
ER

PT J
AU Alves, VLA
   Perez-de-Oliveira, ME
   de Castro, JFL
   Vieira, CL
   Leao, JC
   Perez, DED
AF Assuncao Alves, Violante Lina
   Perez-de-Oliveira, Maria Eduarda
   Lisboa de Castro, Jurema Freire
   Vieira, Camila Lins
   Leao, Jair Carneiro
   da Cruz Perez, Danyel Elias
TI Intraoral Pleomorphic Adenoma in Young Patients
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Adolescents; oral cavity; pediatric; pleomorphic adenoma; upper lip
ID SALIVARY-GLAND TUMORS; CHILDREN
AB Background:Intraoral pleomorphic adenoma (PA) is rare in young individuals, with only single clinical reports or small patient series reported previously.Aim:The aim of this study was to describe the clinicopathological features of PA in 4 patients under 18 years of age, and to discuss the differential diagnosis of pediatric patients presenting with intraoral submucosal nodules.Methods:Between 2000 and 2015, all patients of intraoral PA in patients aged 18 years diagnosed in the Oral Pathology Laboratory of the Universidade Federal de Pernambuco, Brazil, were retrieved for the study. Clinical data were recorded from the clinical charts. Histopathological slides stained with hematoxylin and eosin were reviewed to confirm the diagnosis.Results:There were 4 cases of PA in patients aged 18 years. All patients in this patient series were males, with a mean age of 16.7 years. Three cases occurred in the palate, and in 1 case, the upper lip was affected. All PAs appeared as a painless, smooth surface, well-circumscribed, and submucosal nodule. All patients were surgically excised and subsequent histopathological analysis revealed well-circumscribed tumors composed of cells that were arranged in ducts within a fibromyxoid stroma. No signs of recurrence were observed in 3 patients after a mean follow-up of 30 months. One patient is lost to follow-up.Conclusion:Although PAs are unusual in young patients, they should be considered in the differential diagnosis of oral submucosal nodules.
C1 [Assuncao Alves, Violante Lina; Perez-de-Oliveira, Maria Eduarda; Lisboa de Castro, Jurema Freire; da Cruz Perez, Danyel Elias] Univ Fed Pernambuco, Oral Pathol Unit, Sch Dent, Dept Clin & Prevent Dent, Recife, PE, Brazil.
   [Vieira, Camila Lins; Leao, Jair Carneiro] Univ Fed Pernambuco, Sch Dent, Dept Clin & Prevent Dent, Stomatol Unit, Recife, PE, Brazil.
RP Perez, DED (corresponding author), Univ Fed Pernambuco, Dept Clin & Odontol Prevent, S-N Cidade Univ, BR-50740521 Recife, PE, Brazil.
EM danyel.perez@ufpe.br
RI Leao, Jair Carneiro/AAL-6154-2020; Perez-de-Oliveira, Maria
   Eduarda/N-7969-2019; da Cruz Perez, Danyel Elias/G-5429-2012
OI Leao, Jair Carneiro/0000-0001-8303-2291; Perez-de-Oliveira, Maria
   Eduarda/0000-0003-3265-2671; da Cruz Perez, Danyel
   Elias/0000-0002-4591-4645
CR BUDNICK SD, 1982, J DENT CHILD, V49, P44
   Lopes MLDD, 2017, EUR ARCH OTO-RHINO-L, V274, P543, DOI 10.1007/s00405-016-4253-5
   Fang QG, 2013, INT J PEDIATR OTORHI, V77, P1252, DOI 10.1016/j.ijporl.2013.04.034
   Jorge J, 2002, INT J ORAL MAX SURG, V31, P273, DOI 10.1054/ijom.2002.0206
   Lotufo Monica A, 2008, J Oral Sci, V50, P225, DOI 10.2334/josnusd.50.225
   Perez DED, 2004, INT J PEDIATR OTORHI, V68, P895, DOI 10.1016/j.ijporl.2004.02.004
   Pires FR, 2007, ORAL ONCOL, V43, P463, DOI 10.1016/j.oraloncology.2006.04.008
   Ritwik Priyanshi, 2012, J Med Case Rep, V6, P287, DOI 10.1186/1752-1947-6-287
NR 8
TC 2
Z9 2
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD MAR
PY 2018
VL 29
IS 2
BP E209
EP E211
DI 10.1097/SCS.0000000000004259
PG 3
WC Surgery
SC Surgery
GA GA0FU
UT WOS:000427989400036
PM 29227411
DA 2020-11-30
ER

PT J
AU Leao, JC
   Marques, CDL
   Duarte, ALBP
   de Almeida, OP
   Porter, S
   Gueiros, LA
AF Leao, J. C.
   Marques, C. D. L.
   Duarte, A. L. B. P.
   de Almeida, O. P.
   Porter, S.
   Gueiros, L. A.
TI Chikungunya fever: General and oral healthcare implications
SO ORAL DISEASES
LA English
DT Article
DE arboviruses; chikungunya fever; dental; epidemiology; oral
ID REUNION ISLAND; ADULT PATIENTS; RISK-FACTORS; VIRUS; AMERICA; DISEASE;
   INFECTION; OUTBREAK; ARTHRALGIA; PREVALENCE
AB Chikungunya virus (CHIKV) was first isolated in humans in 1952, following an epidemic in Tanzania. The origin of the name means to bend forward or become contorted, in reference to the posture adopted by patients due to the joint pain that occurs during the infection. Epidemiology data suggest that by the end of 2015, about 1.6 million people had been infected with CHIKV. The acute period of the disease is characterized by high fever, myalgia, joint pain, and severe and disabling polyarthritis, sometimes accompanied by headache, backache, and maculopapular rash, predominantly on the thorax. Around half of the patients will progress to the subacute and chronic phases, that is manifested by persistent polyarthritis/polyarthralgia, accompanied by morning stiffness and fatigue, which could remain for years. Oral features may include gingivitis possibly as a consequence of arthralgia of the hands leading to limited oral health measures as well as burning sensation and oral mucosal ulceration. Treatment in the acute phase includes acetaminophen, and weak opioids (tramadol or codeine) should be used in cases of severe or refractory pain. For patients who have progressed to the subacute stage and who have not had notable benefit from common analgesics or opioids, NSAIDs, or adjunctive pain medications (anticonvulsants or antidepressants) may be of benefit. In patients with moderate-to-severe musculoskeletal pain or in those who cannot be given or tolerate NSIADs or opiates, prednisolone should be prescribed.
C1 [Leao, J. C.; Gueiros, L. A.] Univ Fed Pernambuco, Oral Med Unit, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
   [Marques, C. D. L.; Duarte, A. L. B. P.] Univ Fed Pernambuco, Rheumatol Unit, Hosp Clin, Recife, PE, Brazil.
   [de Almeida, O. P.] Univ Estadual Campinas, Area Patol, Dept Diagnost Oral, Fac Odontol Piracicaba, Piracicaba, Brazil.
   [Porter, S.] UCL, UCL Eastman Dent Inst, UCLH NIHR Biomed Res Ctr, Oral Theme, London, England.
RP Leao, JC (corresponding author), Univ Fed Pernambuco, Programa Posgrad Odontol, Recife, PE, Brazil.
EM jleao@ufpe.br
RI MARQUES, CLAUDIA/P-4008-2019; Leao, Jair Carneiro/AAL-6154-2020;
   Gueiros, Luiz Alcino/B-6429-2015
OI MARQUES, CLAUDIA/0000-0002-3333-2621; Leao, Jair
   Carneiro/0000-0001-8303-2291; Gueiros, Luiz Alcino/0000-0003-4979-4318;
   Porter, Stephen/0000-0002-3328-2759; Paes de Almeida,
   Oslei/0000-0003-2002-8003
CR Agarwal A, 2016, INFECT GENET EVOL, V40, P126, DOI 10.1016/j.meegid.2016.02.033
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P410
   [Anonymous], 2017, MON CAS DENG FEBR CH, V48, P1
   Assuncao-Miranda I., 2010, BIOMEDICAL RES INT, V2013
   Bandyopadhyay Debabrata, 2010, Indian J Dermatol, V55, P64, DOI 10.4103/0019-5154.60356
   Bhat Ramesh M, 2011, Indian J Dermatol, V56, P290, DOI 10.4103/0019-5154.82483
   Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003
   Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537
   Brazilian Medical Council, 2015, FEBR CHIK MAN CLIN
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Chirathaworn C, 2010, VIRAL IMMUNOL, V23, P113, DOI 10.1089/vim.2009.0077
   Chopra A, 2012, EPIDEMIOL INFECT, V140, P842, DOI 10.1017/S0950268811001300
   Chopra A, 2008, ARTHRITIS RHEUM, V58, P2921, DOI 10.1002/art.23753
   Cunha RV, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005319
   Dupuis-Maguiraga L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001446
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Essackjee K, 2013, POSTGRAD MED J, V89, P440, DOI 10.1136/postgradmedj-2012-131477
   Gerardin P, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4137
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Katti Roopa, 2011, Indian J Dent Res, V22, P613, DOI 10.4103/0970-9290.90325
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Marques CDL, 2017, REV BRAS REUMATOL, V57, pS438, DOI 10.1016/j.rbre.2017.06.004
   Marques CDL, 2017, REV BRAS REUMATOL, V57, pS421, DOI 10.1016/j.rbre.2017.05.006
   Lum FM, 2015, ANTIVIR RES, V120, P165, DOI 10.1016/j.antiviral.2015.06.009
   LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X
   MacDonald-Ottevanger MS, 2015, NED TIJDSCHR GENEES, V159, pA8403
   Madariaga M, 2016, BRAZ J INFECT DIS, V20, P91, DOI 10.1016/j.bjid.2015.10.004
   Malvy D, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-200
   Manimunda SP, 2010, T ROY SOC TROP MED H, V104, P392, DOI 10.1016/j.trstmh.2010.01.011
   Marques CDL, 2017, ANN RHEUM DIS, V76, P988, DOI 10.1136/annrheumdis-2017-eular.6431
   Marques C. D. L., 2016, ARTHRITIS RHEUMATISM, V68
   Pan American Health Organization, 2016, CHIK AUT TRANSM AM
   Pan American Health Organization, 2017, CHIK NEW CAS CHIK AM
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Rodriguez-Morales AJ, 2016, ARTHRIT CARE RES, V68, P1849, DOI 10.1002/acr.22900
   Rougeron V, 2015, J CLIN VIROL, V64, P144, DOI 10.1016/j.jcv.2014.08.032
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Simon F, 2015, MED MALADIES INFECT, V45, P243, DOI 10.1016/j.medmal.2015.05.007
   Sissoko D, 2010, TROP MED INT HEALTH, V15, P600, DOI 10.1111/j.1365-3156.2010.02485.x
   Staikowsky F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007603
   Staples JE, 2014, NEW ENGL J MED, V371, P887, DOI 10.1056/NEJMp1407698
   Suryawanshi SD, 2009, INDIAN J MED RES, V129, P438
   Taubitz W, 2007, CLIN INFECT DIS, V45, pE1, DOI 10.1086/518701
   Waymouth HE, 2013, SEMIN ARTHRITIS RHEU, V43, P273, DOI 10.1016/j.semarthrit.2013.03.003
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
NR 45
TC 1
Z9 1
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1354-523X
EI 1601-0825
J9 ORAL DIS
JI Oral Dis.
PD MAR
PY 2018
VL 24
IS 1-2
BP 233
EP 237
DI 10.1111/odi.12777
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA FY0RY
UT WOS:000426520600047
PM 29480628
DA 2020-11-30
ER

PT J
AU de Oliveira, LML
   Batista, LHC
   Neto, APD
   Silva, LB
   Cimoes, R
   Leao, JC
   Cintra, ML
   Ribeiro, CMB
AF Lopes de Oliveira, Livia Maria
   Carvalho Batista, Luiz Henrique
   Santos Neto, Alexandrino Pereira dos
   Silva, Luciano Barreto
   Cimoes, Renata
   Leao, Jair Carneiro
   Cintra, Maria Leticia
   Beder Ribeiro, Camila Maria
TI Oral Lichenoid Lesion Manifesting as Desquamative Gingivitis: Unlikely
   Association? Case Report
SO OPEN DENTISTRY JOURNAL
LA English
DT Article
DE Dental amalgam; Gingivitis diseases; Delayed hypersensitivity; Lichenoid
   lesions; Oral lichen planus; Heterogeneous clinical manifestations
ID PLANUS
AB Introduction:
   The aim of this report is to present a clinical case of oral lichenoid lesions associated with amalgam restorations with the presence of desquamative gingivitis for a nine months follow up period.
   Case Report:
   The histopathologic characteristics and direct immunofluorescence were compatible with Oral Lichenoid Lesion (LLO). Diagnosis was based on a synthesis of all available information, including medical history, clinical examination, histopathology and the results of specific tests, such as the patch test, which confirmed allergy to thimerosal, an organic compound of mercury.
   Discussion:
   The replacement of amalgam restorations has brought improvements to the instrument, as evidenced by the disappearance of desquamative gingivitis, aspect erythematosus and erosive lesions. The fading does not complete the same, however, indicates the need to continue has been under continuous observation, the patient, having in view the possibility of the existence of an underlying lichen planus.
C1 [Lopes de Oliveira, Livia Maria; Santos Neto, Alexandrino Pereira dos; Silva, Luciano Barreto; Cimoes, Renata; Leao, Jair Carneiro] Fed Univ Pernambuco Recife, Dept Prosthesis & Maxillofacial Surg, Fac Dent, Recife, PE, Brazil.
   [Carvalho Batista, Luiz Henrique] Cesmac Univ Ctr, Dent Sch, Dept Periodontol, Maceio, Brazil.
   [Cintra, Maria Leticia] Univ Estadual Campinas, Med Sci Coll, FCM UNICAMP, Campinas, SP, Brazil.
   [Beder Ribeiro, Camila Maria] Cesmac Univ Ctr, Dept Pathol, Fac Dent, Conego Machado 918, BR-57051160 Maceio, Alagoas, Brazil.
RP Ribeiro, CMB (corresponding author), Cesmac Univ Ctr, Dept Pathol, Fac Dent, Conego Machado 918, BR-57051160 Maceio, Alagoas, Brazil.
EM camilabeder@yahoo.com.br
RI Cimoes, Renata/C-7955-2009; Silva, Luciano/W-6477-2019; Leao, Jair
   Carneiro/AAL-6154-2020; Beder Ribeiro Girish Panjwani, Camila
   Maria/M-5453-2017
OI Cimoes, Renata/0000-0003-3673-8739; Leao, Jair
   Carneiro/0000-0001-8303-2291; Beder Ribeiro Girish Panjwani, Camila
   Maria/0000-0003-0203-3079
CR Al-Abeedi Faris, 2015, J Int Oral Health, V7, P88
   Carbone M, 2015, MED ORAL PATOL ORAL, V17, pe555
   Cavalla F, 2018, PATHOGENESIS PERIODO, P59
   Dudhia Bhavin B, 2015, J Oral Maxillofac Pathol, V19, P364, DOI 10.4103/0973-029X.174632
   Ertugrul AS, 2013, ARCH ORAL BIOL, V58, P843, DOI 10.1016/j.archoralbio.2013.01.015
   Holmstrom SB, 2017, J IMMUNOL, V199, P4023, DOI 10.4049/jimmunol.1700672
   Kamath VV, 2015, INDIAN J DERMATOL, V60, DOI 10.4103/0019-5154.147830
   Larsson A, 1998, Oral Dis, V4, P187
   Lartitegui-Sebastian MJ, 2012, MED ORAL PATOL ORAL, V17, pE545, DOI 10.4317/medoral.17733
   Leao JC, 2008, ORAL DIS, V14, P556, DOI 10.1111/j.1601-0825.2007.01420.x
   Lo Russo L, 2014, CLIN ORAL INVEST, V18, P917, DOI 10.1007/s00784-013-1038-8
   Lo Russo L, 2009, INT J DERMATOL, V48, P1049, DOI 10.1111/j.1365-4632.2009.04142.x
   Maderal AD, 2018, J AM ACAD DERMATOL, V78, P839, DOI 10.1016/j.jaad.2017.05.056
   Marell L, 2014, J ORAL REHABIL, V41, P381, DOI 10.1111/joor.12151
   Mastromatteo-Alberga P, 2018, J ORAL RES, V7, P98
   McParland H, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/589569
   Monea M, 2017, J INTERDISCIPLIN MED, V2, P49
   Montebugnoli L, 2012, OR SURG OR MED OR PA, V113, P766, DOI 10.1016/j.oooo.2011.12.007
   Mravak-Stipetic M, 2014, SCI WORLD J, V2014
   Muris J, 2018, METAL ALLERGY METAL, DOI [10.1007/978-3-319-58503-1_22, DOI 10.1007/978-3-319-58503-1_22]
   Pawar Rohini Rangarao, 2016, J Conserv Dent, V19, P289, DOI 10.4103/0972-0707.181950
   Rai Reena, 2014, Indian Dermatol Online J, V5, P282, DOI 10.4103/2229-5178.137778
   Ribeiro C.A.D.S., 2012, THESIS
   ROGERS RS, 1976, ORAL SURG ORAL MED O, V42, P316, DOI 10.1016/0030-4220(76)90166-3
   Scalf L A, 2001, Am J Contact Dermat, V12, P146
   Stone SJ, 2015, J CLIN PERIODONTOL, V42, P356, DOI 10.1111/jcpe.12385
   Suter VGA, 2016, J ORAL PATHOL MED, V45, P48, DOI 10.1111/jop.12328
   van der Meij EH, 2003, J ORAL PATHOL MED, V32, P507, DOI 10.1034/j.1600-0714.2003.00125.x
NR 28
TC 1
Z9 1
U1 0
U2 1
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1874-2106
J9 OPEN DENT J
JI Open Dent. J.
PY 2018
VL 12
BP 679
EP 686
DI 10.2174/1745017901814010679
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA HC1QC
UT WOS:000451575700022
PM 30369977
OA Other Gold, Green Published
DA 2020-11-30
ER

PT J
AU Araujo, PRD
   Silva, LB
   Neto, APD
   de Arruda, JAA
   Alvares, PR
   Sobral, APV
   Alves, S
   Leao, JC
   da Silva, RB
   Sampaio, GC
AF de Souza Araujo, Pollyana Rodrigues
   Silva, Luciano Barreto
   dos Santos Neto, Alexandrino Pereira
   Almeida de Arruda, Jose Alcides
   Alvares, Pamella Recco
   Veras Sobral, Ana Paula
   Alves Junior, Severino
   Leao, Jair Carneiro
   da Silva, Rodivan Braz
   Sampaio, Gerhilde Callou
TI Pulp Revascularization: A Literature Review
SO OPEN DENTISTRY JOURNAL
LA English
DT Review
DE Endodontics; therapeutics; calcium hydroxide; blood vessels
ID DENTAL-PULP; REGENERATIVE ENDODONTICS; STEM-CELLS; IN-VITRO; TEETH;
   APEXOGENESIS; APEXIFICATION; PERIODONTITIS; INCISOR; VIVO
AB Reestablishing blood flow and allowing the continuation of root development are some of the objectives of pulp revascularization. This procedure is currently indicated for teeth with incomplete root formation as an alternative to the traditional treatment of apecification, which consists of inserting calcium hydroxide paste into the root canal for a determined time period in order to induce the formation of a calcified barrier. Although it is considered as the most classically employed therapy, the permanence of the paste for long time periods may lead to the weakening of the root due to hygroscopic properties, as well as proteolytic activities of calcium hydroxide. Therefore, there has been a permanent search for alternatives which allow the full development of immature teeth. Revascularization has emerged as such an alternative, and a range of treatment protocols can be found in the scientific literature. The aim of this paper is to accomplish a literature review concerning this issue.
C1 [de Souza Araujo, Pollyana Rodrigues; Silva, Luciano Barreto; dos Santos Neto, Alexandrino Pereira; Almeida de Arruda, Jose Alcides; Alvares, Pamella Recco; Veras Sobral, Ana Paula; da Silva, Rodivan Braz; Sampaio, Gerhilde Callou] Univ Pernambuco, Dept Operat Dent & Endodont, Dent Coll Pernambuco, Gen Newton Cavalcante 1650, BR-54753901 Camaragibe, PE, Brazil.
   [Alves Junior, Severino; Leao, Jair Carneiro] Univ Fed Pernambuco, Recife, PE, Brazil.
RP Neto, APD (corresponding author), Univ Pernambuco, Dept Operat Dent & Endodont, Dent Coll Pernambuco, Gen Newton Cavalcante 1650, BR-54753901 Camaragibe, PE, Brazil.
EM alexandrinoneto@live.com.br
RI Silva, Luciano/W-6477-2019; Leao, Jair Carneiro/AAL-6154-2020
OI Leao, Jair Carneiro/0000-0001-8303-2291
CR About I, 2000, EXP CELL RES, V258, P33, DOI 10.1006/excr.2000.4909
   Aggarwal Vivek, 2012, J Conserv Dent, V15, P68, DOI 10.4103/0972-0707.92610
   Banchs F, 2004, J ENDODONT, V30, P196, DOI 10.1097/00004770-200404000-00003
   Couble ML, 2000, CALCIFIED TISSUE INT, V66, P129, DOI 10.1007/PL00005833
   Diogenes A, 2016, J AM DENT ASSOC, V147, P372, DOI 10.1016/j.adaj.2016.01.009
   Forghani Maryam, 2013, Restor Dent Endod, V38, P178, DOI 10.5395/rde.2013.38.3.178
   Friedlander LT, 2009, INT ENDOD J, V42, P955, DOI 10.1111/j.1365-2591.2009.01622.x
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   HEITHERSAY GS, 1970, ORAL SURG ORAL MED O, V29, P620, DOI 10.1016/0030-4220(70)90474-3
   Jadhav Ganesh Ranganath, 2013, J Conserv Dent, V16, P568, DOI 10.4103/0972-0707.120932
   Kamal R, 2011, J CLIN EXP DENT, V3, P1
   Kim DS, 2012, INT J ORAL SCI, V4, P109, DOI 10.1038/ijos.2012.23
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   Kvinnsland SR, 2010, INT ENDOD J, V43, P76, DOI 10.1111/j.1365-2591.2009.01645.x
   Lenzi R, 2012, J ENDODONT, V38, P411, DOI 10.1016/j.joen.2011.12.003
   LIEBERMAN J, 1983, J ENDODONT, V9, P257, DOI 10.1016/S0099-2399(86)80025-5
   Moleri AB, 2011, ENDODONTIA BIOL TECN, P1
   Murray PE, 2007, J ENDODONT, V33, P377, DOI 10.1016/j.joen.2006.09.013
   Nevins A, 1977, J Endod, V3, P431, DOI 10.1016/S0099-2399(77)80115-5
   Nevins A J, 1976, J Endod, V2, P159, DOI 10.1016/S0099-2399(76)80058-1
   Nicoli NVV, 2015, FOL FACULDADE ODONTO, V25, P74
   Nosrat A, 2011, J ENDODONT, V37, P562, DOI 10.1016/j.joen.2011.01.011
   NYGAARD-OSTBY B, 1971, Scandinavian Journal of Dental Research, V79, P333
   Okiji T, 2012, SELTZER AND BENDER'S DENTAL PULP, SECOND EDITION, P67
   OSTBY B N, 1961, Acta Odontol Scand, V19, P324
   Pramila R, 2012, J Conserv Dent, V15, P97, DOI 10.4103/0972-0707.94571
   Rafter M, 2005, DENT TRAUMATOL, V21, P1, DOI 10.1111/j.1600-9657.2004.00284.x
   Rule D C, 1966, Br Dent J, V120, P586
   SAAD AY, 1988, ORAL SURG ORAL MED O, V66, P499, DOI 10.1016/0030-4220(88)90277-0
   Shimizu E, 2012, J ENDODONT, V38, P1293, DOI 10.1016/j.joen.2012.06.017
   Silva L., 2015, GLOB J STEM CELL BIO, V1, P12, DOI DOI 10.17352/SSCRT.000004
   Silva L., 2015, GLOB J INFECT DIS CL, V1, P21
   Trope M, 2008, J ENDODONT, V34, pS13, DOI 10.1016/j.joen.2008.04.001
   Yang J, 2013, J ENDODONT, V39, P288, DOI 10.1016/j.joen.2012.10.017
NR 34
TC 2
Z9 2
U1 0
U2 11
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1874-2106
J9 OPEN DENT J
JI Open Dent. J.
PY 2017
VL 11
BP 48
EP 56
DI 10.2174/1874210601711010048
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA FI9FN
UT WOS:000412310900006
PM 28567136
OA Green Published
DA 2020-11-30
ER

PT J
AU Leao, JC
   Gueiros, LA
   Lodi, G
   Robinson, NA
   Scully, C
AF Leao, J. C.
   Gueiros, L. A.
   Lodi, G.
   Robinson, N. A.
   Scully, C.
TI Zika virus: oral healthcare implications
SO ORAL DISEASES
LA English
DT Review
DE Arboviruses; Zika virus; epidemiology; oral; dental
ID FRENCH-POLYNESIA; DECEMBER 2013; TRANSMISSION
AB Zika virus (ZIKV) infection has been recognised since 1947, but just recently it became a worldwide major public health problem. The most common features of ZIKV infection are fever, cutaneous rash, arthralgia and conjunctivitis but most affected patients with the clinical disease present with only mild symptoms. However, severe neurological complications have been described: there is an occasional association with Guillain-Barre syndrome, and emerging data indicate an association between vertical transmission of ZIKV infection and microcephaly, but no specific orofacial manifestations have yet been reported. ZIKV is present in body fluids and has also been demonstrated in the saliva, but there is as yet no reliable evidence to support ZIKV transmission via this pathway. Transmission in oral health care should be effectively prevented using standard infection control measures. There are currently no specific treatments for Zika virus disease and no vaccines available, so prevention of ZIKV is based on vector control.
C1 [Leao, J. C.; Gueiros, L. A.] Univ Fed Pernamuco, Oral Med Unit, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
   [Lodi, G.] Univ Milan, Dipartimento Sci Biomed Chirurg & Odontoiatr, Milan, Italy.
   [Robinson, N. A.] Natl Univ Singapore, Discipline Oral & Maxillofacial Surg, Fac Dent, Singapore, Singapore.
   [Scully, C.] UCL, WHO Collaborating Ctr Oral Hlth Gen Hlth, London, England.
RP Leao, JC (corresponding author), Programa Posgrad Odontol, Ave Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
EM jleao@ufpe.br
RI Leao, Jair Carneiro/AAL-6154-2020; Lodi, Giovanni/C-1049-2013; Gueiros,
   Luiz Alcino/B-6429-2015
OI Leao, Jair Carneiro/0000-0001-8303-2291; Lodi,
   Giovanni/0000-0002-0218-8292; Gueiros, Luiz Alcino/0000-0003-4979-4318
CR [Anonymous], 2017, ORAL DIS, V23, P12
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Butler D, 2015, NATURE, V524, P13, DOI 10.1038/524013a
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Musso D., 2014, POTENTIAL ZIKA VIRUS
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Scully C, 2016, BRIT DENT J, V220, P265, DOI 10.1038/sj.bdj.2016.182
   Shakib K, 2016, BRIT J ORAL MAX SURG, V54, P355, DOI 10.1016/j.bjoms.2016.02.001
   Siqueira WL, 2016, BRAZ ORAL RES, V30, DOI 10.1590/1807-3107BOR-2016.vol30.0046
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   WHO, 2016, ZIK SIT REP
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
NR 30
TC 11
Z9 11
U1 0
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1354-523X
EI 1601-0825
J9 ORAL DIS
JI Oral Dis.
PD JAN
PY 2017
VL 23
IS 1
BP 12
EP 17
DI 10.1111/odi.12512
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA EF4BB
UT WOS:000390268200004
PM 27232461
DA 2020-11-30
ER

PT J
AU Queiroz, IV
   Queiroz, SP
   Medeiros, R
   Ribeiro, RB
   Crusoe-Rebello, IM
   Leao, JC
AF Queiroz, Isaac Vieira
   Queiroz, Samara Pereira
   Medeiros, Rui, Jr.
   Ribeiro, Rodolfo Bonfim
   Crusoe-Rebello, Ieda Margarida
   Leao, Jair Carneiro
TI Brown tumor of secondary hyperparathyroidism: surgical approach and
   clinical outcome
SO ORAL AND MAXILLOFACIAL SURGERY-HEIDELBERG
LA English
DT Article
DE Bone diseases; Osteitis fibrosa cystica; Secondary hyperparathyroidism;
   Renal osteodystrophy; Parathyroidectomy
ID PATIENT; MAXILLA; SPINE
AB Secondary hyperparathyroidism is a frequent complication of chronic renal failure. The brown tumor is an unusual presentation of fibrous osteitis that represents a serious complication of renal osteodystrophy, affecting predominantly the hands, feet, skull, and facial bones.
   The aim of this paper is to describe the case of a 53-year-old female patient, with renal failure who has been on dialysis for 6 years and developed severe secondary hyperparathyroidism and brown tumor of the maxilla and mandible, confirmed by incisional biopsy. Parathyroidectomy was indicated as a result of rapid growth of the tumor and the maintenance of laboratory findings. Despite the normalization of serum parathyroid hormone and alkaline phosphatase, tumor regression was slow and patient's important functional and esthetic deficits persisted. Excision of the mandible tumor was conservative. Osteoplasty was recommended because during a 5-year follow-up there was regression of the lesion, decreased pain, bleeding, and tooth mobility.
C1 [Queiroz, Isaac Vieira; Queiroz, Samara Pereira; Ribeiro, Rodolfo Bonfim; Crusoe-Rebello, Ieda Margarida] Univ Fed Bahia, Salvador, BA, Brazil.
   [Medeiros, Rui, Jr.; Leao, Jair Carneiro] Univ Fed Pernambuco, Recife, PE, Brazil.
RP Queiroz, IV (corresponding author), Univ Fed Bahia, Salvador, BA, Brazil.
EM isaacvq@yahoo.com.br
RI Leao, Jair Carneiro/AAL-6154-2020
OI Leao, Jair Carneiro/0000-0001-8303-2291
CR Ben Fatma L, 2010, SAUDI J KIDNEY DIS T, V21, P772
   Desigan S, 2007, CLIN NUCL MED, V32, P306, DOI 10.1097/01.rlu.0000257293.00744.3c
   Di Daniele N, 2009, INT J ENDOCRINOL, DOI 10.1155/2009/827652
   Jafari-Pozve N, 2014, J RES MED SCI, V19, P1099
   Leal Christianne T.S., 2006, Arq Bras Endocrinol Metab, V50, P963, DOI 10.1590/S0004-27302006000500021
   Mateo L, 2011, CLIN RHEUMATOL, V30, P419, DOI 10.1007/s10067-010-1608-y
   Nabi Z, 2010, HEMODIAL INT, V14, P247, DOI 10.1111/j.1542-4758.2010.00436.x
   Nunes TB, 2016, CASE REP DENT, V2016, DOI 10.1155/2016/5320298
   Proimos Efklidis, 2009, J Med Case Rep, V3, P7495, DOI 10.4076/1752-1947-3-7495
   Qaisi M, 2015, CASE REP MED, DOI 10.1155/2015/567543
   Selvi F, 2009, DENTOMAXILLOFAC RAD, V38, P53, DOI 10.1259/dmfr/81694583
   Takeshita Tohru, 2004, Radiat Med, V22, P265
   Tarrass F, 2006, JOINT BONE SPINE, V73, P748, DOI 10.1016/j.jbspin.2006.01.011
   Verma Pradhuman, 2014, J Oral Maxillofac Pathol, V18, P267, DOI 10.4103/0973-029X.140779
NR 14
TC 10
Z9 10
U1 0
U2 1
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1865-1550
EI 1865-1569
J9 ORAL MAXILLOFAC SURG
JI Oral Maxillofac. Surg.-Heidelb.
PD DEC
PY 2016
VL 20
IS 4
BP 435
EP 439
DI 10.1007/s10006-016-0575-0
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA EF5YL
UT WOS:000390405800015
PM 27640197
DA 2020-11-30
ER

PT J
AU Medeiros, R
   de Almeida, OP
   Leao, JC
   Gueiros, LA
AF Medeiros, R., Jr.
   de Almeida, O. P.
   Leao, J. C.
   Gueiros, L. A.
TI Lymphoepithelial infiltrate of palatal minor salivary glands:
   implications for diagnostic work-up
SO INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
DE minor salivary glands; Sjogren's syndrome; hard palate
ID SJOGRENS-SYNDROME; CLASSIFICATION CRITERIA; LESION
AB Benign lymphoepithelial lesions (BLLs) usually affect the parotid glands, resulting in their asymmetrical enlargement. The condition can be associated with Sjogren's syndrome (SS), which in turn may predispose the affected patient to the development of malignant lymphoma. BLLs arising in the intraoral minor salivary glands are rare; such a lesion should prompt the work-up for SS. In some instances, a BLL of a minor salivary gland could represent the initial stage of a mucosa-associated lymphoid tissue (MALT) lymphoma. A case of BLL arising in the palatal minor salivary glands is reported here. The importance of an appropriate diagnostic work-up is emphasized and the relationship of BLL with SS is reinforced.
C1 [Medeiros, R., Jr.; Leao, J. C.; Gueiros, L. A.] Univ Fed Pernambuco, Dept Clin & Prevent Dent, Oral Med Unit, Ave Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
   [de Almeida, O. P.] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Oral Diag, Oral Pathol Lab, Sao Paulo, Brazil.
RP Gueiros, LA (corresponding author), Univ Fed Pernambuco, Dept Clin & Prevent Dent, Oral Med Unit, Ave Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
EM luiz.mgueiros@ufpe.br
RI Leao, Jair Carneiro/AAL-6154-2020; Gueiros, Luiz Alcino/B-6429-2015
OI Leao, Jair Carneiro/0000-0001-8303-2291; Gueiros, Luiz
   Alcino/0000-0003-4979-4318
FU Pernambuco Research Foundation (FACEPE, Brazil) [APQ 1978-4.02/12]
FX The authors acknowledge the financial support of Pernambuco Research
   Foundation (FACEPE, Brazil - APQ 1978-4.02/12).
CR ANAVI Y, 1992, J ORAL MAXIL SURG, V50, P1111, DOI 10.1016/0278-2391(92)90502-Q
   BHASKAR SN, 1960, ORAL SURG, V13, P1387
   COOPER JC, 1976, BRIT J ORAL SURG, V14, P128, DOI 10.1016/0007-117X(76)90029-9
   Cruickshank HA, 1965, J CLIN PATHOL, V18, P391
   GODWIN JT, 1952, CANCER, V5, P1089, DOI 10.1002/1097-0142(195211)5:6<1089::AID-CNCR2820050604>3.0.CO;2-M
   Goto TK, 2002, DENTOMAXILLOFAC RAD, V31, P198, DOI 10.1038/sj.dmfr.4600690
   LANCASTER J E, 1963, Oral Surg Oral Med Oral Pathol, V16, P1266, DOI 10.1016/0030-4220(63)90350-5
   Liang Y, 2014, ANN RHEUM DIS, V73, P1151, DOI 10.1136/annrheumdis-2013-203305
   Ma Q, 2011, RHEUMATOL INT, V31, P959, DOI 10.1007/s00296-010-1617-9
   MARKER P, 1983, INT J ORAL MAXILLOF, V12, P348, DOI 10.1016/S0300-9785(83)80025-8
   Metwaly H, 2003, VIRCHOWS ARCH, V443, P17, DOI 10.1007/s00428-003-0824-0
   Metwaly H, 2004, ORAL ONCOL EXTRA, V40, P113
   NELSON WR, 1963, ANN SURG, V157, P152, DOI 10.1097/00000658-196301000-00017
   Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591
   TAKEDA Y, 1987, ACTA PATHOL JAPON, V37, P1603
   Tian Z, 2010, INT J ORAL MAX SURG, V39, P235, DOI 10.1016/j.ijom.2009.10.016
   Toida M, 2001, J ORAL MAXIL SURG, V59, P1101, DOI 10.1053/joms.2001.25859
   Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554
NR 18
TC 1
Z9 1
U1 0
U2 3
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0901-5027
EI 1399-0020
J9 INT J ORAL MAX SURG
JI Int. J. Oral Maxillofac. Surg.
PD DEC
PY 2016
VL 45
IS 12
BP 1626
EP 1629
DI 10.1016/j.ijom.2016.08.016
PG 4
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA ED8BH
UT WOS:000389096400020
PM 27634688
DA 2020-11-30
ER

PT J
AU Silva, MLE
   Carvalho, CN
   Carvalho, ADT
   Leao, JC
   Duarte, ALP
   Gueiros, LA
AF Lins e Silva, Marilia
   Carvalho, Camila Nunes
   Tavares Carvalho, Alessandra de Albuquerque
   Leao, Jair Carneiro
   Pinto Duarte, Angela Luzia
   Gueiros, Luiz Alcino
TI Effect of Xerostomia on the Functional Capacity of Subjects with
   Rheumatoid Arthritis
SO JOURNAL OF RHEUMATOLOGY
LA English
DT Article
DE XEROSTOMIA; RHEUMATOID ARTHRITIS; SJOGREN SYNDROME; FUNCTIONAL CAPACITY
ID QUALITY-OF-LIFE; HEALTH-ASSESSMENT QUESTIONNAIRE; SJOGRENS-SYNDROME;
   EXTRAARTICULAR MANIFESTATIONS; DISEASE-ACTIVITY; SICCA SYMPTOMS;
   SALIVARY-GLAND; DRY MOUTH; PREVALENCE; ASSOCIATION
AB Objective. To evaluate the intensity of xerostomia and hyposalivation in subjects with rheumatoid arthritis (RA) as well as the effects of these conditions on functional incapacity and disease activity.
   Methods. The study sample comprised 236 individuals of both sexes who had RA. All the individuals were submitted to clinical evaluation and unstimulated sialometry. Functional capacity was determined by using the Health Assessment Questionnaire (HAQ), xerostomia was assessed using the Xerostomia Inventory, and disease activity was evaluated with the 28-joint Disease Activity Score (DAS28). The effect of Sjgren syndrome (SS) was analyzed, and the sample was divided into 2 groups: RA (191 subjects) and RA/SS (45 subjects).
   Results. The Xerostomia Inventory showed positive and significant correlation with fatigue (r = 0.243; p < 0.0001), number of painful joints (r = 0.218; p = 0.001), HAQ (r = 0.279; p < 0.0001), and DAS28 (r = 0.156; p < 0.0001). On regression analysis, both xerostomia (OR 3.89, 95% CI 1.84-8.23, p < 0.001) and DAS28 (for severe disease activity: OR 13.26, 95% CI 3.15-55.79, p < 0.001) showed influence on functional incapacity. Forty-five individuals (19.1%) presented with secondary SS, and having this diagnosis was not associated with disease activity or functional capacity.
   Conclusion. Xerostomia demonstrated an adverse effect on quality of life of subjects with RA, being associated with a reduction in functional capacity. In this clinical setting, xerostomia can be monitored as a marker of worse clinical evolution.
C1 [Lins e Silva, Marilia; Carvalho, Camila Nunes; Tavares Carvalho, Alessandra de Albuquerque; Leao, Jair Carneiro; Gueiros, Luiz Alcino] Univ Fed Pernambuco, Dept Clin & Prevent Dent, Oral Med Unit, Av Prof Moraes Rego,1235 CDU, BR-50670901 Recife, PE, Brazil.
   [Pinto Duarte, Angela Luzia] Univ Fed Pernambuco, Clin Hosp, Rheumatol Unit, Recife, PE, Brazil.
RP Gueiros, LA (corresponding author), Univ Fed Pernambuco, Dept Clin & Prevent Dent, Oral Med Unit, Av Prof Moraes Rego,1235 CDU, BR-50670901 Recife, PE, Brazil.
EM luiz.mgueiros@ufpe.br
RI Gueiros, Luiz Alcino/B-6429-2015; Leao, Jair Carneiro/AAL-6154-2020
OI Gueiros, Luiz Alcino/0000-0003-4979-4318; Leao, Jair
   Carneiro/0000-0001-8303-2291
CR ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302
   Baker SR, 2006, COMMUNITY DENT ORAL, V34, P351, DOI 10.1111/j.1600-0528.2006.00285.x
   Braam PM, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-3
   Bruce B, 2005, CLIN EXP RHEUMATOL, V23, pS14
   Brun JG, 2003, ARTHRIT RHEUM-ARTHR, V49, P187, DOI 10.1002/art.10999
   Carmona L, 2003, ANN RHEUM DIS, V62, P897, DOI 10.1136/ard.62.9.897
   da Mata ADSP, 2012, ORAL DIS, V18, P293, DOI 10.1111/j.1601-0825.2011.01879.x
   de Souza TR, 2014, J ORAL PATHOL MED, V43, P418, DOI 10.1111/jop.12149
   DROSOS AA, 1992, ARTHRITIS RHEUM, V35, P745, DOI 10.1002/art.1780350705
   FERRAZ MB, 1990, J RHEUMATOL, V17, P813
   Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5
   FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202
   Guggenheimer J, 2003, J AM DENT ASSOC, V134, P61, DOI 10.14219/jada.archive.2003.0018
   Haga HJ, 2012, INT J RHEUM DIS, V15, P284, DOI 10.1111/j.1756-185X.2012.01717.x
   Hochberg MC, 2008, CURR MED RES OPIN, V24, P469, DOI [10.1185/030079908X261177, 10.1185/030079908X261177 ]
   Hopcraft MS, 2010, AUST DENT J, V55, P238, DOI 10.1111/j.1834-7819.2010.01229.x
   Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778
   Ishijima T, 2004, J ORAL REHABIL, V31, P3, DOI 10.1111/j.1365-2842.2004.01033.x
   Kaufman I, 2008, SCAND J RHEUMATOL, V37, P213, DOI 10.1080/03009740701867323
   Kauppi M, 1997, CANCER CAUSE CONTROL, V8, P201, DOI 10.1023/A:1018472213872
   Martens PB, 1999, J RHEUMATOL, V26, P1296
   Mignogna MD, 2005, J ORAL PATHOL MED, V34, P1, DOI 10.1111/j.1600-0714.2004.00264.x
   Moen K, 2005, ORAL DIS, V11, P27, DOI 10.1111/j.1601-0825.2004.01054.x
   Nagler RM, 2003, RHEUMATOLOGY, V42, P1234, DOI 10.1093/rheumatology/keg362
   Navazesh M, 2008, J AM DENT ASSOC, V139, p35S, DOI 10.14219/jada.archive.2008.0353
   Nederfors T, 2002, SWED DENT J, V26, P1
   Oliveira HF, 2015, OR SURG OR MED OR PA, V119, P628, DOI 10.1016/j.oooo.2015.02.479
   Pace-Balzan A, 2004, J ORAL REHABIL, V31, P609, DOI 10.1111/j.1365-2842.2004.01279.x
   Pajukoski H, 2001, ORAL SURG ORAL MED O, V92, P641, DOI 10.1067/moe.2001.118478
   Patinen P, 2004, ORAL DIS, V10, P330, DOI 10.1111/j.1601-0825.2004.01048.x
   Pincus T, 2003, BEST PRACT RES CL RH, V17, P753, DOI 10.1016/S1521-6942(03)00077-9
   Repping-Wuts H, 2007, J CLIN NURS, V16, P377, DOI 10.1111/j.1365-2702.2007.02082.x
   Russell AS, 2008, PHARMACOECONOMICS, V26, P831, DOI 10.2165/00019053-200826100-00004
   Smith HS, 2011, PAIN PHYSICIAN, V14, pE427
   Thomson WM, 2011, ORAL SURG ORAL MED O, V112, P322, DOI 10.1016/j.tripleo.2011.03.024
   Thomson WM, 1999, COMMUNITY DENT HLTH, V16, P12
   Turesson C, 2004, SCAND J RHEUMATOL, V33, P65, DOI 10.1080/03009740310004621
   Turesson C, 2002, J RHEUMATOL, V29, P62
   Tzioufas Athanasios G, 2012, Presse Med, V41, pe451, DOI 10.1016/j.lpm.2012.05.022
   Uhlig T, 1999, ANN RHEUM DIS, V58, P415, DOI 10.1136/ard.58.7.415
   van der Putten GJ, 2011, CLIN ORAL INVEST, V15, P185, DOI 10.1007/s00784-010-0382-1
   VANDERHEIJDE DMFM, 1990, ANN RHEUM DIS, V49, P916, DOI 10.1136/ard.49.11.916
   Visvanathan V, 2010, INT J CLIN PRACT, V64, P404, DOI 10.1111/j.1742-1241.2009.02132.x
   Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554
   Wolfe F, 2001, ANN RHEUM DIS, V60, P811, DOI 10.1136/ard.60.8.811
   Wolfe F, 2008, J RHEUMATOL, V35, P1023
   Young A, 2007, BEST PRACT RES CL RH, V21, P907, DOI 10.1016/j.berh.2007.05.007
NR 47
TC 4
Z9 4
U1 0
U2 6
PU J RHEUMATOL PUBL CO
PI TORONTO
PA 365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA
SN 0315-162X
EI 1499-2752
J9 J RHEUMATOL
JI J. Rheumatol.
PD OCT
PY 2016
VL 43
IS 10
BP 1795
EP 1800
DI 10.3899/jrheum.151211
PG 6
WC Rheumatology
SC Rheumatology
GA EF3OD
UT WOS:000390233000004
PM 27585681
DA 2020-11-30
ER

PT J
AU Carvalho, AT
   Valones, MAA
   Tenorio, LA
   Terto, PB
   Gueiros, LAM
   Leao, JC
   Souza, PRE
   Caldas, AF
AF Carvalho, A. T.
   Valones, M. A. A.
   Tenorio, L. A.
   Terto, P. B.
   Gueiros, L. A. M.
   Leao, J. C.
   Souza, P. R. E.
   Caldas, A. F., Jr.
TI Clinical evaluation of a phytotherapeutic based dentifrice Rosmarinus
   officinalis Linn on dental biofilm
SO ORAL DISEASES
LA English
DT Meeting Abstract
C1 [Carvalho, A. T.; Valones, M. A. A.; Tenorio, L. A.; Terto, P. B.; Gueiros, L. A. M.; Leao, J. C.; Souza, P. R. E.; Caldas, A. F., Jr.] Univ Fed Pernambuco, UFPE, Dept Clin & Prevent Dent, Oral Med Unit, Recife, PE, Brazil.
RI Leao, Jair Carneiro/AAL-6154-2020; Gueiros, Luiz Alcino/B-6429-2015
OI Leao, Jair Carneiro/0000-0001-8303-2291; Gueiros, Luiz
   Alcino/0000-0003-4979-4318
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1354-523X
EI 1601-0825
J9 ORAL DIS
JI Oral Dis.
PD SEP
PY 2016
VL 22
SU 2
SI SI
MA B070
BP 29
EP 29
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA VG0II
UT WOS:000444349600105
DA 2020-11-30
ER

PT J
AU Santos, DD
   dos Santos, LCB
   Carvalho, ADT
   Leao, JC
   Delrieux, C
   Stosic, T
   Stosic, B
AF Santos, Daniel de Souza
   Bezerra dos Santos, Leonardo Cavalcanti
   Tavares Carvalho, Alessandra de Albuquerque
   Leao, Jair Carneiro
   Delrieux, Claudio
   Stosic, Tatijana
   Stosic, Borko
TI Multifractal spectrum and lacunarity as measures of complexity of
   osseointegration
SO CLINICAL ORAL INVESTIGATIONS
LA English
DT Article
DE Dental implants; Osseointegration; Fractal dimension; Multifractal
   spectrum; Lacunarity
ID FRACTAL ANALYSIS; DENTAL RADIOGRAPHS; DIMENSION; PATTERNS; IMAGES; BONE
AB The goal of this study is to contribute to a better quantitative description of the early stages of osseointegration, by application of fractal, multifractal, and lacunarity analysis.
   Fractal, multifractal, and lacunarity analysis are performed on scanning electron microscopy (SEM) images of titanium implants that were first subjected to different treatment combinations of i) sand blasting, ii) acid etching, and iii) exposition to calcium phosphate, and were then submersed in a simulated body fluid (SBF) for 30 days. All the three numerical techniques are applied to the implant SEM images before and after SBF immersion, in order to provide a comprehensive set of common quantitative descriptors.
   It is found that implants subjected to different physicochemical treatments before submersion in SBF exhibit a rather similar level of complexity, while the great variety of crystal forms after SBF submersion reveals rather different quantitative measures (reflecting complexity), for different treatments. In particular, it is found that acid treatment, in most combinations with the other considered treatments, leads to a higher fractal dimension (more uniform distribution of crystals), lower lacunarity (lesser variation in gap sizes), and narrowing of the multifractal spectrum (smaller fluctuations on different scales).
   The current quantitative description has shown the capacity to capture the main features of complex images of implant surfaces, for several different treatments. Such quantitative description should provide a fundamental tool for future large scale systematic studies, considering the large variety of possible implant treatments and their combinations.
   Quantitative description of early stages of osseointegration on titanium implants with different treatments should help develop a better understanding of this phenomenon, in general, and provide basis for further systematic experimental studies. Clinical practice should benefit from such studies in the long term, by more ready access to implants of higher quality.
C1 [Santos, Daniel de Souza] Univ Fed Rural Pernambuco, Dept Fis, Rua Dom Manoel de Medeiros S-N, BR-52171900 Recife, PE, Brazil.
   [Bezerra dos Santos, Leonardo Cavalcanti; Tavares Carvalho, Alessandra de Albuquerque; Leao, Jair Carneiro] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Ave Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
   [Delrieux, Claudio] Univ Nacl Sur, Dept Ingn Elect & Comp, B8000FWB, Bahia Blanca, Buenos Aires, Argentina.
   [Stosic, Tatijana; Stosic, Borko] Univ Fed Rural Pernambuco, Dept Estat & Informat, Rua Dom Manoel de Medeiros S-N, BR-52171900 Recife, PE, Brazil.
RP Stosic, B (corresponding author), Univ Fed Rural Pernambuco, Dept Estat & Informat, Rua Dom Manoel de Medeiros S-N, BR-52171900 Recife, PE, Brazil.
EM borko@pq.cnpq.br
RI Leao, Jair Carneiro/AAL-6154-2020; Delrieux, Claudio/O-8917-2019;
   Stosic, Tatijana/J-3974-2013; Stosic, Borko/B-5808-2014; Delrieux,
   Claudio/M-1688-2019
OI Leao, Jair Carneiro/0000-0001-8303-2291; Delrieux,
   Claudio/0000-0002-2727-8374; Stosic, Tatijana/0000-0002-5691-945X
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FACEPE; MINCYT (Argentinean Ministry of Science,
   Technology and Productive Innovation)
FX This work is supported by research grants from CNPq, CAPES and FACEPE
   (Brazilian research agencies), and MINCYT (Argentinean Ministry of
   Science, Technology and Productive Innovation).
CR ALLAIN C, 1991, PHYS REV A, V44, P3552, DOI 10.1103/PhysRevA.44.3552
   Bagno A, 2004, J MATER SCI-MATER M, V15, P935, DOI 10.1023/B:JMSM.0000042679.28493.7f
   Caniego FJ, 2005, ECOL MODEL, V182, P291, DOI 10.1016/j.ecolmodel.2004.04.014
   CHHABRA A, 1989, PHYS REV LETT, V62, P1327, DOI 10.1103/PhysRevLett.62.1327
   Chung HW, 2000, AM J ROENTGENOL, V174, P1055, DOI 10.2214/ajr.174.4.1741055
   de Benicio RB, 2013, PHYSICA A, V392, P6367, DOI 10.1016/j.physa.2013.08.012
   dos Santos LCB, 2015, INT J PROST IN PRESS
   Ehrenfest DMD, 2011, J ORAL IMPLANTOL, V37, P506, DOI 10.1563/AAID-JOI-D-11-00081
   Feder J., 1988, FRACTALS
   Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499
   Guo CY, 2012, J ADHES SCI TECHNOL, V26, P189, DOI 10.1163/016942411X569390
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lezzi G, 2012, IMPLANT DENT, V20, P131
   Lopes R, 2009, MED IMAGE ANAL, V13, P634, DOI 10.1016/j.media.2009.05.003
   Lovejoy S, 2007, NONLINEAR DYNAMICS IN GEOSCIENCES, P311, DOI 10.1007/978-0-387-34918-3_18
   Malhi Y, 2008, REMOTE SENS ENVIRON, V112, P2074, DOI 10.1016/j.rse.2008.01.009
   Mandelbrot BB, 1982, FRACTAL GEOMEYTRY NA
   Myint S. W., 2005, Computers, Environment and Urban Systems, V29, P501, DOI 10.1016/j.compenvurbsys.2005.01.007
   Perrotti V, 2011, INT J PERIODONT REST, V31, P633
   Plotnick RE, 1996, PHYS REV E, V53, P5461, DOI 10.1103/PhysRevE.53.5461
   Sachs S, 2002, FRACTALS, V10, P253, DOI 10.1142/S0218348X02001385
   Sanchez I, 2011, J DENT, V39, P273, DOI 10.1016/j.jdent.2011.01.010
   Seuront L, 2009, FRACTALS MULTIFRACTA
   Shimizu Y, 2002, FRACTALS, V10, P103, DOI 10.1142/S0218348X02001130
   Stosic T, 2006, IEEE T MED IMAGING, V25, P1101, DOI 10.1109/TMI.2006.879316
   THEILER J, 1990, J OPT SOC AM A, V7, P1055, DOI 10.1364/JOSAA.7.001055
   Updike SX, 2008, J PERIODONTAL RES, V43, P658, DOI 10.1111/j.1600-0765.2007.01056.x
   Velazquez-Camilo O, 2010, J FOOD ENG, V100, P77, DOI 10.1016/j.jfoodeng.2010.03.030
   Yasar F, 2005, DENTOMAXILLOFAC RAD, V34, P261, DOI 10.1259/dmfr/85149245
   Zaia A, 2006, IEEE T INF TECHNOL B, V10, P484, DOI 10.1109/TITB.2006.872078
NR 31
TC 4
Z9 4
U1 0
U2 12
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1432-6981
EI 1436-3771
J9 CLIN ORAL INVEST
JI Clin. Oral Investig.
PD JUL
PY 2016
VL 20
IS 6
BP 1271
EP 1278
DI 10.1007/s00784-015-1606-1
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DQ2CT
UT WOS:000379009600018
PM 26438344
DA 2020-11-30
ER

PT J
AU Carvalho, CN
   do Carmo, RF
   Duarte, ALP
   Carvalho, AAT
   Leao, JC
   Gueiros, LA
AF Carvalho, Camila Nunes
   do Carmo, Rodrigo Feliciano
   Pinto Duarte, Angela Luzia
   Tavares Carvalho, Alessandra Albuquerque
   Leao, Jair Carneiro
   Gueiros, Luiz Alcino
TI IL-17A and IL-17F polymorphisms in rheumatoid arthritis and Sjogren's
   syndrome
SO CLINICAL ORAL INVESTIGATIONS
LA English
DT Article
DE Genetic polymorphism; Interleukin 17; Rheumatoid arthritis; Sjogren's
   syndrome
ID INFLAMMATORY-BOWEL-DISEASE; SALIVARY-GLAND BIOPSY; TH17 CELLS;
   ASSOCIATION; CYTOKINE; CRITERIA; GENES; INTERLEUKIN-17A; CLASSIFICATION;
   SUSCEPTIBILITY
AB The aim of this study was to evaluate the influence of Th17 polymorphisms on the susceptibility or severity of rheumatoid arthritis (RA) and Sjogren's syndrome (SS).
   The study sample comprised 206 individuals of both genders divided into three groups: exclusive rheumatoid arthritis (RA-100 patients), rheumatoid arthritis and Sjogren's syndrome (RA/SS-31 patients), and healthy controls (C-75 individuals). All the individuals were submitted to clinical evaluation, unstimulated sialometry, and Schirmer test; some patients with RA were also submitted to minor salivary gland biopsy for definition of SS diagnosis. Saliva samples were collected for isolation of DNA and genotyping of Th17 genes; IL-17A (-197G/A) and IL-17F (7488T/C).
   IL-17A (-197G/A) and IL-17F (7488T/C) SNPs were not associated with susceptibility to RA or secondary SS (sSS, p > 0.05 for both SNPs). In addition, they did not influence RA activity or clinical markers of SS.
   IL-17A (-197G/A) and IL-17F (7488T/C) polymorphisms are not associated with the susceptibility nor to the severity of RA and sSS in the studied population.
   A better understanding of the pathogenesis of SS is demanded to an adequate treatment as well as to the development of new management strategies.
C1 [Carvalho, Camila Nunes; Tavares Carvalho, Alessandra Albuquerque; Leao, Jair Carneiro; Gueiros, Luiz Alcino] Univ Fed Pernambuco, Oral Med Unit, Dept Clin & Prevent Dent, Recife, PE, Brazil.
   [do Carmo, Rodrigo Feliciano] Fed Univ Vale Sao Francisco, Immunol Sect, Petrolina, Brazil.
   [Pinto Duarte, Angela Luzia] Univ Fed Pernambuco, Rheumatol Unit, Hosp Clin, Recife, PE, Brazil.
RP Gueiros, LA (corresponding author), Univ Fed Pernambuco, Oral Med Unit, Dept Clin & Prevent Dent, Recife, PE, Brazil.
EM lagueiros@gmail.com
RI Leao, Jair Carneiro/AAL-6154-2020; Carmo, Rodrigo Feliciano
   do/V-9795-2017; Gueiros, Luiz Alcino/B-6429-2015
OI Leao, Jair Carneiro/0000-0001-8303-2291; Carmo, Rodrigo Feliciano
   do/0000-0001-9601-6995; Gueiros, Luiz Alcino/0000-0003-4979-4318
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [481469/2012-5]; Pernambuco Research Foundation (FACEPE)
   [APQ-1978-4.02/12]
FX The authors are thankful to The National Council for Scientific and
   Technological Development (CNPq, Grant: 481469/2012-5) and The
   Pernambuco Research Foundation (FACEPE, Grant: APQ-1978-4.02/12), for
   the financial support.
CR Aidar Marisi, 2007, Braz. Dent. J., V18, P148, DOI 10.1590/S0103-64402007000200012
   Arisawa T, 2008, J CLIN IMMUNOL, V28, P44, DOI 10.1007/s10875-007-9125-8
   ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302
   Chen B, 2009, SCAND J GASTROENTERO, V44, P720, DOI 10.1080/00365520902795430
   Daniels TE, 2011, ARTHRITIS RHEUM-US, V63, P2021, DOI 10.1002/art.30381
   de Souza TR, 2014, J ORAL PATHOL MED, V43, P418, DOI 10.1111/jop.12149
   Delaleu N, 2008, RHEUM DIS CLIN N AM, V34, P833, DOI 10.1016/j.rdc.2008.08.004
   Espinoza JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026229
   Furuya T, 2007, CLIN RHEUMATOL, V26, P2137, DOI 10.1007/s10067-007-0745-4
   Hamza N, 2012, PRESSE MED, V41, P471
   Hernandez-Molina G, 2011, AUTOIMMUN REV, V10, P123, DOI 10.1016/j.autrev.2010.09.001
   Ice JA, 2012, J AUTOIMMUN, V39, P57, DOI 10.1016/j.jaut.2012.01.008
   Johns Hopkins Arthritis Center, 2009, RHEUMATOID ARTHRITIS
   Katsifis GE, 2009, AM J PATHOL, V175, P1167, DOI 10.2353/ajpath.2009.090319
   Liu XKK, 2004, J BIOL CHEM, V279, P52762, DOI 10.1074/jbc.M405764200
   MACKAY IM, 2007, REAL TIME PCR MICROB, P1
   Mavragani CP, 2007, CLIN REV ALLERG IMMU, V32, P284, DOI 10.1007/s12016-007-8008-3
   Miossec P, 2009, MICROBES INFECT, V11, P625, DOI 10.1016/j.micinf.2009.04.003
   NAVAZESH M, 1992, J DENT RES, V71, P1363, DOI 10.1177/00220345920710070301
   Nguyen CQ, 2008, ARTHRITIS RHEUM-US, V58, P734, DOI 10.1002/art.23214
   Nordang GBN, 2009, RHEUMATOLOGY, V48, P367, DOI 10.1093/rheumatology/ken512
   Paradowska-Gorycka A, 2010, SCAND J IMMUNOL, V72, P134, DOI 10.1111/j.1365-3083.2010.02411.x
   Pereira DL, 2014, MED ORAL PATOL ORAL, V19, pE237, DOI 10.4317/medoral.19486
   Ramsey CD, 2005, GENES IMMUN, V6, P236, DOI 10.1038/sj.gene.6364170
   Reksten TR, 2009, RHEUMATOLOGY, V48, P1102, DOI 10.1093/rheumatology/kep149
   Reynard MP, 2000, EUR J IMMUNOGENET, V27, P241, DOI 10.1046/j.1365-2370.2000.00227.x
   Roescher N, 2010, ANN RHEUM DIS, V69, P945, DOI 10.1136/ard.2009.115378
   Sakai A, 2008, J IMMUNOL, V181, P2898, DOI 10.4049/jimmunol.181.4.2898
   Sarkar S, 2014, CLIN EXP IMMUNOL, DOI 10.111/cei.12376
   Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775
   Seiderer J, 2008, INFLAMM BOWEL DIS, V14, P437, DOI 10.1002/ibd.20339
   Shibata T, 2009, HUM IMMUNOL, V70, P547, DOI 10.1016/j.humimm.2009.04.030
   Stewart CM, 2008, ORAL SURG ORAL MED O, V106, P392, DOI 10.1016/j.tripleo.2008.04.018
   Tavoni A, 2012, CLIN EXP RHEUMATOL, V30, P929
   Tomsic M, 1999, RHEUMATOLOGY, V38, P164, DOI 10.1093/rheumatology/38.2.164
   TZIOUFAS AG, 2012, PRESSE MED, V41, P451, DOI DOI 10.1016/J.LPM.2012.05.022
   VANBIJST.OP, 1969, ARCH OPHTHALMOL-CHIC, V82, P10
   Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554
   Wang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047917
   Yamada H, 2008, ANN RHEUM DIS, V67, P1299, DOI 10.1136/ard.2007.080341
   Youinou P, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3348
   Zandbelt MM, 2001, ANN RHEUM DIS, V60, P511, DOI 10.1136/ard.60.5.511
NR 42
TC 14
Z9 15
U1 0
U2 2
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1432-6981
EI 1436-3771
J9 CLIN ORAL INVEST
JI Clin. Oral Investig.
PD APR
PY 2016
VL 20
IS 3
BP 495
EP 502
DI 10.1007/s00784-015-1540-2
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DH7HC
UT WOS:000372962300009
PM 26232893
DA 2020-11-30
ER

PT J
AU Vieira, CL
   Vasconcelos, BCD
   Leao, JC
   Laureano, JR
AF Vieira, C. L.
   Vasconcelos, B. C. do E.
   Leao, J. C.
   Laureano Filho, J. R.
TI Effect of the use of combination uridine triphosphate, cytidine
   monophosphate, and hydroxycobalamin on the recovery of neurosensory
   disturbance after bilateral sagittal split osteotomy: a randomized,
   double-blind trial
SO INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
DE orthognathic surgery; mandibular nerve; nervous system trauma;
   therapeutics
ID INFERIOR ALVEOLAR NERVE; REGENERATION; NUCLEOTIDES; INJURY; RAMUS
AB The change in neurosensory lesions that develop after bilateral sagittal split osteotomy (BSSO) was explored, and the influence of the application of combination uridine triphosphate (UTP), cytidine monophosphate (CMP), and hydroxycobalamin (vitamin B12) on patient outcomes was assessed. This was a randomized, controlled, double-blind trial. The study sample comprised 12 patients, each evaluated on both sides (thus 24 sides). All patients fulfilled defined selection criteria. Changes in the lesions were measured both subjectively and objectively. The sample was divided into two patient groups: an experimental group receiving medication and a control group receiving placebo. The statistical analysis was performed using SPSS software. Lesions in both groups improved and no statistically significant difference between the groups was observed at any time. 'Severe' injuries in the experimental group were more likely to exhibit a significant improvement after 6 months. Based on the results of the present study, it is concluded that the combination UTP, CMP, and hydroxycobalamin did not influence recovery from neurosensory disorders.
C1 [Vieira, C. L.] Univ Pernambuco, Sch Dent, Recife, PE, Brazil.
   [Vasconcelos, B. C. do E.; Laureano Filho, J. R.] Univ Pernambuco, Dept Maxillofacial Surg & Traumatol, Recife, PE, Brazil.
   [Leao, J. C.] Univ Pernambuco, Dept Clin & Prevent Dent, Oral Med Unit, Recife, PE, Brazil.
RP Laureano, JR (corresponding author), Univ Pernambuco, Sch Dent, Program Oral Maxillofacial Surg, Av Gen Newton Cavalcanti,1650 Camaragibe, BR-54753220 Camaragibe, PE, Brazil.
EM laureano.filho@upe.br
RI Vasconcelos, Belmiro/AAT-9360-2020
OI Vasconcelos, Belmiro/0000-0002-6515-1489; Laureano Filho,
   Jose/0000-0002-9645-2057
CR Abarca M, 2006, CLIN ORAL INVEST, V10, P269, DOI 10.1007/s00784-006-0065-0
   Barboza KO, 2010, NEUROBIOLOGIA, V73, P111
   Ribeiro CMB, 2008, ACTA CIR BRAS, V23, P364, DOI 10.1590/S0102-86502008000400011
   Colella G, 2007, J ORAL MAXIL SURG, V65, P1707, DOI 10.1016/j.joms.2007.05.009
   Connolly GP, 1999, TRENDS PHARMACOL SCI, V20, P218, DOI 10.1016/S0165-6147(99)01298-5
   Epker B, 1999, DENTOFACIAL DEFORMIT
   Genii PR, 2003, INFLUENCE TOOTH SECT
   Goldberg H., 2009, Revista Brasileira de Medicina, V66, P380
   Hanzelka T, 2011, INT J ORAL MAX SURG, V40, P901, DOI 10.1016/j.ijom.2011.04.002
   Kabasawa Y, 2006, ORAL SURG ORAL MED O, V102, P719, DOI 10.1016/j.tripleo.2005.11.001
   Lacanna SN, 2010, THEM NEUR 2 S NAC NE
   Lauretti GR, 2005, COLUNA-COLUMNA, V4, P27
   Mensink G, 2012, J CRANIO MAXILL SURG, V40, P763, DOI 10.1016/j.jcms.2012.02.003
   Muller D, 2002, Fortschr Med Orig, V120, P131
   Nakajima EK, 2009, EVALUATING EFFECTIVE
   Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005
   Oka HM, 2001, RINSYOU SHINKEI SEIR, V29, P254
   Ow A, 2010, INT J ORAL MAX SURG, V39, P756, DOI 10.1016/j.ijom.2010.04.001
   Panula K, 2004, INT J ORAL MAX SURG, V33, P543, DOI 10.1016/j.ijom.2003.11.005
   Park JW, 2011, ORAL SURG ORAL MED O, V111, P24, DOI 10.1016/j.tripleo.2010.03.045
   Phillips C, 2006, J ORAL MAXIL SURG, V64, P1751, DOI 10.1016/j.joms.2005.11.100
   Santana-Santos T, 2009, REV CIR TRAUMATOL BU, V9, P93
   Teerijoki-Oksa T, 2002, INT J ORAL MAX SURG, V31, P33, DOI 10.1054/ijom.2001.0157
   van Merkesteyn JPR, 2007, J CRANIO MAXILL SURG, V35, P222, DOI 10.1016/j.jcms.2007.04.006
   Venhoff N, 2010, AIDS, V24, P345, DOI 10.1097/QAD.0b013e328335cdea
   Vriens JPM, 2009, INT J ORAL MAX SURG, V38, P1154, DOI 10.1016/j.ijom.2009.06.006
   WATTIG B, 1991, Zentralblatt fuer Pathologie, V137, P409
   WATTIG B, 1992, ACTA HISTOCHEM, P333
   WATTIG B, 1991, Z KLIN MED, V46, P1371
   Westermark A, 1998, BRIT J ORAL MAX SURG, V36, P429, DOI 10.1016/S0266-4356(98)90458-2
   Yamashita Y, 2011, INT J ORAL MAX SURG, V40, P360, DOI 10.1016/j.ijom.2010.11.017
   Ylikontiola L, 2000, J ORAL MAXIL SURG, V58, P1234, DOI 10.1053/joms.2000.16621
NR 32
TC 2
Z9 2
U1 1
U2 4
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0901-5027
EI 1399-0020
J9 INT J ORAL MAX SURG
JI Int. J. Oral Maxillofac. Surg.
PD FEB
PY 2016
VL 45
IS 2
BP 186
EP 193
DI 10.1016/j.ijom.2015.09.007
PG 8
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA DC8IY
UT WOS:000369464300011
PM 26458536
DA 2020-11-30
ER

PT J
AU dos Santos, LCB
   Carvalho, ADT
   Leao, JC
   Neto, PJD
   Stosic, T
   Stosic, B
AF Bezerra dos Santos, Leonardo Cavalcanti
   Tavares Carvalho, Alessandra de Albuquerque
   Leao, Jair Carneiro
   Duarte Neto, Paulo Jose
   Stosic, Tatijana
   Stosic, Borko
TI Fractal Measure and Microscopic Modeling of Osseointegration
SO INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY
LA English
DT Article
AB In this study, the process of osseointegration on titanium implant surfaces with different physicochemical treatments subjected to a simulated corporal fluid submersion was evaluated using the concept of fractal dimension. It was found that different treatments led to rather different calcium phosphate crystal growth patterns, with fractal dimension ranging from 1.68 to 1.93. The observed crystal patterns may be explained by a general deposition, diffusion, and aggregation growth mechanism, where diffusing particle sticking probability plays a fundamental role.
C1 [Bezerra dos Santos, Leonardo Cavalcanti; Tavares Carvalho, Alessandra de Albuquerque; Leao, Jair Carneiro] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
   [Duarte Neto, Paulo Jose; Stosic, Tatijana; Stosic, Borko] Univ Fed Rural Pernambuco, Dept Estat & Informat, BR-52171900 Recife, PE, Brazil.
RP Stosic, B (corresponding author), Univ Fed Rural Pernambuco, Dept Estat & Informat, Rua Dom Manoel Medeiros S-N, BR-52171900 Recife, PE, Brazil.
EM borkostosic@gmail.com
RI Stosic, Borko/B-5808-2014; Stosic, Tatijana/J-3974-2013; Leao, Jair
   Carneiro/AAL-6154-2020; Duarte-Neto, Paulo J/J-5623-2016
OI Leao, Jair Carneiro/0000-0001-8303-2291; Duarte-Neto, Paulo
   J/0000-0002-2592-7297; Stosic, Tatijana/0000-0002-5691-945X
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FACEPE
FX This work was supported through research grants from CNPq, CAPES, and
   FACEPE (Brazilian research agencies). The authors reported no conflicts
   of interest related to this study.
CR Albrektsson T, 2008, PERIODONTOL 2000, V47, P15, DOI 10.1111/j.1600-0757.2007.00247.x
   Chung HW, 2000, AM J ROENTGENOL, V174, P1055, DOI 10.2214/ajr.174.4.1741055
   Dellino P, 2002, J VOLCANOL GEOTH RES, V113, P1, DOI 10.1016/S0377-0273(01)00247-5
   Ehrenfest DMD, 2011, J ORAL IMPLANTOL, V37, P506, DOI 10.1563/AAID-JOI-D-11-00081
   Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499
   Guo CY, 2012, J ADHES SCI TECHNOL, V26, P189, DOI 10.1163/016942411X569390
   Jelinek HF, 1998, J NEUROSCI METH, V81, P9, DOI 10.1016/S0165-0270(98)00021-1
   JENSEN P, 1994, PHYS REV E, V50, P618, DOI 10.1103/PhysRevE.50.618
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lezzi G, 2012, IMPLANT DENT, V20, P131
   Majumdar A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.168101
   Mandelbrot B, 1983, FRACTAL GEOMETRY NAT, P25
   Palmquist A, 2008, ACTA ORTHOP, V79, P78, DOI 10.1080/17453670710014806
   Perrotti V, 2011, INT J PERIODONT REST, V31, P633
   Sanchez I, 2011, J DENT, V39, P273, DOI 10.1016/j.jdent.2011.01.010
   Stosic T, 2006, IEEE T MED IMAGING, V25, P1101, DOI 10.1109/TMI.2006.879316
   THEILER J, 1990, J OPT SOC AM A, V7, P1055, DOI 10.1364/JOSAA.7.001055
   Updike SX, 2008, J PERIODONTAL RES, V43, P658, DOI 10.1111/j.1600-0765.2007.01056.x
   Wazen JJ, 2007, LARYNGOSCOPE, V117, P794, DOI 10.1097/01.mlg.0000231281.76358.cc
   Zaia A, 2006, IEEE T INF TECHNOL B, V10, P484, DOI 10.1109/TITB.2006.872078
NR 21
TC 1
Z9 1
U1 0
U2 2
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0198-7569
EI 1945-3388
J9 INT J PERIODONT REST
JI Int. J. Periodontics Restor. Dent.
PD NOV-DEC
PY 2015
VL 35
IS 6
BP 851
EP 855
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CZ7BN
UT WOS:000367255000015
PM 26509989
DA 2020-11-30
ER

PT J
AU Barkokebas, A
   Silva, IHM
   de Andrade, SC
   Carvalho, AAT
   Gueiros, LAM
   Paiva, SM
   Leao, JC
AF Barkokebas, Andreza
   Morais Silva, Igor Henrique
   de Andrade, Samantha Cardoso
   Tavares Carvalho, Alessandra Albuquerque
   Monteiro Gueiros, Luiz Alcino
   Paiva, Saul Martins
   Leao, Jair Carneiro
TI Impact of oral mucositis on oral-health-related quality of life of
   patients diagnosed with cancer
SO JOURNAL OF ORAL PATHOLOGY & MEDICINE
LA English
DT Article
DE quality of life; mucositis; cancer
ID RECEIVING CHEMOTHERAPY; LUNG-CANCER; NECK-CANCER; VIRAL-INFECTIONS;
   HEAD; RADIOTHERAPY; CHILDREN; LEUKEMIA; TRIAL; VALIDATION
AB IntroductionOral mucositis (OM) has been described as the oral complication most frequently associated with antineoplastic therapy. However, the influence on the quality of life of affected patients is still unclear.
   ObjectiveTo evaluate the impact of OM on the oral-health-related quality of life (OHRQoL) of patients diagnosed with cancer, who developed chemotherapy- and/or radiotherapy-induced OM.
   MethodsThis is a cross-sectional evaluation of QoL using oral health impact profile-14 (OHIP-14). The study group comprised a sample of 60 patients diagnosed with cancer, who developed OM during the treatment. The instrument (OHIP-14) composed of seven dimensions was used: functional limitation, physical pain, psychological discomfort, physical deficiency, psychological deficiency, social incapacity, and deficiency.
   ResultsThe internal consistency of OHIP-14 measured by the Cronbach's coefficient was of 0.76. Physical pain attained the highest score (worst quality of life) among the studied dimensions 60.8% (292/480), followed by physical limitation 52.7% (253/480), and psychological discomfort 50.8% (244/480). The dimension social limitation' obtained the lowest score 27.2% (131/480). There was statistically significant difference as regards gender (P=0.021) for physical pain, with greater impact among patients of the male gender.
   ConclusionOral-health-related quality of life is significantly affected by OM in individuals diagnosed with cancer.
C1 [Barkokebas, Andreza; Morais Silva, Igor Henrique; de Andrade, Samantha Cardoso] Univ Fed Pernambuco, BR-50670901 Recife, PE, Brazil.
   [Tavares Carvalho, Alessandra Albuquerque; Monteiro Gueiros, Luiz Alcino; Leao, Jair Carneiro] Univ Fed Pernambuco, Dept Clin & Prevent Dent, BR-50670901 Recife, PE, Brazil.
   [Paiva, Saul Martins] Univ Fed Minas Gerais, Dept Paediat Dent & Orthodont, Belo Horizonte, MG, Brazil.
RP Leao, JC (corresponding author), Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Av Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
EM jleao@ufpe.br
RI Leao, Jair Carneiro/AAL-6154-2020; Paiva, Saul Martins/H-5757-2012;
   Gueiros, Luiz Alcino/B-6429-2015
OI Leao, Jair Carneiro/0000-0001-8303-2291; Paiva, Saul
   Martins/0000-0002-3968-1638; Gueiros, Luiz Alcino/0000-0003-4979-4318
CR Allen P F, 1997, Community Dent Health, V14, P133
   Armellini DB, 2008, INT J PROSTHODONT, V21, P524
   Barasch A, 2003, ORAL ONCOL, V39, P91, DOI 10.1016/S1368-8375(02)00033-7
   Bonan PRF, 2005, REV BRAS CANCEROL, V51, P235
   Buitenkamp TD, 2010, HAEMATOL-HEMATOL J, V95, P1106, DOI 10.3324/haematol.2009.019778
   Cheng KKF, 2010, SUPPORT CARE CANCER, V18, P1477, DOI 10.1007/s00520-009-0771-7
   Cheng KKF, 2001, EUR J CANCER, V37, P2056, DOI 10.1016/S0959-8049(01)00098-3
   Clarkson J.E., 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000978
   Cruz LB, 2007, PEDIATR BLOOD CANCER, V48, P435, DOI 10.1002/pbc.20943
   de Oliveira BH, 2005, COMMUNITY DENT ORAL, V33, P307
   Dodd MJ, 2000, CANCER PRACT, V8, P291, DOI 10.1046/j.1523-5394.2000.86010.x
   Elad S, 2010, SUPPORT CARE CANCER, V18, P993, DOI 10.1007/s00520-010-0900-3
   Elting LS, 2008, CANCER-AM CANCER SOC, V113, P2704, DOI 10.1002/cncr.23898
   Epstein JB, 1999, HEAD NECK-J SCI SPEC, V21, P1
   FREITAS A. L. P., 2005, S ENGENHARIA PRODUCA, V12
   Fulton Janet S, 2002, Semin Oncol Nurs, V18, P28, DOI 10.1053/sonu.2002.30041
   Gandemer V, 2007, J PEDIAT HEMATOL ONC, V29, P86, DOI 10.1097/MPH.0b013e318030a3e4
   Gautam AP, 2013, SUPPORT CARE CANCER, V21, P1421, DOI 10.1007/s00520-012-1684-4
   Hassel AJ, 2012, J CRANIO MAXILL SURG, V40, pE99, DOI 10.1016/j.jcms.2011.05.011
   Heydecke G, 2003, COMMUNITY DENT ORAL, V31, P161, DOI 10.1034/j.1600-0528.2003.00029.x
   Kim JW, 2012, SUPPORT CARE CANCER, V20, P395, DOI 10.1007/s00520-011-1126-8
   Liu LJ, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-2
   Lopez-Jornet P, 2009, EUR J DERMATOL, V19, P603, DOI 10.1684/ejd.2009.0762
   Luglie P F, 2002, Minerva Stomatol, V51, P231
   Luiz Ana C., 2008, Rev. Bras. Hematol. Hemoter., V30, P480, DOI 10.1590/S1516-84842008000600012
   McMillan AS, 2004, J ORAL REHABIL, V31, P600, DOI 10.1111/j.1365-2842.2004.01383.x
   Melchardt T, 2013, LEUKEMIA LYMPHOMA, V54, P1602, DOI 10.3109/10428194.2012.755178
   Montazeri A, 2003, QUAL LIFE RES, V12, P157, DOI 10.1023/A:1022232624891
   Montazeri A, 1996, Eur J Cancer Care (Engl), V5, P168, DOI 10.1111/j.1365-2354.1996.tb00229.x
   Montazeri A, 1996, Eur J Cancer Care (Engl), V5, P159, DOI 10.1111/j.1365-2354.1996.tb00228.x
   Montazeri A, 2001, LUNG CANCER, V31, P233, DOI 10.1016/S0169-5002(00)00179-3
   Mumcu G, 2006, ORAL DIS, V12, P145, DOI 10.1111/j.1601-0825.2005.01173.x
   Naidu MUR, 2004, NEOPLASIA, V6, P423, DOI 10.1593/neo.04169
   Naito Mariko, 2006, J Oral Sci, V48, P1, DOI 10.2334/josnusd.48.1
   Nonzee NJ, 2008, CANCER-AM CANCER SOC, V113, P1446, DOI 10.1002/cncr.23714
   Palmeira CCA, 2011, REV BRAS ANESTESIOL, V61, P6
   Ruiz-Arguelles GJ, 2007, HEMATOLOGY, V12, P387, DOI 10.1080/10245330701448479
   Sischo L, 2011, J DENT RES, V90, P1264, DOI 10.1177/0022034511399918
   Slade G D, 1994, Community Dent Health, V11, P3
   Slade GD, 1997, COMMUNITY DENT ORAL, V25, P284, DOI 10.1111/j.1600-0528.1997.tb00941.x
   Slade GD, 1996, J DENT RES, V75, P1439, DOI 10.1177/00220345960750070301
   SONIS ST, 1992, ORAL SURG ORAL MED O, V74, P749, DOI 10.1016/0030-4220(92)90402-C
   Sonis ST, 1999, CANCER-AM CANCER SOC, V85, P2103, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0
   Thomson WM, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-86
   Zur Eyal, 2012, Int J Pharm Compd, V16, P22
NR 45
TC 20
Z9 22
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0904-2512
EI 1600-0714
J9 J ORAL PATHOL MED
JI J. Oral Pathol. Med.
PD OCT
PY 2015
VL 44
IS 9
BP 746
EP 751
DI 10.1111/jop.12282
PG 6
WC Dentistry, Oral Surgery & Medicine; Pathology
SC Dentistry, Oral Surgery & Medicine; Pathology
GA CT1SQ
UT WOS:000362581700014
PM 25345344
DA 2020-11-30
ER

PT J
AU dos Santos, LDC
   de Andrade, SC
   Nogueira, GEC
   Leao, JC
   de Freitas, PM
AF dos Santos, Lucia de Fatima C.
   de Andrade, Samantha C.
   Nogueira, Gesse E. C.
   Leao, Jair C.
   de Freitas, Patricia M.
TI Phototherapy on the Treatment of Burning Mouth Syndrome: A Prospective
   Analysis of 20 Cases
SO PHOTOCHEMISTRY AND PHOTOBIOLOGY
LA English
DT Article
AB The aim of this study was to report the effect of laser phototherapy (LPT) on the treatment of burning mouth syndrome (BMS). This prospective clinical study reports on preliminary outcomes of twenty volunteers diagnosed with BMS who have undergone the conventional treatment prior to laser phototherapy. LPT consisted of weekly sessions of LPT (660nm), for a period of 10weeks. The laser protocol consisted of the following parameters: 40mW, 10Jcm(2) and 0.4J per point, irradiation time of 10s. In all sessions, the burning intensity was evaluated with a 10cm Visual Analogue Scale (VAS). The burning intensity evaluation by VAS was performed immediately before and after each LPT session. Nonparametric test of Wilcoxon was used for statistical analysis, considering a significance level of 5%. All volunteers reported reduced burning intensity in all sessions when compared to the previous one and reduction in VAS scores by up to 49% in the last clinical session when compared to the first session. When only the VAS baseline of the first session was compared with the consecutive sessions, there was a statistically significant reduction in VAS scores in almost all sessions. The LPT may be an alternative treatment for the relief of oral burning symptoms in patients with BMS.
C1 [dos Santos, Lucia de Fatima C.; Nogueira, Gesse E. C.] Ctr Lasers & Aplicacoes, Inst Pesquisas Energet & Nucl, Sao Paulo, Brazil.
   [de Andrade, Samantha C.; Leao, Jair C.] Univ Fed Pernambuco, Dept Clin & Odontol Preventiva, Ctr Ciencias Saude, Recife, PE, Brazil.
   [de Freitas, Patricia M.] Univ Sao Paulo, LELO, Dept Dentist, Fac Odontol, Sao Paulo, Brazil.
RP de Freitas, PM (corresponding author), Univ Sao Paulo, LELO, Dept Dentist, Fac Odontol, Sao Paulo, Brazil.
EM pfreitas@usp.br
RI Leao, Jair Carneiro/AAL-6154-2020; Nogueira, Gesse Eduardo C/E-4151-2013
OI Leao, Jair Carneiro/0000-0001-8303-2291; Nogueira, Gesse Eduardo
   C/0000-0001-6406-2022
CR BERGDAHL J, 1993, J ORAL PATHOL MED, V22, P433, DOI 10.1111/j.1600-0714.1993.tb00120.x
   Bogetto F, 1998, PSYCHOSOM MED, V60, P378, DOI 10.1097/00006842-199805000-00028
   Brailo V, 2013, ACUPUNCT MED, V31, P453, DOI 10.1136/acupmed-2013-010419
   dos Santos LDC, 2015, LASERS IN DENTISTRY: GUIDE FOR CLINICAL PRACTICE, P290
   dos Santos LDC, 2011, PHOTOMED LASER SURG, V29, P793, DOI 10.1089/pho.2011.3016
   CEKIC-ARAMBASIN A, 1990, Acta Stomatologica Croatica, V24, P281
   Chavantes MC, 2015, LASERS IN DENTISTRY: GUIDE FOR CLINICAL PRACTICE, P19
   Cibirka RM, 1997, J PROSTHET DENT, V78, P93, DOI 10.1016/S0022-3913(97)70089-1
   Dutree-Meulemberg R. O., 1996, J AM ACAD DERMATOL, V34, P91
   Ferensztajn E, 2013, PSYCHIATR POL, V47, P973, DOI 10.12740/PP/19617
   Gorsky M., 1991, J ORAL MED, V47, P7
   Gremeau-Richard C, 2004, PAIN, V108, P51, DOI 10.1016/j.pain.2003.12.002
   Heckmann SM, 2001, PAIN, V90, P281, DOI 10.1016/S0304-3959(00)00410-3
   HUGOSON A, 1991, ACTA ODONTOL SCAND, V49, P367, DOI 10.3109/00016359109005933
   Karu T. I, 1998, J QUANTUM ELECT, V23, P1703
   Lamey PJ, 2001, J ORAL PATHOL MED, V30, P121, DOI 10.1034/j.1600-0714.2001.300209.x
   Lauria G, 2005, PAIN, V115, P332, DOI 10.1016/j.pain.2005.03.028
   Lopez-Jornet P, 2009, J EUR ACAD DERMATOL, V23, P363, DOI 10.1111/j.1468-3083.2008.02873.x
   Maresky L S, 1993, Ann Dent, V52, P21
   Nakase M, 2004, ORAL DIS, V10, P217, DOI 10.1111/j.1601-0825.2004.01001.x
   Okenson J. P., 1998, DORES BUCOFACIAIS BE
   Pandeshwar P, 2016, J INVESTIG CLIN DENT, V7, P114, DOI 10.1111/jicd.12148
   Patton LL, 2007, ORAL SURG ORAL MED O, V103, pS39, DOI 10.1016/j.tripleo.2006.11.009
   Pesevska S., 2006, ACTA FM NALLS, V23, P75
   Pokupec-Gruden JS, 2000, COLLEGIUM ANTROPOL, V24, P119
   SHIP JA, 1995, J AM DENT ASSOC, V126, P842, DOI 10.14219/jada.archive.1995.0305
   Van der wall I., 1990, BURNING MOUTH SYNDRO
   Yang HW, 2011, PHOTOMED LASER SURG, V29, P123, DOI 10.1089/pho.2010.2787
   ZAKRZEWSKA JM, 1995, PAIN, V62, P253, DOI 10.1016/0304-3959(95)00089-B
   Zeller A, 2001, Praxis (Bern 1994), V90, P1103
   ZISKIN DE, 1946, J AM DENT ASSOC, V33, P1422, DOI 10.14219/jada.archive.1946.0219
NR 31
TC 13
Z9 13
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0031-8655
EI 1751-1097
J9 PHOTOCHEM PHOTOBIOL
JI Photochem. Photobiol.
PD SEP-OCT
PY 2015
VL 91
IS 5
BP 1231
EP 1236
DI 10.1111/php.12490
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CQ7CX
UT WOS:000360761600027
PM 26138316
DA 2020-11-30
ER

PT J
AU Oliveira, HF
   de Souza, TR
   Carvalho, CN
   Duarte, A
   Carvalho, AT
   Leao, JC
   Gueiros, LA
AF Oliveira, Hugo Franklin
   de Souza, Thayse Rodrigues
   Carvalho, Camila Nunes
   Duarte, Angela
   Carvalho, Alessandra Tavares
   Leao, Jair Carneiro
   Gueiros, Luiz Alcino
TI Serologic profile and clinical markers of Sjogren syndrome in patients
   with rheumatoid arthritis
SO ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY
LA English
DT Article
ID CITRULLINATED PEPTIDE ANTIBODIES; SICCA SYMPTOMS; CLASSIFICATION
   CRITERIA; AUTOIMMUNE-DISEASES; ASSOCIATION; PREVALENCE; AUTOANTIBODIES;
   MANIFESTATIONS; VARIABLES
AB Objective. The aim of this study was to evaluate the clinical relevance of rheumatoid factor (RF) and antibodies against cyclic citrullinated peptides (anti-CCP) in patients with Sjogren syndrome (SS) secondary to rheumatoid arthritis (RA).
   Methods. The study included 118 individuals, and the subjects were divided into three groups: rheumatoid arthritis (RA; n = 46), RA with secondary Sjogren syndrome (RA/SS; n = 20) and healthy controls (C; n = 52). Clinical and laboratory characteristics, including ocular, oral, and serum markers, anti-CCP, and rheumatoid factor (RF), were compared in addition to biopsy of labial minor salivary glands.
   Results. The RA group exhibited unstimulated salivary flow rate, and Schirmer test results were similar to those for C and higher than those for RA/SS (P < .05). Furthermore, the frequency of xerophthalmia and xerostomia was similar among the RA and C groups, and much higher in the RA/SS group (P < .05). Anti-CCP positivity and serum levels were similar in both RA groups, irrespective of SS diagnosis (RA x RA/SS; P > .05). RF presented a similar frequency and serum level between the RA and RA/SS groups (P > .05).
   Conclusions. Secondary SS seems to be a cluster of oral and ocular symptoms among patients with RA. Anti-CCP and RF are not relevant to evaluate the presence of SS among these patients.
C1 [Oliveira, Hugo Franklin; de Souza, Thayse Rodrigues; Carvalho, Camila Nunes; Carvalho, Alessandra Tavares; Leao, Jair Carneiro; Gueiros, Luiz Alcino] Univ Fed Pernambuco, Oral Med Unit, Dept Clin & Odontol Prevent, BR-50670901 Recife, PE, Brazil.
   [Duarte, Angela] Univ Fed Pernambuco, Rheumatol Unit, Hosp Clin, BR-50670901 Recife, PE, Brazil.
RP Gueiros, LA (corresponding author), Av Prof Moraes Rego 1235 Cidade Univ, BR-50670901 Recife, PE, Brazil.
EM Luiz.mgueiros@ufpe.br
RI Oliveira, Hugo/AAQ-5801-2020; Leao, Jair Carneiro/AAL-6154-2020;
   Gueiros, Luiz Alcino/F-7171-2012; Gueiros, Luiz Alcino/B-6429-2015
OI Oliveira, Hugo/0000-0002-5073-2096; Leao, Jair
   Carneiro/0000-0001-8303-2291; Gueiros, Luiz Alcino/0000-0003-4979-4318;
   Gueiros, Luiz Alcino/0000-0003-4979-4318
FU Brazilian National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [481469/2012-5]; Pernambuco Research Foundation (FACEPE)
   [1978-4.02/12]
FX This work was supported by the Brazilian National Council for Scientific
   and Technological Development (CNPq/No. 481469/2012-5) and the
   Pernambuco Research Foundation (FACEPE/No. 1978-4.02/12).
CR Aliko A, 2010, J ORAL PATHOL MED, V39, P651, DOI 10.1111/j.1600-0714.2010.00899.x
   Amri Mohamed, 2011, Tunis Med, V89, P231
   Antero DC, 2011, REV ASSOC MED BRAS, V57, P318
   ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302
   Atzeni F, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2420
   Baldini C, 2012, J AUTOIMMUN, V39, P9, DOI 10.1016/j.jaut.2011.12.006
   Bamba R, 2009, LARYNGOSCOPE, V119, P1922, DOI 10.1002/lary.20292
   Barcelos F, 2009, ACTA REUMATOL PORT, V34, P608
   Bhadoria D P, 1989, J Indian Med Assoc, V87, P134
   Brun JG, 2003, ARTHRIT RHEUM-ARTHR, V49, P187, DOI 10.1002/art.10999
   CHO P, 1993, OPTOMETRY VISION SCI, V70, P152, DOI 10.1097/00006324-199302000-00011
   COLL J, 1987, ANN RHEUM DIS, V46, P286, DOI 10.1136/ard.46.4.286
   Gilboe IM, 2001, ANN RHEUM DIS, V60, P1103, DOI 10.1136/ard.60.12.1103
   Goeb V, 2007, CLIN EXP IMMUNOL, V148, P281, DOI 10.1111/j.1365-2249.2007.03337.x
   Gottenberg JE, 2005, ANN RHEUM DIS, V64, P114, DOI 10.1136/ard.2003.019794
   Haga HJ, 2012, INT J RHEUM DIS, V15, P284, DOI 10.1111/j.1756-185X.2012.01717.x
   Hans-Jacob H, 2012, INT J RHEUM DIS, V15, P284
   He J, 2013, RHEUMATOLOGY, V52, P1084, DOI 10.1093/rheumatology/kes374
   Helenius LMJ, 2005, ACTA ODONTOL SCAND, V63, P284, DOI 10.1080/00016350510020043
   Ice JA, 2012, J AUTOIMMUN, V39, P57, DOI 10.1016/j.jaut.2012.01.008
   Iwamoto N, 2009, J RHEUMATOL, V36, P113, DOI 10.3899/jrheum.080193
   Kapsogeorgou EK, 2011, RAED J, V3, pS5
   Katsifis GE, 2009, AM J PATHOL, V175, P1167, DOI 10.2353/ajpath.2009.090319
   Manoussakis MN, 2010, J AUTOIMMUN, V35, P219, DOI 10.1016/j.jaut.2010.06.011
   Mitsias DI, 2002, CLIN EXP IMMUNOL, V128, P562, DOI 10.1046/j.1365-2249.2002.01869.x
   Montenegro R, 2009, TEMAS REUMATOLGIA CL, V10, P74
   MULLER K, 1989, SCAND J RHEUMATOL, V18, P29
   Nguyen CQ, 2007, FRONT BIOSCI-LANDMRK, V12, P1767, DOI 10.2741/2187
   Pinto Maria Raquel da Costa, 2006, Rev. Bras. Reumatol., V46, P219, DOI 10.1590/S0482-50042006000300010
   Ramos-Casals M, 2007, SEMIN ARTHRITIS RHEU, V36, P246, DOI 10.1016/j.semarthrit.2006.08.007
   Seror R, 2014, J AUTOIMMUN, V51, P51, DOI 10.1016/j.jaut.2013.12.010
   Tamhane A, 2013, J RHEUMATOL, V40, P1812, DOI 10.3899/jrheum.121225
   Tzioufas AG, 2012, J AUTOIMMUN, V39, P4, DOI 10.1016/j.jaut.2012.01.002
   Uhlig T, 1999, ANN RHEUM DIS, V58, P415, DOI 10.1136/ard.58.7.415
   Venables PJ, 2008, UPTODATE, P357
   Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554
   Voog O, 2003, ACTA ODONTOL SCAND, V61, P278, DOI 10.1080/00016350310005989
NR 37
TC 8
Z9 8
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 2212-4403
EI 1528-395X
J9 OR SURG OR MED OR PA
JI Oral Surg. Oral Med. Oral Pathol. Oral Radiol.
PD JUN
PY 2015
VL 119
IS 6
BP 628
EP 635
DI 10.1016/j.oooo.2015.02.479
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA CK7YP
UT WOS:000356453800013
PM 25956216
DA 2020-11-30
ER

PT J
AU Medeiros, R
   Gueiros, LA
   Silva, IH
   Carvalho, AD
   Leao, JC
AF Medeiros Junior, Rui
   Gueiros, Luiz Alcino
   Silva, Igor Henrique
   Carvalho, Alessandra de Albuquerque
   Leao, Jair Carneiro
TI Labial frenectomy with Nd:YAG laser and conventional surgery: a
   comparative study
SO LASERS IN MEDICAL SCIENCE
LA English
DT Article
DE Clinical parameters; Laser; Nd:YAG laser; Frenectomy
ID CARBON-DIOXIDE LASER; ND-YAG LASER; PATIENT PERCEPTIONS; MANAGEMENT;
   CO2-LASER; LESIONS
AB Labial frenulums are sagittal fibrous folds of oral mucosa with a periosteal insertion that extend from the lips to the alveolar or gingival mucosa. Occasionally, they assume inadequate size or location and may lead to functional and esthetic limitations. The aim of the present study was to compare pre-, trans-, and postsurgical clinical parameters of labial frenectomies performed with conventional surgery and neodymium-doped yttrium aluminum garnet (Nd:YAG) laser. Forty individuals were assessed as a convenience sample and were divided into two groups according to the treatment: group 1 (G1), conventional surgery (n = 22), and G2, Nd:YAG laser surgery (n = 18). Clinical parameters such as frenulum insertion, location, bleeding, surgical time, suturing, preoperative fear, and postoperative discomfort/functional limitations were evaluated. All surgeries were performed by the same operator, and the level of fear, pain, and discomfort related to oral functions were assessed with a visual numeric scale. Most of the frenulums (90 %) were classified as papillary or transpapillary insertion. Preoperative fear was similar between groups (p = 0.593). All G2 patients did not require suture (p < 0.001), did not bleed during the procedure (p < 0.001), and had surgical time diminished (p < 0.001). No significant statistical difference regarding pain or oral function could be observed. Three individuals (7.5 %) experienced postsurgical complications. Nd:YAG laser frenectomies reduces transoperative bleeding, avoiding the need of suturing, and promotes a significant reduction of surgical time in comparison with conventional surgery. Therefore, further studies are necessary to provide a complete understanding and standardization of the technique as well as the expected clinical results.
C1 [Medeiros Junior, Rui; Gueiros, Luiz Alcino; Silva, Igor Henrique; Carvalho, Alessandra de Albuquerque; Leao, Jair Carneiro] Univ Fed Pernambuco UFPE, CEPLO, Serv Estomatol, Dept Clin & Odontol Prevent, BR-50670901 Recife, PE, Brazil.
RP Leao, JC (corresponding author), Univ Fed Pernambuco UFPE, CEPLO, Serv Estomatol, Dept Clin & Odontol Prevent, Ave Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
EM jleao@ufpe.br
RI Leao, Jair Carneiro/AAL-6154-2020; Gueiros, Luiz Alcino/B-6429-2015
OI Leao, Jair Carneiro/0000-0001-8303-2291; Gueiros, Luiz
   Alcino/0000-0003-4979-4318
FU Coordenacao Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Ciencia do Estado de Pernambuco
   (FACEPE/PRONEX)
FX The paper was supported by the Coordenacao Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) and the Fundacao de Amparo a Ciencia do
   Estado de Pernambuco (FACEPE/PRONEX).
CR Bader H I, 2000, Dent Clin North Am, V44, P779
   Chaubey K Krishna, 2011, J Indian Soc Periodontol, V15, P265, DOI 10.4103/0972-124X.85672
   Convissar Robert A, 2004, Oral Maxillofac Surg Clin North Am, V16, P165, DOI 10.1016/j.coms.2004.01.003
   Corrêa Lívia L., 2005, Arq Bras Endocrinol Metab, V49, P286, DOI 10.1590/S0004-27302005000200016
   Dederick DN, 2004, J AM DENT ASSOC, V135, P204, DOI 10.14219/jada.archive.2004.0153
   Fornaini C, 2007, PHOTOMED LASER SURG, V25, P381, DOI 10.1089/pho.2006.2068
   Gontijo I, 2005, J DENT CHILD, V72, P10
   Gutknecht N, 2005, J ORAL LASER APPL, V5, P207
   Haytac MC, 2006, J PERIODONTOL, V77, P1815, DOI 10.1902/jop.2006.060043
   Junji K, 2007, PHOTOMED LASER SURG, V25, P264
   Kara C, 2008, PHOTOMED LASER SURG, V26, P147, DOI 10.1089/pho.2007.2153
   Matsumoto K, 2002, J ORAL LASER APPL, V2, P25
   MIRKO P, 1974, J PERIODONTOL, V45, P891, DOI 10.1902/jop.1974.45.12.891
   Neiva TGG, 2008, REV DENTAL PRESS PER, V2, P31
   Olivi G, 2010, GEN DENT, V58, P126
   Pie-Sanchez J, 2012, MED ORAL PATOL ORAL, V17, pE228, DOI 10.4317/medoral.17373
   Shetty Kishore, 2008, Gen Dent, V56, P60
   Suter VGA, 2009, J PERIODONTOL, V80, P1204, DOI 10.1902/jop.2009.090086
   Thomson PJ, 2002, INT J ORAL MAX SURG, V31, P145, DOI 10.1054/ijom.2001.0189
   WHITE JM, 1991, LASER SURG MED, V11, P455, DOI 10.1002/lsm.1900110511
   White JM, 1998, J CLIN LASER MED SUR, V16, P299, DOI 10.1089/clm.1998.16.299
   Yang HY, 2009, J CRANIOFAC SURG, V20, P1214, DOI 10.1097/SCS.0b013e3181acdd9f
NR 22
TC 14
Z9 15
U1 1
U2 16
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0268-8921
EI 1435-604X
J9 LASER MED SCI
JI Lasers Med. Sci.
PD FEB
PY 2015
VL 30
IS 2
BP 851
EP 856
DI 10.1007/s10103-013-1461-8
PG 6
WC Engineering, Biomedical; Surgery
SC Engineering; Surgery
GA CB3ST
UT WOS:000349549500050
PM 24146237
DA 2020-11-30
ER

PT J
AU Andrade, S
   Silva, I
   Fonseca, D
   Barkokebas, A
   Carvalho, A
   Leao, J
AF Andrade, S.
   Silva, I.
   Fonseca, D.
   Barkokebas, A.
   Carvalho, A.
   Leao, J.
TI The low-level laser therapy increase the nitric oxide in macrophages
SO ORAL DISEASES
LA English
DT Meeting Abstract
C1 [Andrade, S.; Silva, I.; Fonseca, D.; Barkokebas, A.; Carvalho, A.; Leao, J.] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
RI Leao, Jair Carneiro/AAL-6154-2020
OI Leao, Jair Carneiro/0000-0001-8303-2291
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1354-523X
EI 1601-0825
J9 ORAL DIS
JI Oral Dis.
PD SEP
PY 2014
VL 20
SU 2
SI SI
MA 10
BP 6
EP 7
PG 2
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AP4RN
UT WOS:000342066100020
DA 2020-11-30
ER

PT J
AU Barkokebas, A
   Silva, I
   Fonseca, D
   Andrade, S
   Carvalho, A
   Leao, J
AF Barkokebas, A.
   Silva, I.
   Fonseca, D.
   Andrade, S.
   Carvalho, A.
   Leao, J.
TI Impact of mucositis on the quality of life of cancer patients
SO ORAL DISEASES
LA English
DT Meeting Abstract
C1 [Barkokebas, A.; Silva, I.; Fonseca, D.; Andrade, S.; Carvalho, A.; Leao, J.] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
RI Leao, Jair Carneiro/AAL-6154-2020
OI Leao, Jair Carneiro/0000-0001-8303-2291
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1354-523X
EI 1601-0825
J9 ORAL DIS
JI Oral Dis.
PD SEP
PY 2014
VL 20
SU 2
SI SI
MA 37
BP 12
EP 12
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AP4RN
UT WOS:000342066100047
DA 2020-11-30
ER

PT J
AU Gueiros, L
   Carvalho, C
   Duarte, A
   Carvalho, A
   Leao, J
AF Gueiros, L.
   Carvalho, C.
   Duarte, A.
   Carvalho, A.
   Leao, J.
TI Evaluation of Th17 polymorphism in Sjogren's syndrome and rheumatoid
   arthritis
SO ORAL DISEASES
LA English
DT Meeting Abstract
C1 [Gueiros, L.; Carvalho, C.; Duarte, A.; Carvalho, A.; Leao, J.] Univ Fed Pernambuco, Recife, PE, Brazil.
RI Leao, Jair Carneiro/AAL-6154-2020; Gueiros, Luiz Alcino/B-6429-2015
OI Leao, Jair Carneiro/0000-0001-8303-2291; Gueiros, Luiz
   Alcino/0000-0003-4979-4318
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1354-523X
EI 1601-0825
J9 ORAL DIS
JI Oral Dis.
PD SEP
PY 2014
VL 20
SU 2
SI SI
MA 54
BP 16
EP 16
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AP4RN
UT WOS:000342066100064
DA 2020-11-30
ER

PT J
AU de Souza, TR
   Carvalho, ADT
   Duarte, AP
   Porter, SR
   Leao, JC
   Gueiros, LA
AF de Souza, Thayse Rodrigues
   Tavares Carvalho, Alessandra de Albuquerque
   Duarte, Angela Pinto
   Porter, Stephen R.
   Leao, Jair C.
   Gueiros, Luiz Alcino
TI Th1 and Th2 polymorphisms in Sjogren's syndrome and rheumatoid arthritis
SO JOURNAL OF ORAL PATHOLOGY & MEDICINE
LA English
DT Article
DE cytokines; helper T cells; rheumatoid arthritis; Sjogren's syndrome
ID TUMOR-NECROSIS-FACTOR; INTERLEUKIN-10 GENE PROMOTER; FACTOR-ALPHA GENE;
   SYSTEMIC-LUPUS-ERYTHEMATOSUS; ORAL LICHEN-PLANUS; SALIVARY-GLANDS;
   ASSOCIATION; EXPRESSION; DISEASE; IMMUNOPATHOGENESIS
AB BACKGROUND: Sjogren's syndrome is characterized by T-cell infiltration of exocrine glands leading to parenchymal destruction and impaired glandular function. This process is orchestrated by cytokines, whose secretion can be regulated by genetic polymorphisms.
   MATERIALS AND METHODS: The aim of this study was to investigate the influence of interleukin-6 -174G/C, interleukin-10 -1082G/A, tumor necrosis factor-alpha -308G/A, interferon-gamma +874A/T gene polymorphisms in (RA) and secondary Sjogren's syndrome (sSS). A study sample that comprised of 138 Brazilian patients was divided into three groups: RA (n = 66), sSS (n = 20), and healthy controls - C (n = 52). Patients were subjected to Schirmer's test, unstimulated salivary flow rate, biopsy of minor salivary glands, and serological tests for diagnosing SS. Genomic DNA was obtained from saliva samples and submitted to genotyping. The association between genotypes/alelle frequency and SS susceptibility was tested, as well as their association with clinical features of SS.
   RESULTS: Tumor necrosis factor alpha (TNF alpha)-308GA polymorphisms differed significantly between AR, SS, and C patients (P = 0.008). IL-6 overall G carriers and TNFa A carriers had a higher risk of presenting SS (P = 0.021). IL-6 polymorphism distribution was also distinctive regarding lymphocytic infiltration at the minor salivary glands (P = 0.026) and Schirmer's test (P = 0.035).
   CONCLUSION: These results suggest that IL-6 -174GC and TNF alpha-308GA gene polymorphisms are associated with susceptibility to SS. Additionally, IL-6 polymorphism could influence lymphocytic infiltration of salivary glands and diminish lachrymal gland function.
C1 [de Souza, Thayse Rodrigues; Tavares Carvalho, Alessandra de Albuquerque; Leao, Jair C.; Gueiros, Luiz Alcino] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Oral Med Unit, Recife, PE, Brazil.
   [Duarte, Angela Pinto] Univ Fed Pernambuco UFPE, Hosp Clin, Rheumatol Unit, Recife, PE, Brazil.
   [Porter, Stephen R.] UCL Eastman Dent Inst, Oral Med Unit, London, England.
RP Gueiros, LA (corresponding author), Av Prof Moraes Rego,1235 Cidade Univ, BR-5067090 Recife, PE, Brazil.
EM lagueiros@gmail.com
RI Leao, Jair Carneiro/AAL-6154-2020; Gueiros, Luiz Alcino/B-6429-2015
OI Leao, Jair Carneiro/0000-0001-8303-2291; Gueiros, Luiz
   Alcino/0000-0003-4979-4318; Porter, Stephen/0000-0002-3328-2759
FU PRODOC/CAPESCAPES [031/2008]; FACEPE [PBPG-0833- 4.02/09]
FX The authors wish to thank the Rheumatology Unit of Hospital das Clinicas
   da Universidade Federal de Pernambuco (HC-UFPE), for providing helpful
   guidance in the sample collection, PRODOC/CAPES (No. 031/2008) for
   granting LAG a postdoc scholarship, and FACEPE (PBPG-0833- 4.02/09) for
   granting TRS a master's scholarship.
CR Anaya JM, 2005, SEMIN ARTHRITIS RHEU, V34, P735, DOI 10.1016/j.semarthrit.2004.11.008
   ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302
   Atzeni F, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2420
   Bacman S, 1998, INVEST OPHTH VIS SCI, V39, P151
   Bai JP, 2008, J INTERF CYTOK RES, V28, P351, DOI 10.1089/jir.2007.0056
   Bikker A, 2010, ARTHRITIS RHEUM-US, V62, P969, DOI 10.1002/art.27318
   Bizzaro N, 2001, CLIN CHEM, V47, P1089
   Cantagrel A, 1999, ARTHRITIS RHEUM, V42, P1093, DOI 10.1002/1529-0131(199906)42:6<1093::AID-ANR5>3.0.CO;2-P
   Chiorini JA, 2009, J AUTOIMMUN, V33, P190, DOI 10.1016/j.jaut.2009.09.009
   CHO P, 1993, OPTOMETRY VISION SCI, V70, P152, DOI 10.1097/00006324-199302000-00011
   Coakley G, 1998, BRIT J RHEUMATOL, V37, P988
   Cobb BL, 2008, RHEUM DIS CLIN N AM, V34, P847, DOI 10.1016/j.rdc.2008.08.003
   DANIS VA, 1995, DIS MARKERS, V12, P127, DOI 10.1155/1994/756247
   Dorner T, 2002, ARTHRITIS RES, V4, P360, DOI 10.1186/ar603
   Font J, 2002, RHEUMATOLOGY, V41, P1025, DOI 10.1093/rheumatology/41.9.1025
   Gottenberg JE, 2004, ARTHRITIS RHEUM-US, V50, P570, DOI 10.1002/art.20060
   GREENSPAN JS, 1974, ORAL SURG ORAL MED O, V37, P217, DOI 10.1016/0030-4220(74)90417-4
   Guggenbuhl P, 2000, JOINT BONE SPINE, V67, P290
   Hajeer AH, 1998, SCAND J RHEUMATOL, V27, P142
   Hansen A, 2005, CURR OPIN RHEUMATOL, V17, P558, DOI 10.1097/01.bor.0000172801.56744.c3
   Hoffmann SC, 2001, TRANSPLANTATION, V72, P1444, DOI 10.1097/00007890-200110270-00019
   Hulkkonen J, 2001, RHEUMATOLOGY, V40, P656, DOI 10.1093/rheumatology/40.6.656
   Hulkkonen J, 2001, ARTHRITIS RHEUM, V44, P176, DOI 10.1002/1529-0131(200101)44:1<176::AID-ANR23>3.0.CO;2-K
   Itty S, 2002, T AM OPHTHAL SOC, V106, P75
   Jonsson R, 2002, ORAL DIS, V8, P130, DOI 10.1034/j.1601-0825.2002.02846.x
   Kacem HH, 2001, RHEUMATOLOGY, V40, P1370, DOI 10.1093/rheumatology/40.12.1370
   Kolkowski EC, 1999, J AUTOIMMUN, V13, P155, DOI 10.1006/jaut.1999.0289
   Lin YJ, 2009, LUPUS, V18, P974, DOI 10.1177/0961203309105361
   Manoussakis MN, 2000, BEST PRACT RES CL RH, V14, P73, DOI 10.1053/berh.1999.0078
   Marka M, 2005, SCAND J IMMUNOL, V62, P474, DOI 10.1111/j.1365-3083.2005.01675.x
   Mavragani CP, 2010, J AUTOIMMUN, V35, P225, DOI 10.1016/j.jaut.2010.06.012
   Mitsias DI, 2002, CLIN EXP IMMUNOL, V128, P562, DOI 10.1046/j.1365-2249.2002.01869.x
   Mosaad YM, 2011, INT J IMMUNOGENET, V38, P427, DOI 10.1111/j.1744-313X.2011.01028.x
   Mostafa S, 2012, EXP EYE RES, V96, P88, DOI 10.1016/j.exer.2011.12.016
   NAVAZESH M, 1993, ANN NY ACAD SCI, V694, P72, DOI 10.1111/j.1749-6632.1993.tb18343.x
   Nemec P, 2008, CLIN RHEUMATOL, V27, P59, DOI 10.1007/s10067-007-0653-7
   Nemec P, 2009, ANN NY ACAD SCI, V1173, P501, DOI 10.1111/j.1749-6632.2009.04625.x
   Pascual M, 2000, GENES IMMUN, V1, P338, DOI 10.1038/sj.gene.6363677
   Pawlik A, 2005, SCAND J RHEUMATOL, V34, P109, DOI 10.1080/03009740510026373
   Pertovaara M, 2004, RHEUMATOLOGY, V43, P106, DOI 10.1093/rheumatology/keg446
   Pravica V, 2000, HUM IMMUNOL, V61, P863, DOI 10.1016/S0198-8859(00)00167-1
   Ramos-Casals M, 2005, RHEUMATOLOGY, V44, P1354, DOI 10.1093/rheumatology/keh714
   Rezaieyazdi Z, 2007, RHEUMATOL INT, V28, P189, DOI 10.1007/s00296-007-0444-0
   Rischmueller M, 2000, J RHEUMATOL, V27, P2945
   Rojas-Villarraga A, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/254319
   Segal BM, 2011, ORAL SURG ORAL MED O, V111, P673, DOI 10.1016/j.tripleo.2011.01.040
   Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x
   Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554
   Xanthou G, 1999, CLIN EXP IMMUNOL, V118, P154
   Xavier GM, 2007, J ORAL PATHOL MED, V36, P476, DOI 10.1111/j.1600-0714.2007.00560.x
   Youinou P, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3348
NR 51
TC 11
Z9 11
U1 0
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0904-2512
EI 1600-0714
J9 J ORAL PATHOL MED
JI J. Oral Pathol. Med.
PD JUL
PY 2014
VL 43
IS 6
BP 418
EP 426
DI 10.1111/jop.12149
PG 9
WC Dentistry, Oral Surgery & Medicine; Pathology
SC Dentistry, Oral Surgery & Medicine; Pathology
GA AL3ZG
UT WOS:000339070900004
PM 24393164
DA 2020-11-30
ER

PT J
AU de Faria, ABS
   Silva, IHM
   Almeida, RD
   da Silva, SP
   Carvalho, AT
   Leao, JC
AF Santos de Faria, Andreza Barkokebas
   Moraes Silva, Igor Henrique
   Almeida, Roberta de Godoy
   da Silva, Sirleide Pereira
   Carvalho, Alessandra Tavares
   Leao, Jair Carneiro
TI Seroprevalence of herpes virus associated with the presence and severity
   of oral mucositis in children diagnosed with acute lymphoid leukemia
SO JOURNAL OF ORAL PATHOLOGY & MEDICINE
LA English
DT Article
DE mucositis; acute lymphoid leukemia; herpes virus
ID ACUTE LYMPHOBLASTIC-LEUKEMIA; EPSTEIN-BARR-VIRUS; SIMPLEX-VIRUS;
   VIRAL-INFECTIONS; CANCER-PATIENTS; CHEMOTHERAPY; PREVENTION; RISK; CARE
AB Introduction
   Acute lymphoid leukemia (ALL) is the hematologic neoplasia most commonly diagnosed in children. Among the secondary side effects of chemotherapy, mucositis is the most frequent complication. The aim of this study was to evaluate the seroprevalence of herpes viruses HSV-1, EBV, and CMV and the presence and severity of oral mucositis in children and adolescents diagnosed with ALL.
   Methodology
   Ninety-two patients diagnosed with ALL were evaluated. Serum samples were collected before chemotherapy and tested by ELISA method. Presence of mucositis was observed on the first day before antineoplastic therapy (D0) and on 7th day post-therapy (D7). Classification of mucositis intensity was performed according to toxicity criteria established by the National Cancer Institute.
   Results
   70.7% of the patients presented mucositis on the D7, and of these, 60% were classified as Grade I and 40% as Grade II; of the 92 individuals tested, 59 (64.1%) presented antibodies for HSV-1, 57 (62%) for EBV, 75 (81.5%) for CMV_IgG, and 21 (22.8%) for CMV_IgM. Using a logistic regression model, the presence of HSV-1 was observed to be 4.10 times greater in Grade II mucositis severity than in Grade I (P=0.03).
   Conclusion
   Based on the findings of this study, it was possible to conclude that infection by the herpes viruses HSV-1, EBV, and CMV is ubiquitous in the studied population and that HSV-1 may be a risk factor for aggravating the severity of mucositis.
C1 [Santos de Faria, Andreza Barkokebas; Moraes Silva, Igor Henrique; Carvalho, Alessandra Tavares; Leao, Jair Carneiro] Univ Fed Pernambuco, Dept Clinicae Odontol Prevent, BR-1235 506 Recife, PE, Brazil.
   [Almeida, Roberta de Godoy] Intituto Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [da Silva, Sirleide Pereira] Lab Cent Pernambuco, Recife, PE, Brazil.
RP Leao, JC (corresponding author), Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Av Prof Moraes Rego 1235, BR-1235 506 Recife, PE, Brazil.
EM jleao@ufpe.br
RI Leao, Jair Carneiro/AAL-6154-2020
OI Leao, Jair Carneiro/0000-0001-8303-2291
CR Barasch A, 2003, ORAL ONCOL, V39, P91, DOI 10.1016/S1368-8375(02)00033-7
   Buitenkamp TD, 2010, HAEMATOL-HEMATOL J, V95, P1106, DOI 10.3324/haematol.2009.019778
   Caze MO, 2010, REV HCPA, V1, P5
   Chen YK, 2011, EUR J CLIN MICROBIOL, V30, P753, DOI 10.1007/s10096-010-1148-z
   Cheng KKF, 2001, EUR J CANCER, V37, P2056, DOI 10.1016/S0959-8049(01)00098-3
   Cruz LB, 2007, PEDIATR BLOOD CANCER, V48, P435, DOI 10.1002/pbc.20943
   Dodd MJ, 2000, CANCER PRACT, V8, P291, DOI 10.1046/j.1523-5394.2000.86010.x
   Elad S, 2010, SUPPORT CARE CANCER, V18, P993, DOI 10.1007/s00520-010-0900-3
   Elman I, 2007, REV BRASILEIRA CANCE, V53, P297
   Ernst J, 2012, TRANSPL INFECT DIS, V14, pE82, DOI 10.1111/j.1399-3062.2012.00778.x
   Farias Mariela Granero, 2004, J. Bras. Patol. Med. Lab., V40, P91, DOI 10.1590/S1676-24442004000200008
   Gandemer V, 2007, J PEDIAT HEMATOL ONC, V29, P86, DOI 10.1097/MPH.0b013e318030a3e4
   Glenny AM, 2010, EUR J CANCER, V46, P1399, DOI 10.1016/j.ejca.2010.01.023
   Granato C., 2001, REV BRAS HEMATOL HEM, V23, P3
   Green R, 2010, J PEDIATR ONCOL NURS, V27, P209, DOI 10.1177/1043454209360779
   de Mendonca RMH, 2012, SUPPORT CARE CANCER, V20, P1101, DOI 10.1007/s00520-011-1190-0
   Instituto Nacional do Cancer/Ministerio da Saude, 2012, EST 2012 INC CAN BRA
   Latorre MRDO, 2000, PEDIAT ONCOLOGICA NO, P7
   Lo Nigro L, 2013, J PEDIAT HEMATOL ONC, V35, P245, DOI 10.1097/MPH.0b013e31828f8746
   LOCKHART PB, 1981, J DERMATOL SURG ONC, V7, P1019, DOI 10.1111/j.1524-4725.1981.tb00208.x
   Lopes LF, 2000, PEDIAT ONCOLOGICA NO, P109
   Lorenzi T, 2003, MANUAL HEMATOLOGIA P
   Loutfy SA, 2006, SAUDI MED J, V27, P1139
   Luglie P F, 2002, Minerva Stomatol, V51, P231
   Luiz Ana C., 2008, Rev. Bras. Hematol. Hemoter., V30, P480, DOI 10.1590/S1516-84842008000600012
   Lupi O, 2000, AN BRAS DERMATOL, V75, P261
   Manfrinato JA, 2010, J BRAS TRANSPL, V13, P1393
   McKenna SJ, 2000, ORAL SURG ORAL MED O, V89, P137, DOI 10.1067/moe.2000.102386
   Melchardt T, 2013, LEUKEMIA LYMPHOMA, V54, P1602, DOI 10.3109/10428194.2012.755178
   Naidu MUR, 2004, NEOPLASIA, V6, P423, DOI 10.1593/neo.04169
   National Cancer Institute, 2006, COMM TERM CRIT ADV E
   Okano M, 2012, AM J MED SCI, V343, P483, DOI 10.1097/MAJ.0b013e318236e02d
   Pedrosa Francisco, 2002, Rev. Bras. Saude Mater. Infant., V2, P63, DOI 10.1590/S1519-38292002000100010
   Ramphal R, 2007, PEDIATR INFECT DIS J, V26, P700, DOI 10.1097/INF.0b013e31805cdc11
   Rojas de Morales T, 2001, Med Oral, V6, P326
   Ruiz-Arguelles GJ, 2007, HEMATOLOGY, V12, P387, DOI 10.1080/10245330701448479
   Schlehofer B, 1996, INT J CANCER, V65, P584, DOI 10.1002/(SICI)1097-0215(19960301)65:5<584::AID-IJC5>3.0.CO;2-Z
   Scully C, 2001, WESTERN J MED, V174, P348, DOI 10.1136/ewjm.174.5.348
   Shabaruddin FH, 2013, PHARMACOECONOMICS, V31, P277, DOI 10.1007/s40273-013-0033-x
   Soga Y, 2011, SUPPORT CARE CANCER, V19, P303, DOI 10.1007/s00520-010-1002-y
   SONIS ST, 1992, ORAL SURG ORAL MED O, V74, P749, DOI 10.1016/0030-4220(92)90402-C
   Sonis ST, 2004, CANCER-AM CANCER SOC, V100, P1995, DOI 10.1002/cncr.20162
   Teixeira RAP, 2000, CANCEROLOGIA ATUAL E, P426
   Tsao SY, 2011, ANN HEMATOL, V90, P113, DOI 10.1007/s00277-010-0947-8
   Wade JC, 1989, ANN INTERN MED, V33, P823
   Wananukul Siriwan, 2005, Journal of the Medical Association of Thailand, V88, P817
   WOO SB, 1990, CANCER, V66, P2375, DOI 10.1002/1097-0142(19901201)66:11<2375::AID-CNCR2820661121>3.0.CO;2-6
   WORTHINGTON HV, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001973.PUB2
   Zanichelli Maria Aparecida, 2010, Rev. Bras. Hematol. Hemoter., V32, P54
   Zerra P, 2013, EXPERT OPIN PHARMACO, V14, P1497, DOI 10.1517/14656566.2013.804911
   Zur Eyal, 2012, Int J Pharm Compd, V16, P22
NR 51
TC 8
Z9 8
U1 1
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0904-2512
EI 1600-0714
J9 J ORAL PATHOL MED
JI J. Oral Pathol. Med.
PD APR
PY 2014
VL 43
IS 4
BP 298
EP 303
DI 10.1111/jop.12138
PG 6
WC Dentistry, Oral Surgery & Medicine; Pathology
SC Dentistry, Oral Surgery & Medicine; Pathology
GA AE1RK
UT WOS:000333746900011
PM 24325331
DA 2020-11-30
ER

PT J
AU Iyomasa, MM
   Leao, JC
   Rizzi, EC
   Issa, JPM
   Dias, FJ
   Watanabe, IS
   Iyomasa, DM
AF Iyomasa, Mamie Mizusaki
   Leao, Juliane Caroline
   Rizzi, Elen Camargo
   Mardegan Issa, Joao Paulo
   Dias, Fernando Jose
   Watanabe, Ii-sei
   Iyomasa, Daniela Mizusaki
TI Ultrastructure and Light Microscope Analysis of Intact Skin after a
   Varying Number of Low Level Laser Irradiations in Mice
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID MASSETER MUSCLE; THERAPY; COLLAGEN; NM; VIABILITY; PAIN
AB Low level laser therapy (LLLT) has been used to relieve pain, inflammation, and wound healing processes. Thus, the skin is overexposed to laser and this effect is not completely understood. This study analyzed the effects of the number of laser applications (three, six, and 10) on the intact skin of the masseteric region in mice of strain HRS/J. The animals (n = 30) were equally divided into control (0 J/cm(2)) and irradiated (20 J/cm(2)), and each of these groups was further equally divided according to the number of laser applications (three, six, and 10) and underwent LLLT on alternate days. Samples were analyzed by light microscopy and transmission electron microscope (TEM). The animals receiving applications exhibited open channels more dilated between the keratinocytes and photobiomodulation effect on endothelial cells and fibroblasts by TEM. Under the light microscope after 10 laser applications, the type I collagen decreased (P < 0.05) compared to the three and six applications. Under these experimental conditions, all numbers of applications provided photobiomodulatory effect on the epidermis and dermis, without damage. More studies are needed to standardize the energy density and number of applications recommended for laser therapy to have a better cost-benefit ratio associated with treatment.
C1 [Iyomasa, Mamie Mizusaki; Leao, Juliane Caroline; Rizzi, Elen Camargo; Mardegan Issa, Joao Paulo; Iyomasa, Daniela Mizusaki] Univ Sao Paulo, Fac Dent Ribeirao Preto, Dept Morphol Physiol & Basic Pathol, BR-14040904 Ribeirao Preto, SP, Brazil.
   [Dias, Fernando Jose; Watanabe, Ii-sei] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, BR-05508000 Butanta, SP, Brazil.
RP Iyomasa, MM (corresponding author), Univ Sao Paulo, Fac Dent Ribeirao Preto, Dept Morphol Physiol & Basic Pathol, Ave Cafe S-N, BR-14040904 Ribeirao Preto, SP, Brazil.
EM mamieiyo@hotmail.com
RI WATANABE, II-SEI/G-1461-2016; Dias, Fernando Jose/AAP-7420-2020; Issa,
   Joao Paulo/A-2505-2011; Iyomasa, Daniela M/I-8245-2014; Dias, Fernando
   Jose/D-8228-2014
OI Issa, Joao Paulo/0000-0002-1056-0795; Iyomasa, Daniela
   M/0000-0002-2013-9240; Dias, Fernando Jose/0000-0001-9945-9185;
   Watanabe, Ii-sei/0000-0002-1000-1467
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
FX The authors thank FAPESP for financial support.
CR Amir A, 2000, BRIT J PLAST SURG, V53, P58, DOI 10.1054/bjps.1999.3185
   Basso FG, 2012, INT J DENT, V2012, DOI 10.1155/2012/719452
   Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619
   de Araujo CEN, 2007, J PHOTOCH PHOTOBIO B, V86, P87, DOI 10.1016/j.jphotobiol.2006.08.006
   de Medeiros JS, 2005, PHOTOMED LASER SURG, V23, P373, DOI 10.1089/pho.2005.23.373
   Dias FJ, 2011, PHOTOMED LASER SURG, V29, P677, DOI 10.1089/pho.2010.2879
   Emshoff R, 2008, ORAL SURG ORAL MED O, V105, P452, DOI 10.1016/j.tripleo.2007.09.012
   Forni MF, 2012, BIOL RES, V45, P215, DOI 10.4067/S0716-97602012000300003
   Gal P, 2006, PHOTOMED LASER SURG, V24, P480, DOI 10.1089/pho.2006.24.480
   Gao XJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-4
   Goncalves RV, 2010, BRAZ J MED BIOL RES, V43, P350, DOI 10.1590/S0100-879X2010007500022
   Hawkins D, 2005, PHOTOMED LASER SURG, V23, P251, DOI 10.1089/pho.2005.23.251
   Hawkins DH, 2006, LASER SURG MED, V38, P74, DOI 10.1002/lsm.20271
   Hitomi K, 2005, EUR J DERMATOL, V15, P313
   Iyomasa MM, 2013, LASER MED SCI, V28, P777, DOI 10.1007/s10103-012-1156-6
   Junior AMR, 2009, PHOTOMED LASER SURG, V27, P303
   Khavkin J, 2011, FACIAL PLAST SURG CL, V19, P229, DOI 10.1016/j.fsc.2011.04.003
   Kierszenbaum A. L., 2008, HISTOLOGIA BIOL CELL
   Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357
   Le Guellec D, 2004, INT J DEV BIOL, V48, P217, DOI 10.1387/ijdb.15272388
   Leao JC, 2011, ANAT REC, V294, P1592, DOI 10.1002/ar.21451
   Maciel V. H., 2006, PROTOCOLOS LINICOS A
   Marchionni AMT, 2010, PHOTOMED LASER SURG, V28, P639, DOI 10.1089/pho.2009.2587
   Massironi SMG, 2005, BRAZ J MED BIOL RES, V38, P33, DOI 10.1590/S0100-879X2005000100006
   Medrado AP, 2008, J PHOTOCH PHOTOBIO B, V92, P144, DOI 10.1016/j.jphotobiol.2008.05.008
   Medrado ARAP, 2003, LASER SURG MED, V32, P239, DOI 10.1002/lsm.10126
   Meireles G. C. S., 2005, COMP ANAL EFFECT LAS
   Nunez SC, 2006, PHOTOMED LASER SURG, V24, P45, DOI 10.1089/pho.2006.24.45
   Orringer JS, 2008, ARCH DERMATOL, V144, P1296, DOI 10.1001/archderm.144.10.1296
   Park SH, 2012, J PLAST RECONSTR AES, V65, P1305, DOI 10.1016/j.bjps.2012.04.028
   Pikkula BM, 2005, LASER SURG MED, V36, P117, DOI 10.1002/lsm.20147
   Quan TH, 2004, AM J PATHOL, V165, P741, DOI 10.1016/S0002-9440(10)63337-8
   Rizzi EC, 2010, PHOTOMED LASER SURG, V28, DOI 10.1089/pho.2009.2599
   Schindl A, 2003, BRIT J DERMATOL, V148, P334, DOI 10.1046/j.1365-2133.2003.05070.x
   Siessere S, 2011, PHOTOMED LASER SURG, V29, P453, DOI 10.1089/pho.2010.2917
   Whelan HT, 2001, J CLIN LASER MED SUR, V19, P305, DOI 10.1089/104454701753342758
   Wood VT, 2010, LASER SURG MED, V42, P559, DOI 10.1002/lsm.20932
NR 37
TC 2
Z9 2
U1 0
U2 4
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
VL 2014
AR 506051
DI 10.1155/2014/506051
PG 8
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AA1SC
UT WOS:000330875000001
PM 24616895
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Ribeiro, CMB
   Ferrer, I
   de Farias, ABS
   Fonseca, D
   Silva, IHM
   Gueiros, LAM
   Carvalho, A
   Porter, S
   Leao, JC
AF Beder Ribeiro, Camila Maria
   Ferrer, Iracema
   Santos de Farias, Andreza Barkokebas
   Fonseca, Debora Diniz
   Morais Silva, Igor Henrique
   Monteiro Gueiros, Luiz Alcino
   Carvalho, Alessandra Tavares
   Porter, Stephen Ross
   Leao, Jair Carneiro
TI Oral and genital HPV genotypic concordance between sexual partners
SO CLINICAL ORAL INVESTIGATIONS
LA English
DT Article
DE Sexually transmitted diseases; Viral transmission; Sexual partners; DNA
   probes; HPV; Polymerase chain reaction; Polymorphism restriction
   fragment length
ID HUMAN-PAPILLOMAVIRUS INFECTION; RISK HUMAN-PAPILLOMAVIRUS; SQUAMOUS-CELL
   CARCINOMA; CERVICAL-CANCER; MEDIATED CARCINOGENESIS; PREVALENCE; WOMEN;
   DNA; NEOPLASIA; IDENTIFICATION
AB The aim of this study was to verify human papillomavirus (HPV) transmission and genotype concordance among heterosexual couples.
   Thirty-one married couples were evaluated. All male subjects presented with clinically diagnosed HPV-related malignant or potentially malignant lesions and underwent peniscopy and penile swab. Their female counterparts underwent swabs of the uterine cervix and oral mucosa. HPV-DNA detection was performed by polymerase chain reaction and restriction fragment length polymorphism.
   HPV-DNA was detected in the penis, vagina/cervix, and oral cavity of 16 couples (51.61 %). Of these, HPV-DNA concordance was observed in 14 couples (87.5 %). HPV-DNA was amplified in penile and oral sites of 14 couples. Of these, 13 couples reported fellatio (92.85 %), most of them (10 couples, 76.9 %) without condom use. HPV-DNA concordance was observed in 7/10 of these couples (70 %). The three couples (100 %) who reported use of condom during fellatio were HPV-DNA discordant (p = 0.025).
   Lifetime number of female sexual partners and detection of HPV-DNA in the penile mucosa are surrogate markers of exposure to HPV during marriage. Consistent use of condoms may reduce the risk of HPV transmission.
   Oral acquisition of HPV from oro-genital contact is influenced by lack of condom use and previous sexual behavior of the male partner. In addition, oral transmission of the virus due to fellatio is as common as genital transmission.
C1 [Beder Ribeiro, Camila Maria; Ferrer, Iracema; Santos de Farias, Andreza Barkokebas; Fonseca, Debora Diniz; Morais Silva, Igor Henrique; Monteiro Gueiros, Luiz Alcino; Carvalho, Alessandra Tavares; Leao, Jair Carneiro] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, BR-50670901 Recife, PE, Brazil.
   [Santos de Farias, Andreza Barkokebas] Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
   [Porter, Stephen Ross; Leao, Jair Carneiro] Eastman Dent Inst, Div Maxillofacial Diagnost Surg & Med Sci, London, England.
   [Leao, Jair Carneiro] Univ Fed Pernambuco, Oral Med Unit, BR-50670901 Recife, PE, Brazil.
RP Leao, JC (corresponding author), Univ Fed Pernambuco, Oral Med Unit, Av Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
EM jleao@ufpe.br
RI Gueiros, Luiz Alcino/B-6429-2015; Panjwani, Camila Maria Beder
   Ribeiro/AAP-3535-2020; Leao, Jair Carneiro/AAL-6154-2020
OI Gueiros, Luiz Alcino/0000-0003-4979-4318; Panjwani, Camila Maria Beder
   Ribeiro/0000-0003-0203-3079; Leao, Jair Carneiro/0000-0001-8303-2291;
   Porter, Stephen/0000-0002-3328-2759
CR Bleeker MCG, 2005, CLIN INFECT DIS, V41, P612, DOI 10.1086/431978
   Bosch FX, 1996, JNCI-J NATL CANCER I, V88, P1060, DOI 10.1093/jnci/88.15.1060
   Burk RD, 1996, SEX TRANSM DIS, V23, P333, DOI 10.1097/00007435-199607000-00013
   Canadas MP, 2004, J CLIN MICROBIOL, V42, P1330, DOI 10.1128/JCM.42.3.1330-1332.2004
   Cartwright NH, 1996, CLIN MOL PATHOL, V49, P236
   Castellsague X, 1997, J INFECT DIS, V176, P353, DOI 10.1086/514052
   Castro Therezita M.P.G., 2004, Rev. Bras. Otorrinolaringol., V70, P546, DOI 10.1590/S0034-72992004000400017
   Chow VTK, 2000, PATHOLOGY, V32, P204, DOI 10.1080/713688930
   Collins SI, 2005, INT J CANCER, V114, P498, DOI 10.1002/ijc.20732
   Coutlee F, 1997, SEX TRANSM DIS, V24, P23, DOI 10.1097/00007435-199701000-00006
   Datta SD, 2008, ANN INTERN MED, V148, P493, DOI 10.7326/0003-4819-148-7-200804010-00004
   De Carvalho JJM, 2006, SCAND J UROL NEPHROL, V40, P138, DOI 10.1080/00365590500191241
   Derchain SFM, 1995, REV PAUL MED, V113, P948
   Feller L, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-15
   Feller L, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-14
   Franceschi S, 2002, BRIT J CANCER, V86, P705, DOI 10.1038/sj.bjc.6600194
   Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693
   Giovannelli L, 2007, J MED VIROL, V79, P1882, DOI 10.1002/jmv.21015
   Giraldo P, 2006, EUR J OBSTET GYN R B, V126, P104, DOI 10.1016/j.ejogrb.2005.09.009
   Gravitt PE, 2011, J CLIN INVEST, V121, P4593, DOI 10.1172/JCI57149
   Gutierrez EIC, 2001, REV SALUD PUBLI NUTR, V2, P78
   HILDESHEIM A, 1993, SEX TRANSM DIS, V20, P279, DOI 10.1097/00007435-199309000-00008
   HIPPELAINEN MI, 1994, SEX TRANSM DIS, V21, P76, DOI 10.1097/00007435-199403000-00004
   Kaneshima EM, 2001, MARINGA, V23, P731
   Kreimer AR, 2004, J INFECT DIS, V189, P686, DOI 10.1086/381504
   KYO S, 1994, J INFECT DIS, V170, P682, DOI 10.1093/infdis/170.3.682
   Leao J C, 1999, Rev Assoc Med Bras (1992), V45, P55, DOI 10.1590/S0104-42301999000100011
   Lorenzato F, 2000, INT J GYNECOL CANCER, V10, P143, DOI 10.1046/j.1525-1438.2000.00007.x
   Miller CS, 1996, ORAL SURG ORAL MED O, V82, P57, DOI 10.1016/S1079-2104(96)80378-7
   Miller CS, 2001, ORAL SURG ORAL MED O, V91, P622, DOI 10.1067/moe.2001.115392
   Munoz N, 1996, JNCI-J NATL CANCER I, V88, P1068, DOI 10.1093/jnci/88.15.1068
   Nelson JH, 2000, J CLIN MICROBIOL, V38, P688, DOI 10.1128/JCM.38.2.688-695.2000
   Nonnenmacher B, 2002, REV SAUDE PUBL, V36, P95, DOI 10.1590/s0034-89102002000100015
   Partridge JM, 2006, LANCET INFECT DIS, V6, P21, DOI 10.1016/S1473-3099(05)70323-6
   Ragin C, 2011, INT J MOL SCI, V12, P3928, DOI 10.3390/ijms12063928
   Rama CH, 2008, REV SAUDE PUBL, V42, P123, DOI [10.1590/S0034-89102008000100016, 10.1590/s0034-89102008000100016]
   Rautava J, 2011, J AM DENT ASSOC, V142, P905, DOI 10.14219/jada.archive.2011.0297
   Rintala M, 2006, J CLIN VIROL, V35, P89, DOI 10.1016/j.jcv.2005.05.012
   Rintala MAM, 2005, J CLIN MICROBIOL, V43, P376, DOI 10.1128/JCM.43.1.376-381.2005
   Rolon PA, 2000, INT J CANCER, V85, P486, DOI 10.1002/(SICI)1097-0215(20000215)85:4&lt;486::AID-IJC7&gt;3.0.CO;2-S
   Sanchez-Vargas Luis O, 2010, Infect Agent Cancer, V5, P25, DOI 10.1186/1750-9378-5-25
   Sand L, 2000, ANTICANCER RES, V20, P1183
   STRAND A, 1995, ACTA DERM-VENEREOL, V75, P312
   Syrjanen K, 2007, EUR J EPIDEMIOL, V22, P723, DOI 10.1007/s10654-007-9180-8
   Tezal M, 2012, INT J OTOLARYNGOL, V575, P242
   Varnai AD, 2009, J ORAL PATHOL MED, V38, P181, DOI 10.1111/j.1600-0714.2008.00723.x
   Winer RL, 2006, NEW ENGL J MED, V354, P2645, DOI 10.1056/NEJMoa053284
   Winer RL, 2004, SEX TRANSM DIS, V31, P63, DOI 10.1097/01.OLQ.0000108768.62279.66
   Wright TC, 2000, JAMA-J AM MED ASSOC, V283, P81, DOI 10.1001/jama.283.1.81
   Wu Xiaocheng, 2012, Morbidity and Mortality Weekly Report, V61, P258
   Xi LF, 2009, CANCER EPIDEM BIOMAR, V18, P3490, DOI 10.1158/1055-9965.EPI-09-0763
NR 51
TC 10
Z9 10
U1 0
U2 4
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1432-6981
EI 1436-3771
J9 CLIN ORAL INVEST
JI Clin. Oral Investig.
PD JAN
PY 2014
VL 18
IS 1
BP 261
EP 268
DI 10.1007/s00784-013-0959-6
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 281IP
UT WOS:000329094500028
PM 23483257
DA 2020-11-30
ER

PT J
AU Almouhawis, HA
   Leao, JC
   Fedele, S
   Porter, SR
AF Almouhawis, Hanan A.
   Leao, Jair C.
   Fedele, Stefano
   Porter, Stephen R.
TI Wegener's granulomatosis: a review of clinical features and an update in
   diagnosis and treatment
SO JOURNAL OF ORAL PATHOLOGY & MEDICINE
LA English
DT Review
DE Wegener's granulomatosis; granulomatous disease; oral disease
ID OF-THE-LITERATURE; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; MICROSCOPIC
   POLYANGIITIS; INITIAL MANIFESTATION; PULMONARY VASCULITIS; RARE
   PRESENTATION; PRESENTING SIGN; DISEASE; INVOLVEMENT; GLAND
AB Wegener's granulomatosis (WG) is an idiopathic, systemic inflammatory disease characterized by necrotizing granulomatous inflammation and pauci-immune small-vessel vasculitis of upper and lower respiratory tract and kidneys. The condition affects both genders equally, although some inconsistent gender differences have been observed. The aetiology of WG remains unknown although a number of exogenous factors have been suggested to be of aetiological relevance. Most clinical characteristics of this disease are non-specific, making clinical diagnosis challenging. Histopathological examination of lesional and peritoneal tissue is not pathognomonic, but is an essential investigation to confirm the presence of disease and exclude other disorders. At present, despite the increasingly wide range of potential therapies, cyclophosphamide plus corticosteroids remain the most recognized and effective means of inducing and sustaining remission of WG.
C1 [Almouhawis, Hanan A.; Leao, Jair C.; Fedele, Stefano; Porter, Stephen R.] UCL Eastman Dent Inst, Oral Med unit, Dept Maxillofacial Med & Surg, London WC1X 8LD, England.
   [Leao, Jair C.] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
RP Porter, SR (corresponding author), UCL Eastman Dent Inst, Directors Off, 256 Grays Inn Rd, London WC1X 8LD, England.
EM s.porter@ucl.ac.uk
RI Leao, Jair Carneiro/AAL-6154-2020
OI Leao, Jair Carneiro/0000-0001-8303-2291; Porter,
   Stephen/0000-0002-3328-2759
CR Aasarod K, 2001, NEPHROL DIAL TRANSPL, V16, P953, DOI 10.1093/ndt/16.5.953
   Abdou NI, 2002, J RHEUMATOL, V29, P309
   ABE T, 1995, INTERNAL MED, V34, P705, DOI 10.2169/internalmedicine.34.705
   Ahson GZ, 2002, ACTA OBSTET GYN SCAN, V81, P1086, DOI 10.1034/j.1600-0412.2002.811117.x
   Albanopoulos K, 2006, MT SINAI J MED, V73, P1045
   ALLEN CM, 1991, J ORAL MAXIL SURG, V49, P294, DOI 10.1016/0278-2391(91)90224-A
   ALLEN DC, 1984, BRIT HEART J, V52, P674
   Allende DS, 2009, ANN DIAGN PATHOL, V13, P351, DOI 10.1016/j.anndiagpath.2009.04.005
   AOKI N, 1995, INTERNAL MED, V34, P790, DOI 10.2169/internalmedicine.34.790
   APPEL GB, 1981, AM J KIDNEY DIS, V1, P27, DOI 10.1016/S0272-6386(81)80008-X
   Attaran S, 2010, ANN THORAC SURG, V90, P996, DOI 10.1016/j.athoracsur.2010.02.103
   Awasthi A, 2007, CYTOPATHOLOGY, V18, P8, DOI 10.1111/j.1365-2303.2006.00358.x
   Baaj AA, 2009, J NEUROIMAGING, V19, P194, DOI 10.1111/j.1552-6569.2008.00251.x
   Bachmeyer C, 2006, CLIN EXP DERMATOL, V31, P321, DOI 10.1111/j.1365-2230.2005.02053.x
   Bacon PA, 2005, NEW ENGL J MED, V352, P330, DOI 10.1056/NEJMp048338
   Bader L, 2010, CLIN RHEUMATOL, V29, P1031, DOI 10.1007/s10067-010-1526-z
   Bajema IM, 1997, J LAB CLIN MED, V129, P17, DOI 10.1016/S0022-2143(97)90157-8
   Barrett AW, 2012, J ORAL PATHOL MED, V41, P721, DOI 10.1111/j.1600-0714.2012.01141.x
   Barrett AW, 2011, BRIT J ORAL MAX SURG, V49, P241, DOI 10.1016/j.bjoms.2010.04.015
   Bean SM, 2007, INT J GYNECOL PATHOL, V26, P95, DOI 10.1097/01.pgp.0000225849.90115.6a
   Ben Ghorbel I, 2007, PRESSE MED, V36, P619, DOI 10.1016/j.lpm.2006.11.027
   Berge S, 2000, INT J ORAL MAX SURG, V29, P450, DOI 10.1016/S0901-5027(00)80080-6
   Bertelmann E, 2005, ACTA OPHTHALMOL SCAN, V83, P258, DOI 10.1111/j.1600-0420.2005.00410.x
   Bhatt V, 2009, BRIT J ORAL MAX SURG, V47, P500, DOI 10.1016/j.bjoms.2009.02.012
   Bibas A, 2001, J LARYNGOL OTOL, V115, P304
   Bijol V, 2006, INT J SURG PATHOL, V14, P57, DOI 10.1177/106689690601400110
   Bories N, 2007, DERMATOLOGY, V214, P187, DOI 10.1159/000098583
   Bramsiepe I, 2008, DEUT MED WOCHENSCHR, V133, P1429, DOI 10.1055/s-2008-1081089
   Brijker F, 1999, CLIN NEPHROL, V52, P344
   Brons RH, 2000, CLIN EXP IMMUNOL, V119, P566, DOI 10.1046/j.1365-2249.2000.01172.x
   BULLEN CL, 1983, OPHTHALMOLOGY, V90, P279
   Cadoni G, 2005, ACTA OTO-LARYNGOL, V125, P1105, DOI 10.1080/00016480510028500
   CARRINGTON CB, 1966, AM J MED, V41, P497, DOI 10.1016/0002-9343(66)90214-2
   Chan Alice Y. K., 2007, Hong Kong Medical Journal, V13, P241
   Chinoy H, 2002, RHEUMATOLOGY, V41, P588, DOI 10.1093/rheumatology/41.5.588
   Clark T, 2003, CLIN EXP RHEUMATOL, V21, pS124
   Cocco Giuseppe, 2010, Open Cardiovasc Med J, V4, P57, DOI 10.2174/1874192401004020057
   COHEN PS, 1981, JAMA-J AM MED ASSOC, V246, P2610, DOI 10.1001/jama.246.22.2610
   CORDIER JF, 1990, CHEST, V97, P906, DOI 10.1378/chest.97.4.906
   CORMAN LC, 1995, ARTHRITIS RHEUM, V38, P1174, DOI 10.1002/art.1780380826
   Cotch MF, 1996, ARTHRITIS RHEUM, V39, P87, DOI 10.1002/art.1780390112
   CRUMMY CS, 1971, AM J MED, V51, P544, DOI 10.1016/0002-9343(71)90259-2
   Csernok E, 2010, CURR OPIN RHEUMATOL, V22, P43, DOI 10.1097/BOR.0b013e3283323538
   Dagum P, 1998, ANN OTO RHINOL LARYN, V107, P555, DOI 10.1177/000348949810700702
   Davenport A, 1996, BRIT J UROL, V78, P354, DOI 10.1046/j.1464-410X.1996.00166.x
   DCRUZ DP, 1989, BRIT MED J, V299, P419, DOI 10.1136/bmj.299.6696.419
   de Broe M E, 1996, Curr Opin Nephrol Hypertens, V5, P114, DOI 10.1097/00041552-199603000-00003
   DEKKER PJ, 1993, J OTOLARYNGOL, V22, P364
   Delevaux I, 2005, CHEST, V128, P3074, DOI 10.1378/chest.128.4.3074
   Deliyska B, 2003, NEPHROL DIAL TRANSPL, V18, P13, DOI 10.1093/ndt/gfg1035
   Devaney KO, 1998, ANN OTO RHINOL LARYN, V107, P439, DOI 10.1177/000348949810700515
   Dutta P, 2006, EXP CLIN ENDOCR DIAB, V114, P533, DOI 10.1055/s-2006-924122
   Eden A, 2003, RHEUMATOLOGY, V42, P660, DOI 10.1093/rheumatology/keg206
   Elikowski Waldemar, 2006, Kardiol Pol, V64, P622
   Faratian D, 2009, HISTOPATHOLOGY, V54, P391, DOI 10.1111/j.1365-2559.2009.03229.x
   Fechner FP, 2002, LARYNGOSCOPE, V112, P1945, DOI 10.1097/00005537-200211000-00007
   Flossmann O, 2011, ANN RHEUM DIS, V70, P488, DOI 10.1136/ard.2010.137778
   Frankel SK, 2006, CHEST, V129, P452, DOI 10.1378/chest.129.2.452
   Frosch M, 2004, EUR J PEDIATR, V163, P425, DOI 10.1007/s00431-004-1464-3
   Gaber KA, 2005, UROLOGY, V66, pE26, DOI 10.1016/j.urology.2005.01.045
   Galesic Kresimir, 2009, Lijec Vjesn, V131, P4
   George J, 1997, QJM-MON J ASSOC PHYS, V90, P367, DOI 10.1093/qjmed/90.5.367
   George TM, 1997, ARTHRITIS RHEUM, V40, P1992, DOI 10.1002/art.1780401111
   Grahne B, 1966, Acta Otolaryngol, V62, P362, DOI 10.3109/00016486609119581
   Graves Nichole, 2006, Proc (Bayl Univ Med Cent), V19, P342
   Gregorini G, 1990, APMIS Suppl, V19, P23
   Griffith ME, 1996, RENAL FAILURE, V18, P785, DOI 10.3109/08860229609047707
   Grisaru S, 2010, J RHEUMATOL, V37, P440, DOI 10.3899/jrheum.090688
   Gunnarsson R, 2004, RHEUMATOL INT, V24, P120, DOI 10.1007/s00296-003-0343-y
   HANDLERS JP, 1985, ARCH OTOLARYNGOL, V111, P267
   HANSEN LS, 1985, ORAL SURG ORAL MED O, V60, P524, DOI 10.1016/0030-4220(85)90242-7
   Hashizume T, 2002, CLIN RHEUMATOL, V21, P525, DOI 10.1007/s100670200128
   HAWORTH SJ, 1984, GUT, V25, P1296, DOI 10.1136/gut.25.11.1296
   Hernandez G, 2008, J PERIODONTOL, V79, P1297, DOI [10.1902/jop.2008.070572, 10.1902/jop.2008.070572 ]
   Hewins P, 2000, CURR OPIN RHEUMATOL, V12, P3, DOI 10.1097/00002281-200001000-00002
   Holle JU, 2010, RHEUM DIS CLIN N AM, V36, P507, DOI 10.1016/j.rdc.2010.05.008
   Ibrahim S, 2010, SAUDI J KIDNEY DIS T, V21, P1118
   Jagiello P, 2005, ARTHRITIS RHEUM-US, V52, P4039, DOI 10.1002/art.21487
   Jennette JC, 2011, CLIN EXP IMMUNOL, V164, P7, DOI 10.1111/j.1365-2249.2011.04357.x
   Kamali S, 2003, CLIN RHEUMATOL, V22, P333, DOI 10.1007/s10067-003-0725-2
   Kashiyama T, 1995, INTERNAL MED, V34, P1110, DOI 10.2169/internalmedicine.34.1110
   Kasifoglu T, 2008, ARTHRITIS RHEUM, V58, P2564, DOI 10.1002/art.23502
   Katrib A, 1998, J RHEUMATOL, V25, P1009
   Katzman GL, 1999, AM J NEURORADIOL, V20, P519
   Kettritz R, 1998, AM J KIDNEY DIS, V31, P860, DOI 10.1016/S0272-6386(98)70058-7
   Khan AM, 2006, SURG-J R COLL SURG E, V4, P45, DOI 10.1016/S1479-666X(06)80021-1
   Kishimoto N, 1996, Nihon Kyobu Shikkan Gakkai Zasshi, V34, P790
   KOYAMA T, 1984, AM J OPHTHALMOL, V98, P736, DOI 10.1016/0002-9394(84)90690-1
   Lamprecht P, 2004, HERZ, V29, P47, DOI 10.1007/s00059-004-2525-0
   Lamprecht P, 2004, ARTHRITIS RHEUM-US, V50, P334, DOI 10.1002/art.11475
   Langford CA, 1999, THORAX, V54, P629, DOI 10.1136/thx.54.7.629
   LEAVITT RY, 1990, ARTHRITIS RHEUM, V33, P1101, DOI 10.1002/art.1780330807
   LIAM CK, 1993, POSTGRAD MED J, V69, P754, DOI 10.1136/pgmj.69.815.754
   Lim KS, 2003, BRIT J OPHTHALMOL, V87, P500, DOI 10.1136/bjo.87.4.500
   Liu SY, 2003, J LARYNGOL OTOL, V117, P148, DOI 10.1258/002221503762624666
   Lopez Amado M, 1994, An Otorrinolaringol Ibero Am, V21, P343
   Mahr AD, 2006, CLIN EXP RHEUMATOL, V24, pS82
   Mahr AD, 2009, APMIS, V117, P41, DOI 10.1111/j.1600-0463.2009.02476.x
   Rodrigues CEM, 2010, REV BRAS REUMATOL, V50, P150, DOI 10.1590/S0482-50042010000200005
   Malamou-Mitsi VD, 2000, AM J MED, V109, P74, DOI 10.1016/S0002-9343(00)00422-8
   Mann SD, 2003, INT J CLIN PRACT, V57, P441
   Miszalski-Jamka T, 2011, EUR RADIOL, V21, P2297, DOI 10.1007/s00330-011-2203-6
   Mohammad AJ, 2009, RHEUMATOLOGY, V48, P1560, DOI 10.1093/rheumatology/kep304
   Monteiro MLR, 2005, J NEURO-OPHTHALMOL, V25, P25, DOI 10.1097/00041327-200503000-00007
   Moore PM, 1995, ANN NEUROL, V37, pS131
   Mubashir E, 2006, SOUTH MED J, V99, P977, DOI 10.1097/01.smj.0000232210.04881.d3
   Mukhtyar C, 2009, ANN RHEUM DIS, V68, P318, DOI 10.1136/ard.2008.088351
   Neralic-Meniga I, 2006, WIEN KLIN WOCHENSCHR, V118, P120, DOI 10.1007/s00508-006-0536-y
   Nossent H, 2002, J RHEUMATOL, V29, P1578
   Ntatsaki E, 2010, RHEUM DIS CLIN N AM, V36, P447, DOI 10.1016/j.rdc.2010.04.002
   Papaioannides D, 2002, ANN RHEUM DIS, V61, P185
   Papo T, 1999, ANN RHEUM DIS, V58, P654, DOI 10.1136/ard.58.10.654
   PATTEN SF, 1993, J AM ACAD DERMATOL, V28, P710, DOI 10.1016/0190-9622(93)70098-E
   Ponniah I, 2005, ORAL SURG ORAL MED O, V100, P265, DOI 10.1016/j.tripleo.2005.04.018
   Popa ER, 2002, ARTHRITIS RES, V4, P77, DOI 10.1186/ar392
   Price D B, 1989, Trans Pa Acad Ophthalmol Otolaryngol, V41, P885
   Rasmussen N, 1982, Ugeskr Laeger, V144, P2397
   Reinhold-Keller E, 2005, ARTHRIT RHEUM-ARTHR, V53, P93, DOI 10.1002/art.20928
   Rosenbaum JT, 2006, SEMIN ARTHRITIS RHEU, V35, P271, DOI 10.1016/j.semarthrit.2005.08.005
   Sarlon G, 2010, REV MED INTERNE, V31, P135, DOI 10.1016/j.revmed.2009.06.007
   SCOTT J, 1972, ORAL SURG ORAL MED O, V34, P920, DOI 10.1016/0030-4220(72)90230-7
   Semple D, 2005, CRIT CARE, V9, P193, DOI 10.1186/cc2937
   Seo JB, 2000, BRIT J RADIOL, V73, P1224, DOI 10.1259/bjr.73.875.11144805
   Shaikh FM, 2006, GUT, V55, P1368, DOI 10.1136/gut.2006.096768
   Shen J, 2011, CLIN TRANSPLANT, V25, P380, DOI 10.1111/j.1399-0012.2010.01248.x
   Shiotani A, 1997, INTERNAL MED, V36, P514, DOI 10.2169/internalmedicine.36.514
   Siar CH, 2011, EUR J MED RES, V16, P331, DOI 10.1186/2047-783X-16-7-331
   Silva IP, 2011, ACTA REUMATOL PORT, V36, P81
   SPENCER SJW, 1992, KIDNEY INT, V41, P1059, DOI 10.1038/ki.1992.161
   Stevic R, 2012, COLLEGIUM ANTROPOL, V36, P505
   Stewart C, 2007, J AM DENT ASSOC, V138, P338, DOI 10.14219/jada.archive.2007.0166
   Strivens RL, 2005, CLIN EXP RHEUMATOL, V23, P124
   Strizhakov L. A., 2010, Arkhiv Patologii, V72, P42
   Takizawa M, 2001, AURIS NASUS LARYNX, V28, pS59, DOI 10.1016/S0385-8146(01)00064-5
   Tarabishy AB, 2010, SURV OPHTHALMOL, V55, P429, DOI 10.1016/j.survophthal.2009.12.003
   TemmesfeldWollbrueck B, 1997, GUT, V40, P550, DOI 10.1136/gut.40.4.550
   Tervaert Jan Willem Cohen, 1998, Current Opinion in Rheumatology, V10, P12, DOI 10.1097/00002281-199801000-00003
   Tomasson G, 2011, J RHEUMATOL, V38, P1048, DOI 10.3899/jrheum.100735
   van den Heuvel H, 2011, BMJ CASE REP, V4284, P1
   Veerysami M, 2006, BREAST J, V12, P268, DOI 10.1111/j.1075-122X.2006.00254.x
   Walsh JS, 1999, CUTIS, V64, P183
   Wardyn KA, 2003, CLIN RHEUMATOL, V22, P472, DOI 10.1007/s10067-003-0778-2
   Watts RA, 2000, HOSP MED, V61, P250, DOI 10.12968/hosp.2000.61.4.1313
   Watts RA, 2009, ARTHRIT CARE RES, V61, P1412, DOI 10.1002/art.24544
   WEEKLY clinicopathological exercises, 1950, NEW ENGL J MED, V243, P454
   Woo TL, 2001, OPHTHALMOLOGY, V108, P1535, DOI 10.1016/S0161-6420(01)00655-8
   Wung PK, 2006, NAT CLIN PRACT RHEUM, V2, P192, DOI 10.1038/ncprheum0139
   Yi ES, 2001, SEMIN DIAGN PATHOL, V18, P34, DOI 10.1053/sdia.2001.22139
   Yunt ZX, 2012, THER ADV RESPIR DIS, V6, P375, DOI 10.1177/1753465812454693
NR 149
TC 30
Z9 31
U1 0
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0904-2512
EI 1600-0714
J9 J ORAL PATHOL MED
JI J. Oral Pathol. Med.
PD AUG
PY 2013
VL 42
IS 7
BP 507
EP 516
DI 10.1111/jop.12030
PG 10
WC Dentistry, Oral Surgery & Medicine; Pathology
SC Dentistry, Oral Surgery & Medicine; Pathology
GA 283DW
UT WOS:000329226600001
PM 23301777
DA 2020-11-30
ER

PT J
AU Said, AK
   Leao, JC
   Fedele, S
   Porter, SR
AF Said, Ahmed K.
   Leao, Jair C.
   Fedele, Stefano
   Porter, Stephen R.
TI Focal epithelial hyperplasia - an update
SO JOURNAL OF ORAL PATHOLOGY & MEDICINE
LA English
DT Review
DE focal; HPV; hyperplasia; mucosa; oral
ID HUMAN-PAPILLOMAVIRUS DNA; ORAL MUCOSAL LESIONS; STANDING HECKS-DISEASE;
   INSITU HYBRIDIZATION; MALIGNANT-TRANSFORMATION; CONDYLOMA ACUMINATUM; 2
   SIBLINGS; HPV DNA; INFECTION; HIV
AB Focal epithelial hyperplasia (FEH) is an asymptomatic benign mucosal disease, which is mostly observed in specific groups in certain geographical regions. FEH is usually a disease of childhood and adolescence and is generally associated with people who live in poverty and of low socioeconomic status. Clinically, FEH is typically characterized by multiple, painless, soft, sessile papules, plaques or nodules, which may coalesce to give rise to larger lesions. Human papillomavirus (HPV), especially genotypes 13 and 32, have been associated and detected in the majority of FEH lesions. The clinical examination and social history often allow diagnosis, but histopathological examination of lesional tissue is usually required to confirm the exact diagnosis. FEH sometimes resolves spontaneously however, treatment is often indicated as a consequence of aesthetic effects or any interference with occlusion. There remains no specific therapy for FEH, although surgical removal, laser excision or possibly topical antiviral agents may be of benefit. There remains no evidence that FEH is potentially malignant.
C1 [Said, Ahmed K.; Leao, Jair C.; Fedele, Stefano; Porter, Stephen R.] UCL Eastman Dent Inst, Oral Med Unit, London WC1X 8LD, England.
   [Leao, Jair C.] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
RP Porter, SR (corresponding author), UCL Eastman Dent Inst, Directors Off, 256 Grays Inn Rd, London WC1X 8LD, England.
EM s.porter@ucl.ac.uk
RI Leao, Jair Carneiro/AAL-6154-2020
OI Leao, Jair Carneiro/0000-0001-8303-2291; Porter,
   Stephen/0000-0002-3328-2759
FU Department of Health's National Institute for Health Research Biomedical
   Research Centre (BRC)
FX This work was undertaken at University College London/University College
   London Hospital Trust who received a proportion of funding from the
   Department of Health's National Institute for Health Research Biomedical
   Research Centre (BRC) funding scheme.
CR Akyol A, 2003, INT J DERMATOL, V42, P733, DOI 10.1046/j.1365-4362.2003.01777.x
   Artac H, 2010, EUR J PEDIATR, V169, P1033, DOI 10.1007/s00431-009-1131-9
   Bassioukas K, 2000, EUR J DERMATOL, V10, P395
   BEAUDENON S, 1987, J INVEST DERMATOL, V88, P130, DOI 10.1111/1523-1747.ep12525278
   Bennett LK, 2009, PEDIATR DERMATOL, V26, P87, DOI 10.1111/j.1525-1470.2008.00830.x
   Bombeccari GP, 2009, J EUR ACAD DERMATOL, V23, P197, DOI 10.1111/j.1468-3083.2008.02772.x
   Borborema-Santos Cristina Maria, 2006, Braz. Dent. J., V17, P79, DOI 10.1590/S0103-64402006000100018
   Bravo Ines Maria, 2006, Med Oral Patol Oral Cir Bucal, V11, pE33
   Campisi G, 2007, INT J ONCOL, V30, P813
   CARLOS R, 1994, ORAL SURG ORAL MED O, V77, P631
   Clausen F P, 1970, Scand J Dent Res, V78, P287
   COHEN PR, 1993, PEDIATR DERMATOL, V10, P245, DOI 10.1111/j.1525-1470.1993.tb00369.x
   Cuberos V, 2006, J CLIN VIROL, V37, P21, DOI 10.1016/j.jcv.2006.04.003
   DEVILLIERS EM, 1986, MED MICROBIOL IMMUN, V174, P287, DOI 10.1007/BF02123681
   DEVILLIERS EM, 1986, LARYNGO RHINO OTOL, V65, P177, DOI 10.1055/s-2007-998810
   dos Santos PJB, 2005, DIAGN MICR INFEC DIS, V53, P71, DOI 10.1016/j.diagmicrobio.2005.03.009
   dos Santos PJB, 2004, J ORAL PATHOL MED, V33, P7, DOI 10.1111/j.1600-0714.2004.00003.x
   Durso Braz Campos, 2005, J Can Dent Assoc, V71, P769
   EVERSOLE LR, 1987, J ORAL PATHOL MED, V16, P266, DOI 10.1111/j.1600-0714.1987.tb01491.x
   Falaki F, 2009, J ORAL PATHOL MED, V38, P773, DOI 10.1111/j.1600-0714.2009.00784.x
   Flaitz C M, 2000, Pediatr Dent, V22, P153
   Frezzini C, 2005, J ORAL PATHOL MED, V34, P513, DOI 10.1111/j.1600-0714.2005.00337.x
   Frezzini Cristina, 2006, Dent Update, V33, P276
   Garcia-Corona C, 2004, ARCH DERMATOL, V140, P1227, DOI 10.1001/archderm.140.10.1227
   Garcia-Corona CI, 2000, DERMATOL REV MEX, V44, P262
   Garland SM, 2003, CURR OPIN INFECT DIS, V16, P85, DOI 10.1097/00001432-200304000-00004
   GARLICK JA, 1991, AM J DERMATOPATH, V13, P386
   GARLICK JA, 1989, J ORAL PATHOL MED, V18, P172, DOI 10.1111/j.1600-0714.1989.tb00757.x
   Gonzalez LV, 2005, INT J DERMATOL, V44, P274, DOI 10.1111/j.1365-4632.2005.02321.x
   Greenspan D, 2000, J ACQ IMMUN DEF SYND, V25, P44, DOI 10.1097/00126334-200009010-00006
   Guill CK, 2002, ARCH DERMATOL, V138, P1509, DOI 10.1001/archderm.138.11.1509
   Gultekin SE, 2011, PEDIATR DENT, V33, P522
   Gupta Sanjay, 2004, Indian J Pathol Microbiol, V47, P8
   Ha PK, 2004, CRIT REV ORAL BIOL M, V15, P188, DOI 10.1177/154411130401500402
   HARRIS AMP, 1993, COMMUNITY DENT ORAL, V21, P82, DOI 10.1111/j.1600-0528.1993.tb00726.x
   HENKE RP, 1987, VIRCHOWS ARCH A, V411, P193, DOI 10.1007/BF00712744
   Henley JD, 2004, HISTOPATHOLOGY, V44, P216, DOI 10.1111/j.0309-0167.2004.01818.x
   Jablonska S, 2000, EUR J DERMATOL, V10, P235
   JARAMILLO F, 1991, ARCH DERMATOL, V127, P887, DOI 10.1001/archderm.127.6.888
   Jayasooriya PR, 2004, ORAL DIS, V10, P240, DOI 10.1111/j.1601-0825.2004.01012.x
   Jimenez C, 2001, J ORAL PATHOL MED, V30, P385, DOI 10.1034/j.1600-0714.2001.300701.x
   Karcioglu ZA, 1997, BRIT J OPHTHALMOL, V81, P595, DOI 10.1136/bjo.81.7.595
   King MD, 2002, CLIN INFECT DIS, V34, P641, DOI 10.1086/338637
   Kose O, 2001, J DERMATOL TREAT, V12, P111
   LANDELLS IDR, 1994, PEDIATR DERMATOL, V11, P274, DOI 10.1111/j.1525-1470.1994.tb00603.x
   LANG E, 1984, DEUT MED WOCHENSCHR, V109, P1763, DOI 10.1055/s-2008-1069450
   Laskaris G, 1996, Dent Clin North Am, V40, P395
   Ledesma-Montes Constantino, 2005, Med Oral Patol Oral Cir Bucal, V10, P394
   LUOMANEN M, 1990, INT J ORAL MAX SURG, V19, P205, DOI 10.1016/S0901-5027(05)80391-1
   Majewski S, 1997, J AM ACAD DERMATOL, V36, P659, DOI 10.1016/S0190-9622(97)80315-5
   Majewski S, 1997, CANCER RES, V57, P4214
   Mamabolo M M J, 2006, SADJ, V61, P408
   Martins WD, 2006, INT J PAEDIATR DENT, V16, P65, DOI 10.1111/j.1365-263X.2006.00664.x
   Marvan E, 1998, AUST DENT J, V43, P305, DOI 10.1111/j.1834-7819.1998.tb00178.x
   Maschke Jan, 2004, J Dtsch Dermatol Ges, V2, P848
   MEALEY BL, 1993, J PERIODONTOL, V64, P149, DOI 10.1902/jop.1993.64.2.149
   Michael EJ, 1999, CUTIS, V64, P395
   MIES C, 1994, HUM PATHOL, V25, P555, DOI 10.1016/0046-8177(94)90218-6
   Miller RL, 2002, INT IMMUNOPHARMACOL, V2, P443, DOI 10.1016/S1567-5769(01)00184-9
   Moerman M, 2001, DERMATOLOGY, V203, P339, DOI 10.1159/000051786
   MORROW DJ, 1993, J PERIODONTOL, V64, P63, DOI 10.1902/jop.1993.64.1.63
   Nartey N O, 2002, J Clin Pediatr Dent, V27, P63
   Niebrugge B, 1999, EUR J DERMATOL, V9, P477
   PADAYACHEE A, 1991, J ORAL PATHOL MED, V20, P210, DOI 10.1111/j.1600-0714.1991.tb00420.x
   PADAYACHEE A, 1995, J ORAL PATHOL MED, V24, P329, DOI 10.1111/j.1600-0714.1995.tb01194.x
   PETZOLDT D, 1980, ARCH DERMATOL RES, V268, P313, DOI 10.1007/BF00404293
   Ponte P, 2010, EUR J DERMATOL, V20, P248, DOI 10.1684/ejd.2010.0889
   Praetorius F, 1985, Tandlaegebladet, V89, P589
   Praetorius F, 1997, CLIN DERMATOL, V15, P399, DOI 10.1016/S0738-081X(96)00157-5
   PREMOLIDEPERCOCO G, 1993, HUM GENET, V91, P386
   ROLIGHED J, 1991, APMIS, V99, P583, DOI 10.1111/j.1699-0463.1991.tb01230.x
   Segura-Saint-Gerons Rafael, 2005, Med Oral Patol Oral Cir Bucal, V10, P128
   Steinhoff M, 2001, BRIT J DERMATOL, V144, P1067, DOI 10.1046/j.1365-2133.2001.04201.x
   Syrjanen S, 2003, MED MICROBIOL IMMUN, V192, P123, DOI 10.1007/s00430-002-0173-7
   SYRJANEN SM, 1987, ARCH DERMATOL RES, V279, P543, DOI 10.1007/BF00413287
   TAN AKW, 1995, OTOLARYNG HEAD NECK, V112, P316
   TAN KN, 1969, ARCH DERMATOL, V100, P474, DOI 10.1001/archderm.100.4.474
   Terezhalmy GT, 2001, QUINTESSENCE INT, V32, P664
   Tomai MA, 2000, CELL IMMUNOL, V203, P55, DOI 10.1006/cimm.2000.1673
   UNGER ER, 1986, AM J SURG PATHOL, V10, P1, DOI 10.1097/00000478-198601000-00001
   Vargas-Alarcon G, 2000, HUM IMMUNOL, V61, P341, DOI 10.1016/S0198-8859(99)00180-9
   VILMER C, 1994, J AM ACAD DERMATOL, V30, P497, DOI 10.1016/S0190-9622(08)81951-2
   Viraben R, 1996, DERMATOLOGY, V193, P261, DOI 10.1159/000246261
   Zanotti KM, 2002, CLEV CLIN J MED, V69, P948, DOI 10.3949/ccjm.69.12.948
NR 84
TC 33
Z9 35
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0904-2512
EI 1600-0714
J9 J ORAL PATHOL MED
JI J. Oral Pathol. Med.
PD JUL
PY 2013
VL 42
IS 6
BP 435
EP 442
DI 10.1111/jop.12009
PG 8
WC Dentistry, Oral Surgery & Medicine; Pathology
SC Dentistry, Oral Surgery & Medicine; Pathology
GA 175TD
UT WOS:000321255200001
PM 23061874
DA 2020-11-30
ER

PT J
AU Mota, CCBD
   Gueiros, LA
   Maia, AMA
   Santos-Silva, AR
   Gomes, ASL
   Alves, FD
   Leao, JC
   de Freitas, AZ
   Goes, M
   Lopes, MA
AF Brainer de Oliveira Mota, Claudia Cristina
   Gueiros, Luiz Alcino
   Araujo Maia, Ana Marly
   Santos-Silva, Alan Roger
   Leonidas Gomes, Anderson Stevens
   Alves, Fabio de Abreu
   Leao, Jair Carneiro
   de Freitas, Anderson Zanardi
   Goes, Mario
   Lopes, Marcio Ajudarte
TI Optical Coherence Tomography as an Auxiliary Tool for the Screening of
   Radiation-Related Caries
SO PHOTOMEDICINE AND LASER SURGERY
LA English
DT Article
ID DENTAL ENAMEL; DEMINERALIZATION; IRRADIATION; JUNCTION; COLLAGEN; TEETH
AB Objective: The aim of this study was to evaluate the morphological alterations of radiation-related caries using optical coherence tomography. Methods: Thirty-six extracted teeth from 11 patients who had undergone radiotherapy were sectioned in the sagittal axis in the center of the carious lesion, and 100 mu m thick sections were obtained from each specimen. One sample from each tooth was investigated by an optical coherence tomography (OCT) system, and the results were compared with histological images from polarized light microscopy. Results: In OCT dentin caries images, the demineralized area appeared as a white region, whereas the translucent zone appeared as a dark area, a similar pattern also seen in coronal caries. In noncavitated enamel lesions clinically observed as brown discoloration, the area of high porosity, and also the dark color, absorbs part of the light, resulting in a dark pattern. Finally, the involvement of dentin-enamel junction (DEJ) or cement-enamel junction (CEJ) could be clearly observed, when present and marked alterations along the CEJ could be noted, as junction continuity loss, gap formation, and mineral loss tissue. Conclusions: The OCT technique was able to characterize radiation-related caries, from a morphological point of view. Also demonstrated was its potential benefit for use in the clinical monitoring of radiation-related carious process.
C1 [Brainer de Oliveira Mota, Claudia Cristina; Gueiros, Luiz Alcino; Araujo Maia, Ana Marly; Leao, Jair Carneiro] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
   [Santos-Silva, Alan Roger; Lopes, Marcio Ajudarte] Univ Estadual Campinas, UNICAMP, Dept Diagnost Oral, Piracicaba, SP, Brazil.
   [Leonidas Gomes, Anderson Stevens] Univ Fed Pernambuco, Dept Fis, BR-50739 Recife, PE, Brazil.
   [Alves, Fabio de Abreu] Hosp Canc AC Camargo, Dept Estomatol, Sao Paulo, Brazil.
   [de Freitas, Anderson Zanardi] CNEN SP, IPEN, Sao Paulo, Brazil.
   [Goes, Mario] Univ Estadual Campinas, UNICAMP, Dept Odontol, Piracicaba, SP, Brazil.
RP Gueiros, LA (corresponding author), Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Av Prof Moraes Rego 1235, Recife, PE, Brazil.
EM luiz.mgueiros@ufpe.br
RI Gueiros, Luiz Alcino/F-7171-2012; Mota, Claudia/P-3506-2019; Gueiros,
   Luiz Alcino/B-6429-2015; Lopes, Marcio Ajudarte/AAV-1018-2020; Alves,
   Fabio A/B-7892-2011; Santos-Silva, Alan/C-9947-2016; Santos-Silva, Alan
   Roger/B-6121-2008; Freitas, Anderson Z/F-8287-2010; Leao, Jair
   Carneiro/AAL-6154-2020
OI Gueiros, Luiz Alcino/0000-0003-4979-4318; Mota,
   Claudia/0000-0002-7909-5908; Gueiros, Luiz Alcino/0000-0003-4979-4318;
   Alves, Fabio A/0000-0003-3372-1536; Santos-Silva,
   Alan/0000-0003-2040-6617; Santos-Silva, Alan Roger/0000-0003-2040-6617;
   Freitas, Anderson Z/0000-0002-5018-9126; Leao, Jair
   Carneiro/0000-0001-8303-2291; Maia, Ana Marly/0000-0003-2829-3768
FU National Council for Scientific and Technological Development (CNPq),
   BrazilNational Council for Scientific and Technological Development
   (CNPq) [474697/2012-6]
FX The authors acknowledge the National Council for Scientific and
   Technological Development (CNPq), Brazil, for supporting this research
   (process: 474697/2012-6). The authors also thank Mario Fernando de Goes
   (Dental Materials Area) and Marcelo Giannini (Restorative Dentistry
   Area) from Piracicaba Dental School, University of Campinas, Brazil, for
   their support and contribution with sample preparation and polarized
   light microscopy analysis.
CR Acil Y, 2005, CALCIFIED TISSUE INT, V76, P121, DOI 10.1007/s00223-004-0122-0
   al-Nawas B, 2000, Clin Oral Investig, V4, P168
   Arambawatta Kapila, 2009, J Oral Sci, V51, P623
   Braz AKS, 2009, DENT MATER, V25, P74, DOI 10.1016/j.dental.2008.04.011
   Grotz K. A., 1997, Strahlentherapie und Onkologie, V173, P668
   Hall A, 2004, J Dent Res, V83 Spec No C, pC89
   Huynh GD, 2004, PROC SPIE, V5313, P118, DOI 10.1117/12.539290
   Jansma J, 1993, Am J Dent, V6, P130
   Jongebloed W L, 1988, Am J Dent, V1, P139
   Kielbassa AM, 2006, LANCET ONCOL, V7, P326, DOI 10.1016/S1470-2045(06)70658-1
   Kielbassa AM, 2006, CARIES RES, V40, P130, DOI 10.1159/000091059
   Kielbassa AM, 1997, EUR J ORAL SCI, V105, P444, DOI 10.1111/j.1600-0722.1997.tb02142.x
   Louie T, 2010, LASER SURG MED, V42, P738, DOI 10.1002/lsm.21013
   Maia AMA, 2010, INT J PAEDIATR DENT, V20, P158, DOI 10.1111/j.1365-263X.2009.01025.x
   Matheus Tibério C. U., 2010, Braz. Dent. J., V21, P420, DOI 10.1590/S0103-64402010000500008
   PIOCH T, 1992, ENDOD DENT TRAUMATOL, V8, P241
   Raab W., 2009, STRAHLENTHER ONKOL, V45, P425
   SCHROEDER HE, 1988, J PERIODONTAL RES, V23, P53, DOI 10.1111/j.1600-0765.1988.tb01027.x
   Silva ARS, 2009, CARIES RES, V43, P43, DOI 10.1159/000192799
   Silva ARS, 2010, SUPPORT CARE CANCER, V18, P83, DOI 10.1007/s00520-009-0633-3
   Soares CJ, 2010, J DENT RES, V89, P159, DOI 10.1177/0022034509351251
   Springer IN, 2005, ORAL ONCOL, V41, P723, DOI 10.1016/j.oraloncology.2005.03.011
   Vissink A, 2003, CRIT REV ORAL BIOL M, V14, P199, DOI 10.1177/154411130301400305
   Xu CQ, 2009, CALCIFIED TISSUE INT, V84, P221, DOI 10.1007/s00223-008-9212-8
NR 24
TC 18
Z9 19
U1 0
U2 10
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1549-5418
EI 1557-8550
J9 PHOTOMED LASER SURG
JI Photomed. Laser Surg.
PD JUL
PY 2013
VL 31
IS 7
BP 301
EP 306
DI 10.1089/pho.2012.3415
PG 6
WC Surgery
SC Surgery
GA 175VP
UT WOS:000321262000002
PM 23819504
OA Green Published
DA 2020-11-30
ER

PT J
AU Iyomasa, MM
   Rizzi, EC
   Leao, JC
   Issa, JPM
   Dias, FJ
   Pereira, YCL
   Fonseca, MJV
   Vicentini, FTMD
   Watanabe, IS
AF Iyomasa, Mamie Mizusaki
   Rizzi, Elen Camargo
   Leao, Juliane Caroline
   Mardegan Issa, Joao Paulo
   Dias, Fernando Jose
   Lara Pereira, Yamba Carla
   Vieira Fonseca, Maria Jose
   Moura de Carvalho Vicentini, Fabiana Testa
   Watanabe, Ii-sei
TI Zymographic and ultrastructural evaluations after low-level laser
   irradiation on masseter muscle of HRS/J strain mice
SO LASERS IN MEDICAL SCIENCE
LA English
DT Article
DE Low-level laser therapy; Masseter muscle; Transmission electron
   microscopy; Zymography; VEGF; VEGFR-2
ID ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; MATRIX PROTEINS; TISSUE-REPAIR;
   HUMAN SKIN; THERAPY; CELLS; EXPRESSION; INCREASES; RADIATION
AB Low-level laser therapy (LLLT) has been widely used in the treatment of the stomatognathic system dysfunction; however, its biological effect remains poorly understood. This study evaluated the effect of LLLT (GaAlAs, 780 nm, 20 J/cmA(2), 40 mW) on masseter muscle of HRS/J mice after different numbers of laser irradiations (three, six, and ten) for 20 s in alternate days. Three experimental groups were defined according to the number of laser irradiations and three control groups (n = 5) were used. On the third day after the last irradiation, all animals were killed and the masseter muscle was removed and processed for the following analysis: (a) transmission electron microscopy, (b) zymography, (c) immunohistochemistry for vascular endothelial growth factor (VEGF) and VEGFR-2. The results showed: (a) with six laser applications, a dilation of T tubules, and sarcoplasmic reticulum cistern, increased pinocytosed vesicles in the endothelium; with ten laser applications, few pinocytic vesicles in the endothelium and condensed mitochondria. (b) Under the conditions of this study, the synthesis of other matrix metalloproteinases was not observed, only the MMP-2 and -9. (c) After ten laser irradiations, immunostaining was observed only for VEGFR-2. We conclude that after six laser applications, ultrastructural changes may facilitate the Ca+2 transfer to cytosol and increase the fluid transport from one surface to another. The ultrastructural changes and no immunostaining for VEGF with ten applications may decrease the metabolic activity as well as damage the angiogenic process, suggesting that an effective number of laser applications may be less than ten, associating to this therapy a better cost-benefit.
C1 [Iyomasa, Mamie Mizusaki; Rizzi, Elen Camargo; Leao, Juliane Caroline; Mardegan Issa, Joao Paulo; Dias, Fernando Jose; Lara Pereira, Yamba Carla] Univ Sao Paulo, Dept Morphol Stomatol & Physiol, Fac Dent Ribeirao Preto, BR-14040904 Ribeirao Preto, SP, Brazil.
   [Vieira Fonseca, Maria Jose; Moura de Carvalho Vicentini, Fabiana Testa] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Dept Pharmaceut Sci, BR-14049 Ribeirao Preto, Brazil.
   [Watanabe, Ii-sei] Univ Sao Paulo, Dept Anat, Inst Biomed Sci ICB, BR-14049 Ribeirao Preto, Brazil.
RP Iyomasa, MM (corresponding author), Univ Sao Paulo, Dept Morphol Stomatol & Physiol, Fac Dent Ribeirao Preto, Ave Cafe,S-N Monte Alegre, BR-14040904 Ribeirao Preto, SP, Brazil.
EM mamieiyo@forp.usp.br
RI WATANABE, II-SEI/G-1461-2016; Vicentini, Fabiana T.M.C./F-8065-2012;
   Iyomasa, Mamie Mizusaki/H-5005-2012; Issa, Joao Paulo/A-2505-2011; Dias,
   Fernando Jose/AAP-7420-2020; Fonseca, Maria Jose Vieira
   MJVF/H-7881-2013; Dias, Fernando Jose/D-8228-2014
OI Vicentini, Fabiana T.M.C./0000-0002-0842-9130; Iyomasa, Mamie
   Mizusaki/0000-0002-4001-6440; Issa, Joao Paulo/0000-0002-1056-0795;
   Fonseca, Maria Jose Vieira MJVF/0000-0002-7123-4838; Watanabe,
   Ii-sei/0000-0002-1000-1467; Dias, Fernando Jose/0000-0001-9945-9185;
   Rizzi, Elen/0000-0002-3823-8845
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
FX We are grateful to FAPESP for financial support.
CR AIRAKSINEN O, 1993, ACUPUNCTURE ELECTRO, V18, P9, DOI 10.3727/036012993816357584
   Audet GN, 2011, EXP PHYSIOL, V96, P1138, DOI 10.1113/expphysiol.2011.057711
   Bossini PS, 2011, J TISSUE ENG REGEN M, V5, P229, DOI 10.1002/term.309
   Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x
   de Almeida P, 2011, PHOTOCHEM PHOTOBIOL, V87, P1159, DOI 10.1111/j.1751-1097.2011.00968.x
   de Medeiros JS, 2005, PHOTOMED LASER SURG, V23, P373, DOI 10.1089/pho.2005.23.373
   Dias FJ, 2012, MICRON, V43, P237, DOI 10.1016/j.micron.2011.08.005
   Dias FJ, 2011, PHOTOMED LASER SURG, V29, P677, DOI 10.1089/pho.2010.2879
   Emshoff R, 2008, ORAL SURG ORAL MED O, V105, P452, DOI 10.1016/j.tripleo.2007.09.012
   Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0
   Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003
   Gao F, 2001, ENDOCRINE, V16, P47, DOI 10.1385/ENDO:16:1:47
   Giacca M, 2012, GENE THER, V19, P622, DOI 10.1038/gt.2012.17
   HAAS AF, 1990, J INVEST DERMATOL, V94, P822, DOI 10.1111/1523-1747.ep12874679
   Hsieh YL, 2012, J COMP NEUR IN PRESS
   Hudlicka O, 2009, J VASC RES, V46, P504, DOI 10.1159/000226127
   Iyomasa DM, 2009, MICRON, V40, P413, DOI 10.1016/j.micron.2009.02.002
   KARU T, 1995, J PHOTOCH PHOTOBIO B, V27, P219, DOI 10.1016/1011-1344(94)07078-3
   Karu TI, 2008, PHOTOCHEM PHOTOBIOL, V84, P1091, DOI 10.1111/j.1751-1097.2008.00394.x
   Kitagawa Y, 2004, ORAL DIS, V10, P271, DOI 10.1111/j.1601-0825.2004.01020.x
   Kossodo S, 2004, PHOTOCHEM PHOTOBIOL, V79, P86, DOI 10.1562/0031-8655(2004)79<86:EOUAUC>2.0.CO;2
   Lahmann C, 2001, PHOTOCHEM PHOTOBIOL, V73, P657, DOI 10.1562/0031-8655(2001)073<0657:IOMFMM>2.0.CO;2
   Leao JC, 2011, ANAT REC, V294, P1592, DOI 10.1002/ar.21451
   Lopes-Martins RAB, 2006, J APPL PHYSIOL, V101, P283, DOI 10.1152/japplphysiol.01318.2005
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAXWELL LC, 1981, ANAT REC, V200, P127, DOI 10.1002/ar.1092000203
   Medrado ARAP, 2003, LASER SURG MED, V32, P239, DOI 10.1002/lsm.10126
   Meireles GC, 2008, PHOTOMED LASER SURG, V26, P47
   Renno ACM, 2011, J COSMET LASER THER, V13, P237, DOI 10.3109/14764172.2011.606466
   Nunez SC, 2006, PHOTOMED LASER SURG, V24, P45, DOI 10.1089/pho.2006.24.45
   Pereira LB, 2012, PHOTOMED LASER SURG, V30, P206, DOI 10.1089/pho.2011.3087
   Pikkula BM, 2005, LASER SURG MED, V36, P117
   Leal ECP, 2010, EUR J APPL PHYSIOL, V108, P1083, DOI 10.1007/s00421-009-1321-1
   Racz E, 2010, LASER SURG MED, V42, P201, DOI 10.1002/lsm.20898
   Reis SRA, 2008, PHOTOMED LASER SURG, V26, P307, DOI 10.1089/pho.2007.2151
   Rizzi CF, 2006, LASER SURG MED, V38, P704, DOI 10.1002/lsm.20371
   Rizzi EC, 2010, PHOTOMED LASER SURG, V28, DOI 10.1089/pho.2009.2599
   Rocha AM, 2009, PHOTOMED LASER SURG, V27, P303, DOI 10.1089/pho.2008.2277
   Shefer G, 2003, BBA-MOL CELL RES, V1593, P131, DOI 10.1016/S0167-4889(02)00350-6
   Shibuya Masaubmi, 2006, Angiogenesis, V9, P225, DOI 10.1007/s10456-006-9055-8
   Shinozaki S, 2008, J CELL PHYSIOL, V216, P38, DOI 10.1002/jcp.21372
   Silveira PCL, 2007, J PHOTOCH PHOTOBIO B, V86, P279, DOI 10.1016/j.jphotobiol.2006.10.002
   Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463
   Tafur J, 2008, PHOTOMED LASER SURG, V26, P323, DOI 10.1089/pho.2007.2184
   Tuby H, 2006, LASER SURG MED, V38, P682, DOI 10.1002/lsm.20377
   Tullberg M, 2003, PAIN, V105, P89, DOI 10.1016/S0304-3959(03)00166-0
   Vicentini FTMC, 2008, EUR J PHARM BIOPHARM, V69, P948, DOI 10.1016/j.ejpb.2008.01.012
   WATANABE I, 1983, ARCH HISTOL JAPON, V46, P173, DOI 10.1679/aohc.46.173
   Wilden L, 1998, J CLIN LASER MED SUR, V16, P159, DOI 10.1089/clm.1998.16.159
   Wu EC, 2008, ARCH FACIAL PLAST S, V10, P381, DOI 10.1001/archfaci.10.6.381
   Yen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027514
   Zucker S, 2003, CURR TOP DEV BIOL, V54, P1, DOI 10.1016/S0070-2153(03)54004-2
NR 52
TC 6
Z9 6
U1 0
U2 6
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0268-8921
EI 1435-604X
J9 LASER MED SCI
JI Lasers Med. Sci.
PD MAY
PY 2013
VL 28
IS 3
BP 777
EP 783
DI 10.1007/s10103-012-1156-6
PG 7
WC Engineering, Biomedical; Surgery
SC Engineering; Surgery
GA 134BL
UT WOS:000318184600011
PM 22797825
DA 2020-11-30
ER

PT J
AU Dastoori, M
   Fedele, S
   Leao, JC
   Porter, SR
AF Dastoori, Mahmoud
   Fedele, Stefano
   Leao, Jair C.
   Porter, Stephen R.
TI Sarcoidosis a clinically orientated review
SO JOURNAL OF ORAL PATHOLOGY & MEDICINE
LA English
DT Review
DE oral lesions; oral medicine; sarcoidosis
ID BUDD-CHIARI SYNDROME; ENZYME ACE GENE; PULMONARY SARCOIDOSIS;
   UNITED-STATES; SERUM 1,25-DIHYDROXYVITAMIN-D; CUTANEOUS SARCOIDOSIS;
   INFLAMMATORY ACTIVITY; HEPATIC SARCOIDOSIS; OCULAR INVOLVEMENT;
   CYCLOSPORINE-A
AB Sarcoidosis is a multisystem disease of unknown cause. Sarcoidosis can affect all individuals with any race, sex, or age but commonly affects young- and middle-aged adults and usually presents with bilateral hilar lymphadenopathy, pulmonary infiltration, skin and ocular lesions. Other organs can also be affected. Diagnosis is established when clinical and radiological findings are supported by the presence of non-caseating epithelioid cell granulomas, however, local sarcoid reactions and granulomas of known cause should be excluded. The optimal management has not been well defined yet, although corticosteroids remain the mainstay of treatment, there is little evidence on which to base the indications for treatment including dosage and duration of therapy. Certain clinical features are helpful in the prognosis of the condition that can vary from a self-limiting course to progressive life-threatening fibrosis of the vital organs.
C1 [Dastoori, Mahmoud; Fedele, Stefano; Leao, Jair C.; Porter, Stephen R.] UCL Eastman Dent Inst, Dept Maxillofacial Med & Surg, Oral Med Unit, London WC1X 8LD, England.
   [Leao, Jair C.] Univ Fed Pernambuco Recife, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
RP Porter, SR (corresponding author), UCL Eastman Dent Inst, Directors Off, 256 Grays Inn Rd, London WC1X 8LD, England.
EM s.porter@ucl.ac.uk
RI Leao, Jair Carneiro/AAL-6154-2020
OI Leao, Jair Carneiro/0000-0001-8303-2291; Porter,
   Stephen/0000-0002-3328-2759
CR Abdullah M, 2012, RESPIRATION, V83, P61, DOI 10.1159/000329868
   ADAMS JS, 1989, ANN INTERN MED, V111, P437, DOI 10.7326/0003-4819-111-5-437
   AGBOGU BN, 1995, ARCH NEUROL-CHICAGO, V52, P875, DOI 10.1001/archneur.1995.00540330053014
   Ahmadzai H, 2012, INTERN MED J, V42, P232, DOI 10.1111/j.1445-5994.2011.02576.x
   Ali MM, 2010, J EUR ACAD DERMATOL, V24, P747, DOI 10.1111/j.1468-3083.2009.03517.x
   [Anonymous], 1999, Am J Respir Crit Care Med, V160, P736
   Bagwan IN, 2011, VIRCHOWS ARCH, V458, P671, DOI 10.1007/s00428-010-1003-8
   Baltzan M, 1999, AM J RESP CRIT CARE, V160, P192, DOI 10.1164/ajrccm.160.1.9809024
   Barnard J, 2005, J OCCUP ENVIRON MED, V47, P226, DOI 10.1097/01.jom.0000155711.88781.91
   Baughman RP, 2012, EXPERT REV CLIN IMMU, V8, P95, DOI [10.1586/ECI.11.84, 10.1586/eci.11.84]
   Baughman RP, 2011, AM J RESP CRIT CARE, V183, P573, DOI 10.1164/rccm.201006-0865CI
   Baughman RP, 2010, SEMIN RESP CRIT CARE, V31, P452, DOI 10.1055/s-0030-1262213
   Baughman RP, 2001, AM J RESP CRIT CARE, V164, P1885, DOI 10.1164/ajrccm.164.10.2104046
   Baughman RP, 1999, J CLIN EPIDEMIOL, V52, P1173
   BAUGHMAN RP, 1990, AM REV RESPIR DIS, V142, P1268, DOI 10.1164/ajrccm/142.6_Pt_1.1268
   Baughman RP, 1999, THORAX, V54, P742, DOI 10.1136/thx.54.8.742
   Ben Jennet Salima, 2008, Tunis Med, V86, P447
   Birnbaum AD, 2011, ARCH OPHTHALMOL-CHIC, V129, P409, DOI 10.1001/archophthalmol.2011.52
   Borchers AI, 2003, CLIN REV ALLERG IMMU, V25, P289, DOI 10.1385/CRIAI:25:3:289
   Bradley D, 2002, SEM RESP CRIT CARE M, V23, P543, DOI 10.1055/s-2002-36518
   BRESNITZ EA, 1983, EPIDEMIOL REV, V5, P124, DOI 10.1093/oxfordjournals.epirev.a036255
   Byg KE, 2003, SARCOIDOSIS VASC DIF, V20, P46
   CHAMULEAU RAFM, 1985, NETH J MED, V28, P470
   Chen ES, 2011, NAT REV RHEUMATOL, V7, P457, DOI 10.1038/nrrheum.2011.93
   Cheng DR, 2011, EMERG MED AUSTRALAS, V23, P376, DOI 10.1111/j.1742-6723.2011.01426.x
   COSTABEL U, 1986, ANN NY ACAD SCI, V465, P418, DOI 10.1111/j.1749-6632.1986.tb18518.x
   Costabel U, 1997, CLIN CHEST MED, V18, P827, DOI 10.1016/S0272-5231(05)70421-4
   Costabel U, 2001, EUR RESPIR J, V18, p56S
   Cottin V, 2011, REV MED INTERNE, V32, P93, DOI 10.1016/j.revmed.2010.07.016
   Cozier YC, 2011, CHEST, V139, P144, DOI 10.1378/chest.10-0413
   Cremers J, 2012, EUR J GASTROEN HEPAT, V24, P17, DOI 10.1097/MEG.0b013e32834c7b71
   Croft AP, 2012, CLIN RHEUMATOL, V31, P1013, DOI 10.1007/s10067-011-1933-9
   DEMETER SL, 1988, CHEST, V94, P202, DOI 10.1378/chest.94.1.202
   DEVANEY K, 1993, AM J SURG PATHOL, V17, P1272, DOI 10.1097/00000478-199312000-00009
   Doty JD, 2003, CHEST, V124, P2023, DOI 10.1378/chest.124.5.2023
   Drent M, 1999, EUR RESPIR J, V13, P718, DOI 10.1034/j.1399-3003.1999.13d03.x
   EKLUND A, 1986, LUNG, V164, P325, DOI 10.1007/BF02713657
   Gonzalez SF, 2011, REV CLIN ESP, V211, P291, DOI 10.1016/j.rce.2011.03.001
   FOLZ SJ, 1995, J COMPUT ASSIST TOMO, V19, P573, DOI 10.1097/00004728-199507000-00013
   Fuchs HA, 2009, CURR OPIN OTOLARYNGO, V17, P23, DOI 10.1097/MOO.0b013e32831b9e58
   Furuya K, 1996, THORAX, V51, P777, DOI 10.1136/thx.51.8.777
   Gibson GJ, 1996, THORAX, V51, P238, DOI 10.1136/thx.51.3.238
   Gideon NM, 1996, AM J MED, V100, P423, DOI 10.1016/S0002-9343(97)89518-6
   Gillman A, 2007, INTERN MED J, V37, P356, DOI 10.1111/j.1445-5994.2007.01365.x
   Gottlieb JE, 1997, CHEST, V111, P623, DOI 10.1378/chest.111.3.623
   Grunewald J, 2010, SEMIN RESP CRIT CARE, V31, P380, DOI 10.1055/s-0030-1262206
   HANNO R, 1981, ARCH DERMATOL, V117, P203, DOI 10.1001/archderm.117.4.203
   Hattori T, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-151
   Heath CR, 2012, J AM ACAD DERMATOL, V66, P121, DOI 10.1016/j.jaad.2010.06.068
   HERCULES HD, 1984, ARCH PATHOL LAB MED, V108, P831
   HILLERDAL G, 1984, AM REV RESPIR DIS, V130, P29
   HOMOLKA J, 1992, CLIN INVESTIGATOR, V70, P909
   Hosoda Y, 1997, CLIN CHEST MED, V18, P681, DOI 10.1016/S0272-5231(05)70412-3
   HUBER C, 1984, J EXP MED, V160, P310, DOI 10.1084/jem.160.1.310
   HUNNINGHAKE CW, 1994, AM J RESP CRIT CARE, V149, P893, DOI 10.1164/ajrccm.149.4.8143052
   IRANI SK, 1979, J CLIN GASTROENTEROL, V1, P131
   IWAI K, 1993, ACTA PATHOL JAPON, V43, P372
   JABS DA, 1986, AM J OPHTHALMOL, V102, P297, DOI 10.1016/0002-9394(86)90001-2
   James D G, 1991, Sarcoidosis, V8, P163
   James D G, 1992, Sarcoidosis, V9, P79
   JAMES DG, 1994, SARCOIDOSIS, V11, P2
   James DG, 1998, SARCOIDOSIS VASC DIF, V15, P134
   Johns CJ, 1999, MEDICINE, V78, P65, DOI 10.1097/00005792-199903000-00001
   JOHNS CJ, 1986, ANN NY ACAD SCI, V465, P702, DOI 10.1111/j.1749-6632.1986.tb18549.x
   KATARIA YP, 1980, CHEST, V78, P36, DOI 10.1378/chest.78.1.36
   Katchar K, 2001, AM J RESP CRIT CARE, V163, P1540, DOI 10.1164/ajrccm.163.7.2005028
   KEOGH BA, 1983, AM REV RESPIR DIS, V128, P256
   KLATSKIN G, 1976, ANN NY ACAD SCI, V278, P427, DOI 10.1111/j.1749-6632.1976.tb47054.x
   Kucera GP, 2003, CHEST, V123, P1527, DOI 10.1378/chest.123.5.1527
   LEHMUSKALLIO E, 1977, ACTA MED SCAND, V202, P289
   Lewis SJ, 1999, SARCOIDOSIS VASC DIF, V16, P87
   Lower EE, 1997, ARCH INTERN MED, V157, P1864
   LOWER EE, 1995, ARCH INTERN MED, V155, P846, DOI 10.1001/archinte.155.8.846
   Lu CL, 1999, HEPATO-GASTROENTEROL, V46, P2293
   MANA J, 1994, RESPIRATION, V61, P219
   MARTINET Y, 1988, AM REV RESPIR DIS, V138, P1242, DOI 10.1164/ajrccm/138.5.1242
   MAYERS M, 1990, INT OPHTHALMOL CLIN, V30, P257, DOI 10.1097/00004397-199030040-00008
   MELICONI R, 1990, THORAX, V45, P536, DOI 10.1136/thx.45.7.536
   MELISSANT CF, 1993, CHEST, V103, P628, DOI 10.1378/chest.103.2.628
   Muller-Quernheim J, 1999, EUR RESPIR J, V14, P1117, DOI 10.1183/09031936.99.14511179
   Muller-Quernheim J, 1998, SARCOIDOSIS VASC DIF, V15, P22
   MULLERQUERNHEIM J, 1991, AM REV RESPIR DIS, V144, P1322
   NATALINO MR, 1978, JAMA-J AM MED ASSOC, V239, P2657
   NEVILLE E, 1983, Q J MED, V52, P525
   Newman LS, 2004, AM J RESP CRIT CARE, V170, P1324, DOI 10.1164/rccm.200402-249OC
   Newman LS, 1997, NEW ENGL J MED, V336, P1224, DOI 10.1056/NEJM199704243361706
   OHARA K, 1995, AM J OPHTHALMOL, V119, P806, DOI 10.1016/S0002-9394(14)72794-1
   OLEARY TJ, 1986, NEW ENGL J MED, V315, P727, DOI 10.1056/NEJM198609183151203
   Pacheco Y, 1985, Sarcoidosis, V2, P107
   Peckham DG, 1996, POSTGRAD MED J, V72, P196, DOI 10.1136/pgmj.72.846.196
   PERRY A, 1995, ARCH PATHOL LAB MED, V119, P167
   Pia G, 1996, SARCOIDOSIS VASC DIF, V13, P146
   Pietinalho A, 1999, RESP MED, V93, P408, DOI 10.1053/rmed.1999.0579
   PRIOR C, 1988, CLIN CHIM ACTA, V177, P211, DOI 10.1016/0009-8981(88)90065-4
   Puryear Douglas W., 1996, Comprehensive Therapy, V22, P649
   Qazi FA, 2003, AM J OPHTHALMOL, V136, P752, DOI 10.1016/S0002-9394(03)00454-9
   QUATRARO A, 1990, ANN INTERN MED, V112, P678, DOI 10.7326/0003-4819-112-9-678
   Reich JM, 1996, SARCOIDOSIS VASC DIF, V13, P173
   Rothova A, 2000, BRIT J OPHTHALMOL, V84, P110, DOI 10.1136/bjo.84.1.110
   RUSSI EW, 1986, AM J GASTROENTEROL, V81, P71
   Rybicki BA, 1997, AM J EPIDEMIOL, V145, P234, DOI 10.1093/oxfordjournals.aje.a009096
   SARTWELL PE, 1974, AM J EPIDEMIOL, V99, P250, DOI 10.1093/oxfordjournals.aje.a121609
   Scott GC, 1997, J COMPUT ASSIST TOMO, V21, P369, DOI 10.1097/00004728-199705000-00006
   Sekiguchi M, 1996, CARDIOVASC DRUG THER, V10, P495, DOI 10.1007/BF00050989
   SHARMA OP, 1993, CHEST, V103, P253, DOI 10.1378/chest.103.1.253
   Sharma P, 1997, LANCET, V349, P1602, DOI 10.1016/S0140-6736(05)61631-5
   SILTZBACH LE, 1954, AM J MED, V16, P790, DOI 10.1016/0002-9343(54)90443-X
   SILVERMAN KJ, 1978, CIRCULATION, V58, P1204, DOI 10.1161/01.CIR.58.6.1204
   SPITERI MA, 1985, BRIT J DERMATOL, V112, P315, DOI 10.1111/j.1365-2133.1985.tb04859.x
   STERN BJ, 1992, ARCH NEUROL-CHICAGO, V49, P1065, DOI 10.1001/archneur.1992.00530340089023
   SULAVIK SB, 1990, CLIN NUCL MED, V15, P876, DOI 10.1097/00003072-199012000-00005
   Tachibana T, 2010, CURR OPIN PULM MED, V16, P465, DOI 10.1097/MCP.0b013e32833ae508
   TELENTI A, 1989, MAYO CLIN PROC, V64, P44, DOI 10.1016/S0025-6196(12)65302-6
   Thillai M, 2012, EUR RESPIR J, V39, P775, DOI 10.1183/09031936.00103811
   Tomita H, 1997, AM J RESP CRIT CARE, V156, P255, DOI 10.1164/ajrccm.156.1.9612011
   TURIAF J, 1976, ANN NY ACAD SCI, V278, P743, DOI 10.1111/j.1749-6632.1976.tb47091.x
   Vardhanabhuti V, 2012, CLIN RADIOL, V67, P263, DOI 10.1016/j.crad.2011.04.018
   Vatti R, 1997, SARCOIDOSIS VASC DIF, V14, P73
   Wakefield D, 2010, OCUL IMMUNOL INFLAMM, V18, P5, DOI 10.3109/09273941003597276
   WARSHAUER DM, 1995, RADIOLOGY, V195, P757, DOI 10.1148/radiology.195.3.7754007
   WARSHAUER DM, 1994, RADIOLOGY, V192, P93, DOI 10.1148/radiology.192.1.8208972
   Wasfi YS, 2006, CHEST, V129, P1234, DOI 10.1378/chest.129.5.1234
   Wyser CP, 1997, AM J RESP CRIT CARE, V156, P1371, DOI 10.1164/ajrccm.156.5.9506031
   Yanardag H, 2003, RESP MED, V97, P978, DOI 10.1016/S0954-6111(03)00127-6
   ZIC JA, 1991, ARCH DERMATOL, V127, P1034, DOI 10.1001/archderm.127.7.1034
NR 125
TC 12
Z9 14
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0904-2512
EI 1600-0714
J9 J ORAL PATHOL MED
JI J. Oral Pathol. Med.
PD APR
PY 2013
VL 42
IS 4
BP 281
EP 289
DI 10.1111/j.1600-0714.2012.01198.x
PG 9
WC Dentistry, Oral Surgery & Medicine; Pathology
SC Dentistry, Oral Surgery & Medicine; Pathology
GA 118EW
UT WOS:000317007200001
PM 22845844
DA 2020-11-30
ER

PT J
AU Leao, JC
   de Faria, ABS
   Fonseca, DDD
   Gueiros, LAM
   Silva, IHM
   Porter, SR
AF Leao, Jair Carneiro
   Santos de Faria, Andreza Barkokebas
   Diniz Fonseca, Deborah Daniela
   Monteiro Gueiros, Luiz Alcino
   Morais Silva, Igor Henrique
   Porter, Stephen R.
TI Intrahost genetic variability of human herpes virus-8
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE HHV 8; KSHV; HIV; AIDS
ID SARCOMA-ASSOCIATED HERPESVIRUS; EPIDEMIC KAPOSIS-SARCOMA; MOLECULAR
   EPIDEMIOLOGY; HUMAN-HERPESVIRUS-8 INFECTION; SEQUENCE-ANALYSIS;
   DNA-SEQUENCES; SIMPLEX-VIRUS; AIDS; STRAINS; VARIANTS
AB Studies were conducted to determine whether HHV-8 hyperactivity could be the consequence of the propensity of the host to multiple HHV-8 infection. The aim of the present work was to investigate HHV-8 intrahost genetic variability. HHV-8 subgenomic DNA was amplified by PCR from patients infected with HIV, health care workers (HCW) and bone marrow transplant recipients (BMT), and from oral lesional tissues of AIDS-Kaposi's sarcoma (KS) patients. As controls, blood from HIV-negative health care workers, and the cell lines BC-1, BC-2, and BCP-1 were used. Clones derived from amplicons originating from DNA fragments in open reading frame (ORF) 26 and ORF K1 were isolated. For each ORF, intra-specimen nucleotide sequence differences were determined. The extent of HHV-8 variation in clones derived from blood of patients infected with HIV was significantly higher than in blood from health care workers or post-bone marrow transplantation patients or in AIDS-KS tissue. Among the clones derived from the latter three categories of specimens, sequence variations were not significant. It is concluded that HIV-infected individuals can have multiple of HHV-8, but AIDS-KS lesions are associated with infection by a single HHV-8 variant or a small group of related variants. J. Med. Virol. 85:636645, 2013. (c) 2013 Wiley Periodicals, Inc.
C1 [Leao, Jair Carneiro; Santos de Faria, Andreza Barkokebas; Diniz Fonseca, Deborah Daniela; Monteiro Gueiros, Luiz Alcino; Morais Silva, Igor Henrique] Fed Univ Pernambuco UFPE, Dept Clin & Prevent Dent, Oral Med Unit, Recife, PE, Brazil.
   [Porter, Stephen R.] UCL Eastman Dent Inst, Oral Med Unit, Dept Maxillofacial Med & Surg, London, England.
RP Leao, JC (corresponding author), Univ Fed Pernambuco, Av Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
EM jleao@ufpe.br
RI Gueiros, Luiz Alcino/B-6429-2015; Leao, Jair Carneiro/AAL-6154-2020
OI Gueiros, Luiz Alcino/0000-0003-4979-4318; Leao, Jair
   Carneiro/0000-0001-8303-2291; Porter, Stephen/0000-0002-3328-2759
CR Adjei AA, 2008, BMC INFECT DIS, V8, P1
   Alagiozoglou L, 2000, J GEN VIROL, V81, P2029, DOI 10.1099/0022-1317-81-8-2029
   Beyari MM, 2003, J INFECT DIS, V188, P678, DOI 10.1086/377504
   Biggar RJ, 2000, J INFECT DIS, V181, P1562, DOI 10.1086/315456
   Blasig C, 1997, J VIROL, V71, P7963, DOI 10.1128/JVI.71.10.7963-7968.1997
   Borges JD, 2012, J INFECT DIS, V205, P1869, DOI 10.1093/infdis/jis278
   Boshoff C, 1998, BLOOD, V91, P1671, DOI 10.1182/blood.V91.5.1671.1671_1671_1679
   Butler LM, 2011, J VIROL, V85, P7321, DOI 10.1128/JVI.00021-11
   Butler LM, 2011, J INFECT DIS, V203, P625, DOI 10.1093/infdis/jiq092
   Caselli E, 2003, INTERVIROLOGY, V46, P141, DOI 10.1159/000071454
   CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802
   Chen XY, 2009, NEOPLASIA, V11, P1272, DOI 10.1593/neo.09494
   CHOU SW, 1986, NEW ENGL J MED, V314, P1418, DOI 10.1056/NEJM198605293142205
   Cook PM, 1999, AIDS, V13, P1165, DOI 10.1097/00002030-199907090-00004
   DiAlberti L, 1997, LANCET, V350, P1655, DOI 10.1016/S0140-6736(97)10102-7
   Duprez R, 2006, VIROLOGY, V353, P121, DOI 10.1016/j.virol.2006.04.026
   ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0
   Fouchard N, 2000, INT J CANCER, V85, P166, DOI 10.1002/(SICI)1097-0215(20000115)85:2&lt;166::AID-IJC3&gt;3.0.CO;2-
   Fu BS, 2009, J MED VIROL, V81, P1422, DOI 10.1002/jmv.21550
   GALE RE, 1994, BLOOD, V83, P2899, DOI 10.1182/blood.V83.10.2899.2899
   Gill PS, 1998, P NATL ACAD SCI USA, V95, P8257, DOI 10.1073/pnas.95.14.8257
   Gottwein E, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00165
   Guech-Ongey Mercy, 2010, Infect Agent Cancer, V5, P21, DOI 10.1186/1750-9378-5-21
   Gunther T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000935
   Harrington W, 1997, LANCET, V349, P774
   Hayward GS, 2007, CURR TOP MICROBIOL, V312, P1
   Ilboudo D, 2009, Pak J Biol Sci, V12, P908, DOI 10.3923/pjbs.2009.908.913
   Kadyrova E, 2003, J MED VIROL, V71, P548, DOI 10.1002/jmv.10530
   Kakoola DN, 2001, J GEN VIROL, V82, P2393, DOI 10.1099/0022-1317-82-10-2393
   KATZ BZ, 1988, J INFECT DIS, V157, P299, DOI 10.1093/infdis/157.2.299
   Kazanji M, 2005, J INFECT DIS, V192, P1525, DOI 10.1086/491744
   Lacoste V, 2000, J GEN VIROL, V81, P1217, DOI 10.1099/0022-1317-81-5-1217
   Lacoste V, 2000, VIROLOGY, V278, P60, DOI 10.1006/viro.2000.0629
   Liang DG, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00271
   Luppi M, 1997, J VIROL, V71, P8082, DOI 10.1128/JVI.71.10.8082-8083.1997
   Mancuso R, 2008, J MED VIROL, V80, P2153, DOI 10.1002/jmv.21322
   Marshall V, 2010, J INFECT DIS, V202, P1126, DOI 10.1086/656045
   Mbulaiteye SM, 2003, J INFECT DIS, V187, P1780, DOI 10.1086/374973
   Meng YX, 2001, J GEN VIROL, V82, P499, DOI 10.1099/0022-1317-82-3-499
   Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888
   Moore PS, 1996, J VIROL, V70, P549, DOI 10.1128/JVI.70.1.549-558.1996
   Moore PS, 2001, PHILOS T R SOC B, V356, P499, DOI 10.1098/rstb.2000.0777
   Mwakigonja AR, 2007, ONCOL REP, V17, P1291
   Myoung J, 2011, J CLIN INVEST, V121, P1130, DOI 10.1172/JCI43755
   Nicholas J, 1998, J Natl Cancer Inst Monogr, P79
   Nsubuga MM, 2008, CANCER LETT, V263, P182, DOI 10.1016/j.canlet.2007.12.025
   PAMPFER S, 1993, BIOTECHNIQUES, V15, P590
   Rabkin CS, 1997, NEW ENGL J MED, V336, P988, DOI 10.1056/NEJM199704033361403
   Ramirez-Amador V, 2010, ORAL ONCOL, V46, P135, DOI 10.1016/j.oraloncology.2009.12.006
   Renne R, 1996, J VIROL, V70, P8151, DOI 10.1128/JVI.70.11.8151-8154.1996
   Restrepo CS, 2011, SEMIN ULTRASOUND CT, V32, P456, DOI 10.1053/j.sult.2011.03.007
   Robey RC, 2011, VIRAL IMMUNOL, V24, P211, DOI 10.1089/vim.2010.0133
   ROJAS JM, 1995, J INFECT DIS, V172, P1602, DOI 10.1093/infdis/172.6.1602
   Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862
   SAKAOKA H, 1995, J MED VIROL, V46, P387, DOI 10.1002/jmv.1890460416
   Sirianni MC, 1997, J INFECT DIS, V176, P541, DOI 10.1086/514072
   Stewart JJ, 1997, MOL IMMUNOL, V34, P1067, DOI 10.1016/S0161-5890(97)00130-2
   Sturzl M, 2009, THROMB HAEMOSTASIS, V102, P1117, DOI 10.1160/TH09-07-0472
   Tiussi RM, 2012, AN BRAS DERMATOL, V87, P220, DOI 10.1590/S0365-05962012000200005
   Tornesello ML, 2010, VIROLOGY, V398, P280, DOI 10.1016/j.virol.2009.12.005
   VANLOON NM, 1995, CLIN INFECT DIS, V21, P1017, DOI 10.1093/clinids/21.4.1017
   Varthakavi V, 2002, VIROLOGY, V297, P270, DOI 10.1006/viro.2002.1434
   Verbraak FD, 1998, AIDS, V12, P713, DOI 10.1097/00002030-199807000-00007
   Whitby D, 2004, J GEN VIROL, V85, P155, DOI 10.1099/vir.0.19465-0
   Zaraa Ines, 2012, Tunis Med, V90, P116
   Zhong WD, 1997, J VIROL, V71, P1207, DOI 10.1128/JVI.71.2.1207-1212.1997
   Zong JC, 2002, J CLIN VIROL, V23, P119, DOI 10.1016/S1386-6532(01)00205-0
   Zong JC, 1999, J VIROL, V73, P4156, DOI 10.1128/JVI.73.5.4156-4170.1999
NR 68
TC 5
Z9 5
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD APR
PY 2013
VL 85
IS 4
BP 636
EP 645
DI 10.1002/jmv.23491
PG 10
WC Virology
SC Virology
GA 092LP
UT WOS:000315123600011
PM 23417616
DA 2020-11-30
ER

PT J
AU Torres-Pereira, CC
   Morosini, IDC
   Possebon, RS
   Giovanini, AF
   Bortoluzzi, MC
   Leao, JC
   Piazzetta, CM
AF Torres-Pereira, Cassius C.
   Castro Morosini, Imara de Almeida
   Possebon, Renata Seleme
   Giovanini, Allan Fernando
   Bortoluzzi, Marcelo Carlos
   Leao, Jair Carneiro
   Piazzetta, Cleto Mariosvaldo
TI Teledentistry: Distant Diagnosis of Oral Disease Using E-Mails
SO TELEMEDICINE AND E-HEALTH
LA English
DT Article
DE medical records; telehealth; telemedicine; telecommunications
ID MAXILLOFACIAL SURGERY; TELEMEDICINE; CHILDREN; FEASIBILITY; EXPERIENCE
AB Objective: The purpose of this study was to evaluate the applicability of telediagnosis in oral medicine, through the transmission of clinical digital images by e-mail. Subjects and Methods: The sample included 60 consecutive patients who sought oral medicine services at the Federal University of Parana, in the state of Parana, located in southern Brazil. The clinical history and oral lesion images were recorded using clinical electronic charts and a digital camera, respectively, and sent by e-mail to two oral medicine consultants. The consultants provided a maximum of two clinical hypotheses for each case, which were compared with biopsy results that served as the gold standard. Results: In 31 of the 60 cases (51.7%), both consultants made the correct diagnosis; in 17 cases (28.3%), only one consultant made the correct diagnosis; and in 12 cases (20%), neither consultant made the correct diagnosis. Therefore, in 80% of cases, at least one consultant provided the correct diagnosis. The agreement between the first consultant and the gold standard was substantial (kappa = 0.669), and the agreement between the second consultant and the gold standard was fair (kappa = 0.574). Conclusions: The use of information technology can increase the accuracy of consultations in oral medicine. As expected, the participation of two remote experts increased the possibility of correct diagnosis.
C1 [Torres-Pereira, Cassius C.; Castro Morosini, Imara de Almeida; Piazzetta, Cleto Mariosvaldo] Univ Fed Parana, Dept Stomatol, BR-80210170 Curitiba, Parana, Brazil.
   [Torres-Pereira, Cassius C.; Castro Morosini, Imara de Almeida; Piazzetta, Cleto Mariosvaldo] Univ Fed Parana, Postgrad Program Dent, BR-80210170 Curitiba, Parana, Brazil.
   [Giovanini, Allan Fernando] Univ Posit, Oral Pathol Lab, Curitiba, Parana, Brazil.
   [Bortoluzzi, Marcelo Carlos] Univ Estadual Ponta Grossa, Ponta Grossa, Parana, Brazil.
   [Leao, Jair Carneiro] Univ Fed Pernambuco, Clin & Preventat Dent Dept, Recife, PE, Brazil.
RP Torres-Pereira, CC (corresponding author), Univ Fed Parana, Dept Stomatol, Av Lothario Meissner 632, BR-80210170 Curitiba, Parana, Brazil.
EM cassius@ufpr.br
RI Torres-Pereira, Cassius C/A-8553-2012; Giovanini, Allan
   Fernando/K-5215-2012; Leao, Jair Carneiro/AAL-6154-2020; Torres-Pereira,
   Cassius Carvalho/AAD-8719-2020
OI Leao, Jair Carneiro/0000-0001-8303-2291; Torres-Pereira, Cassius
   Carvalho/0000-0001-8049-7544; Morosini, Imara/0000-0002-7591-5454;
   Bortoluzzi, Marcelo Carlos/0000-0003-2756-5047; Giovanini,
   Allan/0000-0002-1637-2955
FU Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq) [38-04]
FX We thank the Brazilian National Research Council (CNPq) for financial
   support (grant 38-04 Decit-Ministerio da Saude).
CR ABBEY LM, 1995, ORAL SURG ORAL MED O, V80, P188, DOI 10.1016/S1079-2104(05)80201-X
   Amavel R, 2009, STUD HEALTH TECHNOL, V150, P458, DOI 10.3233/978-1-60750-044-5-458
   Aziz SR, 2009, J ORAL MAXIL SURG, V67, P2505, DOI 10.1016/j.joms.2009.03.015
   Berndt J, 2008, AM J ORTHOD DENTOFAC, V134, P700, DOI 10.1016/j.ajodo.2007.12.023
   Ewers R, 2005, J ORAL MAXIL SURG, V63, P1447, DOI 10.1016/j.joms.2005.06.020
   Fricton James, 2009, Dent Clin North Am, V53, P537, DOI 10.1016/j.cden.2009.03.005
   Jones K, 2010, ORAL SURG ORAL MED O, V109, P865, DOI 10.1016/j.tripleo.2009.12.023
   Kopycka-Kedzierawski DT, 2007, PEDIATR DENT, V29, P209
   Kopycka-Kedzierawski DT, 2006, J TELEMED TELECARE, V12, P176, DOI 10.1258/135763306777488744
   Kopycka-Kedzierawski T, 2008, PEDIATR DENT, V30, P329
   Kronz Joseph D, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P81, DOI 10.1097/01.moo.0000156162.20789.66
   Leao J C, 1999, Braz Dent J, V10, P47
   Lozzi GP, 2007, J EUR ACAD DERMATOL, V21, P30, DOI 10.1111/j.1468-3083.2006.01846.x
   Mandall NA, 2005, BRIT DENT J, V199, P659, DOI 10.1038/sj.bdj.4812930
   Massone C, 2007, HUM PATHOL, V38, P546, DOI 10.1016/j.humpath.2006.10.006
   Nickenig HJ, 2008, J TELEMED TELECARE, V14, P93, DOI 10.1258/jtt.2007.070806
   Patterson S, 1998, J Can Dent Assoc, V64, P806
   Piccolo D, 2000, J TELEMED TELECARE, V6, P132, DOI 10.1258/1357633001935202
   Rollert MK, 1999, J ORAL MAXIL SURG, V57, P136, DOI 10.1016/S0278-2391(99)90226-4
   Torres-Pereira C, 2008, J TELEMED TELECARE, V14, P435, DOI 10.1258/jtt.2008.080510
   van der Meij EH, 2003, J ORAL PATHOL MED, V32, P507, DOI 10.1034/j.1600-0714.2003.00125.x
   Westra WH, 2002, HEAD NECK-J SCI SPEC, V24, P684, DOI 10.1002/hed.10105
   Zamzam N, 2001, EUR J ORTHODONT, V23, P75, DOI 10.1093/ejo/23.1.75
NR 23
TC 15
Z9 16
U1 1
U2 11
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-5627
EI 1556-3669
J9 TELEMED E-HEALTH
JI Telemed. e-Health
PD FEB
PY 2013
VL 19
IS 2
BP 117
EP 121
DI 10.1089/tmj.2012.0087
PG 5
WC Health Care Sciences & Services
SC Health Care Sciences & Services
GA 092DS
UT WOS:000315099800009
PM 23356381
OA Green Published
DA 2020-11-30
ER

PT J
AU Brasil, CDV
   Ribeiro, CMB
   Leao, JC
AF Vasconcelos Brasil, Catarina da Mota
   Beder Ribeiro, Camila Maria
   Leao, Jair Carneiro
TI Oral and Genital Human Herpesvirus 8 and Human Papillomavirus in
   heterosexual partners
SO JOURNAL OF ORAL PATHOLOGY & MEDICINE
LA English
DT Article
DE human papillomavirus; human herpesvirus 8; polymerase chain reaction;
   sexual partners
ID SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSIS-SARCOMA; SEXUAL TRANSMISSION;
   HHV-8 INFECTION; MEN; SEROPREVALENCE; BRAZIL; WOMEN; HPV; VIRUS
AB Background: The purpose of this study was to verify a possible co-infection of human herpesvirus 8 (HHV-8) in commonly associated human papillomavirus (HPV) penile lesions and to determine the frequency of detection of these viruses in the oral mucosa of their female counterparts. Methods: Thirty-one male subjects underwent penile swabs from clinical HPV-related lesions. Their female counterparts underwent swabs of the vagina, uterine cervix, and oral mucosa. HPV and HHV-8 detection was performed by polymerase chain reaction using the consensus primers MY11/MY09 and KS1/KS2, respectively. Results: HPV DNA was detected in 31/31 penile lesions. HPV DNA was also detected in 18/31 (58%) female genital brushings and 17/31 (54%) female oral brushings. HHV-8 DNA was detected in 1/31 (3.2%) male genital brushings and 3/31 (9.6%) female oral mucosa brushings. None of the female genital brushings were HHV-8 DNA-infected. Conclusions: Based upon the results of this study, co-infection between HPV and HHV-8 in malignant and pre-malignant penile lesions is an unlikely finding.
C1 [Vasconcelos Brasil, Catarina da Mota; Leao, Jair Carneiro] Univ Fed Pernambuco UFPE, Oral Med Unit, Sch Dent, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
   [Beder Ribeiro, Camila Maria] Ctr Univ CESMAC Maceio, Maceio, AL, Brazil.
RP Leao, JC (corresponding author), Av Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
EM jleao@ufpe.br
RI Leao, Jair Carneiro/AAL-6154-2020; Beder Ribeiro Girish Panjwani, Camila
   Maria/M-5453-2017
OI Leao, Jair Carneiro/0000-0001-8303-2291; Beder Ribeiro Girish Panjwani,
   Camila Maria/0000-0003-0203-3079
CR Adjei AA, 2008, BMC INFECT DIS, V8, P1
   ADLERSTORTHZ K, 1992, J ORAL PATHOL MED, V21, P164, DOI 10.1111/j.1600-0714.1992.tb00095.x
   Baeten JM, 2002, AIDS, V16, P2073, DOI 10.1097/00002030-200210180-00013
   BERNARD C, 1994, MOL CELL PROBE, V8, P337, DOI 10.1006/mcpr.1994.1049
   Brouchet L, 2005, BRIT J CANCER, V92, P743, DOI 10.1038/sj.bjc.6602409
   Cartwright NH, 1996, CLIN MOL PATHOL, V49, P236
   Caselli E, 2003, INTERVIROLOGY, V46, P141, DOI 10.1159/000071454
   Caterino-De-Araujo A, 2007, BRAZ J INFECT DIS, V11, P9, DOI 10.1590/S1413-86702007000100004
   Caterino-de-Araujo Adele, 2003, Braz J Infect Dis, V7, P395, DOI 10.1590/S1413-86702003000600007
   Challine D, 2001, TRANSFUSION, V41, P1120, DOI 10.1046/j.1537-2995.2001.41091120.x
   Chan PKS, 1999, CLIN INFECT DIS, V29, P1584, DOI 10.1086/313544
   Chow VTK, 2000, PATHOLOGY, V32, P204, DOI 10.1080/713688930
   Corbellino M, 1996, NEW ENGL J MED, V335, P1237, DOI 10.1056/NEJM199610173351614
   Cunha AMG, 2005, J GEN VIROL, V86, P2433, DOI 10.1099/vir.0.81087-0
   D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497
   D'Souza G, 2009, J INFECT DIS, V199, P1263, DOI 10.1086/597755
   De Carvalho JJM, 2006, SCAND J UROL NEPHROL, V40, P138, DOI 10.1080/00365590500191241
   Diamond C, 1998, J VIROL, V72, P6223, DOI 10.1128/JVI.72.7.6223-6227.1998
   ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0
   Franca TRT, 2011, J ORAL PATHOL MED, V40, P97
   Giovannelli L, 2007, J MED VIROL, V79, P1882, DOI 10.1002/jmv.21015
   Giuliani M, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-143
   Gomes PS, 2003, THESIS U FEDERAL SAO
   Guvenc MG, 2008, AURIS NASUS LARYNX, V35, P357, DOI 10.1016/j.anl.2007.08.006
   Kedes DH, 1996, NAT MED, V2, P918, DOI 10.1038/nm0896-918
   Lampinen TM, 2000, J INFECT DIS, V181, P1785, DOI 10.1086/315426
   Leao J C, 1999, Rev Assoc Med Bras (1992), V45, P55, DOI 10.1590/S0104-42301999000100011
   Machado DM, 2005, BRAZ J MED BIOL RES, V38, P237, DOI 10.1590/S0100-879X2005000200012
   Mwakigonja AR, 2008, INFECT AGENTS CANC, V3, P1
   Parisi SG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-150
   Pauk J, 2000, NEW ENGL J MED, V343, P1369, DOI 10.1056/NEJM200011093431904
   Rezza G, 2000, NEW ENGL J MED, V343, P1369
   Sand L, 2000, ANTICANCER RES, V20, P1183
   Sanjose S, 2002, INT J CANCER, V98, P155
   Sitas F, 1999, NEW ENGL J MED, V340, P1863, DOI 10.1056/NEJM199906173402403
   Smith NA, 1999, J INFECT DIS, V180, P600, DOI 10.1086/314926
   Taylor MM, 2004, J INFECT DIS, V190, P484, DOI 10.1086/421466
   Varthakavi V, 2002, VIROLOGY, V297, P270, DOI 10.1006/viro.2002.1434
   Widmer IC, 2006, JAIDS-J ACQ IMM DEF, V42, P420, DOI 10.1097/01.qai.0000226790.31463.e6
   Zago A, 2000, SEX TRANSM DIS, V27, P468, DOI 10.1097/00007435-200009000-00009
NR 40
TC 2
Z9 2
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0904-2512
J9 J ORAL PATHOL MED
JI J. Oral Pathol. Med.
PD JAN
PY 2013
VL 42
IS 1
BP 61
EP 65
DI 10.1111/j.1600-0714.2012.01184.x
PG 5
WC Dentistry, Oral Surgery & Medicine; Pathology
SC Dentistry, Oral Surgery & Medicine; Pathology
GA 063KX
UT WOS:000312998500008
PM 22680306
DA 2020-11-30
ER

PT J
AU Gueiros, LA
   Medeiros, R
   Silva, IH
   Xavier, JC
   Carvalho, AT
   Leao, JC
AF Gueiros, L. A.
   Medeiros-Junior, R.
   Silva, I. H.
   Xavier, J. C.
   Carvalho, A. T.
   Leao, J. C.
TI Comparison of Nd: YAG laser and conventional labial frenectomy
SO ORAL DISEASES
LA English
DT Meeting Abstract
C1 [Gueiros, L. A.; Medeiros-Junior, R.; Silva, I. H.; Xavier, J. C.; Carvalho, A. T.; Leao, J. C.] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Serv Estomatol, Recife, PE, Brazil.
RI Gueiros, Luiz Alcino/B-6429-2015; Leao, Jair Carneiro/AAL-6154-2020;
   Gueiros, Luiz Alcino/F-7171-2012
OI Gueiros, Luiz Alcino/0000-0003-4979-4318; Leao, Jair
   Carneiro/0000-0001-8303-2291; Gueiros, Luiz Alcino/0000-0003-4979-4318
NR 0
TC 0
Z9 0
U1 0
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1354-523X
J9 ORAL DIS
JI Oral Dis.
PD SEP
PY 2012
VL 18
SU 1
SI SI
BP 26
EP 27
PG 2
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 004YX
UT WOS:000308718600119
DA 2020-11-30
ER

PT J
AU Carvalho, AAT
   Santos, LFC
   Gueiros, LA
   Barkokebas, A
   Fonseca, DDD
   Cardoso, S
   Freitas, PM
   Nogueira, GEC
   Leao, JC
AF Carvalho, A. A. T.
   Santos, L. F. C.
   Gueiros, L. A.
   Barkokebas, A.
   Fonseca, D. D. D.
   Cardoso, S.
   Freitas, P. M.
   Nogueira, G. E. C.
   Leao, J. C.
TI Low-level laser therapy in the treatment of burning mouth syndrome
SO ORAL DISEASES
LA English
DT Meeting Abstract
C1 [Carvalho, A. A. T.; Santos, L. F. C.; Gueiros, L. A.; Barkokebas, A.; Fonseca, D. D. D.; Cardoso, S.; Leao, J. C.] Univ Fed Pernambuco, Dept Clin & Prevent Dent, Recife, PE, Brazil.
   [Freitas, P. M.; Nogueira, G. E. C.] Univ Sao Paulo, Coll Dent, Inst Nucl Energy & Res, Sao Paulo, SP, Brazil.
   [Leao, J. C.] UCL, Eastman Dent Inst, London, England.
RI Gueiros, Luiz Alcino/F-7171-2012; Gueiros, Luiz Alcino/B-6429-2015;
   Leao, Jair Carneiro/AAL-6154-2020; Nogueira, Gesse Eduardo C/E-4151-2013
OI Gueiros, Luiz Alcino/0000-0003-4979-4318; Gueiros, Luiz
   Alcino/0000-0003-4979-4318; Leao, Jair Carneiro/0000-0001-8303-2291;
   Nogueira, Gesse Eduardo C/0000-0001-6406-2022
NR 0
TC 0
Z9 0
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1354-523X
J9 ORAL DIS
JI Oral Dis.
PD SEP
PY 2012
VL 18
SU 1
SI SI
BP 29
EP 29
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 004YX
UT WOS:000308718600133
DA 2020-11-30
ER

PT J
AU Gueiros, LA
   Souza, TR
   Duarte, AL
   Carvalho, AT
   Leao, JC
AF Gueiros, L. A.
   Souza, T. R.
   Duarte, A. L.
   Carvalho, A. T.
   Leao, J. C.
TI Th1 and Th2 gene polymorphisms in patients with secondary Sjogren
   syndrome and rheumatoid arthritis
SO ORAL DISEASES
LA English
DT Meeting Abstract
C1 [Gueiros, L. A.; Souza, T. R.; Carvalho, A. T.; Leao, J. C.] Univ Fed Pernambuco, Dept Clin & Prevent Dent, Recife, PE, Brazil.
   [Duarte, A. L.] Univ Fed Pernambuco, Hosp Clin, Rheumatol Serv, Recife, PE, Brazil.
RI Pinto Duarte, Angela Luzia/I-1868-2013; Leao, Jair
   Carneiro/AAL-6154-2020; Pinto Duarte, Angela Luzia/N-6538-2017; Gueiros,
   Luiz Alcino/B-6429-2015
OI Pinto Duarte, Angela Luzia/0000-0002-3333-2621; Leao, Jair
   Carneiro/0000-0001-8303-2291; Gueiros, Luiz Alcino/0000-0003-4979-4318
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1354-523X
J9 ORAL DIS
JI Oral Dis.
PD SEP
PY 2012
VL 18
SU 1
SI SI
BP 31
EP 31
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 004YX
UT WOS:000308718600142
DA 2020-11-30
ER

PT J
AU de Souza, TR
   Silva, IHM
   Carvalho, AT
   Gomes, VB
   Duarte, AP
   Leao, JC
   Gueiros, LA
AF de Souza, Thayse Rodrigues
   Morais Silva, Igor Henrique
   Carvalho, Alessandra Tavares
   Gomes, Valder Barbosa
   Duarte, Angela Pinto
   Leao, Jair Carneiro
   Gueiros, Luiz Alcino
TI Juvenile Sjogren Syndrome: Distinctive Age, Unique Findings
SO PEDIATRIC DENTISTRY
LA English
DT Article
DE AUTOIMMUNE DISEASES; SALIVARY GLAND DISEASES; SJOGREN'S SYNDROME
AB Juvenile Sjogren's syndrome is a rare condition that affects children and adolescents with distinctive clinical features. Parotid swelling usually precedes regular oral and ocular symptoms, while typical serological findings may be absent Hence, diagnosing juvenile Sjogren's syndrome may be challenging to the attending pediatric dentist, and long-term management without proper diagnosis may be jeopardized. The purpose of this report was to detail the features of an adolescent with primary Sjogren's syndrome diagnosed 12 years after the onset of the disease. An updated literature review highlighted the unusual aspects of the pediatric form of the disease.
C1 [de Souza, Thayse Rodrigues; Morais Silva, Igor Henrique; Carvalho, Alessandra Tavares; Gomes, Valder Barbosa; Leao, Jair Carneiro; Gueiros, Luiz Alcino] Univ Fed Pernambuco, Hosp Clin, Postgrad Program Dent, Oral Med Unit, Recife, PE, Brazil.
   [Duarte, Angela Pinto] Univ Fed Pernambuco, Hosp Clin, Rheumatol Unit, Recife, PE, Brazil.
RP Gueiros, LA (corresponding author), Univ Fed Pernambuco, Hosp Clin, Postgrad Program Dent, Oral Med Unit, Recife, PE, Brazil.
EM luiz.mgueiros@ufpe.br
RI Pinto Duarte, Angela Luzia/N-6538-2017; Gueiros, Luiz
   Alcino/B-6429-2015; Leao, Jair Carneiro/AAL-6154-2020
OI Gueiros, Luiz Alcino/0000-0003-4979-4318; Leao, Jair
   Carneiro/0000-0001-8303-2291
CR Aliko A, 2010, J ORAL PATHOL MED, V39, P651, DOI 10.1111/j.1600-0714.2010.00899.x
   ANAYA JM, 1995, J RHEUMATOL, V22, P1152
   Bartunkova J, 1999, CLIN EXP RHEUMATOL, V17, P381
   Bartunkova J, 2009, CLIN EXP RHEUMATOL, V32, P195
   CHUDWIN DS, 1981, J PEDIATR-US, V98, P213, DOI 10.1016/S0022-3476(81)80637-3
   Cimaz R, 2003, EUR J PEDIATR, V162, P661, DOI 10.1007/s00431-003-1277-9
   Civilibal M, 2007, CLIN PEDIATR, V46, P738, DOI 10.1177/0009922807301945
   Drosos AA, 1997, ANN RHEUM DIS, V56, P333, DOI 10.1136/ard.56.5.333
   Fang LH, 1990, CHIN MED J, V103, P576
   Fox RI, 2000, J RHEUMATOL, V27, P15
   FRANKLIN DJ, 1986, OTOLARYNG HEAD NECK, V94, P230, DOI 10.1177/019459988609400217
   Gottfried JA, 2001, J CHILD NEUROL, V16, P683, DOI 10.1177/088307380101600911
   HARA T, 1992, ACTA PAEDIATR, V81, P547, DOI 10.1111/j.1651-2227.1992.tb12292.x
   Houghton K, 2005, J RHEUMATOL, V32, P2225
   Iwata Naomi, 2009, Nihon Rinsho Meneki Gakkai Kaishi, V32, P195
   Jung SK, 2010, PEDIATR NEPHROL, V25, P567, DOI 10.1007/s00467-009-1358-8
   Kumon K, 2000, EUR J PEDIATR, V159, P630, DOI 10.1007/PL00008393
   MANTHORPE T, 1992, LANCET, V340, P1359, DOI 10.1016/0140-6736(92)92549-U
   McGuirt WF, 2002, ARCH OTOLARYNGOL, V128, P1279
   Nathavitharana K A, 1995, Int J Paediatr Dent, V5, P173
   Nikitakis NG, 2003, ORAL SURG ORAL MED O, V96, P42, DOI 10.1016/S1079-2104(03)00159-8
   Pessler F, 2006, CLIN RHEUMATOL, V25, P746, DOI 10.1007/s10067-005-0042-z
   Ramos-Casals M, 2010, JAMA-J AM MED ASSOC, V304, P452, DOI 10.1001/jama.2010.1014
   Schuetz C, 2008, CURR RHEUMATOL REP, V10, P147
   Skalova S, 2008, Ghana Med J, V42, P124
   Stiller M, 2000, Clin Oral Investig, V4, P176, DOI 10.1007/s007840000070
   Sutcliffe N., 2002, SJOGRENS SYNDROME
   Tomiita M, 1997, ACTA PAEDIATR JAPON, V39, P268
   Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554
   von Bultzingslowen I, 2007, ORAL SURG ORAL M S57, V103, pe1
   von Bultzingslowen I, 2007, ORAL SURG ORAL MED O, V103, pS57, DOI 10.1016/j.tripleo.2006.11.010
NR 31
TC 26
Z9 27
U1 1
U2 6
PU AMER ACAD PEDIATRIC DENTISTRY
PI CHICAGO
PA 211 E CHICAGO AVENUE SUITE 1036, CHICAGO, IL 60611-2616 USA
SN 0164-1263
EI 1942-5473
J9 PEDIATR DENT
JI Pediatr. Dent.
PD SEP-OCT
PY 2012
VL 34
IS 5
BP 427
EP 430
PG 4
WC Dentistry, Oral Surgery & Medicine; Pediatrics
SC Dentistry, Oral Surgery & Medicine; Pediatrics
GA V35FE
UT WOS:000209135200014
PM 23211922
DA 2020-11-30
ER

PT J
AU Gueiros, LA
   Gondak, R
   Jorge, J
   Della Coletta, R
   Carvalho, AD
   Leao, JC
   de Almeida, OP
   Vargas, PA
AF Gueiros, Luiz Alcino
   Gondak, Rogerio
   Jorge Junior, Jacks
   Della Coletta, Ricardo
   Carvalho, Alessandra de Albuquerque
   Leao, Jair Carneiro
   de Almeida, Oslei Paes
   Vargas, Pablo Agustin
TI Increased number of Langerhans cells in oral lichen planus and oral
   lichenoid lesions
SO ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY
LA English
DT Article
ID DERMAL DENDRITIC CELLS; HLA-DR; EXPRESSION; APOPTOSIS; SKIN; RECEPTOR;
   ACTIVIN; DISEASE; TONGUE
AB Objective. The aim of this study was to quantify the presence of Langerhans cells (LC) in oral lichen planus (OLP) and oral lichenoid lesions (OLL), comparing them with normal epithelium.
   Study Design. Thirty-six patients with biopsy-proven OLP or OLL were selected for the study, as well as 23 control subjects free of inflammatory conditions. Immunohistochemical reactions were performed using the streptavidin-biotin peroxidase complex method with CD1a and CD83 primary antibodies. Densities were compared between groups and correlated with microscopic findings.
   Results. Patients with lichenoid conditions (OLP + OLL) presented higher densities of CD1a(+) cells than the control subjects (P = .03). Higher densities of CD1a were associated with a thinner layer of inflammatory cells (P = .02).
   Conclusions. This study indicates that OLP and OLL are characterized by the recruitment of LC, which may play a significant role on its pathogenesis. (Oral Surg Oral Med Oral Pathol Oral Radiol 2012;113:661-666)
C1 [Vargas, Pablo Agustin] Univ Estadual Campinas, Fac Odontol Piracicaba, Piracicaba Dent Sch, Oral Pathol Sect,Dept Oral Diag, BR-13414901 Piracicaba, SP, Brazil.
   [Gueiros, Luiz Alcino; Carvalho, Alessandra de Albuquerque; Leao, Jair Carneiro] Univ Fed Pernambuco, Dept Clin & Prevent Dent, Oral Med Unit, Recife, PE, Brazil.
RP Vargas, PA (corresponding author), Univ Estadual Campinas, Fac Odontol Piracicaba, Piracicaba Dent Sch, Oral Pathol Sect,Dept Oral Diag, Av Limeira 901, BR-13414901 Piracicaba, SP, Brazil.
EM pavargas@fop.unicamp.br
RI Leao, Jair Carneiro/AAL-6154-2020; Jorge, Jacks/M-6219-2014; Gueiros,
   Luiz Alcino/F-7171-2012; Gueiros, Luiz Alcino/B-6429-2015; Coletta,
   Ricardo D./B-4909-2015; Vargas, Pablo Agustin/C-5208-2012; Gondak,
   Rogerio/D-9260-2013
OI Leao, Jair Carneiro/0000-0001-8303-2291; Gueiros, Luiz
   Alcino/0000-0003-4979-4318; Gueiros, Luiz Alcino/0000-0003-4979-4318;
   Coletta, Ricardo D./0000-0001-5285-3046; Vargas, Pablo
   Agustin/0000-0003-1840-4911; Gondak, Rogerio/0000-0001-7547-660X
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordination for the Improvement of Higher Level Personnel
   (CAPES-PROCAD)
FX Supported by the National Council for Scientific and Technological
   Development (CNPq) and Coordination for the Improvement of Higher Level
   Personnel (CAPES-PROCAD).
CR Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   BOLEWSKA J, 1989, J ORAL PATHOL MED, V18, P525, DOI 10.1111/j.1600-0714.1989.tb01356.x
   CERIO R, 1989, BRIT J DERMATOL, V121, P421, DOI 10.1111/j.1365-2133.1989.tb15509.x
   Cury Patricia Ramos, 2008, Braz. oral res., V22, P258, DOI 10.1590/S1806-83242008000300012
   Deguchi M, 2002, ARCH DERMATOL RES, V294, P297, DOI 10.1007/s00403-002-0334-y
   Dhodapkar MV, 1999, J CLIN INVEST, V104, P173, DOI 10.1172/JCI6909
   Faria PR, 2005, ORAL DIS, V11, P72, DOI 10.1111/j.1601-0825.2004.01070.x
   Fumagalli M, 2007, EXP DERMATOL, V16, P600, DOI 10.1111/j.1600-0625.2007.00571.x
   Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5
   Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815
   Gondak RO, 2012, HISTOPATHOLOGY, V60, P497, DOI 10.1111/j.1365-2559.2011.04068.x
   Grabbe S, 2000, IMMUNOL TODAY, V21, P431, DOI 10.1016/S0167-5699(00)01694-7
   Hubner G, 1996, DEV BIOL, V173, P490, DOI 10.1006/dbio.1996.0042
   Komine M, 2007, J INVEST DERMATOL, V127, P1915, DOI 10.1038/sj.jid.5700799
   Laine J, 1999, J ORAL PATHOL MED, V28, P117
   Larsson A, 1998, Oral Dis, V4, P187
   Orti-Raduan ESL, 2009, J ORAL PATHOL MED, V38, P132, DOI 10.1111/j.1600-0714.2008.00712.x
   MATTSSON T, 1992, ARCH ORAL BIOL, V37, P539, DOI 10.1016/0003-9969(92)90136-V
   McCartan BE, 1997, J ORAL PATHOL MED, V26, P176, DOI 10.1111/j.1600-0714.1997.tb00454.x
   Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852
   Musso T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003271
   Neppleberg E, 2001, EUR J ORAL SCI, V109, P361, DOI 10.1034/j.1600-0722.2001.00081.x
   NESTLE FO, 1993, J IMMUNOL, V151, P6535
   Rattis FM, 1996, EUR J IMMUNOL, V26, P449, DOI 10.1002/eji.1830260227
   Romagnoli P, 1997, Oral Dis, V3, P99
   Santoro A, 2004, AM J CLIN PATHOL, V121, P758, DOI 10.1309/GHY8AL2D45P2R234
   Scully C, 1998, CRIT REV ORAL BIOL M, V9, P86, DOI 10.1177/10454411980090010501
   Sklavounou A, 2000, J ORAL PATHOL MED, V29, P370, DOI 10.1034/j.1600-0714.2000.290802.x
   SLOBERG K, 1984, J ORAL PATHOL MED, V13, P516, DOI 10.1111/j.1600-0714.1984.tb01452.x
   Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841
   Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0
   Valladeau J, 1999, EUR J IMMUNOL, V29, P2695, DOI 10.1002/(SICI)1521-4141(199909)29:09<2695::AID-IMMU2695>3.3.CO;2-H
   van der Meij EH, 2003, ORAL SURG ORAL MED O, V96, P164, DOI 10.1016/S1079-2104(03)00305-6
NR 34
TC 20
Z9 20
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 2212-4403
EI 1528-395X
J9 OR SURG OR MED OR PA
JI Oral Surg. Oral Med. Oral Pathol. Oral Radiol.
PD MAY
PY 2012
VL 113
IS 5
BP 661
EP 666
DI 10.1016/j.oooo.2011.12.008
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 933YE
UT WOS:000303402200023
PM 22668625
DA 2020-11-30
ER

PT J
AU de Franca, TRT
   Carvalho, ADT
   Gomes, VB
   Gueiros, LA
   Porter, SR
   Leao, JC
AF Tenorio de Franca, Talita Ribeiro
   Tavares Carvalho, Alessandra de Albuquerque
   Gomes, Valder Barbosa
   Gueiros, Luiz Alcino
   Porter, Stephen Ross
   Leao, Jair Carneiro
TI Salivary shedding of Epstein-Barr virus and cytomegalovirus in people
   infected or not by human immunodeficiency virus 1
SO CLINICAL ORAL INVESTIGATIONS
LA English
DT Article
DE EBV; Cytomegalovirus; HIV; Saliva; Transmission
ID POLYMERASE-CHAIN-REACTION; HERPES-SIMPLEX-VIRUS; HAIRY LEUKOPLAKIA;
   PERIPHERAL-BLOOD; HUMAN HERPESVIRUSES; HEARING-LOSS; ORAL-MUCOSA; PCR;
   DNA; IDENTIFICATION
AB The purpose of this study is to determine the frequency of EBV and CMV DNA detection in saliva of HIV infected and non-HIV individuals and their siblings. The study group comprised 240 individuals. Group 1 comprised of 40 HIV-infected patients, group 2 40 non-HIV individuals, group 3 two siblings for each patient from group 1 (n = 80), and group 4 two siblings for each individual from group 2 (n = 80). Non-stimulated whole saliva was collected, DNA was extracted, and amplification was performed using a nested PCR protocol. EBV and CMV DNA was detected in 7/40 (17.5%) and 5/40 (12.5%) individuals from group 1, 8/40 (20%) and 3/40 (7.5%) from group 2, 11/80 (13.8%) and 2/80 (2.5%) from group 3, and 8/80 (10%) and 1/80 (1.3%) from group 4, respectively. Five (71.4%) out of seven HIV/EBV coinfected individuals of group 1 had a relative also infected with EBV (OR = 11.25, CI [1.75-72.5], p = 0.011). Regarding group 2, among the eight non-HIV and EBV-infected individuals, three (37.5%) had a relative also positive to EBV (p = 0.320). No individual HIV/CMV coinfected had a relative CMV infected (p = 1.00). Also, only one non-HIV and CMV-infected individual had a relative also positive to CMV (p = 0.075). EBV and CMV DNA was detected mainly in those who had HIV viral load counts < 400/mL (71%, p = 0.2 and 100%, p = 1, respectively) and those who had CD4 T cells counts between 200 and 400/mm(3) (57%, p = 0.544 and 60%, p = 0.249, respectively). HIV-infected individuals and healthy controls showed a similar frequency of viral DNA detection. EBV DNA was significantly amplified in saliva of household members of HIV/EBV coinfected individuals.
C1 [Leao, Jair Carneiro] Univ Fed Pernambuco, Programa Posgrad Odontol, BR-50670901 Recife, PE, Brazil.
   [Porter, Stephen Ross] Univ London, Eastman Dent Inst, Oral Med Unit, Div Maxillofacial Diagnost Surg & Med Sci, London, England.
   [Tenorio de Franca, Talita Ribeiro; Tavares Carvalho, Alessandra de Albuquerque; Gomes, Valder Barbosa; Gueiros, Luiz Alcino; Leao, Jair Carneiro] Univ Fed Pernambuco, Oral Med Unit, Dept Clin & Odontol Prevent, BR-50670901 Recife, PE, Brazil.
RP Leao, JC (corresponding author), Univ Fed Pernambuco, Programa Posgrad Odontol, Av Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
EM jleao@ufpe.br
RI Leao, Jair Carneiro/AAL-6154-2020; Gueiros, Luiz Alcino/B-6429-2015
OI Leao, Jair Carneiro/0000-0001-8303-2291; Gueiros, Luiz
   Alcino/0000-0003-4979-4318; Porter, Stephen/0000-0002-3328-2759
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Pernambuco Research Foundation (FACEPE)
FX The authors are thankful to The National Council for Scientific and
   Technological Development (CNPq) and The Pernambuco Research Foundation
   (FACEPE), for the financial support of this work and to Dr. Chog Gee Teo
   (CDC-Atlanta) who kindly revised this manuscript.
CR Adjei AA, 2008, BMC INFECT DIS, V8, P1
   Ammatuna P, 1998, J ORAL PATHOL MED, V27, P420
   Ammatuna P, 2001, ORAL DIS, V7, P34, DOI 10.1034/j.1601-0825.2001.0070108.x
   Balfour HH, 2005, J INFECT DIS, V192, P1505, DOI 10.1086/491740
   BELLO C, 1991, J CLIN PATHOL, V44, P366, DOI 10.1136/jcp.44.5.366
   Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804
   Chang CM, 2009, VIRUS RES, V143, P209, DOI 10.1016/j.virusres.2009.07.005
   Clementi M, 2000, J CLIN MICROBIOL, V38, P2030
   Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707
   Dawson DR, 2009, ORAL DIS, V15, P554, DOI 10.1111/j.1601-0825.2009.01585.x
   Doniger J, 1999, CLIN MICROBIOL REV, V12, P367, DOI 10.1128/CMR.12.3.367
   Druce J, 2002, J CLIN MICROBIOL, V40, P1728, DOI 10.1128/JCM.40.5.1728-1732.2002
   Fafi-Kremer S, 2005, J INFECT DIS, V191, P985, DOI 10.1086/428097
   Falk KI, 1997, J MED VIROL, V51, P355, DOI 10.1002/(SICI)1096-9071(199704)51:4&lt;355::AID-JMV15&gt;3.0.CO;2-H
   Flaitz CM, 1996, ORAL SURG ORAL MED O, V81, P433, DOI 10.1016/S1079-2104(96)80019-9
   Gulley ML, 2001, J MOL DIAGN, V3, P1, DOI 10.1016/S1525-1578(10)60642-3
   Hara S, 2002, MICROBIOL IMMUNOL, V46, P177, DOI 10.1111/j.1348-0421.2002.tb02683.x
   Hecker M, 2004, VOX SANG, V86, P41, DOI 10.1111/j.0042-9007.2004.00388.x
   Idesawa M, 2004, ORAL MICROBIOL IMMUN, V19, P230, DOI 10.1111/j.1399-302X.2004.00144.x
   Ikuta K, 2000, MICROBES INFECT, V2, P115, DOI 10.1016/S1286-4579(00)00277-X
   Imbronito Ana V, 2008, J Oral Sci, V50, P25, DOI 10.2334/josnusd.50.25
   Jenkins FJ, 2003, CLIN DIAGN LAB IMMUN, V10, P1, DOI 10.1128/CDLI.10.1.1-7.2003
   Johnson G, 2000, J CLIN MICROBIOL, V38, P3274, DOI 10.1128/JCM.38.9.3274-3279.2000
   Kubar A, 2005, J PERIODONTAL RES, V40, P97, DOI 10.1111/j.1600-0765.2005.00770.x
   KUNIMOTO M, 1992, J GEN VIROL, V73, P455, DOI 10.1099/0022-1317-73-2-455
   LaDuca JR, 1998, J INFECT DIS, V178, P1610, DOI 10.1086/314514
   Leao JC, 1999, THESIS EASTMAN DENT
   Lucht E, 1998, CLIN INFECT DIS, V27, P137, DOI 10.1086/514604
   MABRUK MJEMF, 1994, J ORAL PATHOL MED, V23, P302, DOI 10.1111/j.1600-0714.1994.tb00066.x
   Mbulaiteye SM, 2006, J INFECT DIS, V193, P422, DOI 10.1086/499277
   Mbulaiteye SM, 2005, JAIDS-J ACQ IMM DEF, V38, P474, DOI 10.1097/01.qai.0000132495.89162.c0
   Meier J, 2005, J CLIN MICROBIOL, V43, P1318, DOI 10.1128/JCM.43.3.1318-1324.2005
   Miller CS, 2006, J CLIN MICROBIOL, V44, P2409, DOI 10.1128/JCM.00256-06
   Miller CS, 2005, J CLIN MICROBIOL, V43, P2173, DOI 10.1128/JCM.43.5.2173-2180.2005
   Miller CS, 2004, J AM DENT ASSOC, V135, P1311, DOI 10.14219/jada.archive.2004.0407
   NAVAZESH M, 1993, ANN NY ACAD SCI, V694, P72, DOI 10.1111/j.1749-6632.1993.tb18343.x
   Nishiwaki M, 2006, J MED VIROL, V78, P1635, DOI 10.1002/jmv.20748
   Rafailidis PI, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-47
   Rasti N, 2005, SCAND J IMMUNOL, V61, P461, DOI 10.1111/j.1365-3083.2005.01589.x
   Rosenthal LS, 2009, PEDIATR INFECT DIS J, V28, P515, DOI 10.1097/INF.0b013e318198c724
   Ross SA, 2006, J PEDIATR-US, V148, P332, DOI 10.1016/j.jpeds.2005.09.003
   Sahin S, 2009, ORAL MICROBIOL IMMUN, V24, P340, DOI 10.1111/j.1399-302X.2009.00528.x
   Sharland M, 2002, ARCH DIS CHILD-FETAL, V86, P140
   Sitki-Green D, 2002, J VIROL, V76, P9645, DOI 10.1128/JVI.76.19.9645-9656.2002
   Slots J, 2006, J PERIODONTAL RES, V41, P235, DOI 10.1111/j.1600-0765.2006.00865.x
   Tafreshi NK, 2005, J CLIN VIROL, V32, P318, DOI 10.1016/j.jcv.2004.05.018
   Tanaka N, 2000, J MED VIROL, V60, P455, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;455::AID-JMV14&gt;3.0.CO;2-Q
   Tanaka T, 2009, BIOMED RES-TOKYO, V30, P279, DOI 10.2220/biomedres.30.279
   Wada K, 2007, J CLIN MICROBIOL, V45, P1426, DOI 10.1128/JCM.01515-06
   Watanabe Soraia Almeida, 2007, Braz. oral res., V21, P336, DOI 10.1590/S1806-83242007000400010
   Wilms IR, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-107
   Yamamoto AY, 2006, J CLIN VIROL, V36, P228, DOI 10.1016/j.jcv.2006.03.011
NR 52
TC 15
Z9 15
U1 0
U2 3
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1432-6981
EI 1436-3771
J9 CLIN ORAL INVEST
JI Clin. Oral Investig.
PD APR
PY 2012
VL 16
IS 2
BP 659
EP 664
DI 10.1007/s00784-011-0548-5
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 912HL
UT WOS:000301786700039
PM 22186943
DA 2020-11-30
ER

PT J
AU dos Santos, LDC
   Carvalho, ADT
   Leao, JC
   Perez, DED
   de Castro, JFL
AF Cavalcanti dos Santos, Lucia de Fatima
   Tavares Carvalho, Alessandra de Albuquerque
   Leao, Jair Carneiro
   da Cruz Perez, Danyel Elias
   Lisboa de Castro, Jurema Freire
TI Effect of Low-Level Laser Therapy in the Treatment of Burning Mouth
   Syndrome: A Case Series
SO PHOTOMEDICINE AND LASER SURGERY
LA English
DT Article
ID ORAL MUCOSITIS; DIODE-LASER; PREVENTION; PAIN
AB Objective: The aim of this study was evaluate the effect of low-level laser therapy (LLLT) in the treatment of burning mouth syndrome (BMS) patients. Background data: BMS is a clinical condition characterized by a burning sensation in a morphologically normal oral mucosa, without association with systemic disorders. Methods: Ten patients with oral burning sensation were included in the study. After careful evaluation of medical history and oral examination, the diagnosis of BMS was established. All patients were submitted to one weekly session of LLLT for 10 weeks. A continuous wavelength of 660 nm, power 40mW, 20 J/cm(2), 0.8 J/point, with each point irradiated for 10 sec. In all sessions the burning intensity was evaluated with a 10-cm visual analogue scale (VAS), with 0 indicating no symptoms and 10 indicating the worst burning possible. The burning intensity evaluation by VAS was performed immediately before (VAS baseline) and immediately after each LLLT session. The nonparametric Wilcoxon test was used for statistical analysis, considering significance of 5%. Results: All patients reported improvement in all sessions, with reduction in VAS scores by up to 58% in the tenth session. When only the VAS baseline of the first session was compared with the other sessions, there was a statistically significant reduction in VAS scores in the fourth (p = 0.03), fifth (p = 0.03), sixth (p = 0.009), seventh (p = 0.003), eighth, ninth, and tenth (all p = 0.002) sessions. Conclusions: LLLT may be an alternative treatment for the relief of oral burning in patients with BMS.
C1 [Cavalcanti dos Santos, Lucia de Fatima; Tavares Carvalho, Alessandra de Albuquerque; Leao, Jair Carneiro] Univ Fed Pernambuco, Dept Clin & Prevent Dent, Oral Med Unit, BR-50670901 Recife, PE, Brazil.
   [da Cruz Perez, Danyel Elias; Lisboa de Castro, Jurema Freire] Univ Fed Pernambuco, Dept Clin & Prevent Dent, Oral Pathol Unit, BR-50670901 Recife, PE, Brazil.
RP Carvalho, ADT (corresponding author), Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Av Prof Moraes Rego 1235,Cidade Univ, BR-50670901 Recife, PE, Brazil.
EM at.carvalho@uol.com.br
RI da Cruz Perez, Danyel Elias/G-5429-2012; Leao, Jair
   Carneiro/AAL-6154-2020
OI da Cruz Perez, Danyel Elias/0000-0002-4591-4645; Leao, Jair
   Carneiro/0000-0001-8303-2291
CR Brown Ronald S, 2006, Gen Dent, V54, P267
   Dutree-Meulenberg R.O., 1992, J AM ACAD DERMATOL, V34, P91
   De Souza TOF, 2010, PHOTOMED LASER SURG, V28, DOI 10.1089/pho.2009.2661
   Franquin J.C., 1993, SOFT LASER, P11
   Gremeau-Richard C, 2004, PAIN, V108, P51, DOI 10.1016/j.pain.2003.12.002
   GRINSPAN D, 1995, INT J DERMATOL, V34, P483, DOI 10.1111/j.1365-4362.1995.tb00617.x
   GRUSHKA M, 1987, PAIN, V28, P169, DOI 10.1016/0304-3959(87)90114-X
   Grushka M, 2006, ADV OTO-RHINO-LARYNG, V63, P278, DOI 10.1159/000093766
   Hagiwara S, 2007, LASER SURG MED, V39, P797, DOI 10.1002/lsm.20583
   Heckmann SM, 2001, PAIN, V90, P281, DOI 10.1016/S0304-3959(00)00410-3
   Ito M, 2002, PSYCHIAT CLIN NEUROS, V56, P161, DOI 10.1046/j.1440-1819.2002.00950.x
   Jaguar GC, 2007, ORAL DIS, V13, P538, DOI 10.1111/j.1601-0825.2006.01330.x
   Jajarm HH, 2011, PHOTOMED LASER SURG, V29, P421, DOI 10.1089/pho.2010.2876
   Kato IT, 2010, PHOTOMED LASER SURG, V28, P835, DOI 10.1089/pho.2009.2630
   Lauria G, 2005, PAIN, V115, P332, DOI 10.1016/j.pain.2005.03.028
   Lopez-D'alessandro E, 2011, MED ORAL PATOL ORAL, V16, pE635, DOI 10.4317/medoral.16942
   Maresky L S, 1993, Ann Dent, V52, P21
   Nakase M, 2004, ORAL DIS, V10, P217, DOI 10.1111/j.1601-0825.2004.01001.x
   Oton-Leite AF, 2012, HEAD NECK-J SCI SPEC, V34, P398, DOI 10.1002/hed.21737
   Patton LL, 2007, ORAL SURG ORAL MED O, V103, pS39, DOI 10.1016/j.tripleo.2006.11.009
   Pokupec-Gruden JS, 2000, COLLEGIUM ANTROPOL, V24, P119
   Rivinius C, 2009, J AM ACAD NURSE PRAC, V21, P423, DOI 10.1111/j.1745-7599.2009.00424.x
   SHIP JA, 1995, J AM DENT ASSOC, V126, P842, DOI 10.14219/jada.archive.1995.0305
   Yang HW, 2011, PHOTOMED LASER SURG, V29, P123, DOI 10.1089/pho.2010.2787
   ZAKRZEWSKA JM, 1995, PAIN, V62, P253, DOI 10.1016/0304-3959(95)00089-B
   Zanin T, 2010, PHOTOMED LASER SURG, V28, P233, DOI 10.1089/pho.2008.2242
NR 26
TC 26
Z9 26
U1 0
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1549-5418
EI 1557-8550
J9 PHOTOMED LASER SURG
JI Photomed. Laser Surg.
PD DEC
PY 2011
VL 29
IS 12
BP 793
EP 796
DI 10.1089/pho.2011.3016
PG 4
WC Surgery
SC Surgery
GA 863HC
UT WOS:000298152400005
PM 22150094
DA 2020-11-30
ER

PT J
AU Pinheiro, RS
   de Franca, TR
   Rocha, B
   Ferreira, DC
   Ribeiro, CMB
   Cavalcanti, SMB
   de Souza, IPR
   Leao, JC
   Castro, GFB
AF Pinheiro, Raquel Santos
   de Franca, Talita Ribeiro
   Rocha, Barbara
   Ferreira, Dennis Carvalho
   Beder Ribeiro, Camila Maria
   Beata Cavalcanti, Silvia Maria
   Ribeiro de Souza, Ivete Pomarico
   Leao, Jair Carneiro
   Barbosa Castro, Gloria Fernanda
TI Human papillomavirus coinfection in the oral cavity of HIV-infected
   children
SO JOURNAL OF CLINICAL PATHOLOGY
LA English
DT Article
ID HUMAN-IMMUNODEFICIENCY-VIRUS; SQUAMOUS-CELL CARCINOMA; ACTIVE
   ANTIRETROVIRAL THERAPY; HYBRID-CAPTURE; HPV; TRANSMISSION; RISK;
   TYPE-16; DNA; MANIFESTATIONS
AB Aim To identify the early presence of human papillomavirus (HPV) DNA in the oral cavity of HIV-infected children.
   Methods The study group comprised 50 HIV-infected children and 50 healthy aged paired controls. Oral mucosa samples were collected by swab, and a 450 bp HPV DNA fragment was amplified by PCR, using degenerate consensus primers directed to the L1 gene. HPV typing was performed using specifics primers for types 6/16 and 11/18.
   Results All HPV co-infected children had vertical transmission of HIV. HPV DNA was detected in 6/50 (12.0%) of HIV children and three control group individuals 3/50 (6.0%) (p> 0.01). In the HIV group, one had type 11, in the control group one had co-infection of types 11/16, and the others had type 16 and 18.
   Conclusions Based upon the results, it is concluded that HPV DNA may be present in HIV disease, but no association with immunosuppression, delivery, or medical records (CD4 cell count, viral load and use of highly active antiretroviral therapy) was observed, and no differences could be observed between the groups either.
C1 [Pinheiro, Raquel Santos] Univ Fed Rio de Janeiro, Dept Pediat Dent & Orthodont, Rio De Janeiro, Brazil.
   [de Franca, Talita Ribeiro; Leao, Jair Carneiro] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Rocha, Barbara; Ribeiro de Souza, Ivete Pomarico; Barbosa Castro, Gloria Fernanda] Univ Fed Rio de Janeiro, Dept Pediat & Orthodont, Rio De Janeiro, Brazil.
   [Ferreira, Dennis Carvalho] Univ Fed Rio de Janeiro, Dept Microbiol, Rio De Janeiro, Brazil.
   [Beder Ribeiro, Camila Maria] Univ Estadual Campinas, Dept Estomatol, Campinas, SP, Brazil.
   [Beata Cavalcanti, Silvia Maria] Univ Fed Fluminense, Dept Virol, Rio De Janeiro, Brazil.
RP Pinheiro, RS (corresponding author), Univ Fed Rio de Janeiro, Dept Pediat Dent & Orthodont, POB 68066, Rio De Janeiro, Brazil.
EM quelodonto.pinheiro@gmail.com
RI Castro, Gloria/Y-5592-2019; Leao, Jair Carneiro/AAL-6154-2020; Ferreira,
   Dennis/AAC-7407-2020; Beder Ribeiro Girish Panjwani, Camila
   Maria/M-5453-2017
OI Leao, Jair Carneiro/0000-0001-8303-2291; Beder Ribeiro Girish Panjwani,
   Camila Maria/0000-0003-0203-3079; Ferreira, Dennis/0000-0003-4166-3284;
   Souza, Ivete Pomarico/0000-0003-0449-6624; cavalcanti,
   silvia/0000-0002-2994-7172; Castro, Gloria/0000-0002-8137-0307
FU CNPQNational Council for Scientific and Technological Development (CNPq)
FX CNPQ.
CR Adamopoulou M, 2008, IN VIVO, V22, P599
   [Anonymous], 1994, MMWR Recomm Rep, V43, P1
   [Anonymous], 1993, MMWR Recomm Rep, V42, P1
   Bouda M, 2000, MODERN PATHOL, V13, P644, DOI 10.1038/modpathol.3880113
   Cameron JE, 2005, SEX TRANSM DIS, V32, P703, DOI 10.1097/01.olq.0000175398.34610.2e
   Cavuslu S, 1996, J MED VIROL, V49, P319, DOI 10.1002/(SICI)1096-9071(199608)49:4&lt;319::AID-JMV10&gt;3.0.CO;2-5
   Chowa CW, 2007, J PEDIATR SURG, V42, P2035, DOI 10.1016/j.jpedsurg.2007.08.025
   COHEN PR, 1993, PEDIATR DERMATOL, V10, P245, DOI 10.1111/j.1525-1470.1993.tb00369.x
   Collins SI, 2005, INT J CANCER, V114, P498, DOI 10.1002/ijc.20732
   Coogan MM, 2005, B WORLD HEALTH ORGAN, V83, P700
   Coutlee F, 1997, SEX TRANSM DIS, V24, P23, DOI 10.1097/00007435-199701000-00006
   EXPOSITODELGADO AJ, 2004, MED ORAL PATOL ORAL, V9, P410
   Fischer M, 2005, ORL-J OTO-RHIN-LARYN, V67, P237, DOI 10.1159/000089347
   Fonseca R, 2000, QUINTESSENCE INT, V31, P419
   GARLICK JA, 1991, AM J DERMATOPATH, V13, P386
   Gillison ML, 2004, LANCET, V363, P1488, DOI 10.1016/S0140-6736(04)16194-1
   Gutierrez Eic GC, 2001, REV SALUD PUBLICA NU, P2
   Hamza Omar J M, 2006, BMC Oral Health, V6, P12
   Hildesheim A, 2001, JNCI-J NATL CANCER I, V93, P315, DOI 10.1093/jnci/93.4.315
   Hodgson T A, 2006, Adv Dent Res, V19, P106
   Jarboe EA, 2011, AM J CLIN PATHOL, V135, P766, DOI 10.1309/AJCPEI84KRPYWUPK
   JEFTHA AD, 2003, ANN M EXH AADR SAN A
   KAYE JN, 1994, J MED VIROL, V44, P415, DOI 10.1002/jmv.1890440419
   King MD, 2002, CLIN INFECT DIS, V34, P641, DOI 10.1086/338637
   Kojima A, 2003, ORAL ONCOL, V39, P821, DOI 10.1016/S1368-8375(03)00100-3
   Leigh J, 2000, HIV Clin, V12, P7
   LEY C, 1991, J NATL CANCER I, V83, P997, DOI 10.1093/jnci/83.14.997
   Louvanto K, 2010, J CLIN MICROBIOL, V48, P2665, DOI 10.1128/JCM.00783-10
   Naidoo S, 2004, ORAL DIS, V10, P13, DOI 10.1046/j.1354-523X.2003.00973.x
   Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301
   Parra B, 1996, ORAL MICROBIOL IMMUN, V11, P289, DOI 10.1111/j.1399-302X.1996.tb00183.x
   PINHEIRO R, 2009, IADR AADR CADR 87 GE
   Pinheiro RD, 2009, J ORAL PATHOL MED, V38, P613, DOI 10.1111/j.1600-0714.2009.00789.x
   Pinheiro Rdos S, 2009, J ORAL PATHOL MED, V40, P121
   Puranen M, 1996, AM J OBSTET GYNECOL, V174, P694, DOI 10.1016/S0002-9378(96)70452-0
   Puranen MH, 1997, AM J OBSTET GYNECOL, V176, P1039, DOI 10.1016/S0002-9378(97)70399-5
   Razavi Sayed Mohammad, 2009, Dent Res J (Isfahan), V6, P82
   Rintala MAM, 2005, J CLIN MICROBIOL, V43, P376, DOI 10.1128/JCM.43.1.376-381.2005
   SahebJamee M, 2009, MED ORAL PATOL ORAL, V14, pE525
   Sarkola M, 2008, PEDIATR INFECT DIS J, V27, P557, DOI 10.1097/INF.0b013e318169ef47
   Scully C, 2002, ORAL ONCOL, V38, P227, DOI 10.1016/S1368-8375(01)00098-7
   Seaman WT, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-194
   Silva KC, 2009, MEMORIAS I O CRUZ, V104, P12
   Smith EM, 2007, PEDIATR INFECT DIS J, V26, P836, DOI 10.1097/INF.0b013e318124a4ae
   Snietura M, 2010, POL J PATHOL, V61, P133
   Sonnex C, 1999, SEX TRANSM INFECT, V75, P317, DOI 10.1136/sti.75.5.317
   SYRJANEN K, 1983, INT J ORAL MAXILLOF, V12, P418, DOI 10.1016/S0300-9785(83)80033-7
   Syrjanen S, 2000, CRIT REV ORAL BIOL M, V11, P259, DOI 10.1177/10454411000110020801
   WHEELER CM, 1993, SEX TRANSM DIS, V20, P286, DOI 10.1097/00007435-199309000-00009
   Zhang ZY, 2004, INT J ORAL MAX SURG, V33, P71, DOI 10.1054/ijom.2002.0443
NR 50
TC 6
Z9 7
U1 0
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0021-9746
EI 1472-4146
J9 J CLIN PATHOL
JI J. Clin. Pathol.
PD DEC
PY 2011
VL 64
IS 12
BP 1083
EP 1087
DI 10.1136/jclinpath-2011-200187
PG 5
WC Pathology
SC Pathology
GA 851JA
UT WOS:000297263100009
PM 21965827
DA 2020-11-30
ER

PT J
AU Barkokebas, A
   Carvalho, ADT
   de Souza, PRE
   Gomez, RS
   Xavier, GM
   Ribeiro, CMB
   Crovella, S
   Porter, SR
   Leao, JC
AF Barkokebas, Andreza
   Carvalho, Alessandra de Albuquerque T.
   Eleuterio de Souza, Paulo Roberto
   Gomez, Ricardo Santiago
   Xavier, Guilherme Machado
   Beder Ribeiro, Camila Maria
   Crovella, Sergio
   Porter, Stephen Ross
   Leao, Jair Carneiro
TI Mannose-binding lectin gene (MBL-2) polymorphism in oral lichen planus
SO CLINICAL ORAL INVESTIGATIONS
LA English
DT Article
DE Oral lichen planus; Polymorphism; Mannose-binding lectin
ID SYSTEMIC-LUPUS-ERYTHEMATOSUS; TUMOR-NECROSIS-FACTOR;
   RHEUMATOID-ARTHRITIS; INTERFERON-GAMMA; FACTOR-ALPHA; SUSCEPTIBILITY;
   DISEASE; INTERLEUKIN-1-BETA; ASSOCIATION; PROGRESSION
AB TNF-alpha may be associated with the etiopathogenesis of oral lichen planus (OLP), and it has been suggested that polymorphism of mannose-binding lectin (MBL) increases the in vitro production of TNF-alpha. The aim of the present study was to assess the relevance of genetic diversity of MBL in OLP. The study sample comprised 90 individuals, 45 OLP patients and 45 healthy volunteers. MBL-2 gene was amplified using real-time PCR. Frequency of A/A genotype was 55.6% in OLP and 53.3% in healthy volunteers. Likewise, A/0 heterozygote genotype was found in 42.2% and 35.6%; 2.2% and 11.1%, had the recessive 0/0 genotype respectively. Frequencies of the "A" and "0" alleles were 77% and 23% in the OLP group and 71.2% in control group. There were no statistically significant differences regarding genotype frequency (p=0.546) or allele frequency (p=0.497). In conclusion, no significant association was found between polymorphism of MBL-2 gene and OLP.
C1 [Carvalho, Alessandra de Albuquerque T.; Beder Ribeiro, Camila Maria; Leao, Jair Carneiro] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, BR-50670901 Recife, PE, Brazil.
   [Barkokebas, Andreza] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Eleuterio de Souza, Paulo Roberto] Univ Fed Rural Pernambuco, Dept Biol, Recife, PE, Brazil.
   [Gomez, Ricardo Santiago; Xavier, Guilherme Machado] Univ Fed Minas Gerais, Dept Clin Patol & Cirurgia Odontol, Belo Horizonte, MG, Brazil.
   [Crovella, Sergio] Univ Fed Pernambuco, Lab Imunopatol Keiso Asami, Recife, PE, Brazil.
   [Porter, Stephen Ross] Eastman Dent Inst, Oral Med Unit, Div Maxillofacial Diagnost Surg & Med Sci, London, England.
RP Leao, JC (corresponding author), Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Av Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
EM jleao@ufpe.br
RI Crovella, Sergio/K-5050-2016; Gomez, Ricardo Santiago/G-1976-2012; Leao,
   Jair Carneiro/AAL-6154-2020; Beder Ribeiro Girish Panjwani, Camila
   Maria/M-5453-2017
OI Crovella, Sergio/0000-0001-8493-1168; Gomez, Ricardo
   Santiago/0000-0001-8770-8009; Leao, Jair Carneiro/0000-0001-8303-2291;
   Souza, Paulo/0000-0002-9186-9849; Beder Ribeiro Girish Panjwani, Camila
   Maria/0000-0003-0203-3079; Porter, Stephen/0000-0002-3328-2759
CR Arraes LC, 2006, BRAZ J MED BIOL RES, V39, P719, DOI 10.1590/S0100-879X2006000600003
   Bidarra M, 2008, J ORAL PATHOL MED, V37, P582, DOI 10.1111/j.1600-0714.2008.00703.x
   Boniotto M, 2005, J MOL MED, V83, P308, DOI 10.1007/s00109-004-0623-3
   Boniotto M, 2002, IMMUNOGENETICS, V54, P596, DOI 10.1007/s00251-002-0504-2
   Carrozzo M, 2004, J INVEST DERMATOL, V122, P87, DOI 10.1046/j.0022-202X.2003.22108.x
   Chainani-Wu N, 2001, J AM DENT ASSOC, V132, P901, DOI 10.14219/jada.archive.2001.0302
   Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x
   Fayyazi A, 1999, ARCH DERMATOL RES, V291, P485, DOI 10.1007/s004030050442
   Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1
   Garred P, 1999, ARTHRITIS RHEUM, V42, P2145, DOI 10.1002/1529-0131(199910)42:10<2145::AID-ANR15>3.0.CO;2-#
   Garred P, 2000, J RHEUMATOL, V27, P26
   Graudal NA, 1998, J RHEUMATOL, V25, P629
   Grossmann SMC, 2006, ARQUIVOS ODONTOLOGIA, V42, P1
   Hladnik U, 2002, CLIN EXP MED, V2, P105, DOI 10.1007/s102380200014
   Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x
   Ip WK, 2000, ARTHRITIS RHEUM, V43, P1679, DOI 10.1002/1529-0131(200008)43:8<1679::AID-ANR3>3.0.CO;2-D
   Ismail Sumairi B, 2007, J Oral Sci, V49, P89
   Jack DL, 2001, IMMUNOL REV, V180, P86, DOI 10.1034/j.1600-065X.2001.1800108.x
   Jacobsen S, 2001, J RHEUMATOL, V28, P935
   Ji X, 2005, MOL IMMUNOL, V42, P145, DOI 10.1016/j.molimm.2004.06.015
   KARAGOUNI EE, 1994, J ORAL PATHOL MED, V23, P28, DOI 10.1111/j.1600-0714.1994.tb00250.x
   Leao J C, 1999, Rev Assoc Med Bras (1992), V45, P55, DOI 10.1590/S0104-42301999000100011
   Lee YH, 2005, ARTHRITIS RHEUM-US, V52, P3966, DOI 10.1002/art.21484
   Lipscombe R. J., 1992, Human Molecular Genetics, V1, P709, DOI 10.1093/hmg/1.9.709
   Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9
   MADSEN HO, 1995, J IMMUNOL, V155, P3013
   MADSEN HO, 1994, IMMUNOGENETICS, V40, P37, DOI 10.1007/BF00163962
   Madsen HO, 1998, LANCET, V352, P959, DOI 10.1016/S0140-6736(05)61513-9
   Manolache L, 2008, J EUR ACAD DERMATOL, V22, P437, DOI 10.1111/j.1468-3083.2007.02458.x
   Mendonca RMH, 2006, 14 C BRAS EST NAT RN, P279
   Messias-Reason I, 2008, CLIN EXP DERMATOL, V33, P495, DOI 10.1111/j.1365-2230.2008.02743.x
   Mullighan CG, 2000, ARTHRITIS RHEUM, V43, P2851, DOI 10.1002/1529-0131(200012)43:12<2851::AID-ANR28>3.0.CO;2-W
   Navas-Alfaro SE, 2003, J BRAS PATOL MED LAB, V39, P4
   Papapanou Panos N, 2002, Ann Periodontol, V7, P54, DOI 10.1902/annals.2002.7.1.54
   Pezelj-Ribaric S, 2004, MEDIAT INFLAMM, V13, P131, DOI 10.1080/09629350410001688530
   POCIOT F, 1992, EUR J CLIN INVEST, V22, P396, DOI 10.1111/j.1365-2362.1992.tb01480.x
   Sugerman PB, 2002, CRIT REV ORAL BIOL M, V13, P350, DOI 10.1177/154411130201300405
   Tsutsumi A, 2001, GENES IMMUN, V2, P99, DOI 10.1038/sj.gene.6363744
   Turner MW, 2003, MOL IMMUNOL, V40, P423, DOI 10.1016/S0161-5890(03)00155-X
   Villarreal J, 2001, RHEUMATOLOGY, V40, P1009, DOI 10.1093/rheumatology/40.9.1009
   Werth VP, 2002, J INVEST DERMATOL, V119, P1394, DOI 10.1046/j.1523-1747.2002.19608.x
   Worthley DL, 2006, WORLD J GASTROENTERO, V12, P6420, DOI 10.3748/wjg.v12.i40.6420
   Xavier GM, 2007, J ORAL PATHOL MED, V36, P476, DOI 10.1111/j.1600-0714.2007.00560.x
NR 43
TC 3
Z9 3
U1 0
U2 5
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1432-6981
EI 1436-3771
J9 CLIN ORAL INVEST
JI Clin. Oral Investig.
PD OCT
PY 2011
VL 15
IS 5
BP 699
EP 704
DI 10.1007/s00784-010-0428-4
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 846HU
UT WOS:000296888600014
PM 20499118
DA 2020-11-30
ER

PT J
AU Pernambuco, LD
   da Silva, HJ
   Nascimento, GKBO
   da Silva, EGF
   Balata, PMM
   Santos, VD
   Leao, JC
AF Pernambuco, Leandro de Araujo
   da Silva, Hilton Justino
   Bezerra Oliveira Nascimento, Gerlane Karla
   Fernandes da Silva, Elthon Gomes
   Mendes Balata, Patricia Maria
   Santos, Veridiana da Silva
   Leao, Jair Carneiro
TI Electrical activity of the masseter during swallowing after total
   laryngectomy
SO BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY
LA English
DT Article
DE electromyography; laryngeal neoplasms; masseter muscle; swallowing;
   swallowing disorders
ID MASTICATORY MUSCLE-ACTIVITY; TEMPOROMANDIBULAR DISORDERS;
   ELECTROMYOGRAPHIC ACTIVITY; DENTAL STATUS; COORDINATION; OCCLUSION;
   POSITION
AB Total laryngectomy is a surgical procedure that can change swallowing biomechanics, including muscle activity of the masseter; this muscle stabilizes the mandible.
   Aim: To characterize the electrical activity of the masseter muscle during swallowing after total laryngectomy. Series study.
   Material and Methods: An electromyographic evaluation of swallowing was carried out; three different volumes of water (14.5ml, 20ml and 100ml) were swallowed, and there was a rest condition. The electromyographic signal was normalized by Maximum Resisted Voluntary Activity - considered as 100% of electrical activity of muscles. All other values were calculated as a percentage of this parameter.
   Results: There is moderate electrical activity of the masseter during swallowing with higher averages on the left. There was no difference between swallowing 14.5ml or 20ml. Natural swallowing of 100ml had the lowest average. Electromyographic signals were recorded at rest on both sides, indicating the existence of electric activity in this situation.
   Conclusion: Patients submitted to total laryngectomy present electrical activity of the masseter muscles during swallowing and at rest. This activity is influenced by the volume of swallowed liquid, and showed significant differences among the tasks.
C1 [Pernambuco, Leandro de Araujo; da Silva, Hilton Justino; Bezerra Oliveira Nascimento, Gerlane Karla; Fernandes da Silva, Elthon Gomes; Mendes Balata, Patricia Maria] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Pernambuco, Leandro de Araujo] Univ Fed Rio Grande do Norte, BR-59072970 Natal, RN, Brazil.
   [Bezerra Oliveira Nascimento, Gerlane Karla] State Hlth Off Paraiba, Joao Pessoa, Paraiba, Brazil.
   [Mendes Balata, Patricia Maria] Pernambuco State Govt, Human Resources Inst, Recife, PE, Brazil.
   [Santos, Veridiana da Silva] Pernambuco Rural Fed Univ, Serra Talhada Acad Unit, Recife, PE, Brazil.
   [Leao, Jair Carneiro] Univ London, London WC1E 7HU, England.
   [Leao, Jair Carneiro] Univ Fed Pernambuco, Clin & Prevent Dent Dept, Recife, PE, Brazil.
   Univ Fed Pernambuco, Grad Course Hlth Sci, Recife, PE, Brazil.
RP Pernambuco, LD (corresponding author), Rua Dom Jose Tomaz,1130 Apt 1504, BR-59022250 Tirol Natal, PE, Brazil.
RI Leao, Jair Carneiro/AAL-6154-2020; Pernambuco, Leandro/A-8785-2015;
   SILVA, Hilton J/O-8223-2015
OI Leao, Jair Carneiro/0000-0001-8303-2291; Pernambuco,
   Leandro/0000-0001-6246-9769; 
CR Alajbeg IZ, 2006, J ORAL REHABIL, V33, P94, DOI 10.1111/j.1365-2842.2006.01541.x
   Alajbeg IZ, 2005, INT J PROSTHODONT, V18, P333
   Alarcon JA, 2000, AM J ORTHOD DENTOFAC, V118, P328, DOI 10.1067/mod.2000.103252
   Asai T, 2003, J OSAKA DENT U, V37, P135
   BALFE DM, 1982, RADIOLOGY, V143, P501, DOI 10.1148/radiology.143.2.7071354
   Behlau M, 2005, VOZ LIVRO ESPECIALIS, VII, P213
   Biasotto Daiana Cristina, 2005, J. Appl. Oral Sci., V13, P424, DOI 10.1590/S1678-77572005000400020
   Cecilio FA, 2010, J ORAL REHABIL, V37, P248, DOI 10.1111/j.1365-2842.2010.02051.x
   Charbonneau I, 2005, J SPEECH LANG HEAR R, V48, P34, DOI 10.1044/1092-4388(2005/004)
   CHRISTENSEN LV, 1985, J ORAL REHABIL, V12, P429, DOI 10.1111/j.1365-2842.1985.tb01548.x
   Cooper M.H, 2009, NEUROLOGIC DISORDERS, P3
   Corbin-Lewis K, 2005, CLIN ANATOMY PHYSL S
   Danker H, 2010, EUR ARCH OTO-RHINO-L, V267, P593, DOI 10.1007/s00405-009-1087-4
   Ding RY, 2003, J SPEECH LANG HEAR R, V46, P977, DOI 10.1044/1092-4388(2003/076)
   Ding RY, 2002, DYSPHAGIA, V17, P1, DOI 10.1007/s00455-001-0095-3
   Ertekin C, 2001, DYSPHAGIA, V16, P40, DOI 10.1007/s004550000041
   Farella M, 2008, PHYSIOL MEAS, V29, P1397, DOI 10.1088/0967-3334/29/12/004
   Ferrario VF, 2006, J ORAL REHABIL, V33, P341, DOI 10.1111/j.1365-2842.2005.01558.x
   FERRARIO VF, 1993, J ORAL REHABIL, V20, P271, DOI 10.1111/j.1365-2842.1993.tb01609.x
   Ferrario VF, 2007, MANUAL THER, V12, P372, DOI 10.1016/j.math.2006.07.013
   GAY T, 1994, LARYNGOSCOPE, V104, P341
   Goiato Marcelo Coelho, 2007, Acta Odontol Latinoam, V20, P67
   Hiraoka K, 2004, J ORAL REHABIL, V31, P963, DOI 10.1111/j.1365-2842.2004.01325.x
   Hunter EJ, 2007, J APPL PHYSIOL, V103, P206, DOI 10.1152/japplphysiol.00892.2006
   Inagaki D, 2009, J ORAL REHABIL, V36, P703, DOI 10.1111/j.1365-2842.2009.01994.x
   JUNG TTK, 1980, OTOLARYNG HEAD NECK, V88, P25, DOI 10.1177/019459988008800109
   LAIRD WRE, 1974, J DENT RES, V53, P127
   Lazarus CL, 2009, CURR OPIN OTOLARYNGO, V17, P172, DOI 10.1097/MOO.0b013e32832af12f
   Maclean J, 2008, J LARYNGOL OTOL, V122, P728, DOI 10.1017/S0022215108002119
   Maclean J, 2009, DYSPHAGIA, V24, P314, DOI 10.1007/s00455-009-9209-0
   Maclean J, 2009, DYSPHAGIA, V24, P172, DOI 10.1007/s00455-008-9189-5
   Moller E, 1966, Acta Physiol Scand Suppl, V280, P1
   Monaco A, 2008, BMC ORAL HLTH
   Moraes KJR, 2010, BRAZ J ORAL SCI, V9, P196
   Pernambuco LA, 2010, 39 ANN CONV INT ASS
   Pillon Jackeline, 2004, Sao Paulo Med. J., V122, P195, DOI 10.1590/S1516-31802004000500003
   Platteaux N, 2010, DYSPHAGIA, V25, P139, DOI 10.1007/s00455-009-9247-7
   Sabashi K, 2009, CRANIO, V27, P39, DOI 10.1179/crn.2009.007
   Serrao Graziano, 2003, Prog Orthod, V4, P45, DOI 10.1034/j.1600-9975.2002.02031.x
   Sonnesen L, 2005, EUR J ORTHODONT, V27, P58, DOI 10.1093/ejo/cjh069
   Tallgren A, 1995, Int J Prosthodont, V8, P467
   Vaiman M, 2007, HEAD FACE MED, P3
   Vaiman M, 2009, HEAD FACE MED, P5
   Ward EC, 2002, ARCH OTOLARYNGOL, V128, P181, DOI 10.1001/archotol.128.2.181
   Zuccolotto MCC, 2007, GERODONTOLOGY, V24, P105, DOI 10.1111/j.1741-2358.2007.00152.x
NR 45
TC 3
Z9 5
U1 0
U2 2
PU ASSOC BRASILEIRA OTORRINOLARINGOLOGIA & CIRURGIA CERVICOFACIAL
PI SAO PAULO
PA AV INDIANOPOLOS 740, MOEMA, SAO PAULO, SP 04062-001, BRAZIL
SN 1808-8694
EI 1808-8686
J9 BRAZ J OTORHINOLAR
JI Braz. J. Otorhinolaryngol.
PD SEP-OCT
PY 2011
VL 77
IS 5
BP 645
EP 650
PG 6
WC Otorhinolaryngology
SC Otorhinolaryngology
GA 837UM
UT WOS:000296229700018
PM 22030975
OA DOAJ Gold
DA 2020-11-30
ER

PT J
AU Ribeiro, CMB
   Gueiros, LAM
   Leon, JE
   Lima, MDAE
   de Almeida, OP
   Leao, JC
AF Ribeiro, C. M. B.
   Gueiros, L. A. M.
   Leon, J. E.
   do Carmo Abreu e Lima, M.
   de Almeida, O. P.
   Leao, J. C.
TI Oral squamous cell carcinoma in a 7-year-old Brazilian boy
SO INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
ID XERODERMA PIGMENTOSUM; CHILDREN; TONGUE; YOUNG
AB Squamous cell carcinomas (SCCs) are amongst the commonest malignancies in adults but in paediatric patients are exceptionally rare, particularly those involving the oral mucosa. The aim of the present report is to describe the features of a gingival well-differentiated SCC in a 7-year-old Brazilian boy. Immunostaining for p53, Ki-67 and Mcm2 showed increased cellular proliferation compared with normal epithelium. In situ hybridization failed to identify human papilloma virus infection. Correct diagnosis of well-differentiated squamous carcinoma can be difficult in children and differentiation from pseudoepitheliomatous hyperplasia is essential to establish proper treatment.
C1 [Leao, J. C.] Univ Fed Pernambuco, UFPE, Programa Pos Grad Odontol, Dept Clin & Odontol Prevent, BR-50670901 Recife, PE, Brazil.
   [Ribeiro, C. M. B.; Leon, J. E.; de Almeida, O. P.] Univ Estadual Campinas, Fac Odontol Piracicaba, Dept Diagnost Oral Patol, Piracicaba, Brazil.
   [do Carmo Abreu e Lima, M.] Hosp Canc Pernambuco, Dept Patol, Recife, PE, Brazil.
RP Leao, JC (corresponding author), Univ Fed Pernambuco, UFPE, Programa Pos Grad Odontol, Dept Clin & Odontol Prevent, Av Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
EM jleao@ufpe.br
RI JE, Leon/D-7511-2013; Gueiros, Luiz Alcino/B-6429-2015; Leao, Jair
   Carneiro/AAL-6154-2020; Beder Ribeiro Girish Panjwani, Camila
   Maria/M-5453-2017
OI JE, Leon/0000-0002-9668-5870; Gueiros, Luiz Alcino/0000-0003-4979-4318;
   Leao, Jair Carneiro/0000-0001-8303-2291; Beder Ribeiro Girish Panjwani,
   Camila Maria/0000-0003-0203-3079
FU Coordenacao Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES
FX The paper was supported by Coordenacao Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES), which granted LAG a post-doe
   scholarship.
CR Ajayi OF, 2007, INT J PEDIATR OTORHI, V71, P959, DOI 10.1016/j.ijporl.2007.03.008
   Bill TJ, 2001, ORAL SURG ORAL MED O, V91, P682, DOI 10.1067/moe.2001.115029
   Binahmed A, 2007, J CAN DENT ASSOC, V73, P715
   Carvalho Marcos Brasilino De, 1998, Medical and Pediatric Oncology, V31, P96
   Chowa CW, 2007, J PEDIATR SURG, V42, P2035, DOI 10.1016/j.jpedsurg.2007.08.025
   EARLE AS, 1988, ANN PLAS SURG, V20, P148, DOI 10.1097/00000637-198802000-00012
   KEUKENS F, 1989, ACTA DERM-VENEREOL, V69, P530
   Mehanna P, 2009, BRIT J ORAL MAX SURG, V47, P148, DOI 10.1016/j.bjoms.2008.07.198
   Prime SS, 2001, ORAL ONCOL, V37, P1, DOI 10.1016/S1368-8375(00)00055-5
   Siriwardena BSMS, 2007, J ORAL PATHOL MED, V36, P357, DOI 10.1111/j.1600-0714.2007.00548.x
   Stolk-Liefferink SAH, 2008, INT J PEDIATR OTORHI, V72, P127, DOI 10.1016/j.ijporl.2007.09.006
   Thompson L, 1999, ORAL SURG ORAL MED O, V88, P204
   YAGI K, 1981, INT J ORAL MAXILLOF, V10, P73, DOI 10.1016/S0300-9785(81)80011-7
   Zarovnaya E, 2005, ARCH PATHOL LAB MED, V129, P1032
NR 14
TC 6
Z9 7
U1 0
U2 3
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0901-5027
J9 INT J ORAL MAX SURG
JI Int. J. Oral Maxillofac. Surg.
PD SEP
PY 2011
VL 40
IS 9
BP 994
EP 997
DI 10.1016/j.ijom.2011.02.035
PG 4
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 820VZ
UT WOS:000294935500020
PM 21550206
DA 2020-11-30
ER

PT J
AU Leao, JC
   Issa, JPM
   Pitol, DL
   Rizzi, EC
   Dias, FJ
   Siessere, S
   Regalo, SCH
   Iyomasa, MM
AF Leao, Juliane Caroline
   Mardegan Issa, Joao Paulo
   Pitol, Dimitrius Leonardo
   Rizzi, Ellen Camargo
   Dias, Fernando Jose
   Siessere, Selma
   Hallak Regalo, Simone Cecilio
   Iyomasa, Mamie Mizusaki
TI Histomorphological and Angiogenic Analyzes of Skin Epithelium After Low
   Laser Irradiation in Hairless Mice
SO ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY
   BIOLOGY
LA English
DT Article
DE laser; skin; epithelium; light microscopy; endothelial growth factor
ID TISSUE-REPAIR; THERAPY; LEVEL; MUSCLE; INCREASES; CELLS; NM;
   PROLIFERATION; EXPRESSION; VIABILITY
AB It is not well-understood how low-laser therapy affects the skin of the applied area. This study analyzes skin of the masseteric region of mice from the HRS/J strain after three different application regimens (three, six or ten applications per regimen) of low intensity laser at 20 J/cm(2) and 40 mW for 20 sec on alternate days. Three experimental groups according to the number of laser applications (three, six or ten) and three control groups (N = 5 animals for each group) were used. On the third day after the last irradiation, all animals were sacrificed and the skin was removed and processed to analyze the relative occupation of the test area by each epithelial layer and the aspects of neovascularization. Data were submitted to statistical analyzes. The irradiated groups compared to their respective controls at each period of time, showed no significant difference in relative occupation of the test area by the layers and epithelium areas for three and six applications, but for ten applications, a significant decrease (P < 0.05) in the basal and granulosum layers, and epithelium areas were found. From the comparisons of the three irradiated groups together, the group with six laser applications showed statistical difference (P < 0.05) in total epithelium and on the layers. Vascular endothelial growth factor (VEGF) and VEGFR-2 immunoreactivities were similar for the control and irradiated groups. Results suggested a biostimulatory effect with low risks associated with superficial tissues, when the treatment aims the deeper layers after six applications. Anat Rec, 294: 1592-1600, 2011. (C) 2011 Wiley-Liss, Inc.
C1 [Iyomasa, Mamie Mizusaki] Univ Sao Paulo, Fac Odontol Ribeirao Preto, Dept Morfol Estomatol & Fisiol, Sch Dent Ribeirao Preto, BR-14040904 Ribeirao Preto, SP, Brazil.
RP Iyomasa, MM (corresponding author), Univ Sao Paulo, Fac Odontol Ribeirao Preto, Dept Morfol Estomatol & Fisiol, Sch Dent Ribeirao Preto, Ave Cafe S-N, BR-14040904 Ribeirao Preto, SP, Brazil.
EM mamieiyo@forp.usp.br
RI Siessere, Selma/B-7943-2012; Issa, Joao Paulo/A-2505-2011; Iyomasa,
   Mamie Mizusaki/H-5005-2012; Dias, Fernando Jose/AAP-7420-2020; Pitol,
   Dimitrius Loenardo/B-5524-2016; Regalo, Simone C H/B-8097-2012; Dias,
   Fernando Jose/D-8228-2014
OI Siessere, Selma/0000-0001-9756-3771; Issa, Joao
   Paulo/0000-0002-1056-0795; Iyomasa, Mamie Mizusaki/0000-0002-4001-6440;
   Pitol, Dimitrius Loenardo/0000-0001-5943-2359; Cecilio Hallak Regalo,
   Simone/0000-0003-4110-8299; Dias, Fernando Jose/0000-0001-9945-9185
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2007/54385-0]
FX Grant sponsor: FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo); Grant number: 2007/54385-0.
CR Bagazgoitia L, 2008, OPHTHAL PLAST RECONS, V24, P488, DOI 10.1097/IOP.0b013e31818bed57
   BAIBEKOV I M, 1988, Byulleten' Eksperimental'noi Biologii i Meditsiny, V105, P750
   Bossini PS, 2009, LASER MED SCI, V24, P209, DOI 10.1007/s10103-008-0551-5
   Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x
   Dai TH, 2003, LASER SURG MED, V33, P16, DOI 10.1002/lsm.10183
   de Medeiros JS, 2005, PHOTOMED LASER SURG, V23, P373, DOI 10.1089/pho.2005.23.373
   Dudelzak Jacob, 2009, J Drugs Dermatol, V8, P227
   Emshoff R, 2008, ORAL SURG ORAL MED O, V105, P452, DOI 10.1016/j.tripleo.2007.09.012
   Fricton James R, 2004, Curr Pain Headache Rep, V8, P355, DOI 10.1007/s11916-996-0008-0
   Gal P, 2006, PHOTOMED LASER SURG, V24, P480, DOI 10.1089/pho.2006.24.480
   Gao XJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-4
   GENOVESE WJ, 2000, LASER BAIXA INTENSID, P130
   Grossman N, 1998, LASER SURG MED, V22, P212, DOI 10.1002/(SICI)1096-9101(1998)22:4<212::AID-LSM5>3.0.CO;2-S
   HAAS AF, 1990, J INVEST DERMATOL, V94, P822, DOI 10.1111/1523-1747.ep12874679
   Hawkins DH, 2006, LASER SURG MED, V38, P74, DOI 10.1002/lsm.20271
   Hintringer T, 2009, HANDCHIR MIKROCHIR P, V41, P83, DOI 10.1055/s-2008-1038775
   Hudlicka O, 2009, J VASC RES, V46, P504, DOI 10.1159/000226127
   Iyomasa DM, 2009, MICRON, V40, P413, DOI 10.1016/j.micron.2009.02.002
   KARU T, 1995, J PHOTOCH PHOTOBIO B, V27, P219, DOI 10.1016/1011-1344(94)07078-3
   Karu TI, 2008, PHOTOCHEM PHOTOBIOL, V84, P1091, DOI 10.1111/j.1751-1097.2008.00394.x
   Kierszenbaum AL, 2008, DEV DYNAM, V237, P3882, DOI 10.1002/dvdy.21789
   Lopes-Martins RAB, 2006, J APPL PHYSIOL, V101, P283, DOI 10.1152/japplphysiol.01318.2005
   MACIEL VH, 2006, PROTOCOLOS CLIN APLI, P19
   MANDARIMDELACER.CA, 1995, METODOS QUANTITATIVO, P131
   Medrado ARAP, 2003, LASER SURG MED, V32, P239, DOI 10.1002/lsm.10126
   Nicola JH, 2002, J CLIN LASER MED SUR, V20, P307, DOI 10.1089/104454702320901080
   Nunez SC, 2006, PHOTOMED LASER SURG, V24, P45, DOI 10.1089/pho.2006.24.45
   Orringer JS, 2008, ARCH DERMATOL, V144, P1296, DOI 10.1001/archderm.144.10.1296
   Pikkula BM, 2005, LASER SURG MED, V36, P117, DOI 10.1002/lsm.20147
   PONTINEN P, 1992, LOW LEVEL LASER THER, P99
   Posten W, 2005, DERMATOL SURG, V31, P334, DOI 10.1097/00042728-200503000-00016
   Prado Rodrigo Paschoal, 2006, Acta Cir. Bras., V21, P258, DOI 10.1590/S0102-86502006000400013
   Prado RP, 2009, PHOTOMED LASER SURG, V27, P411, DOI 10.1089/pho.2008.2320
   Reis SRA, 2008, PHOTOMED LASER SURG, V26, P307, DOI 10.1089/pho.2007.2151
   Rocha AM, 2009, PHOTOMED LASER SURG, V27, P303, DOI 10.1089/pho.2008.2277
   ROOD PA, 1992, J INVEST DERMATOL, V99, P445, DOI 10.1111/1523-1747.ep12616145
   Shibuya Masaubmi, 2006, Angiogenesis, V9, P225, DOI 10.1007/s10456-006-9055-8
   Winstanley DA, 2008, SEMIN CUTAN MED SURG, V27, P301, DOI 10.1016/j.sder.2008.10.001
   Wu EC, 2008, ARCH FACIAL PLAST S, V10, P381, DOI 10.1001/archfaci.10.6.381
NR 39
TC 4
Z9 4
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-8486
EI 1932-8494
J9 ANAT REC
JI Anat. Rec.
PD SEP
PY 2011
VL 294
IS 9
BP 1592
EP 1600
DI 10.1002/ar.21451
PG 9
WC Anatomy & Morphology
SC Anatomy & Morphology
GA 811AA
UT WOS:000294172200017
PM 21809465
DA 2020-11-30
ER

PT J
AU Pinheiro, RD
   de Franca, TRT
   Ferreira, DD
   Ribeiro, CMB
   Leao, JC
   Castro, GF
AF Pinheiro, Raquel dos Santos
   Tenorio de Franca, Talita Ribeiro
   Ferreira, Dennis de Carvalho
   Beder Ribeiro, Camila Maria
   Leao, Jair Carneiro
   Castro, Gloria Fernanda
TI Human papillomavirus in the oral cavity of children
SO JOURNAL OF ORAL PATHOLOGY & MEDICINE
LA English
DT Review
DE children; human papillomavirus
ID ACTIVE ANTIRETROVIRAL THERAPY; SQUAMOUS-CELL CARCINOMAS; HIGH
   PREVALENCE; CERVICAL-CANCER; HPV; VIRUS; DNA; TYPE-16; INFECTIONS;
   PARENTS
AB Objective:
   The aim of this literature review was to identify studies conducted on the oral Human papillomavirus (HPV) infection in children.
   Methods:
   An electronic database search was performed using the terms 'oral HPV' and 'children'. The studies on the prevalence of oral HPV in children worldwide, descriptive studies, case reports, studies on the association of oral HPV and risk factors and transmission of HPV were included.
   Conclusion:
   The presence of HPV in oral mucosa of children should be investigated in virtue of the various forms of transmission, and the possibility of sexual abuse eliminated, and also of its possible relation with oral carcinoma pathogenesis in children.
C1 [Pinheiro, Raquel dos Santos] Fedral Univ Rio de Janeiro, BR-21941590 Rio De Janeiro, Brazil.
   [Leao, Jair Carneiro] Univ Fed Pernambuco, Dept Clin Odontol Prevent, Recife, PE, Brazil.
   [Ferreira, Dennis de Carvalho; Castro, Gloria Fernanda] Univ Fed Rio de Janeiro, BR-21941 Rio De Janeiro, Brazil.
   [Beder Ribeiro, Camila Maria] Univ Estadual Campinas, Campinas, SP, Brazil.
RP Pinheiro, RD (corresponding author), Fedral Univ Rio de Janeiro, Brigadeiro Trompowsky Ave, BR-21941590 Rio De Janeiro, Brazil.
EM raquelodontouff@click21.com.br
RI Leao, Jair Carneiro/AAL-6154-2020; Ferreira, Dennis/AAC-7407-2020;
   Castro, Gloria/Y-5592-2019; Beder Ribeiro Girish Panjwani, Camila
   Maria/M-5453-2017
OI Leao, Jair Carneiro/0000-0001-8303-2291; Castro,
   Gloria/0000-0002-8137-0307; Beder Ribeiro Girish Panjwani, Camila
   Maria/0000-0003-0203-3079
CR Babich SB, 2003, J AM DENT ASSOC, V134, P331, DOI 10.14219/jada.archive.2003.0162
   BALARAM P, 1995, INT J CANCER, V61, P450, DOI 10.1002/ijc.2910610403
   BOSCH FX, 1993, CANCER EPIDEM BIOMAR, V2, P415
   Bouda M, 2000, MODERN PATHOL, V13, P644, DOI 10.1038/modpathol.3880113
   BRANDWEIN M, 1994, MODERN PATHOL, V7, P720
   Castro Therezita M.P.G., 2004, Rev. Bras. Otorrinolaringol., V70, P546, DOI 10.1590/S0034-72992004000400017
   Chowa CW, 2007, J PEDIATR SURG, V42, P2035, DOI 10.1016/j.jpedsurg.2007.08.025
   de Villiers EM, 2005, BREAST CANCER RES, V7, pR1, DOI 10.1186/bcr940
   ELUFNETO J, 1994, BRIT J CANCER, V69, P114, DOI 10.1038/bjc.1994.18
   Finnen RL, 2003, J VIROL, V77, P4818, DOI 10.1128/JVI.77.8.4818-4826.2003
   Giovannelli L, 2002, J INFECT DIS, V185, P833, DOI 10.1086/339193
   GUTIERREZ EIC, 2001, REV SALUD PUBLICA NU, V2, P1
   Ha PK, 2004, CRIT REV ORAL BIOL M, V15, P188, DOI 10.1177/154411130401500402
   JEFTHA AD, 2003, ANN M EXH AADR SAN A
   Kaufmann AM, 2002, CLIN CANCER RES, V8, P3676
   King MD, 2002, CLIN INFECT DIS, V34, P641, DOI 10.1086/338637
   Kojima A, 2003, ORAL ONCOL, V39, P821, DOI 10.1016/S1368-8375(03)00100-3
   Kojima A, 2002, ORAL ONCOL, V38, P591, DOI 10.1016/S1368-8375(01)00112-9
   Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551
   Kui Liu Lai, 2003, Pediatr Dent, V25, P149
   Lehtinen M, 2006, INT J CANCER, V119, P2612, DOI 10.1002/ijc.22131
   Mant C, 2003, J MED VIROL, V71, P593, DOI 10.1002/jmv.10529
   Medeiros Lidia Rosi, 2005, Cad. Saúde Pública, V21, P1006, DOI 10.1590/S0102-311X2005000400003
   Nicolau SM, 2005, UROLOGY, V65, P251, DOI 10.1016/j.urology.2004.09.031
   Nielsen H, 1996, ORAL ONCOL, V32B, P264, DOI 10.1016/0964-1955(96)00011-5
   OLIVEIRA MC, 2003, REV BRASILEIRA PATOL, V2, P34
   Park Jae-Gahb, 2002, Gan To Kagaku Ryoho, V29 Suppl 1, P89
   Peitsaro P, 2002, J CLIN MICROBIOL, V40, P886, DOI 10.1128/JCM.40.3.886-891.2002
   PINHEIRO R, 2009, IADR AADR CADR 87 GE
   Pinheiro RD, 2009, J ORAL PATHOL MED, V38, P613, DOI 10.1111/j.1600-0714.2009.00789.x
   Praetorius F, 1997, CLIN DERMATOL, V15, P399, DOI 10.1016/S0738-081X(96)00157-5
   Reichman TW, 2002, MOL CELL BIOL, V22, P343, DOI 10.1128/MCB.22.1.343-356.2002
   Rice PS, 2000, J MED VIROL, V61, P70, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;70::AID-JMV11&gt;3.0.CO;2-Y
   Rintala MAM, 2005, J CLIN MICROBIOL, V43, P376, DOI 10.1128/JCM.43.1.376-381.2005
   Rivero Elena Riet Correa, 2006, Braz. oral res., V20, P21, DOI 10.1590/S1806-83242006000100005
   ROMAN A, 1986, J INFECT DIS, V153, P855, DOI 10.1093/infdis/153.5.855
   Rombaldi RL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-106
   Sarkola M, 2008, PEDIATR INFECT DIS J, V27, P557, DOI 10.1097/INF.0b013e318169ef47
   Scully C, 2002, ORAL ONCOL, V38, P227, DOI 10.1016/S1368-8375(01)00098-7
   Silva AMTC, 2003, REV SOC BRAS CANCERO, V49, P167
   Smith E. M., 2010, Infectious Diseases in Obstetrics and Gynecology, V2010, P326369, DOI 10.1155/2010/326369
   Smith EM, 2007, PEDIATR INFECT DIS J, V26, P836, DOI 10.1097/INF.0b013e318124a4ae
   Smith EM, 2004, SEX TRANSM DIS, V31, P57, DOI 10.1097/01.OLQ.0000105327.40288.DB
   Sonnex C, 1999, SEX TRANSM INFECT, V75, P317, DOI 10.1136/sti.75.5.317
   Stubenrauch F, 1999, SEMIN CANCER BIOL, V9, P379, DOI 10.1006/scbi.1999.0141
   Summersgill KF, 2001, ORAL SURG ORAL MED O, V91, P62, DOI 10.1067/moe.2001.108797
   SYRJANEN KJ, 1983, BRIT J ORAL SURG, V21, P147, DOI 10.1016/0007-117X(83)90060-4
   Terai M, 2001, J GEN VIROL, V82, P2035, DOI 10.1099/0022-1317-82-9-2035
   Terai M, 1999, ORAL MICROBIOL IMMUN, V14, P201, DOI 10.1034/j.1399-302X.1999.140401.x
   Terai M, 2001, VIROLOGY, V279, P109, DOI 10.1006/viro.2000.0716
   Teral M, 1999, J ORAL PATHOL MED, V28, P137
   Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F
   Yamamoto Luzia Setuko Umeda, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P189, DOI 10.1590/S0036-46652004000400003
   zurHausen H, 1996, BBA-REV CANCER, V1288, pF55
NR 54
TC 11
Z9 11
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0904-2512
EI 1600-0714
J9 J ORAL PATHOL MED
JI J. Oral Pathol. Med.
PD FEB
PY 2011
VL 40
IS 2
BP 121
EP 126
DI 10.1111/j.1600-0714.2010.00954.x
PG 6
WC Dentistry, Oral Surgery & Medicine; Pathology
SC Dentistry, Oral Surgery & Medicine; Pathology
GA 712QA
UT WOS:000286680100001
PM 20969625
DA 2020-11-30
ER

PT J
AU de Franca, TRT
   de Araujo, RA
   Ribeiro, CMB
   Leao, JC
AF de Franca, Talita Ribeiro T.
   de Araujo, Rachel Alcoforado
   Ribeiro, Camila Maria B.
   Leao, Jair Carneiro
TI Salivary shedding of HHV-8 in people infected or not by human
   immunodeficiency virus 1
SO JOURNAL OF ORAL PATHOLOGY & MEDICINE
LA English
DT Article
DE human herpesvirus 8; Kaposi's sarcoma herpesvirus; Kaposi's sarcoma
ID SARCOMA-ASSOCIATED HERPESVIRUS; EPSTEIN-BARR-VIRUS; MULTIPLEX PCR ASSAY;
   MOTHER-TO-CHILD; KAPOSIS-SARCOMA; HUMAN-HERPESVIRUS-8 INFECTION; GENITAL
   SECRETIONS; ORAL-MUCOSA; DRUG-USERS; TRANSMISSION
AB Background:
   Human herpesvirus 8 (HHV-8), the main agent involved in the etiopathogenesis of Kaposi's sarcoma (KS) is primarily transmitted through sexual contact. The potential of saliva as a source of HHV-8 transmission remains unclear. The purpose of this work was to determine the frequency of HHV-8 detection in saliva of HIV-infected individuals and their family contacts.
   Methods:
   The study group comprised 210 individuals. Group 1: 35 HIV-infected patients; group 2: 35 non-HIV individuals; group 3: two siblings for each patient from group 1; group 4: two siblings for each individual from group 2. Each participant had non-stimulated whole saliva collected and DNA was extracted. HHV-8-DNA amplification from ORF-26 was performed using a nested PCR protocol.
   Results:
   HHV-8 DNA was detected in saliva from 14/35 (40%) HIV-infected individuals and 4/35 (11.4%) non-HIV-infected individuals (OR = 5.16, CI [1.49-17.88], P = 0.006). It was also possible to amplify HHV-8 DNA in 11/70 (15.7%) relatives of HIV-infected participants and 4/70 (5.71%) relatives of non-HIV-infected individuals(P = 0.041). Among the 14 group 1 patients with HHV-8 DNA detected in saliva, eight (57.1%) had a household member in whom HHV-8 DNA was also amplified (OR = 8, CI [1.58-40.29] P = 0.007).
   Conclusions:
   HHV-8 DNA is frequently found in saliva. HIV-infected individuals showed a higher frequency of detection of HHV-8 than healthy controls. HHV-8 DNA was significantly amplified in saliva of household members of HIV/HHV-8 co-infected individuals.
C1 [Leao, Jair Carneiro] Univ Fed Pernambuco, Programa Posgrad Odontol, Oral Med Unit, Dept Clin & Odontol Prevent Recife, BR-50670901 Recife, PE, Brazil.
RP Leao, JC (corresponding author), Univ Fed Pernambuco, Programa Posgrad Odontol, Oral Med Unit, Dept Clin & Odontol Prevent Recife, Av Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
EM jleao@ufpe.br
RI Leao, Jair Carneiro/AAL-6154-2020; Beder Ribeiro Girish Panjwani, Camila
   Maria/M-5453-2017
OI Leao, Jair Carneiro/0000-0001-8303-2291; Beder Ribeiro Girish Panjwani,
   Camila Maria/0000-0003-0203-3079
FU National Counsel of Technological and Scientific Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX The authors are thankful to National Counsel of Technological and
   Scientific Development (CNPq) for the financial support of this work and
   to the staff of CEARGS for their technical support, cooperation and
   assistance.
CR Adjei AA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-33
   Al-Otaibi LM, 2007, J MED VIROL, V79, P1357, DOI 10.1002/jmv.20929
   Ammatuna P, 1998, J ORAL PATHOL MED, V27, P420
   Andreoni M, 1999, J NATL CANCER I, V91, P465, DOI 10.1093/jnci/91.5.465
   Atkinson J, 2003, J INFECT DIS, V187, P974, DOI 10.1086/368332
   Barozzi P, 2003, NAT MED, V9, P554, DOI 10.1038/nm862
   Belec L, 1998, AIDS, V12, P674
   Boshoff C, 2001, PHILOS T R SOC B, V356, P517, DOI 10.1098/rstb.2000.0778
   Brayfield BP, 2004, J INFECT DIS, V189, P2260, DOI 10.1086/421119
   Caselli E, 2003, INTERVIROLOGY, V46, P141, DOI 10.1159/000071454
   Caterino-De-Araujo A, 2007, BRAZ J INFECT DIS, V11, P9, DOI 10.1590/S1413-86702007000100004
   Caterino-de-Araujo Adele, 2003, Braz J Infect Dis, V7, P395, DOI 10.1590/S1413-86702003000600007
   Clementi M, 2000, J CLIN MICROBIOL, V38, P2030
   Cook RD, 2002, J GEN VIROL, V83, P1613, DOI 10.1099/0022-1317-83-7-1613
   Cunha AMG, 2005, J GEN VIROL, V86, P2433, DOI 10.1099/vir.0.81087-0
   de Souza VAUF, 2007, J INFECT DIS, V196, P844, DOI 10.1086/520549
   Dedicoat M, 2004, J INFECT DIS, V190, P1068, DOI 10.1086/423326
   Druce J, 2002, J CLIN MICROBIOL, V40, P1728, DOI 10.1128/JCM.40.5.1728-1732.2002
   Edelman DC, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-78
   ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0
   Gomes PS, 2003, THESIS U FEDERAL SAO
   Gulley ML, 2001, J MOL DIAGN, V3, P1, DOI 10.1016/S1525-1578(10)60642-3
   Hladik W, 2006, NEW ENGL J MED, V355, P1331, DOI 10.1056/NEJMoa055009
   Horl Matthias P, 2002, Curr Opin Urol, V12, P115, DOI 10.1097/00042307-200203000-00006
   Johnson G, 2000, J CLIN MICROBIOL, V38, P3274, DOI 10.1128/JCM.38.9.3274-3279.2000
   LaDuca JR, 1998, J INFECT DIS, V178, P1610, DOI 10.1086/314514
   Lampinen TM, 2000, J INFECT DIS, V181, P1785, DOI 10.1086/315426
   Leao JC, 1999, THESIS EASTMAN DENT
   Lisco A, 2006, J CLIN MICROBIOL, V44, P3863, DOI 10.1128/JCM.00791-06
   Lucht E, 1998, CLIN INFECT DIS, V27, P137, DOI 10.1086/514604
   Machado DM, 2005, BRAZ J MED BIOL RES, V38, P237, DOI 10.1590/S0100-879X2005000200012
   Magri M, 2009, NDT PLUS, V2, P93
   Mantina H, 2001, INT J CANCER, V94, P749, DOI 10.1002/ijc.1529
   Martin JN, 1998, NEW ENGL J MED, V338, P948, DOI 10.1056/NEJM199804023381403
   Mbulaiteye SM, 2005, JAIDS-J ACQ IMM DEF, V38, P474, DOI 10.1097/01.qai.0000132495.89162.c0
   Mbulaiteye SM, 2003, J INFECT DIS, V187, P1780, DOI 10.1086/374973
   Miller CS, 2006, J CLIN MICROBIOL, V44, P2409, DOI 10.1128/JCM.00256-06
   Mwakigonja AR, 2007, ONCOL REP, V17, P1291
   Mwakigonja AR, 2008, INFECT AGENTS CANC, V3, P1
   NAVAZESH M, 1993, ANN NY ACAD SCI, V694, P72, DOI 10.1111/j.1749-6632.1993.tb18343.x
   Pauk J, 2000, NEW ENGL J MED, V343, P1369, DOI 10.1056/NEJM200011093431904
   Pierrotti LC, 2005, SEX TRANSM DIS, V32, P57, DOI 10.1097/01.olq.0000148300.33428.6e
   Plancoulaine S, 2000, LANCET, V356, P1062, DOI 10.1016/S0140-6736(00)02729-X
   Renwick N, 2002, J INFECT DIS, V185, P1808, DOI 10.1086/340817
   Schulz TF, 2006, J PATHOL, V208, P187, DOI 10.1002/path.1904
   Spira TJ, 2000, J CLIN MICROBIOL, V38, P2174
   Tanaka T, 2009, BIOMED RES-TOKYO, V30, P279, DOI 10.2220/biomedres.30.279
   Taylor MM, 2004, J INFECT DIS, V190, P484, DOI 10.1086/421466
   Triantos D, 2004, ORAL MICROBIOL IMMUN, V19, P201, DOI 10.1111/j.0902-0055.2002.00131.x
   Varthakavi V, 2002, VIROLOGY, V297, P270, DOI 10.1006/viro.2002.1434
   Widmer IC, 2006, JAIDS-J ACQ IMM DEF, V42, P420, DOI 10.1097/01.qai.0000226790.31463.e6
   Zago A, 2000, SEX TRANSM DIS, V27, P468, DOI 10.1097/00007435-200009000-00009
NR 52
TC 9
Z9 9
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0904-2512
EI 1600-0714
J9 J ORAL PATHOL MED
JI J. Oral Pathol. Med.
PD JAN
PY 2011
VL 40
IS 1
BP 97
EP 102
DI 10.1111/j.1600-0714.2010.00959.x
PG 6
WC Dentistry, Oral Surgery & Medicine; Pathology
SC Dentistry, Oral Surgery & Medicine; Pathology
GA 702FX
UT WOS:000285881100015
PM 20969629
DA 2020-11-30
ER

PT J
AU Rizzi, EC
   Issa, JPM
   Dias, FJ
   Leao, JC
   Regalo, SCH
   Siessere, S
   Watanabe, IS
   Iyomasa, MM
AF Rizzi, Elen Camargo
   Mardegan Issa, Joao Paulo
   Dias, Fernando Jose
   Leao, Juliane Caroline
   Hallak Regalo, Simone Cecilio
   Siessere, Selma
   Watanabe, Ii-Sei
   Iyomasa, Mamie Mizusaki
TI Low-Level Laser Intensity Application in Masseter Muscle for Treatment
   Purposes
SO PHOTOMEDICINE AND LASER SURGERY
LA English
DT Article
ID HUMAN SKIN FIBROBLASTS; ELECTRICAL-STIMULATION; THERAPY; SKELETAL;
   IRRADIATION; FATIGUE; DISORDERS; HUMANS; NM
AB Objective: This study evaluated with histochemical analysis how the number of laser applications can affect the masseter muscle. Background: In dentistry today, the laser is used in patients with temporomandibular disorders (TMDs), mainly for radiating pain in the masticatory muscles, whose origins may be associated with malocclusion, although the laser effects are not well understood on the cellular level. Materials and Methods: Thirty mice (HRS/J lineage) were randomly distributed into groups according to the number of laser applications (three, six, and 10). For each group of laser applications (experimental, n = 5), it was considered the control group (n = 5), which was not irradiated. All animals inhaled halothane (2-bromo-2-chloro-1, 1, 1-trifluoroethane, minimum 99%, Sigma Aldrich, India) before each laser irradiation performed on the left masseter muscle region, on alternate days with 20 J/cm(2), 40mW, for 20 sec. The muscle samples were collected for histochemical analysis with succinate dehydrogenase (SDH) enzyme 72 h after the last application. Results: (a) A decrease in area of light fibers type (35.91% +/- 6.9%; 32.08% +/- 6.3%, and 27.88% +/- 6.3%), according to the increase of laser applications (p < 0.05); (b) significant increase (p < 0.05) in the area of intermediate fibers, with an increase of laser application (11.08% +/- 3.9%; 16.52% +/- 5.7%, and 15.96% +/- 3.9%), although the increase with 10 applications was small; (c) area increase of dark fibers in the group with three laser applications (0.16% +/- 0.3%) (p < 0.05), and in groups with six and 10 laser applications, respectively (9.68% +/- 6.0% and 9.60% +/- 4.0%). Conclusions: The SDH enzyme activity revealed that the number of laser applications increases the metabolic pattern of the muscle fibers. A minimal difference in metabolic activity between six and 10 applications of a laser suggests that further analyses should be done to confirm that six applications are enough to produce the same clinical effects, thereby contributing data to professionals from different fields in regard to the cost-benefit ratio of this therapy.
C1 [Iyomasa, Mamie Mizusaki] USP, Fac Odontol Ribeirao Preto, Dept Morfol Estomatol & Fisiol, Ribeirao Preto Sch Dent, BR-14040904 Ribeirao Preto, SP, Brazil.
   [Watanabe, Ii-Sei] Univ Sao Paulo, Dept Anat, Inst Biomed Sci, Sao Paulo, Brazil.
RP Iyomasa, MM (corresponding author), USP, Fac Odontol Ribeirao Preto, Dept Morfol Estomatol & Fisiol, Ribeirao Preto Sch Dent, Ave Cafe S-N, BR-14040904 Ribeirao Preto, SP, Brazil.
EM mamieiyo@forp.usp.br
RI Dias, Fernando Jose/AAP-7420-2020; Iyomasa, Mamie Mizusaki/H-5005-2012;
   WATANABE, II-SEI/G-1461-2016; Regalo, Simone C H/B-8097-2012; Siessere,
   Selma/B-7943-2012; Issa, Joao Paulo/A-2505-2011; Dias, Fernando
   Jose/D-8228-2014
OI Iyomasa, Mamie Mizusaki/0000-0002-4001-6440; Siessere,
   Selma/0000-0001-9756-3771; Issa, Joao Paulo/0000-0002-1056-0795; Cecilio
   Hallak Regalo, Simone/0000-0003-4110-8299; Watanabe,
   Ii-sei/0000-0002-1000-1467; Dias, Fernando Jose/0000-0001-9945-9185
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
FX This study was supported by FAPESP.
CR Avni D, 2005, PHOTOMED LASER SURG, V23, P273, DOI 10.1089/pho.2005.23.273
   Belizario JE, 2007, BRAZ J MED BIOL RES, V40, P1011, DOI 10.1590/S0100-879X2006005000109
   BIBIKOVA A, 1995, ANAT REC, V241, P123, DOI 10.1002/ar.1092410116
   Fikackova H, 2007, PHOTOMED LASER SURG, V25, P297, DOI 10.1089/pho.2007.2053
   Fricton James R, 2004, Curr Pain Headache Rep, V8, P355, DOI 10.1007/s11916-996-0008-0
   Hawkins D, 2005, PHOTOMED LASER SURG, V23, P251, DOI 10.1089/pho.2005.23.251
   Hawkins DH, 2006, LASER SURG MED, V38, P74, DOI 10.1002/lsm.20271
   Iyomasa DM, 2009, MICRON, V40, P413, DOI 10.1016/j.micron.2009.02.002
   KARU T, 1989, HEALTH PHYS, V56, P691, DOI 10.1097/00004032-198905000-00015
   Lopes-Martins RAB, 2006, J APPL PHYSIOL, V101, P283, DOI 10.1152/japplphysiol.01318.2005
   NACHLAS MM, 1957, J HISTOCHEM CYTOCHEM, V5, P420, DOI 10.1177/5.4.420
   Nunez SC, 2006, PHOTOMED LASER SURG, V24, P45, DOI 10.1089/pho.2006.24.45
   Oron U, 2006, PHOTOMED LASER SURG, V24, P111, DOI 10.1089/pho.2006.24.111
   Leal ECP, 2008, PHOTOMED LASER SURG, V26, P419, DOI 10.1089/pho.2007.2160
   Leal ECP, 2009, LASER MED SCI, V24, P425, DOI 10.1007/s10103-008-0592-9
   Podbielski M, 2006, MED WETER, V62, P1158
   Posten W, 2005, DERMATOL SURG, V31, P334, DOI 10.1097/00042728-200503000-00016
   Rizzi CF, 2006, LASER SURG MED, V38, P704, DOI 10.1002/lsm.20371
   Sato Iwao, 2003, Kaibogaku Zasshi, V78, P83
   Shirani AM, 2009, LASER MED SCI, V24, P715, DOI 10.1007/s10103-008-0624-5
   WEIBEL ER, 1966, J CELL BIOL, V30, P23, DOI 10.1083/jcb.30.1.23
   Xu XY, 2008, PHOTOMED LASER SURG, V26, P197, DOI 10.1089/pho.2007.2125
   Yamamoto Y, 1996, J Clin Laser Med Surg, V14, P129
NR 23
TC 7
Z9 7
U1 0
U2 3
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1549-5418
J9 PHOTOMED LASER SURG
JI Photomed. Laser Surg.
PD OCT
PY 2010
VL 28
SU 2
DI 10.1089/pho.2009.2599
PG 5
WC Surgery
SC Surgery
GA 798AL
UT WOS:000293172400006
PM 20932186
DA 2020-11-30
ER

PT J
AU Barkokebas, A
   Carvalho, AAT
   Souza, PRE
   Gomez, RS
   Xavier, GM
   Ribeiro, CMB
   Crovella, S
   Porter, SR
   Leao, JC
AF Barkokebas, A.
   Carvalho, A. A. T.
   Souza, P. R. E.
   Gomez, R. S.
   Xavier, G. M.
   Ribeiro, C. M. B.
   Crovella, S.
   Porter, S. R.
   Leao, J. C.
TI Mannose binding lectin gene (MBL-2) polymorphism in oral lichen planus
SO ORAL DISEASES
LA English
DT Meeting Abstract
C1 [Barkokebas, A.] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Carvalho, A. A. T.; Ribeiro, C. M. B.; Leao, J. C.] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
   [Souza, P. R. E.] Univ Fed Rural de Pernambuco, Dept Biol, Recife, PE, Brazil.
   [Gomez, R. S.; Xavier, G. M.] Univ Fed Minas Gerais, Dept Clin Patologica & Cirurgia Odontologica, Belo Horizonte, MG, Brazil.
   [Crovella, S.] Univ Fed Pernambuco, Lab Imunopatol Keiso Asami, Recife, PE, Brazil.
   [Porter, S. R.] Univ London, Eastman Dent Inst, Div Maxillofacial Diagnost Surg & Med Sci, Oral Med unit, London, England.
RI Crovella, Sergio/K-5050-2016; Leao, Jair Carneiro/AAL-6154-2020; Gomez,
   Ricardo Santiago/G-1976-2012
OI Crovella, Sergio/0000-0001-8493-1168; Leao, Jair
   Carneiro/0000-0001-8303-2291; Gomez, Ricardo
   Santiago/0000-0001-8770-8009; Porter, Stephen/0000-0002-3328-2759
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1354-523X
J9 ORAL DIS
JI Oral Dis.
PD SEP
PY 2010
VL 16
IS 6
BP 524
EP 524
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 643HZ
UT WOS:000281287500047
DA 2020-11-30
ER

PT J
AU Gueiros, LA
   Ribeiro, C
   de Carvalho, AT
   Jorge, J
   Vargas, PA
   Lopes, MA
   de Almeida, OP
   Leao, JC
AF Gueiros, L. A.
   Ribeiro, C.
   de Carvalho, A. Tavares
   Jorge, J., Jr.
   Vargas, P. A.
   Lopes, M. Ajudarte
   de Almeida, O. Paes
   Leao, J. C.
TI Serum levels of IL-17 in patients diagnosed with Oral Lichen Planus or
   Oral Lichenoid Lesions: a preliminary study
SO ORAL DISEASES
LA English
DT Meeting Abstract
C1 [Gueiros, L. A.; Ribeiro, C.; de Carvalho, A. Tavares; Leao, J. C.] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
   [Ribeiro, C.; Jorge, J., Jr.; Vargas, P. A.; Lopes, M. Ajudarte; de Almeida, O. Paes] Univ Estadual Campinas, Fac Odontol Piracicaba, Dept Oral Diag, Piracicaba, Brazil.
RI Gueiros, Luiz Alcino/F-7171-2012; Lopes, Marcio Ajudarte/AAV-1018-2020;
   Leao, Jair Carneiro/AAL-6154-2020; Vargas, Pablo Agustin/C-5208-2012;
   Gueiros, Luiz Alcino/B-6429-2015; Jorge, Jacks/M-6219-2014
OI Gueiros, Luiz Alcino/0000-0003-4979-4318; Leao, Jair
   Carneiro/0000-0001-8303-2291; Vargas, Pablo Agustin/0000-0003-1840-4911;
   Gueiros, Luiz Alcino/0000-0003-4979-4318; 
NR 0
TC 0
Z9 0
U1 0
U2 3
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1354-523X
J9 ORAL DIS
JI Oral Dis.
PD SEP
PY 2010
VL 16
IS 6
BP 543
EP 543
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 643HZ
UT WOS:000281287500131
DA 2020-11-30
ER

PT J
AU de Albuquerque, A
   Carvalho, T
   de Castro, JFL
   Carvalho, EJD
   Perez, D
   Leao, JC
AF de Albuquerque, A.
   Carvalho, T.
   Lisboa de Castro, J. F.
   de Amorim Carvalho, E. J.
   Perez, D.
   Leao, J. C.
TI Verrucous carcinoma: report of a case
SO ORAL DISEASES
LA English
DT Meeting Abstract
C1 [de Albuquerque, A.; Carvalho, T.; Lisboa de Castro, J. F.; de Amorim Carvalho, E. J.; Perez, D.; Leao, J. C.] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
RI Leao, Jair Carneiro/AAL-6154-2020
OI Leao, Jair Carneiro/0000-0001-8303-2291
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1354-523X
J9 ORAL DIS
JI Oral Dis.
PD SEP
PY 2010
VL 16
IS 6
BP 563
EP 563
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 643HZ
UT WOS:000281287500222
DA 2020-11-30
ER

PT J
AU Silva, IHM
   Leao, JC
   Evencio, LB
   Porter, SR
   de Castro, RM
AF Morais Silva, Igor Henrique
   Leao, Jair Carneiro
   Evencio, Liriane Baratella
   Porter, Stephen Ross
   de Castro, Raul Manhaes
TI MORPHOLOGICAL ANALYSIS OF THE ENAMEL ORGAN IN RATS TREATED WITH
   FLUOXETINE
SO CLINICS
LA English
DT Article
DE Enamel organ; Development; Fluoxetine; Tooth germ; Serotonin
ID FINE-STRUCTURE; SEROTONIN UPTAKE; AMELOBLASTS; EXPRESSION;
   MORPHOGENESIS; NEUROTRANSMITTERS; MATURATION
AB PURPOSE: Previous studies have evaluated the presence of serotonin in the dental epithelia and mesenchyme during odontogenesis, suggesting its participation in tooth development.
   MATERIALS AND METHODS: Here, we used fluoxetine, a selective serotonin re-uptake inhibitor, at a dose of 10 mg/kg, administered for 20 days during pregnancy in 12 Wistar rats to examine the influence of this drug on the development of the enamel organ of the upper first molars of rat fetuses at 17 days of intra-uterine life (i.u.l.), and at one, five and ten days postpartum. The pregnant rats were anesthetized with xylazine at 10 mg/kg and ketamine at 25 mg/kg. The fetuses were removed and beheaded; their jaws were removed, and the upper jaws were exposed. The tissues were fixed in Bouin's fixative, decalcified in 5% nitric acid for 4 - 12 h, conventionally processed for microscopy, and embedded in paraffin. Serial sections of approximately 5 mm were obtained and stained with hematoxylin and eosin, as well as periodic acid-Schiff.
   RESULTS AND CONCLUSION: Morphological analysis showed no structural changes in the experimental group compared to the controls, suggesting that, at the dose used, fluoxetine does not interfere with serotonin-mediated development of the enamel organ or the process of amelogenesis.
C1 [Morais Silva, Igor Henrique; Leao, Jair Carneiro] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
   [Evencio, Liriane Baratella] Univ Fed Pernambuco, Dept Embriol & Histol Recife, Recife, PE, Brazil.
   [Porter, Stephen Ross] Eastman Dent Inst Oral Hlth Care Sci, Oral Med Unit, London, England.
   [de Castro, Raul Manhaes] Univ Fed Pernambuco, Dept Nutr, Recife, PE, Brazil.
RP Silva, IHM (corresponding author), Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
EM jleao@ufpe.br
RI de Castro, Raul Manhaes/A-1635-2014; Leao, Jair Carneiro/AAL-6154-2020
OI Leao, Jair Carneiro/0000-0001-8303-2291; Porter,
   Stephen/0000-0002-3328-2759
CR Addison WHF, 1922, AM J ANAT, V31, P160
   Baratella L, 2000, J ANAT, V197, P303, DOI 10.1046/j.1469-7580.2000.19720303.x
   BEEMAN CS, 1994, ARCH ORAL BIOL, V39, P733, DOI 10.1016/0003-9969(94)90001-9
   BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0
   Buznikov GA, 1996, CELL MOL NEUROBIOL, V16, P533, DOI 10.1007/BF02152056
   Buznikov GA, 2001, CELL TISSUE RES, V305, P177, DOI 10.1007/s004410100408
   Byrd KE, 2000, ANAT RECORD, V258, P369
   Hoffman BJ, 1998, FRONT NEUROENDOCRIN, V19, P187, DOI 10.1006/frne.1998.0168
   JOHNSON DS, 1995, MOL CELL NEUROSCI, V6, P122, DOI 10.1006/mcne.1995.1012
   KALLENBACH E, 1968, J ULTRA MOL STRUCT R, V22, P90, DOI 10.1016/S0022-5320(68)90051-8
   KATCHBURIAN E, 1972, J CELL SCI, V11, P415
   KATCHBURIAN E, 1977, ARCH ORAL BIOL, V22, P551, DOI 10.1016/0003-9969(77)90054-1
   KATCHBURIAN E, 2004, HISTOLOGIA EMBRIOLOG, P237
   Lauder J M, 1981, Adv Exp Med Biol, V133, P477
   LAUDER JM, 1988, J CRAN GENET DEV BIO, V8, P265
   Lauder JM, 2000, INT J DEV NEUROSCI, V18, P653, DOI 10.1016/S0736-5748(00)00032-0
   MILETICH I, 2003, HUMAN MOL GENETICS R, V12, P162
   Moiseiwitsch JRD, 1998, ARCH ORAL BIOL, V43, P789, DOI 10.1016/S0003-9969(98)00067-3
   Moiseiwitsch JRD, 2000, CRIT REV ORAL BIOL M, V11, P230, DOI 10.1177/10454411000110020601
   Moiseiwitsch JRD, 1996, ARCH ORAL BIOL, V41, P161, DOI 10.1016/0003-9969(95)00117-4
   REITH EJ, 1961, J BIOPHYS BIOCHEM CY, V9, P825, DOI 10.1083/jcb.9.4.825
   SHUEY DL, 1992, TERATOLOGY, V46, P367, DOI 10.1002/tera.1420460407
   TECOTT L, 1995, MOL CELL NEUROSCI, V6, P43, DOI 10.1006/mcne.1995.1005
   Turlejski K, 1996, ACTA NEUROBIOL EXP, V56, P619
NR 24
TC 3
Z9 4
U1 0
U2 1
PU HOSPITAL CLINICAS, UNIV SAO PAULO
PI SAO PAULO
PA FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL
SN 1807-5932
EI 1980-5322
J9 CLINICS
JI Clinics
PD JAN
PY 2010
VL 65
IS 1
BP 61
EP 65
DI 10.1590/S1807-59322010000100010
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA 556YC
UT WOS:000274628800009
PM 20126347
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Gueiros, LA
   Soares, MSM
   Leao, JC
AF Gueiros, Luiz Alcino
   Marques Soares, Maria Sueli
   Leao, Jair Carneiro
TI Impact of ageing and drug consumption on oral health
SO GERODONTOLOGY
LA English
DT Article
DE saliva; age groups; xerostomia; drug therapy
ID SALIVARY FLOW-RATE; DRY MOUTH; HISTOLOGICAL-CHANGES; SENSORY COMPLAINTS;
   DENTAL PATIENTS; AGE; GLANDS; XEROSTOMIA; ASSOCIATION; HYPOSALIVATION
AB The impact of ageing on oral health and salivary flow is usually over-estimated possibly because of the high frequency of polypharmacy observed in this subset of patients. Understanding the physiological changes and treatment-related oral complications of older patients is essential to promote accurate management of symptoms and improve their quality of life. The current paper reviews age-related physiological chances in salivary glands and the effect of polypharmacy on oral health, focusing on xerostomia and hyposalivation.
C1 [Gueiros, Luiz Alcino; Leao, Jair Carneiro] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, BR-50670901 Recife, PE, Brazil.
   [Gueiros, Luiz Alcino; Marques Soares, Maria Sueli] Univ Fed Paraiba, Programa Posgrad Odontol, BR-58059900 Joao Pessoa, Paraiba, Brazil.
RP Gueiros, LA (corresponding author), Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Av Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
EM lagueiros@gmail.com
RI SOARES, MARIA SUELI MARQUES/AAL-7936-2020; Gueiros, Luiz
   Alcino/B-6429-2015; Leao, Jair Carneiro/AAL-6154-2020; Gueiros, Luiz
   Alcino/F-7171-2012
OI SOARES, MARIA SUELI MARQUES/0000-0003-0712-8456; Gueiros, Luiz
   Alcino/0000-0003-4979-4318; Leao, Jair Carneiro/0000-0001-8303-2291;
   Gueiros, Luiz Alcino/0000-0003-4979-4318
CR Azevedo LR, 2005, ARCH ORAL BIOL, V50, P565, DOI 10.1016/j.archoralbio.2004.10.019
   Barford KL, 2008, CURR TREAT OPTION ON, V9, P204, DOI 10.1007/s11864-008-0062-4
   Baum B J, 1981, Spec Care Dentist, V1, P156, DOI 10.1111/j.1754-4505.1981.tb01239.x
   BAUM BJ, 1981, J DENT RES, V60, P1292, DOI 10.1177/00220345810600070101
   Bergdahl M, 2000, J DENT RES, V79, P1652, DOI 10.1177/00220345000790090301
   Bergdahl M, 2000, COMMUNITY DENT ORAL, V28, P59, DOI 10.1034/j.1600-0528.2000.280108.x
   Bergdahl Maud, 2002, Clin Oral Investig, V6, P145, DOI 10.1007/s00784-002-0169-0
   Cassolato Sandra F, 2003, Gerodontology, V20, P64, DOI 10.1111/j.1741-2358.2003.00064.x
   Dawes C, 2004, CARIES RES, V38, P236, DOI 10.1159/000077760
   DAWES C, 1987, J DENT RES, V66, P648, DOI 10.1177/00220345870660S207
   DEWILDE PCM, 1986, J CLIN PATHOL, V39, P406, DOI 10.1136/jcp.39.4.406
   Dodds MWJ, 2005, J DENT, V33, P223, DOI 10.1016/j.jdent.2004.10.009
   Ghezzi EM, 2003, J DENT RES, V82, P844, DOI 10.1177/154405910308201016
   Ghezzi EM, 2000, J GERONTOL A-BIOL, V55, pM34
   Granot M, 2005, J PAIN, V6, P581, DOI 10.1016/j.jpain.2005.03.010
   Gupta A, 2006, J CAN DENT ASSOC, V72, P841
   Hochberg MC, 1998, J RHEUMATOL, V25, P486
   Jainkittivong A, 2002, ORAL DIS, V8, P218, DOI 10.1034/j.1601-0825.2002.01789.x
   Nagler RM, 2005, ARCH ORAL BIOL, V50, P7, DOI 10.1016/j.archoralbio.2004.07.012
   Nagler RM, 2004, BIOGERONTOLOGY, V5, P223, DOI 10.1023/B:BGEN.0000038023.36727.50
   Narhi TO, 1999, DRUG AGING, V15, P103
   NARHI TO, 1992, J DENT RES, V71, P1875, DOI 10.1177/00220345920710120401
   Nederfors T, 1997, COMMUNITY DENT ORAL, V25, P211, DOI 10.1111/j.1600-0528.1997.tb00928.x
   PARVINEN T, 1982, J DENT RES, V61, P1052, DOI 10.1177/00220345820610090501
   SCOTT J, 1987, J ORAL PATHOL MED, V16, P505, DOI 10.1111/j.1600-0714.1987.tb00681.x
   Scully C, 2003, ORAL DIS, V9, P165, DOI 10.1034/j.1601-0825.2003.03967.x
   Ship JA, 2007, J ORAL REHABIL, V34, P724, DOI 10.1111/j.1365-2842.2006.01718.x
   Ship JA, 2002, J AM GERIATR SOC, V50, P535, DOI 10.1046/j.1532-5415.2002.50123.x
   Smith R G, 1994, Spec Care Dentist, V14, P96, DOI 10.1111/j.1754-4505.1994.tb01112.x
   SREEBNY LM, 1989, COMPEND S, V13, pS461
   Streckfus C, 2002, GERONTOLOGY, V48, P282, DOI 10.1159/000065250
   STRECKFUS CF, 1995, J AM DENT ASSOC, V126, P1012, DOI 10.14219/jada.archive.1995.0277
   Terai H, 2007, ORAL DIS, V13, P440, DOI 10.1111/j.1601-0825.2006.01325.x
   Vissink A, 1996, Spec Care Dentist, V16, P95, DOI 10.1111/j.1754-4505.1996.tb00842.x
NR 34
TC 20
Z9 24
U1 1
U2 8
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0734-0664
J9 GERODONTOLOGY
JI Gerodontology
PD DEC
PY 2009
VL 26
IS 4
BP 297
EP 301
DI 10.1111/j.1741-2358.2009.00284.x
PG 5
WC Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology
SC Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology
GA 521RH
UT WOS:000271940300009
PM 19392837
DA 2020-11-30
ER

PT J
AU Gueiros, LA
   Leon, JE
   Leao, JC
   Lopes, MA
   Jorge, J
   de Almeida, OP
AF Gueiros, Luiz Alcino
   Leon, Jorge Esquiche
   Leao, Jair Carneiro
   Lopes, Marcio Ajudarte
   Jorge, Jacks
   de Almeida, Oslei Paes
TI Subgemmal neurogenous plaque: Clinical and microscopic evaluation of 7
   cases
SO ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND
   ENDODONTOLOGY
LA English
DT Article
ID TASTE-BUDS; FILAMENTS; TONGUE
AB Subgemmal neurogenous plaques (SNPs) are biphasic neural structures found on the posterolateral border of the tongue. Fewer than 40 cases have been reported and only a few were symptomatic. The present report details the features of 7 cases of SNP retrieved from the files of a single institution. Clinical and histopathological data were reviewed and immunohistochemical analysis was performed for S100, CD56, neuron-specific enolase, epithelial membrane antigen, CK7, CK8, CK14, and CK20. All cases showed similar morphological and immunohistochemical characteristics. Neural markers highlighted the biphasic pattern and CK7, CK8, and CK20 were detected on taste buds confined to the epithelium adjacent to the SNPs. Five patients presented pain/discomfort as the main symptom. Symptomatic SNPs seems to be more common than previously reported, presenting as focal burning on the posterolateral border of the tongue. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 108: 920-924)
C1 [Gueiros, Luiz Alcino; Leon, Jorge Esquiche; Lopes, Marcio Ajudarte; Jorge, Jacks; de Almeida, Oslei Paes] Univ Estadual Campinas, Piracicaba Dent Sch, Pathol Sect, Dept Oral Diag, BR-13414903 Piracicaba, SP, Brazil.
   [Gueiros, Luiz Alcino; Leao, Jair Carneiro] Univ Fed Pernambuco, Oral Med Unit, Dept Clin & Prevent Dent, Recife, PE, Brazil.
RP Gueiros, LA (corresponding author), Univ Estadual Campinas, Piracicaba Dent Sch, Oral Pathol Sect, Av Limeira 901,Caixa Postal 52, BR-13414903 Piracicaba, SP, Brazil.
EM luizgueiros@fop.unicamp.br
RI JE, Leon/D-7511-2013; Leao, Jair Carneiro/AAL-6154-2020; Gueiros, Luiz
   Alcino/B-6429-2015; Gueiros, Luiz Alcino/F-7171-2012; Lopes, Marcio
   Ajudarte/AAV-1018-2020; Jorge, Jacks/M-6219-2014
OI JE, Leon/0000-0002-9668-5870; Leao, Jair Carneiro/0000-0001-8303-2291;
   Gueiros, Luiz Alcino/0000-0003-4979-4318; Gueiros, Luiz
   Alcino/0000-0003-4979-4318; 
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); State of Sao Paulo Research Foundation (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
FX Supported by The National Council for Scientific and Technological
   Development (CNPq) and The State of Sao Paulo Research Foundation
   (FAPESP).
CR Barrett AW, 2000, ARCH ORAL BIOL, V45, P879, DOI 10.1016/S0003-9969(00)00050-9
   Cuffari L, 2006, ORAL SURG ORAL MED O, V102, P56, DOI 10.1016/j.tripleo.2005.10.041
   Val-Bernal JF, 2006, PATHOL INT, V56, P462, DOI 10.1111/j.1440-1827.2006.01990.x
   Gueiros LA, 2008, INT J ORAL MAX SURG, V37, P773, DOI 10.1016/j.ijom.2008.01.025
   McDaniel RK, 1999, ORAL SURG ORAL MED O, V87, P605, DOI 10.1016/S1079-2104(99)70142-3
   SQUIER CA, 2003, T CATES ORAL HISTOLO, P329
   Triantafyllou A, 2004, HUM PATHOL, V35, P991, DOI 10.1016/j.humpath.2004.04.010
   Witt M, 1999, ANAT EMBRYOL, V199, P291, DOI 10.1007/s004290050229
   Witt M, 2000, PHILOS T ROY SOC B, V355, P1233, DOI 10.1098/rstb.2000.0674
NR 9
TC 8
Z9 9
U1 0
U2 3
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1079-2104
J9 ORAL SURG ORAL MED O
JI Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.
PD DEC
PY 2009
VL 108
IS 6
BP 920
EP 924
DI 10.1016/j.tripleo.2009.07.038
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 519HU
UT WOS:000271756800019
PM 19913727
DA 2020-11-30
ER

PT J
AU Pinheiro, RD
   Franca, TT
   Ribeiro, CMB
   Leao, JC
   de Souza, IPR
   Castro, GF
AF Pinheiro, Raquel dos Santos
   Franca, Talita Tenorio
   Beder Ribeiro, Camila Maria
   Leao, Jair Carneiro
   Ribeiro de Souza, Ivete Pomarico
   Castro, Gloria Fernanda
TI Oral manifestations in human immunodeficiency virus infected children in
   highly active antiretroviral therapy era
SO JOURNAL OF ORAL PATHOLOGY & MEDICINE
LA English
DT Review
DE AIDS; HIV infection; oral mucosa
ID RECONSTITUTION INFLAMMATORY SYNDROME; SARCOMA-ASSOCIATED HERPESVIRUS;
   IMMUNE RESTORATION DISEASE; KAPOSIS-SARCOMA; PEDIATRIC HIV; AIDS
   PATIENTS; OPPORTUNISTIC INFECTIONS; PROTEASE INHIBITORS; HAIRY
   LEUKOPLAKIA; CANDIDA-ALBICANS
AB Objective:
   Conducted a literature review to identify studies that reported on the oral manifestations in human immunodeficiency virus (HIV) infected children in highly active antiretrovial therapy (HAART) era.
   Methods:
   A search electronic data base were used and the terms used were 'oral lesions' and 'oral manifestations'. The studies of prevalence of oral manifestation in children with HIV worldwide, descriptive studies, case reports, studies on the association of oral lesions and levels of immune suppression, use of HAART and transmission of HIV were included.
   Results:
   There have been substantial changes in the management of HIV disease, especially in the past decade because of the use of HAART. However, children are still being infected and present some peculiarities when compared with adults. Molecular epidemiology, transmission and therapy of the common opportunistic oral infections of HIV disease need to be better understood as a consequence of improved anti-HIV strategies. Treatment with HAART improves the immune function and decreases mortality, morbidity, and opportunistic infections in HIV-infected persons.
   Conclusion:
   The frequency and severity of oral disease associated with HIV infection have reduced considerably, although the use of HAART may be associated with an increased appearance of oral lesions associated with human papillomavirus and potentially increase the risk of later oral squamous cell carcinoma.
C1 [Pinheiro, Raquel dos Santos; Ribeiro de Souza, Ivete Pomarico; Castro, Gloria Fernanda] Univ Fed Rio de Janeiro, Dept Orthodont & Pediat Dent, Sch Dent, BR-21941590 Rio De Janeiro, Brazil.
   [Franca, Talita Tenorio; Leao, Jair Carneiro] Univ Fed Pernambuco, Dept Estomatol, Sch Dent, Recife, PE, Brazil.
   [Beder Ribeiro, Camila Maria] Univ Estadual Campinas, Sch Dent, Dept Estomatol, Sao Paulo, Brazil.
RP Pinheiro, RD (corresponding author), Univ Fed Rio de Janeiro, Dept Orthodont & Pediat Dent, Sch Dent, Trompowsky Ave, BR-21941590 Rio De Janeiro, Brazil.
EM raquelodontouff@click21.com.br; gfbacastro@yahoo.com.br
RI Castro, Gloria/Y-5592-2019; Charone, Senda/J-8393-2013; Leao, Jair
   Carneiro/AAL-6154-2020; Beder Ribeiro Girish Panjwani, Camila
   Maria/M-5453-2017
OI Charone, Senda/0000-0002-9713-8676; Leao, Jair
   Carneiro/0000-0001-8303-2291; Beder Ribeiro Girish Panjwani, Camila
   Maria/0000-0003-0203-3079; Castro, Gloria/0000-0002-8137-0307; Souza,
   Ivete Pomarico/0000-0003-0449-6624
CR AGUIRRE JM, 1992, REV VASCA ODONTOESTO, V2, P55
   Andreoni M, 1999, J NATL CANCER I, V91, P465, DOI 10.1093/jnci/91.5.465
   Arany I, 1998, INT J STD AIDS, V9, P268, DOI 10.1258/0956462981922197
   Blauvelt A, 1997, J INFECT DIS, V176, P771, DOI 10.1086/517298
   Brayfield BP, 2003, J INFECT DIS, V187, P559, DOI 10.1086/367985
   Castetbon K, 2000, Sante, V10, P103
   Cauda R, 1999, J ACQ IMMUN DEF SYND, V21, P20, DOI 10.1097/00126334-199905010-00003
   Ceballos-Salobrena A, 2000, AIDS PATIENT CARE ST, V14, P627, DOI 10.1089/10872910050206540
   Cerqueira DF, 2007, J DENT CHILD, V74, P98
   Cheng VCC, 2000, CLIN INFECT DIS, V30, P882, DOI 10.1086/313809
   Chhieng DC, 1999, DIAGN CYTOPATHOL, V21, P260
   Chigurupati Radhika, 1996, Pediatric Dentistry, V18, P106
   Chou LL, 2000, J ORAL PATHOL MED, V29, P394, DOI 10.1034/j.1600-0714.2000.290805.x
   CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801
   Cook RD, 2002, J GEN VIROL, V83, P1613, DOI 10.1099/0022-1317-83-7-1613
   Costa LRRS, 1998, J DENT CHILD, V65, P186
   COUTSOUDIS A, 1995, AM J PUBLIC HEALTH, V85, P1076, DOI 10.2105/AJPH.85.8_Pt_1.1076
   Dave SP, 2007, LARYNGOSCOPE, V117, P106, DOI 10.1097/01.mlg.0000246196.35413.35
   Del Toro Agnes, 1996, Pediatric Dentistry, V18, P114
   DeSimone JA, 2000, ANN INTERN MED, V133, P447, DOI 10.7326/0003-4819-133-6-200009190-00013
   Dias Eliane Pedra, 2006, Braz. oral res., V20, P103, DOI 10.1590/S1806-83242006000200003
   EXPOSITODELGADO AJ, 2004, MED ORAL PATOL ORAL, V9, P410
   Eyeson JD, 2002, J ORAL PATHOL MED, V31, P169, DOI 10.1034/j.1600-0714.2002.310308.x
   Ferguson Fred S., 1993, Pediatric Dentistry, V15, P280
   Flint S R, 2006, Adv Dent Res, V19, P146
   Fonseca R, 2000, QUINTESSENCE INT, V31, P419
   French M A, 2000, HIV Med, V1, P107, DOI 10.1046/j.1468-1293.2000.00012.x
   French MA, 2004, AIDS, V18, P1615, DOI 10.1097/01.aids.0000131375.21070.06
   French MA, 2003, AIDS, V17, P1977, DOI 10.1097/00002030-200309050-00017
   Frezzini C, 2005, J ORAL PATHOL MED, V34, P513, DOI 10.1111/j.1600-0714.2005.00337.x
   FRIEDMANKIEN AE, 2006, J AM ACAD DERMATOL 2, V22, P1237
   Gaitan-Cepeda L, 2002, AIDS PATIENT CARE ST, V16, P151, DOI 10.1089/10872910252930858
   Goetghebuer T, 2009, EUR J PEDIATR, V168, P79, DOI 10.1007/s00431-008-0717-y
   Gona P, 2006, JAMA-J AM MED ASSOC, V296, P292, DOI 10.1001/jama.296.3.292
   Grando Liliane Janete, 2005, Braz. oral res., V19, P228, DOI 10.1590/S1806-83242005000300013
   GREENSPAN JS, 1988, AIDS, V2, P143, DOI 10.1097/00002030-198804000-00020
   Hamza Omar J M, 2006, BMC Oral Health, V6, P12
   He J, 1998, J INFECT DIS, V178, P1787, DOI 10.1086/314512
   Hicks M. John, 2000, Pediatric Dentistry, V22, P359
   Hirsch HH, 2004, CLIN INFECT DIS, V38, P1159, DOI 10.1086/383034
   Howell R. Bruce, 1996, Pediatric Dentistry, V18, P117
   ITIN PH, 1994, DERMATOLOGY, V189, P167, DOI 10.1159/000246824
   Jabra-Rizk MA, 2000, J CLIN MICROBIOL, V38, P2423
   Jacobson MA, 1997, LANCET, V349, P1443, DOI 10.1016/S0140-6736(96)11431-8
   Kasolo FC, 1997, J GEN VIROL, V78, P847, DOI 10.1099/0022-1317-78-4-847
   KATZ MH, 1993, AM J DIS CHILD, V147, P45, DOI 10.1001/archpedi.1993.02160250047015
   Kaufmann GR, 2000, AIDS, V14, P959, DOI 10.1097/00002030-200005260-00007
   KETCHEM L, 1990, Pediatric Dentistry, V12, P143
   King MD, 2002, CLIN INFECT DIS, V34, P641, DOI 10.1086/338637
   KLEIN RS, 1984, NEW ENGL J MED, V311, P354, DOI 10.1056/NEJM198408093110602
   Kumarasamy N, 2004, JAIDS-J ACQ IMM DEF, V37, P1574, DOI 10.1097/00126334-200412150-00007
   Lamster I B, 1998, Ann Periodontol, V3, P62
   LAPOINTE N, 1985, NEW ENGL J MED, V312, P1325, DOI 10.1056/NEJM198505163122012
   LEGGOTT PJ, 1992, ORAL SURG ORAL MED O, V73, P187, DOI 10.1016/0030-4220(92)90193-T
   Lewis D E, 1990, Int Rev Immunol, V7, P1, DOI 10.3109/08830189009061761
   Li TS, 1998, LANCET, V351, P1682, DOI 10.1016/S0140-6736(97)10291-4
   MACPHAIL LA, 1995, J AM DENT ASSOC, V126, P74, DOI 10.14219/jada.archive.1995.0026
   MAGALHAES M, 2004, INT DENT J, V54, P131
   Magalhaes M G, 2001, J Clin Pediatr Dent, V25, P103
   Mastroianni CM, 1998, AIDS, V12, P1939
   Merchant R H, 2001, Indian Pediatr, V38, P239
   Michelet C, 1998, AIDS, V12, P1815, DOI 10.1097/00002030-199814000-00013
   Miziara ID, 2008, J ORAL PATHOL MED, V37, P99, DOI 10.1111/j.1600-0714.2007.00598.x
   MONIACI D, 1993, J ORAL PATHOL MED, V22, P8, DOI 10.1111/j.1600-0714.1993.tb00111.x
   Munro CA, 2002, TRENDS MICROBIOL, V10, P173, DOI 10.1016/S0966-842X(02)02330-2
   Myint M, 2000, J CLIN PERIODONTOL, V27, P513, DOI 10.1034/j.1600-051x.2000.027007513.x
   Naidoo S, 2004, ORAL DIS, V10, P13, DOI 10.1046/j.1354-523X.2003.00973.x
   Navazesh M, 2003, ORAL SURG ORAL MED O, V95, P693, DOI 10.1067/moe.2003.230
   Nittayananta W, 2001, J ORAL PATHOL MED, V30, P224, DOI 10.1034/j.1600-0714.2001.300406.x
   Olsen SJ, 1998, AIDS, V12, P1921, DOI 10.1097/00002030-199814000-00024
   Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301
   Patton LL, 2000, ORAL SURG ORAL MED O, V89, P299, DOI 10.1016/S1079-2104(00)70092-8
   Patton LL, 2002, ORAL DIS, V8, P98, DOI 10.1034/j.1601-0825.2002.00020.x
   Plana M, 2000, AIDS, V14, P1921, DOI 10.1097/00002030-200009080-00007
   Plancoulaine S, 2000, LANCET, V356, P1062, DOI 10.1016/S0140-6736(00)02729-X
   Pol RR, 2007, INDIAN J PEDIATR, V74, P1071, DOI 10.1007/s12098-007-0199-3
   Pongsiriwet S, 2003, Int J Paediatr Dent, V13, P180, DOI 10.1046/j.1365-263X.2003.00448.x
   Pontesilli O, 1999, J INFECT DIS, V180, P76, DOI 10.1086/314837
   Portela MB, 2004, J CLIN MICROBIOL, V42, P5925, DOI 10.1128/JCM.42.12.5925-5927.2004
   Puthanakit T, 2006, PEDIATR INFECT DIS J, V25, P53, DOI 10.1097/01.inf.0000195618.55453.9a
   QUINN TC, 1986, SCIENCE, V234, P955, DOI 10.1126/science.3022379
   Race EM, 1998, LANCET, V351, P252, DOI 10.1016/S0140-6736(97)04352-3
   Ramirez-Amador V, 2003, MEDICINE, V82, P39, DOI 10.1097/00005792-200301000-00004
   Ramos-Gomez F, 2002, ORAL DIS, V8, P49, DOI 10.1034/j.1601-0825.2002.00012.x
   Ramos-Gomez F J, 2000, Int J Paediatr Dent, V10, P3, DOI 10.1046/j.1365-263x.2000.00170.x
   Ramos-Gomez F J, 1999, J Clin Pediatr Dent, V23, P85
   Ramos-Gomez Francisco J., 1996, Pediatric Dentistry, V18, P121
   Ranganathan K, 2006, Adv Dent Res, V19, P63
   Ranganathan K, 2000, ORAL DIS, V6, P152, DOI 10.1111/j.1601-0825.2000.tb00326.x
   Regezi JA, 1996, ORAL SURG ORAL MED O, V81, P55, DOI 10.1016/S1079-2104(96)80149-1
   Reznik David A, 2005, Top HIV Med, V13, P143
   RIBEIRO AA, 2002, PESQUI ODONTOL BRAS, V16, P144
   Robinson PG, 2000, J CLIN PERIODONTOL, V27, P273, DOI 10.1034/j.1600-051x.2000.027004273.x
   Salvatori F, 1998, AIDS RES HUM RETROV, V14, P1679, DOI 10.1089/aid.1998.14.1679
   Samaranayake LP, 2002, ORAL DIS, V8, P151, DOI 10.1034/j.1601-0825.8.s2.6.x
   Santos L C, 2001, Braz Dent J, V12, P135
   Santos RA, 2000, VIROLOGY, V275, P306, DOI 10.1006/viro.2000.0507
   *SAUDE RIO SECR MU, 1984, SER HIST CAS AIDS CR
   Scarlatti G, 1996, LANCET, V348, P863, DOI 10.1016/S0140-6736(95)11030-5
   Serraino D, 2001, INT J CANCER, V91, P740, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1115&gt;3.0.CO;2-O
   Shelburne SA, 2005, AIDS, V19, P399, DOI 10.1097/01.aids.0000161769.06158.8a
   Shelburne SA, 2002, MEDICINE, V81, P213, DOI 10.1097/00005792-200205000-00005
   Soares Lívia Ferreira, 2004, Braz. oral res., V18, P6, DOI 10.1590/S1806-83242004000100002
   SOUZA IPR, 2008, ABORDAGEM ODONTOLOGI
   Spitzer TR, 2008, BIOL BLOOD MARROW TR, V14, P59, DOI 10.1016/j.bbmt.2007.03.014
   SULLIVAN D, 1993, J CLIN MICROBIOL, V31, P2124, DOI 10.1128/JCM.31.8.2124-2133.1993
   Sungkanuparph S, 2003, AIDS, V17, P2129, DOI 10.1097/00002030-200309260-00018
   Syrjanen S, 1999, J ORAL PATHOL MED, V28, P204
   Tangsinmankong N, 2004, J ALLERGY CLIN IMMUN, V113, P742, DOI 10.1016/j.jaci.2004.01.768
   Tappuni AR, 2001, ORAL SURG ORAL MED O, V92, P623, DOI 10.1067/moe.2001.118902
   THIRY L, 1985, LANCET, V2, P891
   Tyring SK, 2000, J AM ACAD DERMATOL, V43, pS18
   VALDEZ IH, 1994, J DENT CHILD, V61, P114
   VALENTINE C, 1992, LANCET, V340, P1542, DOI 10.1016/0140-6736(92)92791-D
   WILLIAMS DM, 1993, J ORAL PATHOL MED, V22, P289
   Wood SM, 2008, PEDIATRICS, V121, pE150, DOI 10.1542/peds.2007-0564
   Woods ML, 1998, AIDS, V12, P1491, DOI 10.1097/00002030-199812000-00011
   1999, ANN PERIODONTOL, V4, P1112
NR 118
TC 28
Z9 28
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0904-2512
EI 1600-0714
J9 J ORAL PATHOL MED
JI J. Oral Pathol. Med.
PD SEP
PY 2009
VL 38
IS 8
BP 613
EP 622
DI 10.1111/j.1600-0714.2009.00789.x
PG 10
WC Dentistry, Oral Surgery & Medicine; Pathology
SC Dentistry, Oral Surgery & Medicine; Pathology
GA 490LV
UT WOS:000269503300001
PM 19614862
DA 2020-11-30
ER

PT J
AU Castro, JL
   Cazal, C
   Henriques, ACG
   Leao, JC
   Carvalho, MD
   Dourado, HTD
   Carvalho, AAT
AF Castro, Jurema Lisboa
   Cazal, Claudia
   Gomes Henriques, Aguida Cristina
   Leao, Jair Carneiro
   Carvalho, Marianne de Vasconcelos
   de Carvalho Dourado, Hilda Texeira
   Tavares Carvalho, Alessandra A.
TI Pigmented Oral Squamous Cell Carcinoma: A Case Report and Brief Review
   of the Literature
SO INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
LA English
DT Article
DE squamous cell carcinoma; melanocyte colonization; melanin; oral mucosa
ID COMPREHENSIVE CLINICOPATHOLOGICAL CLASSIFICATION; MELANOCYTE
   COLONIZATION; BOWENS-DISEASE
AB Melanin impregnation in squamous cell carcinoma (SCC) is all Uncommon histological finding. Rare non-melanocytic entities were previously described as having melanocyte colonization. A 57-year-old Brazilian woman was referred with a pigmented lesion in the lower lip and alveolar ridge with a prior clinical diagnosis of melanoma. The incisional biopsy of the tumor revealed an SCC with strong colonization of melanocytes in the stroma. The authors report a case of an unusual SCC variant and a brief review of the literature.
C1 [Castro, Jurema Lisboa; Cazal, Claudia; Gomes Henriques, Aguida Cristina] Univ Fed Pernambuco, Dept Oral Pathol, Recife, PE, Brazil.
   [Castro, Jurema Lisboa; Carvalho, Marianne de Vasconcelos; de Carvalho Dourado, Hilda Texeira; Tavares Carvalho, Alessandra A.] Univ Fed Pernambuco, Dept Oral Diag, Recife, PE, Brazil.
RP Cazal, C (corresponding author), Cristianopolis 20, BR-50721490 Recife, PE, Brazil.
EM claudiacazal@yahoo.com.br
RI Leao, Jair Carneiro/AAL-6154-2020; Carvalho, Marianne V/J-6189-2015
OI Leao, Jair Carneiro/0000-0001-8303-2291; Carvalho, Marianne
   V/0000-0002-6815-5696; Cazal Lira, Claudia/0000-0003-4015-6256
CR Affleck AG, 2005, CLIN EXP DERMATOL, V30, P382, DOI 10.1111/j.1365-2230.2005.01785.x
   Cassarino DS, 2006, J CUTAN PATHOL, V33, P191, DOI 10.1111/j.0303-6987.2006.00516_1.x
   Cassarino DS, 2006, J CUTAN PATHOL, V33, P261, DOI 10.1111/j.0303-6987.2006.00516.x
   Contreras Elisa, 2005, Med Oral Patol Oral Cir Bucal, V10, P11
   DEWAAL JW, 1994, BRIT J PLAST SURG, V47, P138, DOI 10.1016/0007-1226(94)90174-0
   Eversole LR, 2002, ESSENTIALS ORAL MED, P217
   GEORGE FM, 1997, LEVERS HISTOPATHOLOG, P5
   Gu GM, 2003, ORAL SURG ORAL MED O, V96, P404, DOI 10.1016/S1079-2104(03)00320-2
   Han Phuu P, 2007, Head Face Med, V3, P35, DOI 10.1186/1746-160X-3-35
   JAUREGUI HO, 1976, CANCER, V38, P778, DOI 10.1002/1097-0142(197608)38:2<778::AID-CNCR2820380221>3.0.CO;2-A
   Kahn MA, 2005, ORAL SURG ORAL MED O, V100, P454, DOI 10.1016/j.tripleo.2005.01.018
   Kamiya M, 1999, PATHOL INT, V49, P909, DOI 10.1046/j.1440-1827.1999.00963.x
   Krishnan R, 2001, DERMATOL SURG, V27, P673, DOI 10.1046/j.1524-4725.2001.01021.x
   KUWABARA H, 1994, ORAL SURG ORAL MED O, V77, P61, DOI 10.1016/S0030-4220(06)80108-8
   Marucci G, 2005, INT J SURG PATHOL, V13, P295, DOI 10.1177/106689690501300313
   Mathews A, 1998, HISTOPATHOLOGY, V33, P184, DOI 10.1046/j.1365-2559.1998.1019a.x
   MODICA LA, 1990, HISTOPATHOLOGY, V17, P477, DOI 10.1111/j.1365-2559.1990.tb00775.x
   Morgan MB, 2000, J CUTAN PATHOL, V27, P381, DOI 10.1034/j.1600-0560.2000.027008381.x
   Paller AS, 2001, ARCH DERMATOL, V137, P1236
   Papageorgiou PP, 1998, BRIT J DERMATOL, V138, P515
   RAGI G, 1988, J DERMATOL SURG ONC, V14, P765, DOI 10.1111/j.1524-4725.1988.tb01161.x
   Sutton DN, 2003, INT J ORAL MAX SURG, V32, P30, DOI 10.1054/ijom.2002.0313
   Yuen APW, 2000, AM J SURG, V180, P139, DOI 10.1016/S0002-9610(00)00433-5
NR 23
TC 2
Z9 2
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1066-8969
EI 1940-2465
J9 INT J SURG PATHOL
JI Int. J. Surg. Pathol.
PD APR
PY 2009
VL 17
IS 2
BP 153
EP 157
DI 10.1177/1066896908315747
PG 5
WC Pathology; Surgery
SC Pathology; Surgery
GA 423PW
UT WOS:000264509200013
PM 18397902
DA 2020-11-30
ER

PT J
AU Leao, JC
   Ribeiro, CMB
   Carvalho, AAT
   Frezzini, C
   Porter, S
AF Leao, Jair C.
   Ribeiro, Camila M. B.
   Carvalho, Alessandra A. T.
   Frezzini, Cristina
   Porter, Stephen
TI ORAL COMPLICATIONS OF HIV DISEASE
SO CLINICS
LA English
DT Review
DE HIV; AIDS; Oral diseases; Oral manifestations; Mouth
ID HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY;
   EPSTEIN-BARR-VIRUS; HUMAN-PAPILLOMAVIRUS INFECTION; RECEIVING
   MEDICAL-CARE; WOMENS INTERAGENCY HIV; KAPOSIS-SARCOMA; RISK-FACTORS;
   LYMPHOCYTOSIS SYNDROME; BACTERIAL-INFECTIONS
AB Oral lesions are among the early signs of HIV infection and can predict its progression to acquired immunodeficiency syndrome (AIDS). A better understanding of the oral manifestations of AIDS in both adults and children has implications for all health care professionals. The knowledge of such alterations would allow for early recognition of HIV-infected patients. The present paper reviews epidemiology, relevant aspects of HIV infection related to the mouth in both adults and children, as well as current trends in antiretroviral therapy and its connection with orofacial manifestations related to AIDS.
C1 [Leao, Jair C.; Ribeiro, Camila M. B.; Carvalho, Alessandra A. T.] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
   [Frezzini, Cristina; Porter, Stephen] UCL Eastman Dent Inst, Div Maxillofacial Diagnost Med & Surg Sci, London, England.
RP Leao, JC (corresponding author), Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
EM jleao@ufpe.br
RI Leao, Jair Carneiro/AAL-6154-2020; Beder Ribeiro Girish Panjwani, Camila
   Maria/M-5453-2017
OI Leao, Jair Carneiro/0000-0001-8303-2291; Porter,
   Stephen/0000-0002-3328-2759; Beder Ribeiro Girish Panjwani, Camila
   Maria/0000-0003-0203-3079
CR Aleman S, 2002, AIDS, V16, P1039, DOI 10.1097/00002030-200205030-00010
   Arendorf T, 2000, ORAL DIS, V6, P133, DOI 10.1111/j.1601-0825.2000.tb00323.x
   Arora Anita, 2007, Cancer Treat Res, V133, P21
   ASCHER MS, 1988, CLIN EXP IMMUNOL, V73, P165
   Barasch A, 2004, ORAL SURG ORAL MED O, V97, P204, DOI 10.1016/j.tripleo.2003.09.005
   Beitler JJ, 1999, INT J RADIAT ONCOL, V45, P451, DOI 10.1016/S0360-3016(99)00179-0
   Bendick C, 2002, J ORAL PATHOL MED, V31, P1, DOI 10.1034/j.1600-0714.2002.310101.x
   Berretta M, 2003, ONCOGENE, V22, P6646, DOI 10.1038/sj.onc.1206771
   Blignaut E, 2002, DIAGN MICR INFEC DIS, V44, P169, DOI 10.1016/S0732-8893(02)00440-6
   Butt F M A, 2007, East Afr Med J, V84, P383
   Caccialanza M, 2008, J EUR ACAD DERMATOL, V22, P297, DOI 10.1111/j.1468-3083.2007.02405.x
   Cameron JE, 2005, SEX TRANSM DIS, V32, P703, DOI 10.1097/01.olq.0000175398.34610.2e
   Campo J, 2006, ORAL DIS, V12, P219, DOI 10.1111/j.1601-0825.2005.01187.x
   Campo J, 2002, J ORAL PATHOL MED, V31, P5, DOI 10.1034/j.1600-0714.2002.310102.x
   Ceballos-Salobrena A, 2000, AIDS PATIENT CARE ST, V14, P627, DOI 10.1089/10872910050206540
   CHALLACOMBE S, 1991, BR DENT J, V20, P305
   Chhieng DC, 1999, DIAGN CYTOPATHOL, V21, P260
   Chidzonga MM, 2008, JAIDS-J ACQ IMM DEF, V47, P579, DOI 10.1097/QAI.0b013e318160a554
   Chidzonga MM, 2003, ORAL DIS, V9, P317, DOI 10.1034/j.1601-0825.2003.00962.x
   Chua AC, 2008, SINGAP MED J, V49, P376
   Convissar RA, 2002, J AM DENT ASSOC, V133, P591, DOI 10.14219/jada.archive.2002.0234
   Convissar RA, 2002, J AM DENT ASSOC, V133, P624
   Coogan MM, 2005, B WORLD HEALTH ORGAN, V83, P700
   COOPER DA, 1985, LANCET, V1, P537
   Coulter ID, 2002, QUAL LIFE RES, V11, P57, DOI 10.1023/A:1014443418737
   Coutlee F, 1997, SEX TRANSM DIS, V24, P23, DOI 10.1097/00007435-199701000-00006
   DARMINIO MA, 2005, ARCH INTERN MED, V0165
   Dave SP, 2007, LARYNGOSCOPE, V117, P106, DOI 10.1097/01.mlg.0000246196.35413.35
   Dezube Bruce J, 2002, Expert Rev Anticancer Ther, V2, P193, DOI 10.1586/14737140.2.2.193
   Eldridge K, 2000, Int J Paediatr Dent, V10, P19, DOI 10.1046/j.1365-263x.2000.00168.x
   Eyeson JD, 2002, J ORAL PATHOL MED, V31, P169, DOI 10.1034/j.1600-0714.2002.310308.x
   Feller L, 2008, AIDS Res Ther, V5, P2, DOI 10.1186/1742-6405-5-2
   Ferris M, 2007, AIDS CARE, V19, P1088, DOI 10.1080/09540120701367124
   Flaitz C, 2001, Pediatr Dent, V23, P44
   Flint S, 2002, ORAL DIS, V8, P115, DOI 10.1034/j.1601-0825.2002.00022.x
   Fonseca R, 2000, QUINTESSENCE INT, V31, P419
   FRASER VJ, 1995, ANNU REV MED, V46, P203
   French MA, 2003, AIDS, V17, P1977, DOI 10.1097/00002030-200309050-00017
   Frezzini C, 2005, J ORAL PATHOL MED, V34, P513, DOI 10.1111/j.1600-0714.2005.00337.x
   Greenspan D, 2001, LANCET, V357, P1411, DOI 10.1016/S0140-6736(00)04578-5
   Greenspan D, 2000, J ACQ IMMUN DEF SYND, V25, P44, DOI 10.1097/00126334-200009010-00006
   Greenspan JS, 2002, ORAL DIS, V8, P34, DOI 10.1034/j.1601-0825.2002.00009.x
   Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580
   Hicks M. John, 2000, Pediatric Dentistry, V22, P359
   *HLTH PROT AG, 2006, CDR WEEKLY, V16, P51
   *HLTH PROT AG, 2005, EYE NEEDL SURV SIGN, P1
   Hodgson TA, 2002, ORAL DIS, V8, P80, DOI 10.1034/j.1601-0825.2002.00017.x
   HOFFMANN C, 2007, HIV MED, P89
   Holmes HK, 2002, ORAL DIS, V8, P40, DOI 10.1034/j.1601-0825.2002.00010.x
   Horowitz H W, 1998, Dis Mon, V44, P545, DOI 10.1016/S0011-5029(98)90014-1
   Jacobson LP, 1999, J ACQ IMMUN DEF SYND, V21, pS34
   James J, 2002, DERMATOL SURG, V28, P979, DOI 10.1046/j.1524-4725.2002.02099.x
   Jeeninga RE, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-37
   Johnson Victoria A, 2005, Top HIV Med, V13, P51
   Kahn JO, 1998, NEW ENGL J MED, V339, P33, DOI 10.1056/NEJM199807023390107
   KAMPS BS, 2007, HIV MED, P28
   Khongkunthian P, 2001, J ORAL PATHOL MED, V30, P549, DOI 10.1034/j.1600-0714.2001.300907.x
   Kreimer AR, 2004, J INFECT DIS, V189, P686, DOI 10.1086/381504
   Krown SE, 2001, CURR OPIN ONCOL, V13, P374, DOI 10.1097/00001622-200109000-00010
   Leao J C, 1999, Rev Assoc Med Bras (1992), V45, P55, DOI 10.1590/S0104-42301999000100011
   Levine AM, 2001, EUR J CANCER, V37, P1288, DOI 10.1016/S0959-8049(01)00109-5
   Lin HC, 2001, J DENT RES, V80, P1486, DOI 10.1177/00220345010800052001
   Magalhaes M G, 2001, J Clin Pediatr Dent, V25, P103
   Mandel L, 2002, ORAL SURG ORAL MED O, V94, P454, DOI 10.1067/moe.2002.126025
   Mandel L, 2001, J ORAL MAXIL SURG, V59, P283, DOI 10.1053/joms.2001.20992
   Mandel L, 1998, ORAL SURG ORAL MED O, V85, P565, DOI 10.1016/S1079-2104(98)90292-X
   MARCUS R, 1989, B WORLD HEALTH ORGAN, V67, P577
   Martro E, 2007, INT J CANCER, V120, P1129, DOI 10.1002/ijc.22281
   Mathews SA, 2008, J DENT RES, V87, P308, DOI 10.1177/154405910808700411
   MEDLEY GF, 1988, PROC R SOC SER B-BIO, V233, P367, DOI 10.1098/rspb.1988.0026
   METSCH LR, 2002, J ACQUIR IMMUNE D S2, V1, pS72
   Miralles P, 2002, MED CLIN-BARCELONA, V118, P788, DOI 10.1016/S0025-7753(02)72531-1
   Miro JM, 2004, ENFERM INFEC MICR CL, V22, P643, DOI 10.1157/13069207
   Miziara ID, 2008, J ORAL PATHOL MED, V37, P99, DOI 10.1111/j.1600-0714.2007.00598.x
   Monforte AD, 2005, ARCH INTERN MED, V165, P1200
   Moutsopoulos N M, 2006, Adv Dent Res, V19, P52
   Muzyka BC, 2001, ORAL SURG ORAL MED O, V92, P56, DOI 10.1067/moe.2001.112542
   *NACO, 2004, COMB HIV AIDS IND
   Naidoo S, 2004, ORAL DIS, V10, P13, DOI 10.1046/j.1354-523X.2003.00973.x
   Najioullah F, 2004, J MED VIROL, V73, P347, DOI 10.1002/jmv.20097
   Narani N, 2001, J CLIN PERIODONTOL, V28, P137, DOI 10.1034/j.1600-051x.2001.028002137.x
   Navarro CM, 2008, J PERIODONTOL, V79, P562, DOI 10.1902/jop.2008.070229 
   Navazesh M, 2003, ORAL SURG ORAL MED O, V95, P693, DOI 10.1067/moe.2003.230
   Nittayananta W, 2001, J ORAL PATHOL MED, V30, P224, DOI 10.1034/j.1600-0714.2001.300406.x
   Orlando G, 2007, AIDS PATIENT CARE ST, V21, P833, DOI 10.1089/apc.2007.0029
   Panayiotakopoulos GD, 2003, RHEUMATOLOGY, V42, P1164, DOI 10.1093/rheumatology/keg316
   Patton L, 2004, ORAL SURG ORAL MED O, V90, P182
   Patton LL, 2000, ORAL SURG ORAL MED O, V89, P299, DOI 10.1016/S1079-2104(00)70092-8
   Patton LL, 2002, ORAL DIS, V8, P98, DOI 10.1034/j.1601-0825.2002.00020.x
   Pongsiriwet S, 2003, Int J Paediatr Dent, V13, P180, DOI 10.1046/j.1365-263X.2003.00448.x
   Porter S R, 1998, Oral Dis, V4, P159
   Porter SR, 2004, ORAL SURG ORAL MED O, V97, P28, DOI 10.1016/j.tripleo.2003.07.010
   RAHMAN MA, 1989, J INFECT DIS, V159, P472, DOI 10.1093/infdis/159.3.472
   Ramirez-Amador V, 2002, ORAL ONCOL, V38, P460, DOI 10.1016/S1368-8375(01)00100-2
   Ramos-Gomez F J, 1999, J Clin Pediatr Dent, V23, P85
   Ranganathan K, 2006, Adv Dent Res, V19, P63
   Ranganathan K, 2000, ORAL DIS, V6, P152, DOI 10.1111/j.1601-0825.2000.tb00326.x
   Reichart P A, 1999, Mund Kiefer Gesichtschir, V3, P236, DOI 10.1007/s100060050142
   Reichart PA, 2003, MED MICROBIOL IMMUN, V192, P165, DOI 10.1007/s00430-002-0175-5
   Robinson PG, 2002, ORAL DIS, V8, P91, DOI 10.1034/j.1601-0825.2002.00019.x
   Robinson PG, 2000, J CLIN PERIODONTOL, V27, P273, DOI 10.1034/j.1600-051x.2000.027004273.x
   Rothenberg RB, 1998, AIDS, V12, P2095, DOI 10.1097/00002030-199816000-00004
   Salvatori F, 1998, AIDS RES HUM RETROV, V14, P1679, DOI 10.1089/aid.1998.14.1679
   SCHOFER H, 2007, HIV MED, P477
   Scully C, 2006, J DENT RES, V85, P794, DOI 10.1177/154405910608500903
   Scully C, 2001, ORAL DIS, V7, P205
   Scully C, 2000, ORAL DIS, V6, P92, DOI 10.1111/j.1601-0825.2000.tb00107.x
   Spina Michele, 1999, Current Opinion in Oncology, V11, P522, DOI 10.1097/00001622-199911000-00015
   Spitzer TR, 2008, BIOL BLOOD MARROW TR, V14, P59, DOI 10.1016/j.bbmt.2007.03.014
   Sroussi HY, 2007, J CAN DENT ASSOC, V73, P949
   Stahl-Hennig C, 1999, SCIENCE, V285, P1261, DOI 10.1126/science.285.5431.1261
   Stankov M. V., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P237, DOI 10.2174/187153007782794362
   Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5
   Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853
   Syrjanen S, 2005, J CLIN VIROL, V32, pS59, DOI 10.1016/j.jcv.2004.11.017
   Tang JW, 2004, J CLIN VIROL, V30, P1, DOI 10.1016/j.jcv.2003.12.002
   Tappuni AR, 2001, ORAL SURG ORAL MED O, V92, P623, DOI 10.1067/moe.2001.118902
   Teanpalsan R, 2001, J CLIN PERIODONTOL, V28, P311, DOI 10.1034/j.1600-051x.2001.028004311.x
   Thomas AO, 2001, SEMIN ONCOL, V28, P198, DOI [10.1016/S0093-7754(01)90092-2, 10.1053/sonc.2001.21965]
   TUKUTUKU K, 1990, J ORAL PATHOL MED, V19, P232, DOI 10.1111/j.1600-0714.1990.tb00832.x
   Turner MD, 2008, J AM DENT ASSOC, V139, P252
   Turner MD, 2007, J AM DENT ASSOC, V138, p15S, DOI 10.14219/jada.archive.2007.0358
   *UNAIDS, 2007, REP GLOB AIDS EP 200
   *UNAIDS, 2008, 2 UNAIDS JOINT UN PR
   VALENTINE C, 1992, LANCET, V340, P1542, DOI 10.1016/0140-6736(92)92791-D
   Walling DM, 2003, J INFECT DIS, V188, P883, DOI 10.1086/378072
   Walling DM, 2001, J INFECT DIS, V184, P1499, DOI 10.1086/323992
   WILLIAMS DM, 1993, J ORAL PATHOL MED, V22, P289
   Williams FM, 1998, ARTHRITIS RHEUM-US, V41, P863, DOI 10.1002/1529-0131(199805)41:5&lt;863::AID-ART13&gt;3.0.CO;2-F
   Williams IG, 2003, INT J CLIN PRACT, V57, P890
   Wood R, 2002, ORAL DIS, V8, P32, DOI 10.1034/j.1601-0825.2002.00008.x
   Younai FS, 2001, ORAL SURG ORAL MED O, V92, P629, DOI 10.1067/moe.2001.117816
   1992, LANCET, V340, P1259
NR 133
TC 31
Z9 36
U1 0
U2 4
PU HOSPITAL CLINICAS, UNIV SAO PAULO
PI SAO PAULO
PA FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL
SN 1807-5932
EI 1980-5322
J9 CLINICS
JI Clinics
PY 2009
VL 64
IS 5
BP 459
EP 470
DI 10.1590/S1807-59322009000500014
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA 455BX
UT WOS:000266732100014
PM 19488613
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Leao, JC
   Ingafou, M
   Khan, A
   Scully, C
   Porter, S
AF Leao, J. C.
   Ingafou, M.
   Khan, A.
   Scully, C.
   Porter, S.
TI Linear IgA disease and desquamative gingivitis
SO ORAL DISEASES
LA English
DT Letter
C1 [Leao, J. C.; Ingafou, M.; Khan, A.; Scully, C.; Porter, S.] UCL Eastman Dent Inst, Div Maxillofacial Diagnost Med & Surg Sci, London, England.
   [Leao, J. C.] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
RP Leao, JC (corresponding author), UCL Eastman Dent Inst, Div Maxillofacial Diagnost Med & Surg Sci, London, England.
EM jleao@ufpe.br
RI Porter, Stephen/B-3519-2009; Leao, Jair Carneiro/AAL-6154-2020; Ingafou,
   Mohamed/AAF-2548-2019
OI Leao, Jair Carneiro/0000-0001-8303-2291; Porter,
   Stephen/0000-0002-3328-2759
CR PORTER SR, 1992, ORAL SURG ORAL MED O, V74, P179, DOI 10.1016/0030-4220(92)90379-5
NR 1
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1354-523X
J9 ORAL DIS
JI Oral Dis.
PD NOV
PY 2008
VL 14
IS 8
BP 770
EP 770
DI 10.1111/j.1601-0825.2008.01487.x
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 361AS
UT WOS:000260100500015
DA 2020-11-30
ER

PT J
AU Leao, JC
   Ingafou, M
   Khan, A
   Scully, C
   Porter, S
AF Leao, J. C.
   Ingafou, M.
   Khan, A.
   Scully, C.
   Porter, S.
TI Desquamative gingivitis: retrospective analysis of disease associations
   of a large cohort
SO ORAL DISEASES
LA English
DT Article
DE desquamative gingivitis; oral lesions; immunologically mediated diseases
ID ORAL LICHEN-PLANUS; LINEAR IGA DISEASE; PEMPHIGUS-VULGARIS; LESIONS;
   CANCER; MANIFESTATIONS; MUCOSA; OPINIONS; DENTISTS
AB BACKGROUND: Desquamative gingivitis (DG) is usually a manifestation of immunologically mediated mucocutaneous disorders, although it was previously suggested to be hormonally related.
   METHODS: One hundred and eighty-seven Caucasian UK residents with clinical features of DG (126 female, median age of 51 years, range 23-93 years) were retrospectively evaluated.
   RESULTS: It was established that, in this population, the largest cohort yet reported, oral lichen planus was most common (70.5%) while mucous membrane pemphigoid (14%), pemphigus vulgaris (13%), linear IgA disease (1.6%), dermatomyositis (0.5%) and mixed connective tissue disease (0.5%) were less common.
   CONCLUSION: Oral lichen planus is the main disorder associated with DG. However, DG may be a feature of bullous disease and connective tissue disease.
C1 [Leao, J. C.; Ingafou, M.; Khan, A.; Scully, C.; Porter, S.] UCL Eastman Dent Inst, Div Maxillofacial Diagnost Med & Surg Sci, London, England.
   [Leao, J. C.] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
RP Porter, S (corresponding author), UCL Eastman Dent Inst, Div Maxillofacial Diagnost Med & Surg Sci, London, England.
EM sporter@eastman.ucl.ac.uk
RI Ingafou, Mohamed/AAF-2548-2019; Leao, Jair Carneiro/AAL-6154-2020;
   Porter, Stephen/B-3519-2009
OI Leao, Jair Carneiro/0000-0001-8303-2291; Porter,
   Stephen/0000-0002-3328-2759
CR Ahlfors EE, 2001, ACTA ODONTOL SCAND, V59, P248, DOI 10.1080/00016350152509283
   Alkan A, 2003, J INT MED RES, V31, P340, DOI 10.1177/147323000303100414
   Anil S, 1994, Ann Dent, V53, P15
   Arteaga S, 1990, Conn Dent Stud J, V10, P25
   BELDING JH, 1968, J AM DENT ASSOC, V77, P612
   Blanco A, 2000, MED ORAL, V5, P231
   Challacombe SJ, 2001, ACTA ODONTOL SCAND, V59, P226, DOI 10.1080/00016350152509256
   Chlebowski RT, 2004, NEW ENGL J MED, V350, P991, DOI 10.1056/NEJMoa032071
   Chorzelski T P, 1975, Int J Dermatol, V14, P429, DOI 10.1111/j.1365-4362.1975.tb00135.x
   Clovis Joanne B, 2002, J Can Dent Assoc, V68, P421
   del Valle AE, 2003, J PERIODONTOL, V74, P879
   Egan CA, 2001, AM J GASTROENTEROL, V96, P1927, DOI 10.1016/S0002-9270(01)02460-1
   Egan CA, 1997, IRISH J MED SCI, V166, P241, DOI 10.1007/BF02944243
   Eisen D, 2002, J AM ACAD DERMATOL, V46, P207, DOI 10.1067/mjd.2002.120452
   GANDARA RJM, 2003, MED ORAL, V8, P309
   Hacker-foegen MK, 2003, J INVEST DERMATOL, V121, P1365, DOI 10.1111/j.1523-1747.2003.12601.x
   HERLOFSON BB, 1993, ACTA ODONTOL SCAND, V51, P39, DOI 10.3109/00016359309041146
   JONES LE, 1972, J PERIODONTOL, V43, P35, DOI 10.1902/jop.1972.43.1.35
   KOSSARD S, 1979, ACTA DERM-VENEREOL, V59, P527
   Kuttan Nithyanand A. A., 2001, General Dentistry, V49, P596
   LASKARIS G, 1982, ORAL SURG ORAL MED O, V54, P656, DOI 10.1016/0030-4220(82)90080-9
   Lodi G, 2005, ORAL SURG ORAL MED O, V100, P40, DOI 10.1016/j.tripleo.2004.06.077
   Markopoulos A K, 1996, Quintessence Int, V27, P763
   Mignogna MD, 2004, ORAL ONCOL, V40, P120, DOI 10.1016/j.oraloncology.2003.08.001
   Navarro CM, 1999, J PERIODONTOL, V70, P808, DOI 10.1902/jop.1999.70.7.808
   NISENGARD RJ, 1981, J PERIODONTOL, V52, P500, DOI 10.1902/jop.1981.52.9.500
   Oostingh Gertie J., 2002, Autoimmunity Reviews, V1, P267, DOI 10.1016/S1568-9972(02)00056-3
   PORTER SR, 1992, ORAL SURG ORAL MED O, V74, P179, DOI 10.1016/0030-4220(92)90379-5
   Puranwasi R, 2001, SADJ, V56, P554
   Ricketts DNJ, 1997, ORAL SURG ORAL MED O, V84, P488, DOI 10.1016/S1079-2104(97)90263-8
   Rodstrom PO, 2004, ORAL ONCOL, V40, P131, DOI 10.1016/S1368-8375(03)00134-9
   ROGERS RS, 1982, J AM ACAD DERMATOL, V7, P729, DOI 10.1016/S0190-9622(82)70153-7
   Rogers RS, 2003, DERMATOL CLIN, V21, P49, DOI 10.1016/S0733-8635(02)00061-X
   Scully C, 1999, J CLIN PERIODONTOL, V26, P234, DOI 10.1034/j.1600-051X.1999.260406.x
   Scully C, 1999, BRIT J DERMATOL, V140, P84
   Scully C, 1997, SEMIN CUTAN MED SURG, V16, P308, DOI 10.1016/S1085-5629(97)80021-1
   SKLAVOUNOU A, 1983, ORAL SURG ORAL MED O, V56, P141, DOI 10.1016/0030-4220(83)90278-5
   Slomov E, 2003, HUM IMMUNOL, V64, P771, DOI 10.1016/S0198-8859(03)00092-2
   Stahlberg C, 2004, INT J CANCER, V109, P721, DOI 10.1002/ijc.20016
   Stoopler ET, 2003, QUINTESSENCE INT, V34, P582
   Vaillant L, 2000, ANN DERMATOL VENER, V127, P381
   Warnakulasuriya KAAS, 1999, ORAL DIS, V5, P10
   Whiteside OJH, 2003, J LARYNGOL OTOL, V117, P885, DOI 10.1258/002221503322542917
   Yellowitz J, 1998, J AM DENT ASSOC, V129, P579, DOI 10.14219/jada.archive.1998.0275
   Yih WY, 2000, J PERIODONTOL, V71, P482, DOI 10.1902/jop.2000.71.3.482
   Yih WY, 1998, J PERIODONTOL, V69, P678
NR 46
TC 42
Z9 43
U1 0
U2 1
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1354-523X
J9 ORAL DIS
JI Oral Dis.
PD SEP
PY 2008
VL 14
IS 6
BP 556
EP 560
DI 10.1111/j.1601-0825.2007.01420.x
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 337BF
UT WOS:000258409800013
PM 18298421
DA 2020-11-30
ER

PT J
AU Gueiros, LA
   Lopes, MA
   Leao, JC
AF Gueiros, Luiz Alcino
   Lopes, Marcio Ajudarte
   Leao, Jair Carneiro
TI Paget's disease and bisphosphonate-associated osteonecrosis of the jaws
SO JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Letter
RI Gueiros, Luiz Alcino/B-6429-2015; Gueiros, Luiz Alcino/F-7171-2012;
   Leao, Jair Carneiro/AAL-6154-2020; Lopes, Marcio Ajudarte/AAV-1018-2020
OI Gueiros, Luiz Alcino/0000-0003-4979-4318; Gueiros, Luiz
   Alcino/0000-0003-4979-4318; Leao, Jair Carneiro/0000-0001-8303-2291; 
CR Bamias A, 2005, J CLIN ONCOL, V23, P8580, DOI 10.1200/JCO.2005.02.8670
   Boissier S, 1997, CANCER RES, V57, P3890
   Bone HG, 2004, NEW ENGL J MED, V350, P1189, DOI 10.1056/NEJMoa030897
   Hosking D, 2006, BONE, V38, P3, DOI 10.1016/j.bone.2005.11.011
   MCMAHON P, 1986, ARCH OTOLARYNGOL, V112, P668
   Reid IR, 2005, NEW ENGL J MED, V353, P898, DOI 10.1056/NEJMoa044241
   Shane E, 2006, J BONE MINER RES, V21, P1503, DOI 10.1359/JBMR.060712
   THOMAS DW, 1994, AUST DENT J, V39, P162, DOI 10.1111/j.1834-7819.1994.tb03085.x
NR 8
TC 2
Z9 2
U1 0
U2 2
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0278-2391
EI 1531-5053
J9 J ORAL MAXIL SURG
JI J. Oral Maxillofac. Surg.
PD JUN
PY 2008
VL 66
IS 6
BP 1319
EP 1319
DI 10.1016/j.joms.2008.02.011
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 306SJ
UT WOS:000256267800040
PM 18486809
DA 2020-11-30
ER

PT J
AU Torres-Pereira, C
   Possebon, RS
   Simoes, A
   Bortoluzzi, MC
   Leao, JC
   Giovanini, AF
   Piazetta, CM
AF Torres-Pereira, Cassius
   Possebon, Renata Seleme
   Simoes, Andre
   Bortoluzzi, Marcelo Carlos
   Leao, Jair Carneiro
   Giovanini, Allan Fernando
   Piazetta, Cleto Mariosvaldo
TI Email for distance diagnosis of oral diseases: a preliminary study of
   teledentistry
SO JOURNAL OF TELEMEDICINE AND TELECARE
LA English
DT Article
ID TELEMEDICINE SYSTEM; LESIONS; EXPERIENCE
AB We examined the feasibility of distance diagnosis of oral diseases, using transmission of digital images by email. Twenty-five cases of oral lesions were documented during a 12-month study in a primary care public health clinic in Parana in Southern Brazil. Clinical electronic charts and images were produced and sent by email to two oral medicine specialists with a median of 10 years experience in the field. The consultants provided a maximum of two clinical hypotheses for each case. In 15 of the 25 cases (60%) both consultants made a correct diagnosis; in seven cases (28%) only one consultant made a correct diagnosis; and in three cases (12%) neither consultant made a correct diagnosis. Thus in 88% of cases, at least one consultant was able to provide the correct diagnosis. The results suggest that distant diagnosis can be an effective alternative in the diagnosis of oral lesions and that the using two distant consultants improves diagnostic accuracy. Primary care public health clinics may benefit from the use of email and digital cameras for telehealth in remote areas where oral medicine specialists are not available.
C1 [Torres-Pereira, Cassius; Piazetta, Cleto Mariosvaldo] Univ Fed Parana, Dept Stomatol, BR-80210170 Curitiba, Parana, Brazil.
   [Simoes, Andre] Dept Oral Hlth, Doutor Ulysses, PR USA.
   [Bortoluzzi, Marcelo Carlos] Univ Oeste Santa Catarina, Dept Stomatol, Joacaba, SC, Brazil.
   [Leao, Jair Carneiro] Univ Fed Pernambuco, Clin & Preventat Dent Dept, Recife, PE, Brazil.
   [Giovanini, Allan Fernando] Univ Positivo, Oral Pathol Lab, Curitiba, Parana, Brazil.
RP Torres-Pereira, C (corresponding author), Univ Fed Parana, Dept Stomatol, Ave Lothario Meissner 632, BR-80210170 Curitiba, Parana, Brazil.
EM cassius@ufpr.br
RI Giovanini, Allan Fernando/K-5215-2012; Leao, Jair
   Carneiro/AAL-6154-2020; Torres-Pereira, Cassius C/A-8553-2012;
   Torres-Pereira, Cassius Carvalho/AAD-8719-2020
OI Leao, Jair Carneiro/0000-0001-8303-2291; Torres-Pereira, Cassius
   Carvalho/0000-0001-8049-7544; Giovanini, Allan/0000-0002-1637-2955
FU Brazilian National Research CouncilNational Council for Scientific and
   Technological Development (CNPq) [38-2004]
FX We thank the Brazilian National Research Council for financial support
   (grant 38-2004 Decit-Ministerio da Saude).
CR Baker WP, 2000, J ENDODONT, V26, P39, DOI 10.1097/00004770-200001000-00010
   Corr P, 2000, J TELEMED TELECARE, V6, P233, DOI 10.1258/1357633001935293
   Farman A G, 1993, Dent Clin North Am, V37, P669
   Hayakawa Y, 1996, Quintessence Int, V27, P175
   Jacobs MJE, 2002, BRIT J ORAL MAX SURG, V40, P156, DOI 10.1054/bjom.2001.0751
   Knol A, 2006, J TELEMED TELECARE, V12, P75, DOI 10.1258/135763306776084365
   Leao J C, 1999, Braz Dent J, V10, P47
   Lee S, 2003, J PEDIATR SURG, V38, P1281, DOI 10.1016/S0022-3468(03)00382-8
   Lozzi GP, 2007, J EUR ACAD DERMATOL, V21, P30, DOI 10.1111/j.1468-3083.2006.01846.x
   Massone C, 2007, HUM PATHOL, V38, P546, DOI 10.1016/j.humpath.2006.10.006
   Mistak EJ, 1998, J ENDODONT, V24, P262, DOI 10.1016/S0099-2399(98)80110-6
   Piccolo D, 2000, J TELEMED TELECARE, V6, P132, DOI 10.1258/1357633001935202
   Roccia F, 2005, J ORAL MAXIL SURG, V63, P1101, DOI 10.1016/j.joms.2005.04.020
   Rollert MK, 1999, J ORAL MAXIL SURG, V57, P136, DOI 10.1016/S0278-2391(99)90226-4
   Stephens Chris, 2002, Dent Clin North Am, V46, P507, DOI 10.1016/S0011-8532(02)00010-1
   TYNDALL DA, 1995, ORAL SURG ORAL MED O, V80, P599, DOI 10.1016/S1079-2104(05)80156-8
   Vassallo DJ, 2001, J TELEMED TELECARE, V7, P125, DOI 10.1258/1357633011936273
NR 17
TC 34
Z9 37
U1 0
U2 9
PU ROYAL SOC MEDICINE PRESS LTD
PI LONDON
PA 1 WIMPOLE STREET, LONDON W1G 0AE, ENGLAND
SN 1357-633X
J9 J TELEMED TELECARE
JI J. Telemed. Telecare
PY 2008
VL 14
IS 8
BP 435
EP 438
DI 10.1258/jtt.2008.080510
PG 4
WC Health Care Sciences & Services
SC Health Care Sciences & Services
GA 393FH
UT WOS:000262355900007
PM 19047454
DA 2020-11-30
ER

PT J
AU Leao, JC
   Gomes, VB
   Porter, S
AF Leao, Jair Carneiro
   Gomes, Valder Barbosa
   Porter, Stephen
TI Ulcerative lesions of the mouth: An update for the general medical
   practitioner
SO CLINICS
LA English
DT Review
DE oral ulceration; oral medicine; oral lesions; recurrent aphthous
   stomatitis; recurrent oral ulceration
ID ORAL LICHEN-PLANUS; KAPOSIS-SARCOMA; CROHNS-DISEASE; DOUBLE-BLIND;
   OROFACIAL MANIFESTATIONS; DESQUAMATIVE GINGIVITIS; APHTHOUS STOMATITIS;
   PRIMARY SYPHILIS; VIRUS INFECTION; HIV-INFECTION
AB Oral ulceration is a common complaint of patients attending out-patient clinics. Because of the diversity in causes of oral ulceration, patients presenting with oral mucosal disease can be challenging to diagnose and manage. Patients with signs or symptoms of oral ulcers are sometimes referred to gastroenterology clinics; however, in most instances the ulcers do not result from gastrointestinal disease. The aim of the present article is to review aspects of the etiology, diagnosis and management of common ulcerative disorders of the oral mucosa. A search in the National Library of Medicine computerized bibliographic database MEDLINE was performed. Selection of publications, extraction of data, and validity assessment were then performed by the authors. Based upon the searched literature, it is concluded that there are several systemic disorders that can present with similar clinical signs and symptoms, and knowledge of each disease is necessary for the clinician to provide proper management.
C1 [Leao, Jair Carneiro; Gomes, Valder Barbosa] Univ Fed Pernambuco, Dept Clin Odontol Prevent, Recife, PE, Brazil.
   [Porter, Stephen] Univ London, Eastman Dent Inst Oral Hlth Care Sci, Div Maxillofacial Diagnost, Oral Med Unit, London WC1E 7HU, England.
RP Leao, JC (corresponding author), Univ Fed Pernambuco, Dept Clin Odontol Prevent, Recife, PE, Brazil.
EM jleao@ufpe.br
RI Leao, Jair Carneiro/AAL-6154-2020; Porter, Stephen/B-3519-2009
OI Leao, Jair Carneiro/0000-0001-8303-2291; Porter,
   Stephen/0000-0002-3328-2759
CR ADEKEYE EO, 1983, J MAXILLOFAC SURG, V11, P160, DOI 10.1016/S0301-0503(83)80040-X
   Ajay G N, 2006, Indian J Dent Res, V17, P87
   Alam F, 2000, BRIT DENT J, V189, P352, DOI 10.1038/sj.bdj.4800767a
   Arayssi T, 2004, CURR OPIN PHARMACOL, V4, P183, DOI 10.1016/j.coph.2003.10.009
   BACCAGLINI L, 2007, ORAL SURG ORAL MED O, V103, P21
   Barrons RW, 2001, AM J HEALTH-SYST PH, V58, P41, DOI 10.1093/ajhp/58.1.41
   Blanksma CJ, 2005, INT DENT J, V55, P365
   Bratel J, 1998, J ORAL PATHOL MED, V27, P415
   Bunzli D, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-10
   DIALBERTI L, 1997, ORAL DIS, V1, P133
   Dios PD, 1998, ORAL ONCOL, V34, P236
   Dorr W, 2005, RADIOTHER ONCOL, V75, P99, DOI 10.1016/j.radonc.2004.12.006
   Eisen D, 2001, CUTIS, V68, P201
   Enwonwu CO, 1999, AM J TROP MED HYG, V60, P223, DOI 10.4269/ajtmh.1999.60.223
   Epstein Joel B, 2006, Expert Opin Emerg Drugs, V11, P353, DOI 10.1517/14728214.11.2.353
   Feder HM, 2000, CURR OPIN PEDIATR, V12, P253, DOI 10.1097/00008480-200006000-00014
   Femiano F, 2003, ORAL SURG ORAL MED O, V95, P324, DOI 10.1067/moe.2003.4
   FICARRA G, 1993, ORAL SURG ORAL MED O, V75, P220, DOI 10.1016/0030-4220(93)90097-N
   Ficarra G, 1997, Oral Dis, V3 Suppl 1, pS183
   FIRTH NA, 1994, AUST DENT J, V39, P273, DOI 10.1111/j.1834-7819.1994.tb05560.x
   Flaitz CM, 1996, ORAL SURG ORAL MED O, V81, P433, DOI 10.1016/S1079-2104(96)80019-9
   Fleischer G, 2006, STRAHLENTHER ONKOL, V182, P567, DOI 10.1007/s00066-006-1587-8
   FLUCKIGER R, 1994, GASTROENTEROLOGY, V106, P506
   GANDARAREY JM, 2002, MED ORAL, V7
   Gibson J, 2000, NUCL MED COMMUN, V21, P155, DOI 10.1097/00006231-200002000-00006
   Goodger NM, 2005, BRIT DENT J, V198, P333, DOI 10.1038/sj.bdj.4812171
   GUPTA PC, 1986, LANCET, V1, P1235
   Harty S, 2005, CLIN GASTROENTEROL H, V3, P886, DOI 10.1016/S1542-3565(05)00424-6
   Hegarty AM, 2002, J AM ACAD DERMATOL, V47, P271, DOI 10.1067/mjd.2002.120922
   Hernandez-Martin A, 2003, BRIT J DERMATOL, V149, P663, DOI 10.1046/j.1365-2133.2003.05503.x
   HUNTER L, 1987, BRIT DENT J, V162, P106, DOI 10.1038/sj.bdj.4806042
   Ilyas S E, 2002, HIV Med, V3, P283
   Jones AC, 2000, ORAL SURG ORAL MED O, V89, P323, DOI 10.1016/S1079-2104(00)70097-7
   Kaliakatsou F, 2002, J AM ACAD DERMATOL, V46, P35, DOI 10.1067/mjd.2002.120535
   Kauzman A, 2006, J CAN DENT ASSOC, V72, P325
   Kleymann G, 2005, EXPERT OPIN INV DRUG, V14, P135, DOI 10.1517/13543784.14.2.135
   Kokuba H, 1998, BRIT J DERMATOL, V138, P952
   Kominek Pavel, 2006, Ear Nose Throat J, V85, P604
   Lackey Mark A, 2003, Gen Dent, V51, P250
   Lager I, 2003, ORAL SURG ORAL MED O, V96, P701, DOI 10.1016/S1079-2104(03)00370-6
   LEBOURGEOIS JP, 1994, RADIOTHER ONCOL, V30, P263, DOI 10.1016/0167-8140(94)90467-7
   LOH FC, 1989, J ORAL PATHOL MED, V18, P533, DOI 10.1111/j.1600-0714.1989.tb01358.x
   MacPhail L, 1997, SEMIN CUTAN MED SURG, V16, P301, DOI 10.1016/S1085-5629(97)80020-X
   MacPhail LA, 1997, ORAL DISEASES S1, V3, P190
   Malkin Jean-Elie, 2004, Herpes, V11 Suppl 1, p2A
   Masucci G, 2005, MED ONCOL, V22, P247, DOI 10.1385/MO:22:3:247
   McCartan B E, 1997, Oral Dis, V3, P58
   Moraru RA, 2000, CUTIS, V66, P15
   Morrel EM, 2006, CLIN INFECT DIS, V43, P460, DOI 10.1086/505872
   Myoken Y, 1996, J ORAL MAXIL SURG, V54, P263, DOI 10.1016/S0278-2391(96)90737-5
   Nagao Y, 1996, EUR J CLIN INVEST, V26, P1171, DOI 10.1046/j.1365-2362.1996.610607.x
   Nowak Maciej, 2002, Wiad Lek, V55, P542
   O'Regan E, 2004, ARCH OTOLARYNGOL, V130, P469, DOI 10.1001/archotol.130.4.469
   Okolo Sn, 2006, Ghana Med J, V40, P22
   Orosz Mihaly, 2004, Fogorv Sz, V97, P113
   PORTER S, 1994, BRIT J ORAL MAX SURG, V32, P241, DOI 10.1016/0266-4356(94)90209-7
   PORTER SR, 1993, BRIT J DERMATOL, V129, P753, DOI 10.1111/j.1365-2133.1993.tb03352.x
   Porter SR, 1998, CRIT REV ORAL BIOL M, V9, P306, DOI 10.1177/10454411980090030401
   Porter SR, 1997, ORAL SURG ORAL MED O, V83, P325, DOI 10.1016/S1079-2104(97)90237-7
   Porter Stephen, 2002, Clin Evid, P1397
   Rajkumar T, 2003, EUR J CANCER PREV, V12, P135, DOI 10.1097/00008469-200304000-00007
   Ramirez-Amador V, 2002, ORAL ONCOL, V38, P460, DOI 10.1016/S1368-8375(01)00100-2
   Ramirez-Amador VA, 1999, CLIN INFECT DIS, V28, P892, DOI 10.1086/515222
   Ranganathan K, 2006, Adv Dent Res, V19, P63
   REICHART PA, 1989, INT J ORAL MAX SURG, V18, P197, DOI 10.1016/S0901-5027(89)80050-5
   Robinson JA, 2005, BIOORGAN MED CHEM, V13, P2055, DOI 10.1016/j.bmc.2005.01.009
   Rodstrom PO, 2004, ORAL ONCOL, V40, P131, DOI 10.1016/S1368-8375(03)00134-9
   Sanderson J, 2005, INFLAMM BOWEL DIS, V11, P840, DOI 10.1097/01.MIB.0000178261.88356.67
   Sarisky RT, 2002, ANTIMICROB AGENTS CH, V46, P2848, DOI 10.1128/AAC.46.9.2848-2853.2002
   Sathishkumar T, 2005, Indian J Dermatol Venereol Leprol, V71, P432
   Schofer H, 2004, HAUTARZT, V55, P112, DOI 10.1007/s00105-003-0608-0
   Scope A, 2003, CLIN INFECT DIS, V37, pE83, DOI 10.1086/377045
   SCULLY C, 1991, ORAL SURG ORAL MED O, V71, P158, DOI 10.1016/0030-4220(91)90459-P
   SCULLY C, 1991, ORAL SURG ORAL MED O, V71, P167, DOI 10.1016/0030-4220(91)90460-T
   SCULLY C, 1992, J ORAL PATHOL MED, V21, P289, DOI 10.1111/j.1600-0714.1992.tb01013.x
   Scully C, 1998, CRIT REV ORAL BIOL M, V9, P86, DOI 10.1177/10454411980090010501
   Shetty K, 2005, SPEC CARE DENT, V25, P236, DOI 10.1111/j.1754-4505.2005.tb01656.x
   SILVERMAN S, 1976, CANCER-AM CANCER SOC, V38, P1790, DOI 10.1002/1097-0142(197610)38:4<1790::AID-CNCR2820380456>3.0.CO;2-I
   Solomon LW, 2007, ORAL SURG ORAL MED O, V103, pE39, DOI 10.1016/j.tripleo.2006.08.005
   Srinivasan U, 1998, BMJ-BRIT MED J, V316, P206
   STEINER M, 1966, ORAL SURG ORAL MED O, V21, P530, DOI 10.1016/0030-4220(66)90413-0
   Szczepanski T, 2004, PEDIATR BLOOD CANCER, V42, P343, DOI 10.1002/pbc.10466
   TYLDESLEY WR, 1979, BRIT J ORAL SURG, V17, P1, DOI 10.1016/0007-117X(79)90001-5
   VANDERPIJI JW, 1992, PRESSE MED, V21, P395
   Wu JJ, 2005, DERMATOL CLIN, V23, P313, DOI 10.1016/j.det.2004.09.001
NR 85
TC 20
Z9 20
U1 2
U2 8
PU HOSPITAL CLINICAS, UNIV SAO PAULO
PI SAO PAULO
PA FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL
SN 1807-5932
EI 1980-5322
J9 CLINICS
JI Clinics
PD DEC
PY 2007
VL 62
IS 6
BP 769
EP 780
DI 10.1590/S1807-59322007000600018
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA 278YD
UT WOS:000254321300018
PM 18209920
OA DOAJ Gold
DA 2020-11-30
ER

PT J
AU Frezzini, C
   Cedro, M
   Leao, JC
   Porter, S
AF Frezzini, Cristina
   Cedro, Monika
   Leao, Jair C.
   Porter, Stephen
TI Darier disease affecting the gingival and oral mucosal surfaces
SO ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND
   ENDODONTOLOGY
LA English
DT Article
AB Darier disease is an uncommon genodermatosis reflecting defective desmosomal structure and function. The present report details the oral features of a patient with well-characterized Darier disease and reviews current knowledge of the genetic basis of this genodermatosis that can often affect the craniofacial tissues. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:e29-e33)
C1 [Frezzini, Cristina; Cedro, Monika; Porter, Stephen] UCL, Div Maxillofacial Diagnost Med & Surg Sci, Eastman Dent Inst Oral Hlth Care Sci, London WC1X 8LD, England.
   [Leao, Jair C.] Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
RP Porter, S (corresponding author), UCL, Div Maxillofacial Diagnost Med & Surg Sci, Eastman Dent Inst Oral Hlth Care Sci, 256 Grays Inn Rd, London WC1X 8LD, England.
EM sporter@eastman.ucl.ac.uk
RI Leao, Jair Carneiro/AAL-6154-2020
OI Leao, Jair Carneiro/0000-0001-8303-2291; Porter,
   Stephen/0000-0002-3328-2759
CR ADAMS AM, 1994, DENTOMAXILLOFAC RAD, V23, P25, DOI 10.1259/dmfr.23.1.8181655
   Ahn W, 2003, J BIOL CHEM, V278, P20795, DOI 10.1074/jbc.M301638200
   Beier C, 1999, ARCH DERMATOL, V135, P423, DOI 10.1001/archderm.135.4.423
   BURGE SM, 1992, J AM ACAD DERMATOL, V27, P40, DOI 10.1016/0190-9622(92)70154-8
   Burnouf M, 2003, PRESSE MED, V32, P1219
   Chao SC, 2002, BRIT J DERMATOL, V146, P958, DOI 10.1046/j.1365-2133.2002.04786.x
   COHEN KI, 1976, ARCH DERMATOL, V112, P504
   Dhitavat J, 2004, BRIT J DERMATOL, V150, P821, DOI 10.1111/j.1365-2133.2004.05904.x
   Dolci M, 2004, ORAL ONCOL, V40, P856, DOI 10.1016/j.oraloncology.2004.01.016
   FERRIS T, 1990, BRIT DENT J, V168, P71, DOI 10.1038/sj.bdj.4807086
   GRAHAMBROWN RAC, 1983, J ROY SOC MED, V76, P609
   Inada M, 1999, DERMATOLOGY, V198, P167, DOI 10.1159/000018097
   Jones I, 2002, MOL PSYCHIATR, V7, P424, DOI 10.1038/sj.mp.4000989
   LATOUR DL, 1981, J DERMATOL SURG ONC, V7, P408, DOI 10.1111/j.1524-4725.1981.tb00666.x
   Liu LH, 2001, J BIOL CHEM, V276, P26737, DOI 10.1074/jbc.C100275200
   MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815
   MACLEOD RI, 1991, BRIT DENT J, V171, P133, DOI 10.1038/sj.bdj.4807636
   MCELROY JA, 1990, J AM ACAD DERMATOL, V23, P893, DOI 10.1016/0190-9622(90)70311-5
   MUNRO CS, 1992, BRIT J DERMATOL, V127, P126, DOI 10.1111/j.1365-2133.1992.tb08044.x
   Onozuka T, 2004, BRIT J DERMATOL, V150, P652, DOI 10.1111/j.0007-0963.2004.05868.x
   PRINDIVILLE DE, 1976, J ORAL SURG, V34, P1001
   Ringpfeil F, 2001, EXP DERMATOL, V10, P19, DOI 10.1034/j.1600-0625.2001.100103.x
   Ruiz-Perez VL, 1999, HUM MOL GENET, V8, P1621, DOI 10.1093/hmg/8.9.1621
   Sakuntabhai A, 1999, NAT GENET, V21, P271
   Sakuntabhai A, 1999, HUM MOL GENET, V8, P1611, DOI 10.1093/hmg/8.9.1611
   SPOUGE JD, 1966, ORAL SURG ORAL MED O, V21, P441, DOI 10.1016/0030-4220(66)90401-4
   Takahashi H, 2001, J DERMATOL SCI, V26, P169, DOI 10.1016/S0923-1811(00)00173-0
   Tavadia S, 2004, BRIT J DERMATOL, V151, P440, DOI 10.1111/j.1365-2133.2004.06130.x
   TEGNER E, 1990, ACTA DERM-VENEREOL, V70, P451
   WEATHERS DR, 1974, ORAL SURG ORAL MED O, V37, P711, DOI 10.1016/0030-4220(74)90136-4
   Yang Y, 2001, J INVEST DERMATOL, V116, P482, DOI 10.1046/j.1523-1747.2001.127910.x
   ZACHARIAE H, 1979, ACTA DERM-VENEREOL, V59, P184
   ZACHARIAE H, 1992, J AM ACAD DERMATOL, V27, P136, DOI 10.1016/S0190-9622(08)80832-8
NR 33
TC 8
Z9 9
U1 0
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1079-2104
J9 ORAL SURG ORAL MED O
JI Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.
PD OCT
PY 2006
VL 102
IS 4
BP E29
EP E33
DI 10.1016/j.tripleo.2005.10.040
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA V16OS
UT WOS:000207879500007
PM 16997091
DA 2020-11-30
ER

PT J
AU Campisi, G
   Giovannelli, L
   Calvino, F
   Matranga, D
   Colella, G
   Di Liberto, C
   Capra, G
   Leao, JC
   Lo Muzio, L
   Capogreco, M
   D'Angelo, M
AF Campisi, G.
   Giovannelli, L.
   Calvino, F.
   Matranga, D.
   Colella, G.
   Di Liberto, C.
   Capra, G.
   Leao, J. C.
   Lo Muzio, L.
   Capogreco, M.
   D'Angelo, M.
TI HPV infection in relation to OSCC histological grading and TNM stage.
   Evaluation by traditional statistics and fuzzy logic model
SO ORAL ONCOLOGY
LA English
DT Article
DE OSCC; HPV-DNA; grading; TNM; stage; fuzzy logic
ID SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS INFECTION; NUCLEAR ANTIGEN
   EXPRESSION; NORMAL ORAL-MUCOSA; NECK CANCERS; TONSILLAR CARCINOMAS;
   DNA-SEQUENCES; HEAD; RISK; TYPE-16
AB We aimed to evaluate if in oral squamous cell carcinoma (OSCC) there is a relationship between histological grading (HG), TNM clinical stage and HPV infection; and to study the performance of fuzzy Logic compared to traditional statistics, in the analysis of HPV status and correlates of OSCC. In cross-sectional analysis, the study group comprised 63 patients (mean age 68.89 years (SD +/- 11.78), range (32-93); mates 28 (44.4%), females 35 (55.6%)) with OSCC histologically diagnosed. HPV-DNA was studied in exfoliated oral epithelial. cells by nested PCR (MY09/MY11 and GP5+/GP6+ primers). Data were analysed in parallel by traditional. statistics with multivariate analysis and a fuzzy logic (FL) technique (membership functions as input, the ANFIS methodology, and the Sugeno's model of first order). HPV infection was detected in 24/63 (38.1%) of OSCC, as being HPV+ve 14/36 (38.9%) in G1, 7/18 (38.9%) in G2, and 3/9 (33.3%) in G3; HPV+ve 8/33 (24.2%) in Stage I, 9/12 (75.0%) in Stage II, 6/11(54.5%) in Stage III, and 1/7 (14.3%) in Stage IV. In both methods of analysis, no significantly increased risk of HPV infection was found for any HG score; whereas, TNM stage II was significantly associated to HPV infection (p=0.004; OR=9.375 (95% CI=2.030:43.30); OR'=11.148 (95% CI = 1.951:43.30)), and, in particular, to primary tumour size T2 (p = 0.0036; OR = 7.812 (95% CI = 1.914:31.890); OR' = 9.414 (95% CI = 1.846:48.013)); FL (% of prevision: 79.8; Root Mean-Square Error (RMSE): 0.29). No association was found between HPV infection and any demographical variable. Our findings show an association between HPV infection with TNM (stage II - T2), but not with histological grading of OSCC. Also, FL seems to be an additional effective tool. in analysing the relationship of HPV infection with correlates of OSCC. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Palermo, Dipartimento Sci Stomatol, I-90127 Palermo, Italy.
   Univ Palermo, Dipartimento Igiene & Microbiol, I-90127 Palermo, Italy.
   Dipartimento Biotecnol Med & Med Legale, I-90127 Palermo, Italy.
   Univ Naples Federico II, Dipartimento Patol Testa & Collo, SUN, I-80100 Naples, Italy.
   Univ Fed Pernambuco, Dept Clin & Odontol Prevent, BR-50670420 Recife, PE, Brazil.
   Univ Foggia, Dipartimento Sci Chirurg, I-71100 Foggia, Italy.
   Univ Aquila, Dipartimento Sci Chirurg, I-67110 Coppito, AQ, Italy.
RP Campisi, G (corresponding author), Univ Palermo, Dipartimento Sci Stomatol, Via Vespro 129, I-90127 Palermo, Italy.
EM campisi@odonto.unipa.it
RI Matranga, Domenica/I-4974-2019; Muzio, Lorenzo Lo/C-8533-2011;
   Giovannelli, Lucia/K-9377-2016
OI Matranga, Domenica/0000-0002-2466-937X; Muzio, Lorenzo
   Lo/0000-0003-4633-4893; Giovannelli, Lucia/0000-0002-4629-8362; campisi,
   giuseppina/0000-0002-9443-0495; CAPRA, Giuseppina/0000-0002-1407-7282
CR Agresti A., 2002, CATEGORICAL DATA ANA
   ALTMANN A, 1992, EUR J CANCER, V28A, P326, DOI 10.1016/S0959-8049(05)80047-4
   Armstrong DJ, 1997, VIROLOGY, V239, P238, DOI 10.1006/viro.1997.8885
   BALARAM P, 1995, INT J CANCER, V61, P450, DOI 10.1002/ijc.2910610403
   BORING CC, 1994, CA-CANCER J CLIN, V44, P7, DOI 10.3322/canjclin.44.1.7
   Bouda M, 2000, MODERN PATHOL, V13, P644, DOI 10.1038/modpathol.3880113
   Braakhuis BJM, 2004, JNCI-J NATL CANCER I, V96, P998, DOI 10.1093/jnci/djh183
   Brown DR, 1996, J MED VIROL, V48, P108, DOI 10.1002/(SICI)1096-9071(199601)48:1<108::AID-JMV17>3.0.CO;2-C
   Campisi G, 2004, ORAL ONCOL, V40, P835, DOI 10.1016/j.oraloncology.2004.02.007
   Castellsague X, 2004, INT J CANCER, V108, P741, DOI 10.1002/ijc.11627
   Castellsague X, 2002, VIRUS RES, V89, P191, DOI 10.1016/S0168-1702(02)00188-0
   Chang JYF, 2003, AM J CLIN PATHOL, V120, P909, DOI 10.1309/C5P6UQ2NW6LCTBP
   Correnti M, 2004, ORAL DIS, V10, P163, DOI 10.1046/j.1601-0825.2003.00989.x
   Dahlstrom KR, 2003, CLIN CANCER RES, V9, P2620
   Dayhoff JE, 2001, CANCER, V91, P1615, DOI 10.1002/1097-0142(20010415)91:8+<1615::AID-CNCR1175>3.0.CO;2-L
   de Jong RJB, 2001, HEAD NECK-J SCI SPEC, V23, P718
   De Villiers EM, 2004, INT J CANCER, V109, P253, DOI 10.1002/ijc.11685
   DONOFRIO V, 1995, ORAL ONCOL, V31B, P174, DOI 10.1016/0964-1955(95)00003-Z
   Fortin A, 2001, J CLIN ONCOL, V19, P4107, DOI 10.1200/JCO.2001.19.21.4107
   Gillison Maura L., 1999, Current Opinion in Oncology, V11, P191, DOI 10.1097/00001622-199905000-00010
   Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709
   Gillison ML, 2001, CURR OPIN ONCOL, V13, P183, DOI 10.1097/00001622-200105000-00009
   Giovannelli L, 2002, J INFECT DIS, V185, P833, DOI 10.1086/339193
   Gonzalez-Moles M A, 1996, Acta Stomatol Belg, V93, P113
   Ha PK, 2004, CRIT REV ORAL BIOL M, V15, P188, DOI 10.1177/154411130401500402
   Heffner Dennis K, 2002, Ann Diagn Pathol, V6, P399, DOI 10.1053/adpa.2002.36652
   Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg107, 10.1093/jnci/djg/107]
   Higa M, 2003, ORAL ONCOL, V39, P405, DOI 10.1016/S1368-8375(02)00164-1
   HOSMER DW, 2000, SL APPL LOGISTIC REG
   JALAL H, 1992, J ORAL PATHOL MED, V21, P465, DOI 10.1111/j.1600-0714.1992.tb00976.x
   Klussmann JP, 2001, CANCER, V92, P2875, DOI 10.1002/1097-0142(20011201)92:11&lt;2875::AID-CNCR10130&gt;3.0.CO;2-7
   Klussmann JP, 2003, MED MICROBIOL IMMUN, V192, P129, DOI 10.1007/s00430-002-0126-1
   Kojima A, 2002, ORAL ONCOL, V38, P591, DOI 10.1016/S1368-8375(01)00112-9
   Krul EJT, 1999, INT J GYNECOL CANCER, V9, P206
   Kumar RV, 2003, INT J ORAL MAX SURG, V32, P539, DOI 10.1054/ijom.2002.0407
   KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0
   LAWTON G, 1992, J ORAL PATHOL MED, V21, P265, DOI 10.1111/j.1600-0714.1992.tb01008.x
   Li W, 2003, INT J CANCER, V106, P553, DOI 10.1002/ijc.11261
   Lindel K, 2001, CANCER-AM CANCER SOC, V92, P805, DOI 10.1002/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO;2-9
   MIN BM, 1994, EUR J CANC B, V5, P338
   Mork J, 2001, NEW ENGL J MED, V344, P1125, DOI 10.1056/NEJM200104123441503
   NEVILLE BW, 2002, ORAL MAXILLOFACIAL P, P365
   Nielsen H, 1996, ORAL ONCOL, V32B, P264, DOI 10.1016/0964-1955(96)00011-5
   OSTWALD C, 1994, J ORAL PATHOL MED, V23, P220, DOI 10.1111/j.1600-0714.1994.tb01117.x
   Park JS, 1996, GYNECOL ONCOL, V60, P418, DOI 10.1006/gyno.1996.0066
   Pintos J, 1999, CANCER-AM CANCER SOC, V85, P1903, DOI 10.1002/(SICI)1097-0142(19990501)85:9<1903::AID-CNCR4>3.0.CO;2-6
   Ringstrom E, 2002, CLIN CANCER RES, V8, P3187
   Ritchie JM, 2003, INT J CANCER, V104, P336, DOI 10.1002/ijc.10960
   Schwartz SM, 1998, JNCI-J NATL CANCER I, V90, P1626, DOI 10.1093/jnci/90.21.1626
   Schwartz SR, 2001, OTOLARYNG HEAD NECK, V125, P1, DOI 10.1067/mhn.2001.116979
   Sebbelov AM, 2000, MICROBES INFECT, V2, P121, DOI 10.1016/S1286-4579(00)00276-8
   SHINDOH M, 1995, CANCER, V76, P1513, DOI 10.1002/1097-0142(19951101)76:9<1513::AID-CNCR2820760903>3.0.CO;2-4
   Sisk EA, 2000, HEAD NECK-J SCI SPEC, V22, P649, DOI 10.1002/1097-0347(200010)22:7<649::AID-HED2>3.0.CO;2-B
   Smith EM, 1998, LARYNGOSCOPE, V108, P1098, DOI 10.1097/00005537-199807000-00027
   Smith EM, 2004, JNCI-J NATL CANCER I, V96, P449, DOI 10.1093/jnci/djh074
   Smith EM, 2004, INT J CANCER, V108, P766, DOI 10.1002/ijc.11633
   Snijders PJF, 1996, INT J CANCER, V66, P464, DOI 10.1002/(SICI)1097-0215(19960516)66:4<464::AID-IJC9>3.0.CO;2-U
   Soares CP, 2003, ANAL QUANT CYTOL, V25, P19
   Sugiyama M, 2003, ORAL SURG ORAL MED O, V95, P594, DOI 10.1067/moe.2003.36
   Tang XF, 2003, J ORAL PATHOL MED, V32, P393, DOI 10.1034/j.1600-0714.2003.00122.x
   Vernon SD, 2000, J CLIN MICROBIOL, V38, P651, DOI 10.1128/JCM.38.2.651-655.2000
   Yen J, 1999, FUZZY LOGIC INTELLIG
   ZADEH LA, 1982, COGNITION, V12, P291, DOI 10.1016/0010-0277(82)90036-1
   Zhang ZY, 2004, INT J ORAL MAX SURG, V33, P71, DOI 10.1054/ijom.2002.0443
   ZURHAUSEN H, 1994, ANNU REV MICROBIOL, V48, P427, DOI 10.1146/annurev.micro.48.1.427
NR 65
TC 17
Z9 19
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1368-8375
EI 1879-0593
J9 ORAL ONCOL
JI Oral Oncol.
PD JUL
PY 2006
VL 42
IS 6
BP 638
EP 645
DI 10.1016/j.oraloncology.2005.11.007
PG 8
WC Oncology; Dentistry, Oral Surgery & Medicine
SC Oncology; Dentistry, Oral Surgery & Medicine
GA 068VK
UT WOS:000239402400014
PM 16483833
DA 2020-11-30
ER

PT J
AU Leao, JC
   Teo, CG
   Porter, SR
AF Leao, JC
   Teo, CG
   Porter, SR
TI HCV infection: aspects of epidemiology and transmission relevant to oral
   health care workers
SO INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Review
ID HEPATITIS-C-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; INJECTION-DRUG USERS;
   IATROGENIC TRANSMISSION; OCCUPATIONAL RISK; SJOGRENS-SYNDROME;
   VIRAL-HEPATITIS; SALIVARY-GLANDS; SAN-FRANCISCO; BLOOD-DONORS
AB Hepatitis C virus (HCV) infection is a common worldwide problem, giving rise to long-term viral carriage and risk of chronic hepatic disease, hepatic malignancy and a wide spectrum Of immunologically mediated disorders. The present report describes relevant data suggesting that nosocomial transmission to oral health care workers is unlikely, but in view of medical and occupational consequences of such infection, and the absence of long-term effective treatment or vaccine, the oral surgery profession must continue to be vigilant and to maintain the highest standards of infection control procedures to minimize the possible acquisition of HCV during dental treatment.
C1 Univ Fed Pernambuco, Dept Clin & Odontol Prevent, BR-50970901 Recife, PE, Brazil.
   Hlth Protect Agcy, Ctr Communicable Dis Surveillance, Viral Ref Div, London, England.
   UCL, Eastman Dent Inst Oral Hlth Care Sci, Div Maxillofacial Diagnost Med & Surg Sci, London, England.
RP Leao, JC (corresponding author), Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Av Prof Moraes Rego 1235, BR-50970901 Recife, PE, Brazil.
EM jleao@upfe.br
RI Porter, Stephen/B-3519-2009
OI Porter, Stephen/0000-0002-3328-2759
CR Ammon A, 2000, EPIDEMIOL INFECT, V125, P407, DOI 10.1017/S0950268899004537
   Arrieta JJ, 2000, HEPATOLOGY, V32, P97, DOI 10.1053/jhep.2000.8533
   Arrieta JJ, 2001, AM J PATHOL, V158, P259, DOI 10.1016/S0002-9440(10)63964-8
   Balogun MA, 2002, J INFECTION, V45, P219, DOI 10.1053/jinf.2002.1059
   Belec L, 2003, J HEPATOL, V38, P833, DOI 10.1016/S0168-8278(03)00119-3
   Beltrami EM, 2003, AM J INFECT CONTROL, V31, P168, DOI 10.1067/mic.2003.27
   Boonyarad V, 2003, J GASTROENTEROL, V38, P1053, DOI 10.1007/s00535-003-1205-9
   Bourlet T, 2002, J CLIN MICROBIOL, V40, P3252, DOI 10.1128/JCM.40.9.3252-3255.2002
   BRESEE JS, 1996, JAMA-J AM MED ASSOC, P1563
   Butsashvili M, 2001, EUR J EPIDEMIOL, V17, P693, DOI 10.1023/A:1015566132757
   Carrozzo M, 2002, J HEPATOL, V37, P364, DOI 10.1016/S0168-8278(02)00183-6
   Chatzipantazi P, 2004, ARCH DIS CHILD, V89, P185, DOI 10.1136/adc.2003.031310
   Chernetsova O V, 2003, Klin Med (Mosk), V81, P37
   CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562
   Chung H, 2003, J GASTROENTEROL, V38, P877, DOI 10.1007/s00535-003-1156-1
   Cody SH, 2002, ARCH INTERN MED, V162, P345, DOI 10.1001/archinte.162.3.345
   Desenclos J C, 2000, Rev Prat, V50, P1066
   Di Stefano R, 2002, J MED VIROL, V67, P339, DOI 10.1002/jmv.10081
   Dinsmoor M J, 2001, Curr Womens Health Rep, V1, P27
   Esteban JI, 1996, NEW ENGL J MED, V334, P555, DOI 10.1056/NEJM199602293340902
   Evans JL, 2003, J URBAN HEALTH, V80, P137, DOI 10.1093/jurban/jtg137
   File E, 2003, TRANSPLANTATION, V76, P1096, DOI 10.1097/01.TP.0000088663.76640.C9
   Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7
   FRIED MW, 1995, SEMIN LIVER DIS, V15, P82, DOI 10.1055/s-2007-1007265
   GERBERDING JL, 1994, J INFECT DIS, V170, P1410, DOI 10.1093/infdis/170.6.1410
   HADDAD J, 1992, LANCET, V339, P321, DOI 10.1016/0140-6736(92)91645-O
   Hammer GP, 2003, SEX TRANSM DIS, V30, P919, DOI 10.1097/01.OLQ.0000091152.31366.E6
   Hansurabhanon T, 2002, ANN TROP MED PARASIT, V96, P615, DOI 10.1179/000349802125001465
   Henderson DK, 2003, CLIN MICROBIOL REV, V16, P546, DOI 10.1128/CMR.16.3.546-568.2003
   HERBERT AM, 1992, LANCET, V339, P305
   Hermida M, 2002, J VIROL METHODS, V101, P29, DOI 10.1016/S0166-0934(01)00417-7
   Hosoglu S, 2003, AM J INFECT CONTROL, V31, P502, DOI 10.1016/j.ajic.2003.03.005
   Ishida T, 2002, J CLIN VIROL, V24, P31, DOI 10.1016/S1386-6532(01)00222-0
   Judd A, 2003, J MED VIROL, V71, P49, DOI 10.1002/jmv.10463
   KLEIN RS, 1991, LANCET, V338, P1539, DOI 10.1016/0140-6736(91)92369-D
   Kuboki M, 1999, LIVER, V19, P88, DOI 10.1111/j.1478-3231.1999.tb00016.x
   KUO MYP, 1993, J MED VIROL, V40, P10, DOI 10.1002/jmv.1890400104
   Lagging LM, 2002, SCAND J INFECT DIS, V34, P580, DOI 10.1080/00365540110080926
   Li Min-min, 2003, Di Yi Jun Yi Da Xue Xue Bao, V23, P1290
   Lodi G, 1997, BRIT DENT J, V183, P329, DOI 10.1038/sj.bdj.4809488
   Lucidarme D, 2003, GASTROEN CLIN BIOL, V27, P159
   Madhava V, 2002, LANCET INFECT DIS, V2, P293, DOI 10.1016/S1473-3099(02)00264-5
   Mastromatteo AM, 2001, HEPATO-GASTROENTEROL, V48, P193
   Maticic M, 2003, ORAL MICROBIOL IMMUN, V18, P176, DOI 10.1034/j.1399-302X.2003.00063.x
   Maticic M, 2001, J PERIODONTOL, V72, P11, DOI 10.1902/jop.2001.72.1.11
   Minor P D, 2002, Dev Biol (Basel), V108, P15
   Montella M, 2003, EUR J CANCER PREV, V12, P85, DOI 10.1097/00008469-200302000-00013
   MULLER HM, 1993, J GEN VIROL, V74, P669, DOI 10.1099/0022-1317-74-4-669
   Murphy EL, 2000, HEPATOLOGY, V31, P756, DOI 10.1002/hep.510310329
   Neyts J, 1999, Verh K Acad Geneeskd Belg, V61, P661
   Nie Qinghe, 2002, Zhonghua Fu Chan Ke Za Zhi, V37, P19
   Njouom R, 2003, J MED VIROL, V71, P219, DOI 10.1002/jmv.10473
   Nyamathi Adeline, 2002, Biol Res Nurs, V4, P22, DOI 10.1177/1099800402004001004
   Ortiz-Movilla N, 2002, J MED VIROL, V68, P529, DOI 10.1002/jmv.10238
   Pappalardo BL, 2003, INT J EPIDEMIOL, V32, P727, DOI 10.1093/ije/dyg107
   Pekler VA, 2003, J CLIN LAB ANAL, V17, P264, DOI 10.1002/jcla.10107
   PETERS M, 1986, PROG LIVER DIS, V8, P453
   Rey D, 2001, J MED VIROL, V63, P117, DOI 10.1002/1096-9071(20000201)63:2&lt;117::AID-JMV1005&gt;3.0.CO;2-1
   Ross RS, 2002, J MED VIROL, V66, P461, DOI 10.1002/jmv.2166
   Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601
   Shehab TM, 2004, CLIN GASTROENTEROL H, V2, P425, DOI 10.1016/S1542-3565(04)00018-7
   Sherriff LCH, 2003, J PUBLIC HEALTH MED, V25, P358, DOI 10.1093/pubmed/fdg088
   Shiffman ML, 2004, GASTROENTEROLOGY, V126, P1015, DOI 10.1053/j.gastro.2004.01.014
   Thierfelder W, 2001, EUR J EPIDEMIOL, V17, P429, DOI 10.1023/A:1013792013184
   Thomas DL, 1996, AM J MED, V100, P41, DOI 10.1016/S0002-9343(96)90009-1
   Thorburn D, 2003, GUT, V52, P1333, DOI 10.1136/gut.52.9.1333
   Thorpe LE, 2002, AM J EPIDEMIOL, V155, P645, DOI 10.1093/aje/155.7.645
   Torre F, 2004, CLIN EXP IMMUNOL, V136, P507, DOI 10.1111/j.1365-2249.2004.02476.x
   Toussirot E, 2002, J RHEUMATOL, V29, P2382
   Valdivia José A, 2003, Rev. gastroenterol. Perú, V23, P265
   Vogel W, 1996, DIGEST DIS SCI, V41, pS81, DOI 10.1007/BF02087880
   Weissenbacher M, 2003, CLIN INFECT DIS, V37, pS348, DOI 10.1086/377560
   WILLIAMS L, 1999, AM J MED, V107, pS2
   Zuccotti G V, 2003, Pediatr Med Chir, V25, P6
NR 74
TC 13
Z9 13
U1 0
U2 3
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0901-5027
EI 1399-0020
J9 INT J ORAL MAX SURG
JI Int. J. Oral Maxillofac. Surg.
PD APR
PY 2006
VL 35
IS 4
BP 295
EP 300
DI 10.1016/j.ijom.2004.09.011
PG 6
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 025DG
UT WOS:000236244900001
PM 16487681
DA 2020-11-30
ER

PT J
AU Frezzini, C
   Leao, JC
   Porter, S
AF Frezzini, C
   Leao, JC
   Porter, S
TI Current trends of HIV disease of the mouth
SO JOURNAL OF ORAL PATHOLOGY & MEDICINE
LA English
DT Review
DE AIDS; developed; developing; HIV infection; mouth; oral
ID HUMAN-IMMUNODEFICIENCY-VIRUS; SARCOMA-ASSOCIATED HERPESVIRUS;
   EPSTEIN-BARR-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; SQUAMOUS-CELL
   CARCINOMA; ORAL HUMAN-PAPILLOMAVIRUS; INFILTRATIVE LYMPHOCYTOSIS
   SYNDROME; PEGYLATED-LIPOSOMAL DOXORUBICIN; PERIODONTAL ATTACHMENT LOSS;
   WOMENS INTERAGENCY HIV
AB HIV infection affects residents of all countries of the world, but the greater majority of affected individuals reside in the developing world. In the past decade there have been substantial changes in the management of HIV disease, particularly the introduction of highly active antiretroviral therapy (HAART). Such agents have reduced significantly the morbidity and mortality associated with HIV disease, however, they are not available for most HIV-infected individuals in the developing world. There is now considerable understanding of the molecular epidemiology, transmission and therapy of the common opportunistic oral infections of HIV disease, and as a consequence of improved anti-HIV strategies, the frequency and severity of oral disease associated with HIV infection have reduced considerably, although HAART may predispose to human papilloma virus infection of the mouth and potentially increase the risk of later oral squamous cell carcinoma. Despite advances in clinical care the majority of individuals with HIV disease worldwide will continue to develop oral disease, as they are resident in the developing world and do not have ready access to even simple therapies.
C1 Univ London, Eastman Dent Inst Oral Hlth Care Sci, Oral Med Div Maxillofacial Diagnost Med & Surg Sc, UCL, London WC1X 8LD, England.
   Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
RP Porter, S (corresponding author), Univ London, Eastman Dent Inst Oral Hlth Care Sci, Div Maxillofacial Diagnost Med & Surg Sci, UCL, 256 Grays Inn Rd, London WC1X 8LD, England.
EM sporter@eastman.ucl.ac.uk
RI Porter, Stephen/B-3519-2009; Leao, Jair Carneiro/AAL-6154-2020
OI Leao, Jair Carneiro/0000-0001-8303-2291; Porter,
   Stephen/0000-0002-3328-2759
CR *1999 INT WORKSH C, 1999, ANN PERIODONTOL, V4, P112
   Almeida OP, 2003, CRIT REV ORAL BIOL M, V14, P377, DOI 10.1177/154411130301400508
   Alpagot T, 2003, J CLIN PERIODONTOL, V30, P944, DOI 10.1034/j.1600-051X.2003.00403.x
   Ammaranond P, 2003, J CLIN VIROL, V26, P153, DOI 10.1016/S1386-6532(02)00114-2
   Anil S, 1996, Dent Update, V23, P424
   Appleby P, 2000, JNCI-J NATL CANCER I, V92, P1823, DOI 10.1093/jnci/92.22.1823
   Arendorf T, 2000, ORAL DIS, V6, P133, DOI 10.1111/j.1601-0825.2000.tb00323.x
   Arendorf T M, 1997, Oral Dis, V3 Suppl 1, pS54
   Baqui AAMA, 2000, ORAL MICROBIOL IMMUN, V15, P67, DOI 10.1034/j.1399-302x.2000.150201.x
   Barasch Andrei, 2000, Pediatric Dentistry, V22, P215
   Barillari G, 2003, DRUG RESIST UPDATE, V6, P173, DOI 10.1016/S1368-7646(03)00060-8
   Beitler JJ, 1995, AIDS PATIENT CARE, V9, P271, DOI 10.1089/apc.1995.9.271
   Beitler JJ, 1999, INT J RADIAT ONCOL, V45, P451, DOI 10.1016/S0360-3016(99)00179-0
   Bendick C, 2002, J ORAL PATHOL MED, V31, P1, DOI 10.1034/j.1600-0714.2002.310101.x
   Berretta M, 2003, ONCOGENE, V22, P6646, DOI 10.1038/sj.onc.1206771
   Beyari MM, 2003, J INFECT DIS, V188, P678, DOI 10.1086/377504
   Bicalho RN, 2001, ORAL DIS, V7, P56, DOI 10.1034/j.1601-0825.2001.70111.x
   Black KP, 2000, ORAL MICROBIOL IMMUN, V15, P74, DOI 10.1034/j.1399-302x.2000.150202.x
   BLATT SP, 1991, J INFECT DIS, V164, P215, DOI 10.1093/infdis/164.1.215
   Blignaut E, 2003, J CLIN MICROBIOL, V41, P1838, DOI 10.1128/JCM.41.5.1838-1842.2003
   Blignaut E, 2002, DIAGN MICR INFEC DIS, V44, P169, DOI 10.1016/S0732-8893(02)00440-6
   BOIOCCHI M, 1993, AM J PATHOL, V142, P33
   Borg-von Zepelin M, 2002, AIDS, V16, P1237, DOI 10.1097/00002030-200206140-00005
   Borrero JJ, 2002, AIDS, V16, P1979, DOI 10.1097/00002030-200209270-00022
   Bosch X, 2003, LANCET INFECT DIS, V3, P261, DOI 10.1016/S1473-3099(03)00622-4
   BOUDREAUX AA, 1993, J AM ACAD DERMATOL, V28, P61, DOI 10.1016/0190-9622(93)70010-Q
   Boulter AW, 1996, AIDS, V10, P935, DOI 10.1097/00002030-199610090-00002
   BOUQUOT JE, 1986, J AM DENT ASSOC, V112, P50, DOI 10.14219/jada.archive.1986.0007
   Bower M, 1999, AIDS, V13, P2105, DOI 10.1097/00002030-199910220-00014
   Brown Diana M., 2000, Pediatric Dentistry, V22, P234
   Campisi G, 2002, ORAL SURG ORAL MED O, V93, P281, DOI 10.1067/moe.2002.120804
   Campisi G, 2001, ORAL SURG ORAL MED O, V91, P546, DOI 10.1067/moe.2001.113548
   Campo J, 2002, J ORAL PATHOL MED, V31, P5, DOI 10.1034/j.1600-0714.2002.310102.x
   Canuto MM, 2000, EUR J CLIN MICROBIOL, V19, P593, DOI 10.1007/s100960000323
   Casariego Z, 2002, Med Oral, V7, P84
   Casariego Z, 2001, Med Oral, V6, P19
   Cassone A, 2002, J INFECT DIS, V185, P188, DOI 10.1086/338445
   Cathomas G, 2000, VIRCHOWS ARCH, V436, P195, DOI 10.1007/s004280050031
   Cattelan AM, 1999, EUR J CANCER, V35, P1809, DOI 10.1016/S0959-8049(99)00161-6
   Cattelan Anna M, 2002, Am J Clin Dermatol, V3, P451, DOI 10.2165/00128071-200203070-00002
   Ceballos-Salobrena A, 2000, AIDS PATIENT CARE ST, V14, P627, DOI 10.1089/10872910050206540
   CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802
   CHAK LY, 1988, J CLIN ONCOL, V6, P863, DOI 10.1200/JCO.1988.6.5.863
   CHAVANET P, 1990, LANCET, V336, P383, DOI 10.1016/0140-6736(90)91932-Z
   Chhieng DC, 1999, DIAGN CYTOPATHOL, V21, P260
   Chidzonga MM, 2004, ORAL DIS, V10, P229, DOI 10.1111/j.1601-0825.2004.01013.x
   Chidzonga MM, 2003, ORAL DIS, V9, P317, DOI 10.1034/j.1601-0825.2003.00962.x
   Cioc AM, 2004, AM J SURG PATHOL, V28, P41, DOI 10.1097/00000478-200401000-00003
   Cobb CM, 2003, J PERIODONTAL RES, V38, P147, DOI 10.1034/j.1600-0765.2003.02011.x
   Coleman DC, 1998, MED MYCOL, V36, P156
   Conant MA, 2000, J AM ACAD DERMATOL, V43, pS27, DOI 10.1067/mjd.2000.107810
   Conant MA, 1997, AIDS, V11, P1300, DOI 10.1097/00002030-199710001-00007
   Contreras A, 2000, J PERIODONTAL RES, V35, P3, DOI 10.1034/j.1600-0765.2000.035001003.x
   Contreras A, 1997, ORAL MICROBIOL IMMUN, V12, P259, DOI 10.1111/j.1399-302X.1997.tb00389.x
   Contreras A, 1999, J PERIODONTOL, V70, P478, DOI 10.1902/jop.1999.70.5.478
   Contreras A, 2001, J CLIN PERIODONTOL, V28, P96, DOI 10.1034/j.1600-051x.2001.280115.x
   Cook RD, 2002, J VIROL METHODS, V105, P297, DOI 10.1016/S0166-0934(02)00123-4
   Cook RD, 2002, J GEN VIROL, V83, P1613, DOI 10.1099/0022-1317-83-7-1613
   Coutlee F, 1997, SEX TRANSM DIS, V24, P23, DOI 10.1097/00007435-199701000-00006
   Dal Maso L, 2003, LANCET ONCOL, V4, P110, DOI 10.1016/S1470-2045(03)00983-5
   DeBernardis F, 1996, INFECT IMMUN, V64, P466, DOI 10.1128/IAI.64.2.466-471.1996
   Deeks SG, 2003, LANCET, V362, P2002, DOI 10.1016/S0140-6736(03)15022-2
   Del Mistro A, 2001, EUR J CANCER, V37, P1227, DOI 10.1016/S0959-8049(01)00107-1
   Delecluse HJ, 1997, BLOOD, V89, P1413, DOI 10.1182/blood.V89.4.1413
   DeRossi SS, 2004, CUTIS, V73, P191
   Dezube Bruce J, 2004, AIDS Read, V14, P236
   DIZ DP, 1999, ORAL SURG ORAL MED O, V87, P437
   DODD CL, 1991, AIDS, V5, P1339, DOI 10.1097/00002030-199111000-00009
   Domingo P, 2001, AM J MED, V110, P605, DOI 10.1016/S0002-9343(01)00703-3
   Eldridge K, 2000, Int J Paediatr Dent, V10, P19, DOI 10.1046/j.1365-263x.2000.00168.x
   Engels EA, 1999, J INFECT DIS, V180, P1784, DOI 10.1086/315146
   Eyeson JD, 2002, J ORAL PATHOL MED, V31, P169, DOI 10.1034/j.1600-0714.2002.310308.x
   Ferreira OG, 2002, ORAL SURG ORAL MED O, V93, P654, DOI 10.1067/moe.2002.122588
   Fichtenbaum CJ, 2000, AIDS, V14, P845, DOI 10.1097/00002030-200005050-00011
   Fingleton B, 2001, CURR OPIN ONCOL, V13, P368, DOI 10.1097/00001622-200109000-00009
   Fisher J M, 2001, SADJ, V56, P599
   Flaitz C, 2001, Pediatr Dent, V23, P44
   FLAITZ CM, 1995, ORAL SURG ORAL MED O, V80, P55, DOI 10.1016/S1079-2104(95)80016-6
   Fleury HJ, 2003, LANCET, V362, P210, DOI 10.1016/S0140-6736(03)13911-6
   Flint S, 2002, ORAL DIS, V8, P115, DOI 10.1034/j.1601-0825.2002.00022.x
   Fonseca R, 2000, QUINTESSENCE INT, V31, P419
   French MA, 2003, AIDS, V17, P1977, DOI 10.1097/00002030-200309050-00017
   Friedland G H, 1988, Int Nurs Rev, V35, P44
   FRIEDLAND GH, 1988, INT NURS REV, V35, P54
   Fumero E, 2003, CLIN MICROBIOL INFEC, V9, P1077, DOI 10.1046/j.1469-0691.2003.00730.x
   Fung HB, 2004, CLIN THER, V26, P352, DOI 10.1016/S0149-2918(04)90032-X
   Gee SF, 2002, J CLIN MICROBIOL, V40, P556, DOI 10.1128/JCM.40.2.556-574.2002
   Gelbier M, 2000, Int J Paediatr Dent, V10, P13, DOI 10.1046/j.1365-263x.2000.00169.x
   Giammanco GM, 2002, ORAL MICROBIOL IMMUN, V17, P89, DOI 10.1046/j.0902-0055.2001.00097.x
   GILLESPIE GM, 1993, J ORAL PATHOL MED, V22, P2, DOI 10.1111/j.1600-0714.1993.tb00110.x
   Giovani EM, 2000, ORAL DIS, V6, P327, DOI 10.1111/j.1601-0825.2000.tb00146.x
   GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401
   Greenspan D, 2001, LANCET, V357, P1411, DOI 10.1016/S0140-6736(00)04578-5
   Greenspan D, 2000, J ACQ IMMUN DEF SYND, V25, P44, DOI 10.1097/00126334-200009010-00006
   Greenspan JS, 2002, ORAL DIS, V8, P34, DOI 10.1034/j.1601-0825.2002.00009.x
   Greenwood I, 2002, ORAL DIS, V8, P90, DOI 10.1034/j.1601-0825.2002.1o787.x
   Gugnani HC, 2003, MYCOSES, V46, P299
   Harris NL, 1999, AM J CLIN PATHOL, V111, pS94
   Hernandez SL, 2004, J ORAL PATHOL MED, V33, P445
   Hille JJ, 2002, ORAL DIS, V8, P161, DOI 10.1034/j.1601-0825.2002.00028.x
   Hodgson TA, 2002, ORAL DIS, V8, P80, DOI 10.1034/j.1601-0825.2002.00017.x
   Hofer D, 2002, J CLIN PERIODONTOL, V29, P630, DOI 10.1034/j.1600-051X.2002.290707.x
   Holmes HK, 2002, ORAL DIS, V8, P40, DOI 10.1034/j.1601-0825.2002.00010.x
   Iamaroon A, 2003, ORAL DIS, V9, P14, DOI 10.1034/j.1601-0825.2003.01808.x
   Ishida CE, 1998, INT J DERMATOL, V37, P283, DOI 10.1046/j.1365-4362.1998.00426.x
   Jabra-Rizk MA, 1999, J CLIN MICROBIOL, V37, P321, DOI 10.1128/JCM.37.2.321-326.1999
   Jabra-Rizk MA, 2001, ORAL MICROBIOL IMMUN, V16, P383, DOI 10.1034/j.1399-302X.2001.160611.x
   JACOBSON LP, 1999, J ACQUIR IMMUNE D S1, V2, P34
   James J, 2002, DERMATOL SURG, V28, P979, DOI 10.1046/j.1524-4725.2002.02099.x
   Kedes DH, 1997, J CLIN INVEST, V99, P2082, DOI 10.1172/JCI119380
   Kerdpon D, 2004, ORAL DIS, V10, P138, DOI 10.1046/j.1601-0825.2003.00990.x
   Khongkunthian P, 2001, J ORAL PATHOL MED, V30, P220, DOI 10.1034/j.1600-0714.2001.300405.x
   Khongkunthian P, 2001, J ORAL PATHOL MED, V30, P549, DOI 10.1034/j.1600-0714.2001.300907.x
   King MD, 2002, CLIN INFECT DIS, V34, P641, DOI 10.1086/338637
   Kozinetz CA, 2000, AIDS PATIENT CARE ST, V14, P89, DOI 10.1089/108729100318028
   KREIDER JW, 1987, INT J CANCER, V39, P459, DOI 10.1002/ijc.2910390409
   Kreimer AR, 2004, J INFECT DIS, V189, P686, DOI 10.1086/381504
   Krown SE, 2003, HEMATOL ONCOL CLIN N, V17, P763, DOI 10.1016/S0889-8588(03)00042-X
   Krown SE, 2001, CURR OPIN ONCOL, V13, P374, DOI 10.1097/00001622-200109000-00010
   Kucharski L D, 2000, Braz J Infect Dis, V4, P255
   Langford A, 1995, Quintessence Int, V26, P635
   LASKARIS G, 1992, J ORAL PATHOL MED, V21, P120, DOI 10.1111/j.1600-0714.1992.tb00994.x
   Lasker BA, 2001, MED MYCOL, V39, P341
   LASSOUED K, 1990, CANCER, V66, P1869, DOI 10.1002/1097-0142(19901101)66:9<1869::AID-CNCR2820660903>3.0.CO;2-S
   Lateef F, 1998, ARCH DERMATOL, V134, P1169, DOI 10.1001/archderm.134.9.1169
   Leao JC, 2004, ORAL DIS, V10, P327, DOI 10.1111/j.1601-0825.2004.01042.x
   Leao JC, 2003, ORAL SURG ORAL MED O, V95, P142, DOI 10.1067/moe.2003.27
   Leao JC, 2000, ORAL SURG ORAL MED O, V90, P694, DOI 10.1067/moe.2000.110036
   Lebbe C, 1998, AIDS, V12, pF45, DOI 10.1097/00002030-199807000-00002
   Ledergerber B, 1999, BRIT MED J, V319, P23, DOI 10.1136/bmj.319.7201.23
   LEIGH IM, 1999, J ACQUIR IMMUNE D S1, V21, pOS49
   Levine AM, 2001, EUR J CANCER, V37, P1288, DOI 10.1016/S0959-8049(01)00109-5
   Lin AL, 2003, J DENT RES, V82, P719, DOI 10.1177/154405910308200912
   Lin AL, 2001, ORAL MICROBIOL IMMUN, V16, P270, DOI 10.1034/j.1399-302x.2001.016005270.x
   Lin HC, 2001, J DENT RES, V80, P1486, DOI 10.1177/00220345010800052001
   Lischewski A, 1999, MYCOSES, V42, P371, DOI 10.1046/j.1439-0507.1999.00474.x
   Little RF, 2000, J CLIN ONCOL, V18, P2593, DOI 10.1200/JCO.2000.18.13.2593
   Lukashov VV, 2000, INT J ANTIMICROB AG, V16, P463, DOI 10.1016/S0924-8579(00)00276-4
   Luomanen M, 1992, Proc Finn Dent Soc, V88, P49
   LUQUE AE, 2000, 40 INT C ANT AG CHEM
   Magalhaes M G, 2001, J Clin Pediatr Dent, V25, P103
   Mandel L, 2002, ORAL SURG ORAL MED O, V94, P454, DOI 10.1067/moe.2002.126025
   Mandel L, 2001, J ORAL MAXIL SURG, V59, P283, DOI 10.1053/joms.2001.20992
   MANDEL L, 1992, ORAL SURG ORAL MED O, V74, P273, DOI 10.1016/0030-4220(92)90057-W
   Mandel L, 1998, ORAL SURG ORAL MED O, V85, P565, DOI 10.1016/S1079-2104(98)90292-X
   Mardirossian A, 2000, J PERIODONTAL RES, V35, P278, DOI 10.1034/j.1600-0765.2000.035005278.x
   Margiotta V, 2000, ORAL DIS, V6, P194
   Martin DF, 1999, NEW ENGL J MED, V340, P1063, DOI 10.1056/NEJM199904083401402
   Martin JN, 1998, NEW ENGL J MED, V338, P948, DOI 10.1056/NEJM199804023381403
   Martinez M, 2002, J CLIN MICROBIOL, V40, P3135, DOI 10.1128/JCM.40.9.3135-3139.2002
   Martins MD, 1998, CLIN INFECT DIS, V27, P1291, DOI 10.1086/515006
   McArthur CP, 2000, ARCH PATHOL LAB MED, V124, P1773
   Medveczky MM, 1997, AIDS, V11, P1327, DOI 10.1097/00002030-199711000-00006
   Meiller TF, 1999, ORAL SURG ORAL MED O, V88, P573, DOI 10.1016/S1079-2104(99)70088-0
   Milan EP, 2001, DIAGN MICR INFEC DIS, V41, P29, DOI 10.1016/S0732-8893(01)00290-5
   MINTZER DM, 1985, ANN INTERN MED, V102, P200, DOI 10.7326/0003-4819-102-2-200
   Moore PS, 1996, SCIENCE, V274, P1739, DOI 10.1126/science.274.5293.1739
   Moraru RA, 2000, CUTIS, V66, P15
   Morgan D, 2002, AIDS, V16, P597, DOI 10.1097/00002030-200203080-00011
   Morgan D, 2001, AIDS, V15, P223, DOI 10.1097/00002030-200101260-00012
   Muzyka BC, 2001, ORAL SURG ORAL MED O, V92, P56, DOI 10.1067/moe.2001.112542
   Naburi AE, 2000, INT J STD AIDS, V11, P254, DOI 10.1258/0956462001915804
   Naesse EP, 2003, J PERIODONTAL RES, V38, P575, DOI 10.1034/j.1600-0765.2003.00687.x
   Naidoo S, 2004, ORAL DIS, V10, P13, DOI 10.1046/j.1354-523X.2003.00973.x
   Navazesh M, 2003, ORAL SURG ORAL MED O, V95, P693, DOI 10.1067/moe.2003.230
   Nicolatou-Galitis O, 2004, ORAL DIS, V10, P145, DOI 10.1046/j.1601-0825.2003.00994.x
   Nittayananta W, 2001, J ORAL PATHOL MED, V30, P224, DOI 10.1034/j.1600-0714.2001.300406.x
   Nittayananta W, 2001, J ORAL PATHOL MED, V30, P347, DOI 10.1034/j.1600-0714.2001.300604.x
   Nobre Vandack, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P69, DOI 10.1590/S0036-46652003000200003
   Northfelt DW, 1998, J CLIN ONCOL, V16, P2445, DOI 10.1200/JCO.1998.16.7.2445
   Oksenhendler E, 2002, BLOOD, V99, P2331, DOI 10.1182/blood.V99.7.2331
   Okunseri C, 2003, AIDS PATIENT CARE ST, V17, P5, DOI 10.1089/108729103321042863
   PAREDES J, 1995, J ACQ IMMUN DEF SYND, V9, P138
   Patel M, 2003, ORAL MICROBIOL IMMUN, V18, P199, DOI 10.1034/j.1399-302X.2003.00064.x
   Patton L, 2004, ORAL SURG ORAL MED O, V90, P182
   Patton LL, 2000, ORAL SURG ORAL MED O, V89, P299, DOI 10.1016/S1079-2104(00)70092-8
   Patton LL, 2002, ORAL DIS, V8, P98, DOI 10.1034/j.1601-0825.2002.00020.x
   Pauk J, 2000, NEW ENGL J MED, V343, P1369, DOI 10.1056/NEJM200011093431904
   PEREZ PA, 2004, FARM HOSP, V28, P106
   PETERSON PE, 2004, 5 WORLD WORKSH OR HL, P29
   Pillay D, 2000, REV MED VIROL, V10, P231, DOI 10.1002/1099-1654(200007/08)10:4&lt;231::AID-RMV290&gt;3.0.CO;2-P
   Pongsiriwet S, 2003, Int J Paediatr Dent, V13, P180, DOI 10.1046/j.1365-263X.2003.00448.x
   Porter SR, 2004, ORAL SURG ORAL MED O, V97, P28, DOI 10.1016/j.tripleo.2003.07.010
   Powderly WG, 1998, JAMA-J AM MED ASSOC, V280, P72, DOI 10.1001/jama.280.1.72
   Price P, 1999, TISSUE ANTIGENS, V54, P391, DOI 10.1034/j.1399-0039.1999.540409.x
   Race EM, 1998, LANCET, V351, P252, DOI 10.1016/S0140-6736(97)04352-3
   RAHMAN MA, 1989, J INFECT DIS, V159, P472, DOI 10.1093/infdis/159.3.472
   Ramirez-Amador V, 2002, ORAL ONCOL, V38, P460, DOI 10.1016/S1368-8375(01)00100-2
   Ramirez-Amador V, 2001, AIDS, V15, P1910, DOI 10.1097/00002030-200109280-00032
   Ramos-Gomez F, 2002, ORAL DIS, V8, P49, DOI 10.1034/j.1601-0825.2002.00012.x
   Ramos-Gomez F J, 1999, J Clin Pediatr Dent, V23, P85
   Ranganathan K, 2000, ORAL DIS, V6, P152, DOI 10.1111/j.1601-0825.2000.tb00326.x
   Regezi JA, 2002, ORAL SURG ORAL MED O, V94, P724, DOI 10.1067/moe.2002.129760
   Reichart P A, 1999, Mund Kiefer Gesichtschir, V3, P236, DOI 10.1007/s100060050142
   Reichart PA, 2000, COMMUNITY DENT ORAL, V28, P390, DOI 10.1034/j.1600-0528.2000.028005390.x
   ROBINSON P, 1993, BRIT DENT J, V175, P383, DOI 10.1038/sj.bdj.4808331
   Robinson PG, 2000, J CLIN PERIODONTOL, V27, P273, DOI 10.1034/j.1600-051x.2000.027004273.x
   Roland ME, 2001, J INFECT DIS, V184, P1608, DOI 10.1086/324580
   Ruhnke M, 1999, MYCOSES, V42, P385, DOI 10.1046/j.1439-0507.1999.00479.x
   Salvatori F, 1998, AIDS RES HUM RETROV, V14, P1679, DOI 10.1089/aid.1998.14.1679
   Samaranayake LP, 2002, ORAL DIS, V8, P151, DOI 10.1034/j.1601-0825.8.s2.6.x
   Samaranayake YH, 2003, MYCOSES, V46, P375, DOI 10.1046/j.0933-7407.2003.00919.x
   Samaranayake YH, 2003, J MED MICROBIOL, V52, P349, DOI 10.1099/jmm.0.04972-0
   Santos L C, 2001, Braz Dent J, V12, P135
   Scheifele C, 2003, ORAL ONCOL, V39, P619, DOI 10.1016/S1368-8375(03)00050-2
   Schiffman SS, 1999, NUTRITION, V15, P767, DOI 10.1016/S0899-9007(99)00152-5
   Schiodt M, 1997, Oral Dis, V3 Suppl 1, pS208
   Schmidt-Westhausen AM, 2000, J ORAL PATHOL MED, V29, P336, DOI 10.1034/j.1600-0714.2000.290708.x
   Schoofs AG, 1998, MYCOSES, V41, P203, DOI 10.1111/j.1439-0507.1998.tb00325.x
   SCHULTEN EAJM, 1989, J ORAL PATHOL MED, V18, P42, DOI 10.1111/j.1600-0714.1989.tb00731.x
   Schwartz SM, 1998, JNCI-J NATL CANCER I, V90, P1626, DOI 10.1093/jnci/90.21.1626
   Scully C, 1997, Oral Dis, V3 Suppl 1, pS200
   Scully C, 2000, Oral Dis, V6, P395
   Scully C, 2001, ORAL DIS, V7, P205
   Sgadari C, 2003, LANCET ONCOL, V4, P537, DOI 10.1016/S1470-2045(03)01192-6
   Sgadari C, 2002, NAT MED, V8, P225, DOI 10.1038/nm0302-225
   Shiboski CH, 1999, J ACQ IMMUN DEF SYND, V21, P236, DOI 10.1097/00126334-199907010-00009
   Simonart T, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-1
   Singh B, 1996, ARCH OTOLARYNGOL, V122, P639
   Singh B, 1999, ACTA ONCOL, V38, P1047, DOI 10.1080/028418699432347
   Sitas F, 2001, J Natl Cancer Inst Monogr, P1
   Slots J, 2000, ORAL MICROBIOL IMMUN, V15, P277, DOI 10.1034/j.1399-302x.2000.150501.x
   SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276
   Spina M, 1999, ANN ONCOL, V10, P87
   Spina M, 1999, ANN ONCOL, V10, P1271, DOI 10.1023/A:1008390028330
   Spina Michele, 1999, Current Opinion in Oncology, V11, P522, DOI 10.1097/00001622-199911000-00015
   SPOSTO MR, 1993, ORAL SURG ORAL MED O, V75, P461, DOI 10.1016/0030-4220(93)90171-Y
   Stewart S, 1998, J CLIN ONCOL, V16, P683, DOI 10.1200/JCO.1998.16.2.683
   Sullivan DJ, 2004, FEMS YEAST RES, V4, P369, DOI 10.1016/S1567-1356(03)00240-X
   Summersgill KF, 2001, ORAL SURG ORAL MED O, V91, P62, DOI 10.1067/moe.2001.108797
   Syrjanen S, 2005, J CLIN VIROL, V32, pS59, DOI 10.1016/j.jcv.2004.11.017
   Tacconelli E, 2002, JAIDS-J ACQ IMM DEF, V31, P38, DOI 10.1097/00126334-200209010-00005
   Tack PC, 1999, JAMA-J AM MED ASSOC, V281, P1085, DOI 10.1001/jama.281.12.1085
   TALACKO AA, 1991, J ORAL PATHOL MED, V20, P20, DOI 10.1111/j.1600-0714.1991.tb00882.x
   Tang JW, 2004, J CLIN VIROL, V30, P1, DOI 10.1016/j.jcv.2003.12.002
   Tangsinmankong N, 2004, J ALLERGY CLIN IMMUN, V113, P742, DOI 10.1016/j.jaci.2004.01.768
   TAPPERO JW, 1992, J AM ACAD DERMATOL, V27, P526, DOI 10.1016/0190-9622(92)70217-4
   TAPPERO JW, 1993, J AM ACAD DERMATOL, V28, P371, DOI 10.1016/0190-9622(93)70057-Z
   Tappuni AR, 2001, ORAL SURG ORAL MED O, V92, P623, DOI 10.1067/moe.2001.118902
   Tavio M, 1998, ANN ONCOL, V9, P923, DOI 10.1023/A:1008359628245
   Teanpalsan R, 2001, J CLIN PERIODONTOL, V28, P311, DOI 10.1034/j.1600-051x.2001.028004311.x
   TENZER JA, 1992, J AM DENT ASSOC, V123, P65, DOI 10.14219/jada.archive.1992.0318
   Teo CG, 2002, ORAL DIS, V8, P88, DOI 10.1034/j.1601-0825.2002.00018.x
   Thomas AO, 2001, SEMIN ONCOL, V28, P198, DOI [10.1016/S0093-7754(01)90092-2, 10.1053/sonc.2001.21965]
   TIRELLI U, 1995, J CLIN ONCOL, V13, P1758, DOI 10.1200/JCO.1995.13.7.1758
   Toni TD, 2002, AIDS, V16, P488, DOI 10.1097/00002030-200202150-00024
   Truong HHM, 2002, J ACQ IMMUN DEF SYND, V29, P232, DOI 10.1097/00042560-200203010-00003
   Tsang CSP, 1999, BRIT J DERMATOL, V141, P852, DOI 10.1046/j.1365-2133.1999.03158.x
   Tulpule A, 2000, J CLIN ONCOL, V18, P716, DOI 10.1200/JCO.2000.18.4.716
   *UNAIDS, 2004, REP GLOB AIDS EP 200
   VALENTINE C, 1992, LANCET, V340, P1542, DOI 10.1016/0140-6736(92)92791-D
   Von Roenn J H, 1998, Oncology (Williston Park), V12, P1
   Walling DM, 2003, J INFECT DIS, V188, P883, DOI 10.1086/378072
   Walling DM, 2001, J INFECT DIS, V184, P1499, DOI 10.1086/323992
   Wargon O, 1996, Australas J Dermatol, V37, P149, DOI 10.1111/j.1440-0960.1996.tb01035.x
   WHEELAND RG, 1985, J DERMATOL SURG ONC, V11, P1180, DOI 10.1111/j.1524-4725.1985.tb03092.x
   WILLIAMS DM, 1993, J ORAL PATHOL MED, V22, P289
   Williams FM, 1998, ARTHRITIS RHEUM-US, V41, P863, DOI 10.1002/1529-0131(199805)41:5&lt;863::AID-ART13&gt;3.0.CO;2-F
   Williams IG, 2003, INT J CLIN PRACT, V57, P890
   Wood R, 2002, ORAL DIS, V8, P32, DOI 10.1034/j.1601-0825.2002.00008.x
   Yarchoan R, 1999, J ACQ IMMUN DEF SYND, V21, pS66
   Younai FS, 2001, ORAL SURG ORAL MED O, V92, P629, DOI 10.1067/moe.2001.117816
NR 262
TC 27
Z9 32
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0904-2512
EI 1600-0714
J9 J ORAL PATHOL MED
JI J. Oral Pathol. Med.
PD OCT
PY 2005
VL 34
IS 9
BP 513
EP 531
DI 10.1111/j.1600-0714.2005.00337.x
PG 19
WC Dentistry, Oral Surgery & Medicine; Pathology
SC Dentistry, Oral Surgery & Medicine; Pathology
GA 960VQ
UT WOS:000231621700001
PM 16138890
DA 2020-11-30
ER

PT J
AU Leao, JC
   Goes, P
   Sobrinho, CB
   Porter, S
AF Leao, JC
   Goes, P
   Sobrinho, CB
   Porter, S
TI Knowledge and clinical expertise regarding oral cancer among Brazilian
   dentists
SO INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
DE oral cancer; general dental practitioner; attitudes; knowledge
ID PROFESSIONAL DIAGNOSTIC DELAYS; AERODIGESTIVE TRACT CARCINOMA;
   SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; PROGNOSIS
AB The aim of the present work was to assess the knowledge and attitudes of Brazilian General Dental Practitioners with regard to aspects of the aetiology, early diagnosis and prevention of oral cancer relevant for general dental practice. A convenience sample of 129 dentists in Brazil was randomly selected and asked to complete a questionnaire. Results of bi-variated analysis revealed that a self-perceived good knowledge regarding relevant aspects of oral cancer was statistically significantly associated with male gender (Chi square = 4.59, P < 0.05). Simple logistic regression revealed that male professionals were 2.9 times more knowledgeable than their female colleagues (OR = 2.9, 1.1-8.1 95% CI, P = 0.037), although, this association was not statistically significant when adjusted for age using multiple regression analysis (OR = 2.7, 0.9-7.5 95% CI, P = 0.059). There were no significant differences in relevant knowledge and attitudes of private compared with public dentists. Importantly, General Dental Practitioners who spent more than half of time of a patient's initial consultation undertaking a clinical examination were the more likely to detect oral cancer (Chi square = 4.245, P = 0.039) than those who set aside little time examining their patients. It is concluded that the knowledge of dentists in Brazil regarding relevant aspects of oral cancer is suboptimal, and may not e associated with any examined social-demographic variables. Further research is required to clarify the role of continuing professional education in improving the knowledge and attitudes of dentists relevant to oral cancer in Brazil.
C1 Univ Fed Pernambuco, Dept Clin & Odontol Prevent, BR-50670901 Recife, PE, Brazil.
   Univ London, Eastman Dent Inst Oral Hlth Care Sci, Div Maxillofacial Diagnost Med & Surg Sci, UCL, London, England.
   Univ Fed Pernambuco, Fac Odontol Pernambuco, Dept Odontol Prevent & Social, Recife, PE, Brazil.
RP Leao, JC (corresponding author), Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Av Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
EM jleao@ufpe.br
RI Porter, Stephen/B-3519-2009; Leao, Jair Carneiro/AAL-6154-2020
OI Leao, Jair Carneiro/0000-0001-8303-2291; Porter,
   Stephen/0000-0002-3328-2759
CR Allison P, 1998, ORAL ONCOL, V34, P127, DOI 10.1016/S1368-8375(97)00078-X
   Allison P, 1998, ORAL ONCOL, V34, P161, DOI 10.1016/S1368-8375(97)00071-7
   Allison P, 1998, ORAL ONCOL, V34, P147, DOI 10.1016/S1368-8375(97)00088-2
   Antunes JLF, 2001, ORAL ONCOL, V37, P345, DOI 10.1016/S1368-8375(00)00113-5
   Carvalho AL, 2004, HEAD NECK-J SCI SPEC, V26, P31, DOI 10.1002/hed.10354
   Clovis Joanne B, 2002, J Can Dent Assoc, V68, P415
   de Carvalho M B, 2001, Rev Assoc Med Bras (1992), V47, P208
   Greenwood M, 2003, INT J ORAL MAX SURG, V32, P74, DOI 10.1054/ijom.2002.0274
   Kerdpon D, 2001, ORAL ONCOL, V37, P216, DOI 10.1016/S1368-8375(00)00067-1
   Kumar RV, 2003, INT J ORAL MAX SURG, V32, P539, DOI 10.1054/ijom.2002.0407
   Macpherson LMD, 2003, BRIT DENT J, V195, P277, DOI 10.1038/sj.bdj.4810481
   Porter S, 2000, BRIT DENT J, V189, P238
   Zhang ZY, 2004, INT J ORAL MAX SURG, V33, P71, DOI 10.1054/ijom.2002.0443
NR 13
TC 12
Z9 13
U1 0
U2 2
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0901-5027
J9 INT J ORAL MAX SURG
JI Int. J. Oral Maxillofac. Surg.
PD JUN
PY 2005
VL 34
IS 4
BP 436
EP 439
DI 10.1016/j.ijom.2004.10.004
PG 4
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 930WZ
UT WOS:000229449100018
PM 16053856
DA 2020-11-30
ER

PT J
AU Leao, JC
   Batista, V
   Guimaraes, PB
   Belo, J
   Porter, SR
AF Leao, JC
   Batista, V
   Guimaraes, PB
   Belo, J
   Porter, SR
TI Cowden's syndrome affecting the mouth, gastrointestinal, and central
   nervous system: A case report and review of the literature
SO ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS
LA English
DT Review
ID MULTIPLE HAMARTOMA SYNDROME; HEREDITARY BREAST-CANCER; NEOPLASIA
   SYNDROME; DISEASE; LESIONS; DIAGNOSIS; GENE
AB Cowden's syndrome (CS) is a rare genodermatosis, of autosomal dominant inheritance and variable phenotype, principally characterized by the formation of hamartomas in various organs, including skin, thyroid, breast, brain, and gastrointestinal tract and by the increased risk for the development of malignancy. The present report details the features of a very rare presentation of Cowden's syndrome affecting not only the mouth and gastrointestinal mucosa but also the central nervous system.
C1 Univ Fed Pernambuco, Dept Clin & Odontol Prevent, BR-50670901 Recife, PE, Brazil.
   Univ London, UCL, Eastman Dent Inst Oral Hlth Care Sci, Div Maxillofacial Diagnost Med & Surg Sci, London, England.
   Univ Fed Pernambuco, Hosp Clin, Serv Dermatol, BR-50670901 Recife, PE, Brazil.
RP Leao, JC (corresponding author), Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Av Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
EM jleao@ufpe.br
RI Leao, Jair Carneiro/AAL-6154-2020
OI Leao, Jair Carneiro/0000-0001-8303-2291; Porter,
   Stephen/0000-0002-3328-2759
CR BAGAN JV, 1989, J ORAL MAXIL SURG, V47, P291, DOI 10.1016/0278-2391(89)90234-6
   BROWNSTEIN MH, 1978, CANCER, V41, P2393, DOI 10.1002/1097-0142(197806)41:6<2393::AID-CNCR2820410644>3.0.CO;2-K
   Chaudhry SI, 2000, ORAL DIS, V6, P248
   Cnudde F, 1996, ANN DERMATOL VENER, V123, P739
   Eng C, 2000, J MED GENET, V37, P828, DOI 10.1136/jmg.37.11.828
   Fackenthal JD, 2001, J MED GENET, V38, P159, DOI 10.1136/jmg.38.3.159
   Fistarol SK, 2002, EUR J DERMATOL, V12, P411
   Guruswamy S, 2001, JNCI-J NATL CANCER I, V93, P516, DOI 10.1093/jnci/93.7.516
   Hildenbrand C, 2001, DERMATOLOGY, V202, P362, DOI 10.1159/000051684
   Kato M, 2000, INTERNAL MED, V39, P559, DOI 10.2169/internalmedicine.39.559
   Kelly P, 2003, CANCER NURS, V26, P370, DOI 10.1097/00002820-200310000-00005
   LLOYD KM, 1963, ANN INTERN MED, V58, P136, DOI 10.7326/0003-4819-58-1-136
   MIGNOGNA MD, 1995, ORAL SURG ORAL MED O, V79, P295, DOI 10.1016/S1079-2104(05)80222-7
   Nelen MR, 1996, NAT GENET, V13, P114, DOI 10.1038/ng0596-114
   Porter S, 1996, ORAL SURG ORAL MED O, V82, P295, DOI 10.1016/S1079-2104(96)80355-6
   Sanson M, 1999, ACTA ONCOL, V38, P973, DOI 10.1080/028418699432699
   TAKENOSHITA Y, 1993, J ORAL MAXIL SURG, V51, P682, DOI 10.1016/S0278-2391(10)80270-8
   Thull DL, 2004, ONCOLOGIST, V9, P13, DOI 10.1634/theoncologist.9-1-13
   VINCHON M, 1994, J NEUROL NEUROSUR PS, V57, P699, DOI 10.1136/jnnp.57.6.699
   WEARY PE, 1972, ARCH DERMATOL, V106, P682, DOI 10.1001/archderm.106.5.682
   WILLIARD W, 1992, CANCER-AM CANCER SOC, V69, P2969, DOI 10.1002/1097-0142(19920615)69:12<2969::AID-CNCR2820691217>3.0.CO;2-2
NR 21
TC 14
Z9 14
U1 0
U2 0
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 1079-2104
J9 ORAL SURG ORAL MED O
JI Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.
PD MAY
PY 2005
VL 99
IS 5
BP 569
EP 572
DI 10.1016/j.tripleo.2004.08.032
PG 4
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 919ZA
UT WOS:000228655300011
PM 15829879
DA 2020-11-30
ER

PT J
AU Leao, JC
   Ferreira, AMC
   Bandeira, V
   Figueiroa, FV
   Porter, SR
AF Leao, JC
   Ferreira, AMC
   Bandeira, V
   Figueiroa, FV
   Porter, SR
TI Anhydrotic ectodermal dysplasia (Christ-Siemens-Touraine syndrome). A
   case report
SO INTERNATIONAL DENTAL JOURNAL
LA English
DT Article
DE ectodermal dysplasias; oral care
ID IMPLANT
AB The ectodermal dysplasias (EDs) are a complex group of diseases clinically characterised by congenital absence of ectodermally derived structures. The present report details the features of a 13 year old schoolboy with the rare anhydrotic ectodermal dysplasia (Christ-Siemens-Touraine syndrome).
C1 Univ Fed Pernambuco, Pos Grad Onontol, BR-50670901 Recife, PE, Brazil.
RP Leao, JC (corresponding author), Univ Fed Pernambuco, Pos Grad Onontol, Av Prof Moraes Rego,1235, BR-50670901 Recife, PE, Brazil.
EM jleao@ufpe.br
RI Leao, Jair Carneiro/AAL-6154-2020; Porter, Stephen/B-3519-2009
OI Leao, Jair Carneiro/0000-0001-8303-2291; Porter,
   Stephen/0000-0002-3328-2759
CR Bryant SR, 1998, INT J PROSTHODONT, V11, P470
   Cambiaghi S, 2000, ARCH DERMATOL, V136, P217, DOI 10.1001/archderm.136.2.217
   Daniel E, 2002, LARYNGOSCOPE, V112, P962, DOI 10.1097/00005537-200206000-00005
   Donahue JP, 1999, J AAPOS, V3, P372, DOI 10.1016/S1091-8531(99)70048-0
   Ezer S, 1999, HUM MOL GENET, V8, P2079, DOI 10.1093/hmg/8.11.2079
   Guckes Albert D., 1997, Pediatric Dentistry, V19, P282
   Hizli S, 1998, INT J DERMATOL, V37, P132
   Ho LL, 1998, AM J HUM GENET, V62, P1102, DOI 10.1086/301839
   Imirzalioglu P, 2002, J PROSTHET DENT, V88, P569, DOI 10.1067/mpr.2002.130146
   McGrath JA, 1999, BRIT J DERMATOL, V140, P297
   MOHLER DN, 1959, AM J MED, V27, P682, DOI 10.1016/0002-9343(59)90053-1
   Munoz F, 1997, AM J HUM GENET, V61, P94
   Nordgarden H, 1998, Oral Dis, V4, P152
   PINHEIRO M, 1994, AM J MED GENET, V53, P153, DOI 10.1002/ajmg.1320530207
   Priolo M, 2000, CLIN GENET, V58, P415, DOI 10.1034/j.1399-0004.2000.580601.x
   Richard G, 2002, AM J HUM GENET, V70, P1341, DOI 10.1086/339986
   SALISBURY DM, 1981, LANCET, V1, P153
   SMITH RA, 1993, ORAL SURG ORAL MED O, V75, P669, DOI 10.1016/0030-4220(93)90419-5
   THOMAS NST, 1993, HUM MOL GENET, V2, P1679, DOI 10.1093/hmg/2.10.1679
   Vierucci S, 1994, J Clin Pediatr Dent, V18, P291
   1999, CLIN EXP IMMUN S1, V118, P1
NR 21
TC 2
Z9 3
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-6539
EI 1875-595X
J9 INT DENT J
JI Int. Dent. J.
PD APR
PY 2005
VL 55
IS 2
BP 89
EP 92
PG 4
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 916VX
UT WOS:000228415800005
PM 15880963
DA 2020-11-30
ER

PT B
AU Leao, JC
   Affonso, CM
   Freitas, W
   da Silva, LCP
AF Leao, JC
   Affonso, CM
   Freitas, W
   da Silva, LCP
GP ieee
TI Impact of dynamic reactive power compensation on induction generator
   islanding detection
SO 2004 IEEE POWER ENGINEERING SOCIETY GENERAL MEETING, VOLS 1 AND 2
LA English
DT Proceedings Paper
CT IEEE-Power-Engineering-Society General Meeting
CY JUN 06-10, 2004
CL Denver, CO
DE DSTATCOM; induction generator; islanding detection; SVC; under/over
   voltage relays
AB This work presents an investigation about the impact of SVC (Static Var Compensator) and DSTATCOM (Distribution Static Synchronous Compensator) devices on induction generator islanding detection. Simulation results show that these devices can become more difficult the successful islanding detection of induction generators based on under/over voltage relays.
C1 State Campinas, Dept Elect Energy Syst, Campinas, SP, Brazil.
RP Leao, JC (corresponding author), State Campinas, Dept Elect Energy Syst, Campinas, SP, Brazil.
EM jleao@fee.unicamp.br; cartolina@dsce.fee.uriicamp.br;
   walmir@dsee.fee.unicamp.br; lui@dsce.fee.unicamp.br
RI da silva, luiz carlos/H-3866-2012; Freitas, Walmir/A-2516-2008; Affonso,
   Carolina/AAU-8591-2020
OI Freitas, Walmir/0000-0002-2042-6741; Affonso,
   Carolina/0000-0002-7284-7679
CR Acha E., 2002, POWER ELECT CONTROL
   Akhmatov V, 2003, INT J ELEC POWER, V25, P123, DOI 10.1016/S0142-0615(02)00017-0
   [Anonymous], 1999, 3723 CIGRE WORK GROU
   BELHOMME R, 1995, IEEE T POWER DELIVER, V10, P1677, DOI 10.1109/61.400956
   Jenkins N., 2000, EMBEDDED GENERATION
   Kundur P., 1994, POWER SYSTEM STABILI
   MCQUIN NP, 1989, IEE CONF PUBL, V310, P251
NR 7
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8465-2
PY 2004
BP 810
EP 813
PG 4
WC Engineering, Electrical & Electronic
SC Engineering
GA BBK17
UT WOS:000225860300196
DA 2020-11-30
ER

PT J
AU Leao, JC
   Kumar, N
   McLean, KA
   Porter, SR
   Scully, CM
   Swan, AV
   Teo, CG
AF Leao, JC
   Kumar, N
   McLean, KA
   Porter, SR
   Scully, CM
   Swan, AV
   Teo, CG
TI Effect of human immunodeficiency virus-1 protease inhibitors on the
   clearance of human herpesvirus 8 from blood of human immunodeficiency
   virus-1-infected patients
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE protease inhibitors; antiviral chemotherapy; human herpesvirus 8; human
   immunodeficiency virus; Kaposi's sarcoma
ID SARCOMA-ASSOCIATED HERPESVIRUS; ACTIVE ANTIRETROVIRAL THERAPY;
   MULTICENTRIC CASTLEMANS-DISEASE; KAPOSIS-SARCOMA; PERIPHERAL-BLOOD;
   HIV-1 PROTEASE; DNA-SEQUENCES; HUMAN-HERPESVIRUS-8; AIDS; REGRESSION
AB The effect of human immunodeficiency virus-1 protease inhibitors on the frequency of human herpesvirus 8 DNA detection from peripheral blood of human immunodeficiency virus-positive persons was evaluated. Thirty-three human immunodeficiency virus-seropositive male patients were studied longitudinally. DNA from open reading frame 26 of the human herpesvirus 8 genome was amplified by the polymerase chain reaction from the CD45+ fraction of peripheral blood before and after the introduction of protease inhibitor therapy. Human herpesvirus 8 IgG status, CD4+ cell counts, and human immunodeficiency virus-1 plasma viral load were also assessed before and after therapy. When both reverse transcriptase inhibitor and protease inhibitor treatment were introduced at the same time, there was an increase in CD4+ T cell counts (P=0.0041), a decrease in human immunodeficiency virus plasma load (P=0.0584), and a decrease in the detection rate of human herpesvirus 8 DNA (P=0.0077). Introducing protease inhibitor to patients already receiving reverse transcriptase inhibitor treatment was associated with an increase in CD4+ T cell counts (P=0.0003), a decrease in human immunodeficiency virus plasma viral load (P=0.0911), and a decrease in the human herpesvirus 8 detection rate (P=0.0412). No significant changes in the titters of anti-human herpesvirus 8 IgG were observed. Treatment with human immunodeficiency virus-1 protease inhibitors is therefore associated with the clearance of human herpesvirus 8 DNA from peripheral blood of human immunodeficiency virus-infected patients. The concomitant decrease in the human immunodeficiency virus plasma load and increase in the peripheral CD4+ cell count suggest that an amelioration in the immune defect following reduction in the burden of human immunodeficiency virus-1 infection is responsible for the clearance of human herpesvirus 8 by protease inhibitors. J. Med. Virol. 62:416-420, 2000. (C) 2000 Wiley-Liss, Inc.
C1 Cent Publ Hlth Lab, PHLS, Hepatitis & Retrovirus Lab, London NW9 5HT, England.
   Univ Fed Pernambuco, Dept Clin & Odontol Prevent, Recife, PE, Brazil.
   Univ London, Eastman Dent Inst Oral Hlth Care Sci, Dept Oral Med, London, England.
   Charing Cross Hosp, Dept Genitourinary Med, London, England.
   PHLS Stat Unit, London, England.
RP Teo, CG (corresponding author), Cent Publ Hlth Lab, PHLS, Hepatitis & Retrovirus Lab, 61 Colindale Ave, London NW9 5HT, England.
OI Porter, Stephen/0000-0002-3328-2759
FU NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Dental & Craniofacial Research (NIDCR)
   [R01DE012176, R01DE012176, R01DE012176] Funding Source: NIH RePORTER;
   NIDCR NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Dental &
   Craniofacial Research (NIDCR) [R01DE12176] Funding Source: Medline
CR Aboulafia DM, 1998, MAYO CLIN PROC, V73, P439
   Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112
   Blum L, 1997, AIDS, V11, P1653
   Burdick AE, 1997, J AM ACAD DERMATOL, V37, P648, DOI 10.1016/S0190-9622(97)70188-9
   CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802
   De Milito A, 1999, J MED VIROL, V57, P140, DOI 10.1002/(SICI)1096-9071(199902)57:2&lt;140::AID-JMV9&gt;3.0.CO;2-Y
   DiAlberti L, 1997, LANCET, V350, P1655, DOI 10.1016/S0140-6736(97)10102-7
   Dupin N, 1997, AIDS, V11, P1400
   GILES RE, 1998, MDA9842, P1
   Hammoud Z, 1998, CLIN INFECT DIS, V26, P1233, DOI 10.1086/598351
   Harrington W, 1997, LANCET, V349, P774
   Kedes DH, 1997, J CLIN INVEST, V99, P2082, DOI 10.1172/JCI119380
   Lebbe C, 1998, AIDS, V12, pF45, DOI 10.1097/00002030-199807000-00002
   Li TS, 1998, LANCET, V351, P1682, DOI 10.1016/S0140-6736(97)10291-4
   Martinelli C, 1998, AIDS, V12, P1717
   Medveczky MM, 1997, AIDS, V11, P1327, DOI 10.1097/00002030-199711000-00006
   MONTAGNINO G, 1994, AM J NEPHROL, V14, P121, DOI 10.1159/000168700
   Moore PS, 1996, AIDS, V10, P175, DOI 10.1097/00002030-199602000-00007
   Murphy M, 1997, AIDS, V11, P261
   NAVIA MA, 1989, NATURE, V337, P615, DOI 10.1038/337615a0
   Neyts J, 1997, ANTIMICROB AGENTS CH, V41, P2754, DOI 10.1128/AAC.41.12.2754
   Notermans DW, 1998, AIDS, V12, P167, DOI 10.1097/00002030-199802000-00006
   Pialoux G, 1998, NEW ENGL J MED, V339, P1269, DOI 10.1056/NEJM199810293391802
   Rizzieri DA, 1997, LANCET, V349, P775, DOI 10.1016/S0140-6736(05)60200-0
   Shaw AJ, 1999, INT J STD AIDS, V10, P417, DOI 10.1258/0956462991914249
   SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276
   Spina M, 1998, AIDS, V12, P955
   Staskus KA, 1999, J VIROL, V73, P4181, DOI 10.1128/JVI.73.5.4181-4187.1999
   Unal A, 1997, J VIROL, V71, P7030, DOI 10.1128/JVI.71.9.7030-7038.1997
   WLODAWER A, 1989, SCIENCE, V245, P616, DOI 10.1126/science.2548279
NR 30
TC 19
Z9 21
U1 0
U2 1
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0146-6615
J9 J MED VIROL
JI J. Med. Virol.
PD DEC
PY 2000
VL 62
IS 4
BP 416
EP 420
DI 10.1002/1096-9071(200012)62:4<416::AID-JMV4>3.0.CO;2-Z
PG 5
WC Virology
SC Virology
GA 369PX
UT WOS:000165077100004
PM 11074468
DA 2020-11-30
ER

PT J
AU Bez, C
   Leao, JC
   Porter, SR
   Teo, CG
   Scully, C
AF Bez, C
   Leao, JC
   Porter, SR
   Teo, CG
   Scully, C
TI Lack of association between HHV8 antibodies and Recurrent Aphthous
   Stomatitis
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Meeting Abstract
C1 Cent Publ Hlth Lab Serv, Div Virus Reference, London, England.
   Univ London, Dept Oral Med, Eastman Dent Inst, London, England.
OI Porter, Stephen/0000-0002-3328-2759
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC DENTAL RESEARCH
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD MAY
PY 1999
VL 78
IS 5
BP 1082
EP 1082
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 196PK
UT WOS:000080316601129
DA 2020-11-30
ER

PT J
AU Triantos, D
   Boulter, AW
   Leao, JC
   Di Alberti, L
   Porter, SR
   Scully, CM
   Birnbaum, W
   Johnson, NW
   Teo, CG
AF Triantos, D
   Boulter, AW
   Leao, JC
   Di Alberti, L
   Porter, SR
   Scully, CM
   Birnbaum, W
   Johnson, NW
   Teo, CG
TI Diversity of naturally occurring Epstein-Barr virus revealed by
   nucleotide sequence polymorphism in hypervariable domains in the BamHI K
   and N subgenomic regions
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
ID POLYMERASE CHAIN-REACTION; LYMPHOID-CELL LINES; NUCLEAR ANTIGEN;
   PERIPHERAL-BLOOD; TISSUE DISTRIBUTION; BNLF-1 GENE; CARRIERS; STRAINS;
   IDENTIFICATION; RESTRICTION
AB The extent of nucleotide sequence microheterogeneity varies among subgenomic: regions of Epstein-Barr virus (EBV), We examined, in EBV-carrying lymphoid cell lines, the extent of polymorphism in EBV DNA fragments amplified from the BamHI E, K, N and Z regions, and then investigated the diversity of the more hypervariable regions in tissues and body fluids, In cell lines, sequence dissimilarities in a genotype-specifying fragment of the EBNA-3C gene varied from < 1-4 % within each genotype; dissimilarities in the first intron of the BZLF-1 gene were < 2% within each genotype, By contrast, dissimilarities in a C-terminal unique domain of the EBNA-1 gene, and in a fragment that encompasses and is upstream of the LMP-1 start codon, varied between 2 and 7% and were not genotype-specific, The sequence diversity in BamHI K and N regions was then examined in tissues and body fluids by single-strand conformation polymorphism (SSCP) analysis and cycle sequencing. Extensive inter-host diversity was observed, whether the host was co-infected by human immunodeficiency virus (HIV) or not. In the oral cavity of HIV-infected patients, inter-compartmental EBV diversity could be demonstrated, even between sites that were anatomically proximate. Studies of BamHI K clones derived from EBV in oral lesions revealed infection by multiple variants, Identification of hypermutable loci within the EBV genome such as those located in the BamHI K and N regions should permit fine discrimination of individual EBV variants.
C1 Cent Publ Hlth Lab, Div Virus Reference, London NW9 5HT, England.
   Univ London, Dept Oral Med, Eastman Dent Inst Oral Hlth Care Sci, London WC1X 8LD, England.
RP Teo, CG (corresponding author), Cent Publ Hlth Lab, Div Virus Reference, 61 Colindale Ave, London NW9 5HT, England.
EM BPurohit@PHLS.co.uk
RI Johnson, Newell W/D-8152-2019
OI Johnson, Newell W/0000-0001-5866-262X; Porter,
   Stephen/0000-0002-3328-2759
CR AITKEN C, 1994, J GEN VIROL, V75, P95, DOI 10.1099/0022-1317-75-1-95
   Alfieri C, 1996, BLOOD, V87, P812, DOI 10.1182/blood.V87.2.812.bloodjournal872812
   ANDERSSON M, 1976, VIROLOGY, V73, P96, DOI 10.1016/0042-6822(76)90064-7
   APOLLONI A, 1994, VIROLOGY, V202, P978, DOI 10.1006/viro.1994.1422
   Bhatia K, 1996, ONCOGENE, V13, P177
   BUISSON M, 1994, J GEN VIROL, V75, P431, DOI 10.1099/0022-1317-75-2-431
   BUSSON P, 1995, J GEN VIROL, V76, P139, DOI 10.1099/0022-1317-76-1-139
   CEN H, 1991, J VIROL, V65, P976, DOI 10.1128/JVI.65.2.976-980.1991
   Chen HL, 1996, J VIROL, V70, P7301, DOI 10.1128/JVI.70.10.7301-7305.1996
   FALK K, 1995, J GEN VIROL, V76, P779, DOI 10.1099/0022-1317-76-4-779
   Falk KI, 1997, J MED VIROL, V51, P355, DOI 10.1002/(SICI)1096-9071(199704)51:4&lt;355::AID-JMV15&gt;3.0.CO;2-H
   GRATAMA JW, 1994, J GEN VIROL, V75, P85, DOI 10.1099/0022-1317-75-1-85
   Gratama JW, 1995, ADV CANCER RES, V67, P197, DOI 10.1016/S0065-230X(08)60714-9
   Gutierrez MI, 1997, J GEN VIROL, V78, P1663, DOI 10.1099/0022-1317-78-7-1663
   HU LF, 1991, J GEN VIROL, V72, P2399, DOI 10.1099/0022-1317-72-10-2399
   Jenkins PJ, 1996, SEMIN CANCER BIOL, V7, P209, DOI 10.1006/scbi.1996.0028
   LIN JC, 1993, BLOOD, V81, P3372
   LUNG ML, 1990, VIROLOGY, V177, P44, DOI 10.1016/0042-6822(90)90458-4
   LUNG ML, 1988, J VIROL, V62, P3862, DOI 10.1128/JVI.62.10.3862-3866.1988
   LUNG ML, 1991, J INFECT DIS, V64, P213
   Menin C, 1996, MOL CELL PROBE, V10, P453, DOI 10.1006/mcpr.1996.0062
   MILLER WE, 1994, J GEN VIROL, V75, P2729, DOI 10.1099/0022-1317-75-10-2729
   OCHERT AS, 1994, PCR METH APPL, V3, P365
   OOSTERVEER MAP, 1993, J MED VIROL, V41, P261, DOI 10.1002/jmv.1890410402
   PACKHAM G, 1993, VIROLOGY, V192, P541, DOI 10.1006/viro.1993.1070
   Palefsky JM, 1996, J INFECT DIS, V173, P710, DOI 10.1093/infdis/173.3.710
   RICKINSON AB, 1987, J VIROL, V61, P1310, DOI 10.1128/JVI.61.5.1310-1317.1987
   Rickinson AB, 1996, FIELDS VIROLOGY, P2397
   RYMO L, 1981, VIROLOGY, V115, P115, DOI 10.1016/0042-6822(81)90093-3
   SAMPLE J, 1990, J VIROL, V64, P4084, DOI 10.1128/JVI.64.9.4084-4092.1990
   SANDVEJ K, 1994, BLOOD, V84, P4053, DOI 10.1182/blood.V84.12.4053.bloodjournal84124053
   SIXBEY JW, 1989, LANCET, V2, P761
   SIXBEY JW, 1991, J INFECT DIS, V163, P1008, DOI 10.1093/infdis/163.5.1008
   SMITH DB, 1987, J GEN VIROL, V68, P2729, DOI 10.1099/0022-1317-68-11-2729
   SNUDDEN DK, 1995, ONCOGENE, V10, P1545
   WRIGHTHAM MN, 1995, VIROLOGY, V208, P521, DOI 10.1006/viro.1995.1183
   YAO QY, 1991, J GEN VIROL, V72, P1579, DOI 10.1099/0022-1317-72-7-1579
   Yao QY, 1996, J VIROL, V70, P4884, DOI 10.1128/JVI.70.8.4884-4894.1996
NR 38
TC 13
Z9 14
U1 0
U2 1
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD NOV
PY 1998
VL 79
BP 2809
EP 2817
DI 10.1099/0022-1317-79-11-2809
PN 11
PG 9
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA 133VE
UT WOS:000076706600028
PM 9820158
OA Bronze
DA 2020-11-30
ER

EF